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Abstract
Asymmetric synthesis on polymer support remains a relatively underdeveloped area of organic 
chemistry. Recently, interest has grown in the development of polymer-supported chiral auxiliaries 
and a review of the literature in this area demonstrates that efficient asymmetric synthesis using a 
polymer-supported chiral auxiliary is possible. However, in most cases, there are issues associated 
with the transfer of solution phase techniques to solid supported systems and reaction conditions 
need to be re-optimised.
This study aimed to develop an efficient and versatile polymer-supported chiral auxiliary based on 
the Evans oxazolidin-2-one. Phenolic oxazolidin-2-one fragment 1 was immobilised onto 2- 
chlorotrityl-chloride resin; the latter being selected as a development resin due to its orthogonal 
cleavage properties. Preliminary studies developed techniques to effect cleavage of the solid- 
supported species at various sites to enable solution phase characterisation of solid-phase 
intermediates, and thus facilitate optimisation of the solid-phase asymmetric reaction.
2-CI-Trt supported oxazolidin-2-one 2 was firstly applied to an asymmetric enolate alkylation 
reaction. It was found that the reaction had conflicting temperature and time requirements for 
enolate reactivity versus enolate decomposition. In addition, it was discovered that the use of 
excess base could cause epimerisation of the newly formed stereocentre of the a-alkylated product, 
although this issue could be avoided by a slight alteration to the reaction conditions. The optimised 
conditions allowed an array of a-alkylated acids to be prepared in good yields and excellent 
enantioselectivity. In addition, it was shown that the resin could be recycled up to three times with 
no loss in stereoselectivity and only slight loss in yield.
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Scheme i): Optimised reaction conditions for the asymmetric enolate alkylation reaction of the enolates of 
polymer-supported N-acyl-oxazolidin-2-ones.
Attempts to develop a Merrifield resin supported version of this auxiliary were less successful, as 
the alteration to the solid support caused a marked decrease in the levels of diastereoselectivity 
achieved in the subsequent asymmetric reaction. Preliminary investigations into 2-CI-Trt supported 
SuperQuat auxiliaries suggested they too could achieve high levels of diastereoselectivity in 
polymer-supported asymmetric enolate alkylation reactions and due to their superior cleavage 
profile compared to Evans-oxazolidin-2-ones, could in some cases offer advantages over the latter.
Finally, early investigations into new strategies for the use of Evans oxazolidin-2-one type 
auxiliaries, both in solid and solution phase were conducted. The stereodefined hydroxyl group of 
an Evans-oxazolidin-2-one aldol product was used to direct a second asymmetric reaction, thus the 
oxazolidin-2-one fragment indirectly induced chirality at a site remote to its normal area of influence. 
This strategy was demonstrated in the solution phase synthesis of a cyclopropane-containing 
natural product Grenadamide and the key directed cyclopropanation reaction was also 
demonstrated on a solid supported aldol product, prepared via a solid-phase aldol reaction.
Scheme ii): Retrosynthesis of Grenadamide.
A similar strategy employed a directed epoxidation reaction on polymer-supported allylic alcohols 
(again prepared via oxazolidin-2-one-mediated aldol reactions, which resulted in the formation of 
chiral y-lactones in high de via an epoxidation / intramolecular cyclisation mechanism. Again, 
preliminary experiments into the analogous solid phase reaction gave promising results.
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1.1 Introduction
There are only three fundamentally different methods for preparing enantiomerically pure 
compounds: resolution, use o f enantiopure starting materials available from the pool o f  
chiral natural products and the use o f asymmetric transformations.1
Resolution involves the separation o f a racemic mixture o f two enantiomers and can be 
achieved via a number o f methods including formation o f diastereomers, enzymatic 
resolution and kinetic resolution. Each of these techniques suffers an inherent drawback in 
that the maximum possible yield o f any one enantiomer is just 50%, however the fact that 
often both enantiomers can be isolated can be a significant advantage. Dynamic kinetic 
resolution, which combines a kinetic resolution o f two enantiomers with an in situ 
racemisation o f the unwanted enantiomer, can (in principle) afford the desired enantiomer 
in 100% ee and 100% yield (for example, see scheme 1.1a).
1
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Scheme 1.1a: First published example o f chemical dynamic kinetic resolution by Noyori et al.2 Syn-aldols 
form ed in excellent yield and de.
The use of chiral pool starting materials such as amino acids, terpenes and steroids (see Fig. 
1.1a.) can be a reliable method of introducing asymmetry into a system. However, obvious 
limitations include the existence and availability of the correct enantiomer of a suitable 
starting material whilst extensive modifications to remove or introduce functional groups 
can significantly lengthen synthetic protocols.
o
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Fig 1.1a: (S)-alanine, (S)-limonene and testosterone: an amino acid, a terpene and a steroid respectively.
Asymmetric transformations involve the introduction of asymmetry into a prochiral system. 
This is achieved by incorporating a chiral component into a reagent/catalyst or into the 
substrate itself and then using this chirality to induce asymmetry in a subsequent chemical 
reaction. This results in diastereomeric transition states of differing energy, which can 
allow one enantiomer to be formed preferentially. This approach represents a more 
versatile option than the use of chiral pool starting materials and also has the potential to 
form a single enantiomer in 100% yield.
Asymmetric transformations can be divided into three categories, involving the use of 
chiral reagents, chiral catalysts or chiral auxiliaries. Chiral reagents and chiral catalysts
2
can transform prochiral substrates to produce single enantiomers of chiral products with 
excellent levels of enantioselectivity. It is often suggested that chiral catalysts hold an 
advantage over chiral reagents as the former can be used in sub-stoichiometric quantities as 
they are regenerated in the reaction cycle, affording them the potential to be recycled (as 
demonstrated by example in Scheme 1.1b). Chiral reagents on the other hand, require the 
use of stoichiometric quantities and are generally consumed in the reaction.
Catalyst
reuse No Time (h)
Conversion
'BuOK
P rO H -D M F
Scheme 1.1b: Asymmetric reduction o f  conjugated ketone with polystyrene (ps)-supported BINAP catalyst 3 
as reported by Noyori et a l}  Catalyst 3 could be recycled at least 11 times with no loss in selectivity, however 
increasingly longer reaction times were required to achieve high conversions.
The use of chiral auxiliaries represents a different strategy, with the source of chirality 
being reversibly incorporated into the substrate itself. A chiral auxiliary (CA) is an 
enantiomerically pure compound that is temporarily attached to a prochiral substrate (S) in 
order to exert stereocontrol in a subsequent reaction with achiral reagents. Following the 
asymmetric reaction, the chiral auxiliary is removed from the product (CA-P), leaving an 
enantiomeric product (P) and recovering the chiral auxiliary (CA), see Fig. 1.1b. Again, 
excellent levels o f stereoselectivity can be achieved.
CA C o u p le  to g e th e r CA-S
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S e p a r a te  d ia s te r e o m e r s
if n e c e s s a r y  CA-P
R e m o v e  CA from  C A -P
Fig 1.1b: General chiral auxiliary strategy where CA = chiral auxiliary, S = substrate, P = product.
3
In such asymmetric reactions, the ability to recycle stoichiometric amounts o f the chiral 
auxiliary fragment is crucial to the cost-effectiveness o f the system; however in practice, its 
efficient recovery and reuse is often difficult to achieve. It is perhaps for this reason that a 
renewed interest in developing solid-phase asymmetric reactions has emerged over the last 
15 years. As well as the significant benefit o f facile recovery and recycling o f the auxiliary, 
other advantages o f solid phase reactions apply. These include purification being achieved 
by simple filtrations and the use o f excess reagents to be drive reactions to completion. It 
has also been proposed that the microenvironment o f the polymeric support may potentially 
lead to increased levels o f stereoselectivity in the asymmetric reaction.3,4
Consequently, extensive work has been undertaken towards the development o f solid- 
supported chiral auxiliaries and many successful systems have been identified. 
Comprehensive reviews exist covering all aspects o f solid-supported asymmetric synthesis, 
including the use o f polymer-bound chiral ligands with metal centres,5 polymer-supported 
chiral organic catalysts 6 and polymer-supported chiral auxiliaries.7 As in solution phase, a 
successful polymer-supported chiral auxiliary suffers some disadvantages when compared 
to a successful polymer-supported catalytic system. For example, stoichiometric quantities 
o f chiral auxiliaries are required whereas catalysts are generally employed in sub- 
stoichiometric amounts. Additionally, the use o f a chiral auxiliary necessarily adds another 
two steps to the reaction sequence during addition and removal o f the auxiliary fragment. 
However, catalysts, both in solution and solid-phase have often been found to be highly 
substrate and reaction specific resulting in reaction failure or loss o f stereocontrol. Chiral 
auxiliaries on the other hand, often demonstrate a greater degree o f versatility, with high 
tolerances for different substrates and the ability to be applied to several different types o f  
asymmetric reaction. For this reason, it was decided to focus the following literature 
review, and the subsequent research work on polymer-supported chiral auxiliaries. It should 
be noted that this literature review is by no means exhaustive but aims to highlight some of 
the more interesting results achieved in recent years, focussing on the accessibility o f the 
methodology to a non-specialist organic chemist and the effect o f  the solid support upon the 
reaction. In the vast majority o f cases, the chiral auxiliary (or an immediate precursor) is 
prepared in solution phase and attached to the polymer support as a final synthetic step. In
4
the interests of brevity, full details of the synthesis o f the chiral auxiliaries before their 
attachment to polymer support are not included in this review.
1.2 Early examples of polymer-supported chiral auxiliaries
In 1972, Kawana et al. reported the first example of a polymer-supported chiral auxiliary in
8  3asymmetric synthesis, with additional examples provided in a subsequent report in 1974. 
In this work, both D- and L-l,2-0-cyclohexylidene-a-xylofuranose were used as chiral 
auxiliaries in the asymmetric synthesis o f a-hydroxy acids (see Scheme 1.2a, D-form 
shown). The auxiliary fragments, prepared in 2 steps from D- and L-xylose respectively, 
were immobilised onto trityl resin in 73 - 87% yield via their primary hydroxyl group. 
Esterification of immobilised auxiliary 4 with either benzoylformic acid or pyruvic acid 
afforded a-ketoesters 5 which were then treated with a Grignard reagent. After hydrolysis 
of the resulting product, a range of a-hydroxy acids were obtained in yields of 18-84% and 
ee’s o f  36-65%. The authors reported that in many cases, these results were superior to 
those gained in the analogous solution phase reaction. Importantly, it was also reported that 
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Scheme 1.2a: The first example o f  a polymer-supported chiral auxiliary to produce chiral a-hydroxy acids as 
reported by Kawana et al.
A second, successful system was reported by Leznoff et al. in 1979, this time employing a 
polymer-supported alaninol derived auxiliary in the asymmetric a-alkyation of imines of 
cyclohexanone.9 The polymer-bound auxiliary 6 was readily prepared in just three steps by 
attachment of A-phthalimide protected L-alaninol to Merrifield resin under basic conditions
5
and subsequent A-deprotection. In this case, the resulting resin was treated with tri-/i-butyl- 
tin hydride to remove any un-reacted chlorobenzyl groups present that might interfere with 
the subsequent alkylation reaction. Attachment of the cyclohexanone substrate as its imine 
7 was followed by deprotonation with LDA (at 0 °C), quenching o f the enolate at room 
temperature with an electrophile and finally acidic hydrolysis, to afford a-alkyated 
cyclohexanone 8 in 80% yield and 60 -  95% ee (see Scheme 1.2b). Again, it was found 
that the resin-bound auxiliary could be reused in subsequent reaction cycles with little loss 
o f stereoselectivity, although the yields of a-alkylated cyclohexanone produced did 
decrease.
a °h 3c ,  h 3q . 2 ) r ° iA  h 3Q.NHa ---- ► \J~\ 'f~\    \J~\ >_N
M errifield 0  /  Merrifield /  \  M errifield 0  /  \  R = M e, Pr
R
Yield  = 8 0  %  
e e  -  6 0  - 9 5  %
8
Scheme 1.2b: Polymer-supported (L)-alaninol auxiliary 6 fo r  the preparation o f chiral a-alkyated
cyclohexanones 8.
However, a third early report describing the immobilisation of the established solution 
phase oxazoline chiral auxiliary onto polymer-support proved to be less successful. 
McManus et al. attached a chiral oxazoline to Merrifield resin and alkylated its enolate at 
its a-position using benzyl chloride (see Scheme 1.2c).10 However, attempts to hydrolyse 
product 9 to form a-benzylated ethyl ester 10 employing the standard solution phase 
method (H2SO4 in EtOH / THF) were unsatisfactory affording only low yields o f 10. 
Unfortunately, the use of harsher acidic cleavage conditions also resulted in cleavage o f the 
auxiliary fragment from the polymer support. With incomplete cleavage occurring, not 
only were yields of product low in that cycle, but the recycling of the resin was effectively 
prevented. Therefore, although the oxazoline ring could be re-formed on polymer support, 
the presence of some un-hydrolysed products from the previous cycles lead to reduced
6
yields and contamination of the product. Additionally, the optical purity of the product {ee 
= 56%) was much lower than that reported for the analogous solution phase reaction.
Merrifield
Scheme 1.2c: Application o f  a polymer-supported oxazoline auxiliary by McManus et al.
These early results clearly showed that asymmetric synthesis on solid support and recycling 
of the polymer-bound auxiliary was possible. However, the problems encountered by 
M cM anus demonstrate that solution phase reaction conditions are not necessarily 
applicable to solid phase systems.
1.3 Recent examples of polymer-supported chiral auxiliaries
After these early accounts, there was a lull in further investigations into this field, until the 
early 1990s when several different types o f immobilised auxiliaries were developed and 
applied to a variety of different reactions. A selection of these applications are described 
below, organised according to the nature of the polymer-bound auxiliary used for 
asymmetric synthesis.
1.3.1 Alcohol and carbohydrate-based auxiliaries
Kunz et al. reported an asymmetric Ugi four-component condensation involving chiral O- 
pivaloylated-galactosylamine 11 as achiral auxiliary and ‘asymmetric am m onia’ equivalent 
(see Scheme 1.3.1a) .11 In order to synthesise the functionalised resin, O-pivaloylated- 
galactosylazide was attached to Wang resin via a tetramethylazelaic acid spacer and then 
reduced to its amine. It was found that shorter linkers resulted in sluggish Ugi reactions. A 
series of stereoselective Ugi four-component condensations, performed with five 
equivalents of aldehyde, isonitrile and formic acid under Lewis acid conditions led to the
o
H2S 0 4, EtOHi) n-BuLi
ii) BnCI G
MerrifieldM errifield
Y ield  =  4 3 - 4 8  %  
e e  = 5 6  %
7
formation of polymer-bound glycine amides 12. However, due to the acid lability of the 
Wang resin support, it was not possible to cleave the enantiomeric products from the resin 
directly. Instead the entire auxiliary fragment was removed via treatment with TFA and the 
yields (20-59% ) and des (71-88% ) of the diastereomeric products 13 determined. After 
purification, 13 was treated with hydrochloric acid in methanol to afford enantiomerically 
pure a-am ino amides 14. Subsequent application of the Ugi reaction conditions to a 
hydroxymethyl polystyrene-supported auxiliary resulted in a more stable ester linkage and 
allowed the direct cleavage of amides from solid support in similar stereoselectivities but 
reduced yields (30-33%).
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Scheme 1.3.1a: Asymmetric Ugi four component condensation employing a polymer-supported chiral O- 
pivaloylated-galactosylamine-derived chiral auxiliary, as reported by Kunz and co-workers.
Calmes and co-workers have reported the use of a polymer-supported pantolactone-based 
auxiliary for stereoselective reactions with prochiral ketenes ’ and later in Diels Alder 
cycloadditions.14
Synthesis of the auxiliary fragment 15 from pantolactone was lengthy, involving eight 
synthetic steps. The synthesis was initially achiral with the two enantiomers being 
separated via conversion to their (S)-camphoric esters, column chromatography o f the 
resulting diastereomers and separate saponification of each compound. The overall yield of 
15 was not given. After immobilisation of the carboxylate group of 15 onto Rink Amide 
resin 16, the resultant polymer-supported auxiliary 17 was treated with ketene (pre-formed 
by treatment of the corresponding acid chloride with triethyl amine) under basic conditions
to form polymer-supported chiral ester 18 (see Scheme 1.3.1b).12 The judicious use of 
Rink amide resin enabled ester 18 to undergo orthogonal cleavage at two different sites. 
Acidic cleavage of the benzhydrylamine bond cleaved the entire auxiliary-substrate 
fragment 19 and allowed determination of the de of the chiral product. The option to cleave 
the product as the diastereomer also enabled purification or enrichment of the chiral 
product if moderate levels of stereocontrol were observed. Alternatively, basic hydrolysis 
afforded the desired chiral propionic fragment 20. Although excellent diastereoselectivity 
in the asymmetric protonation reaction was observed (98 -  99% de), it was found that the 
basic hydrolysis step caused racemisation o f the newly formed stereogenic centre and hence 
reduced the ee of the resulting chiral propionic acids 20, in some cases affording racemic 
mixtures. Recycling of polymer-supported auxiliary 17, easily recovered after 
saponification of 18, and its use in a second asymmetric reaction afforded 20 in acceptable 
yield (70%) but good ee (84%), representing a slight decrease compared to the first cycle.
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Scheme 1.3.1b: Application o f a solid-supported pantolactone-derived chiral auxiliary 17 in an asymmetric 
reaction with a prochiral ketene, as reported by Calmes et al.
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Polymer-supported chiral auxiliary 17 was also applied to the asymmetric synthesis of p2- 
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Scheme 1.3.1c: Asymmetric synthesis o f ff-homoarylglycines 21, as reported by Calmes et al.
Calmes et al. have also reported the application of a structurally related auxiliary to 
asymmetric Diels Alder reactions (see Scheme 1.3.Id ).14 The second generation auxiliary 
incorporated an additional phenyl spacer unit with acrylate derivative 22a being found to 
react with 2,3-dimethylbutadiene, cyclopentadiene and 1,3-cyclohexadiene in good yield 
and selectivity to afford 23, 24 and 25 respectively after basic hydrolysis. In the Diels 
Alder reaction of 22a with the less reactive diene isoprene, cycloadduct 26 was formed in a 
poor 40% ee. However, for the same reaction, the use of an alternative auxiliary 22b which 
included an additional alkyl chain spacer resulted in an increase in the ee of acid 26 to 70%, 
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Scheme 1.3.Id: The use o f a polymer-supported pantolactone-derived auxiliary in asymmetric Diels Alder 
reactions, as described by Calmes et al.
1.3.2 Amine and hydrazine derived auxiliaries
Schore and co-workers reported the use of a proline-derived solid-supported chiral 
auxiliary and its application in the synthesis of chiral 3,5-disubstituted-y-butyrolactones in a 
three step process involving N-acylation, C-a-alkylation and iodocyclisation (see Scheme 
1.3.2a, i).15 Pentamide 27 (prepared in one step from L-prolinol and propionyl chloride) 
was immobilised onto Merrifield resin and the resulting resin 28 treated with LDA and allyl 
iodide to effect a-allylation of the resin-bound amide. The product o f this reaction could 
not be monitored directly, but treatment with iodine afforded a mixture of the four possible 
a-substituted-y-butyrolactones 29 in 33% yield, with the predominant product 29a achieved 
in 32% ee. This result was reported to be similar to that obtained in solution phase using a 
proline chiral auxiliary of this type. Importantly, the cyclisation process simultaneously 
regenerated the reactive polymer supported auxiliary 30, ready for subsequent A-acylation 
and use in further reactions. The authors showed that a second reaction cycle could be 
performed on the same batch of resin without any decrease in stereoselectivity although the 
yield of a-substituted-y-butyrolactones prepared in the second cycle was not disclosed.
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Scheme 1.3.2a: Application o f three generations o f  polym er supported proline-derived chiral auxiliaries fo r  
the synthesis o f  chiral 3,5-disubstituted-y-butyrolactones, as described by Schore and coworkers.
In a later report, the authors described an improved pseudo-C2-symmetric polymer- 
supported chiral auxiliary, also derived from (L)-proline (see Scheme 1.3.2a ii) .16 In a 
similar reaction to that investigated previously, N-propionyl auxiliary 31 was a-alkylated 
and then treated with iodine to effect iodocyclisation with simultaneous cleavage o f trans- 
2,5-disubstituted-y-butyrolactone 29b in 34% crude yield and 88% ee. In this case there 
was no sign of any of the cw-products, implying a highly selective iodocyclisation process.
In a third iteration, Schore and co-workers reported another variation of a (L)-proline 
derived polymer-supported chiral auxiliary, (see Scheme 1.3.2a, iii).4 In this case, the
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authors actually incorporated the chiral auxiliary as a cross-linker into the polystyrene 
support itself by using auxiliary 32 as a monomer in a suspension polymerisation reaction 
with styrene. The resulting a-substituted-y-butyrolactone 29a was prepared in 45% crude 
yield and 78% ee. This result is a significant improvement when compared to the results 
obtained for auxiliary 28 that had been prepared in a conventional manner. The authors 
proposed that chiral auxiliary 33, cross-linked into the polymer matrix, was likely to 
experience a more constrained environment than a pendant-bound auxiliary fragment 
which, in this case, fortuitously resulted in enhanced stereocontrol. However, the authors 
note that there are also examples in the literature where the close proximity o f the auxiliary 
to the polystyrene back bone has caused a reduction in stereoselectivity and hence 
conclusions regarding the merit o f pendant- versus cross-linked chiral auxiliaries could not 
be drawn without further study.
Procter et al. have used polymer-supported pseudoephedrine as a chiral auxiliary in solid- 
phase asymmetric enolate alkylations (see Scheme 1.3.2b).17’18 Pseudoephedrine was 
immobilised onto Merrifield resin selectively via its hydroxyl group, thus creating the 
polymer-supported chiral auxiliary 34 in just one step. The secondary amine group was 
then N-acylated with a variety o f acid chlorides and anhydrides to give a small library o f  
the corresponding polymer-supported amides 35, which were subsequently deprotonated 
and alkylated using modified Myers’ LDA-LiCl conditions to give a-alkylated amides 36  
(see Scheme 1.3.2b). Further diversity was introduced by the use o f different cleavage 
methods to release the chiral product from the resin. Primary alcohols 37 were obtained in 
moderate yield and good ee by cleavage o f a-alkylated amides 36 with lithium  
amidotrihydroborate whilst chiral ketones 38 were obtained in moderate yield and good ee 
via treatment with alkyl-, aryl- or heteroaryl-lithium reagents. Importantly, the authors 
demonstrated that the pseudoephedrine resin 34 could be recycled at least three times with 
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Scheme 1.3.2b: Polymer-supported pseudoephedrine as a chiral auxiliary fo r  solid-phase asymmetric
enolate alkylations, as reported by Procter et al.
Procter and co-workers also reported the asymmetric synthesis of y-butyrolactones 41 using 
polymer-supported ephedrine as a chiral linker (see Scheme 1.3.2c).19 In this case, 
ephedrine was attached to Wang resin selectively via its amino functionality to form 39, 
leaving the alcohol group free for subsequent esterification reactions to allow attachment of 
the chiral linker to the substrate. In this way, both acryloyl- and crotonoyl-esters 40 were 
prepared. Treatment of resin 40 with an aldehyde and Sm l2 at low temperatures resulted in 
a samarium (Il)-mediated intermolecular ketyl-alkene addition between the aldehyde and 
the resin-bound a,p-unsaturated ester, with spontaneous cyclative cleavage from the resin 
to afford y-butyrolactones 41 in moderate yield and high ee.
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Scheme 1.3.2c: Application o f polymer-supported ephedrine as a chiral linker in the asymmetric synthesis o f  
y-butyrolactones, as described by Procter et al.
Enders et al. reported the use of two chiral hydrazine resins for the asymmetric synthesis of 
non-racemic a-branched primary amines (see Scheme 1.3.2d).20 Two enantiopure 0-
14
methoxyamino auxiliaries, derived from rra/25-hydroxy-(S)-proline and (/?)-leucine 
respectively, were attached to Merrifield resin as their protected amines, then converted to 
the corresponding hydrazines via nitrosation and reduction with DIBAL-H. In the case of 
(S)-proline-derived auxiliary 42, immobilisation of various aliphatic and aromatic 
aldehydes gave hydrazones 43, with subsequent 1,2-addition of aliphatic and aromatic 
organolithium reagents to the C=N double bond to afford chiral hydrazines 44. The chiral 
a-branched primary amines 45 were released from the resin via reductive borane cleavage. 
In order to determine the ee of the resulting chiral amines 45, it was necessary to convert 
them to their benzoyl- or acetyl-amides for analysis via chiral HPLC, and it was found that 
amides 46 had been formed in moderate yields (24 - 43%) and acceptable ees (66 -  83%). 
An identical procedure employing (/?)-leucine-derived auxiliary 47 afforded chiral amides 
48 of the opposite configuration, in similar yields (28 -  51%) and ees (50 - 86%).
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Scheme 1.3.2d: The application o f  two chiral hydrazine resins 42 and 47 fo r  the synthesis o f  chiral a- 
branched primary amines 45 as reported by Enders and co-workers.
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1.3.3 Sulfoxide and sulfinamide auxiliaries
Sulfur-containing compounds such as sulfoxides, sulfinamides and sulfinate esters have the 
potential to be chiral due to the presence of a stereogenic sulfur atom. Ellman and co­
workers have developed a polymer-supported enantiopure sulfinamide as a chiral auxiliary 
for the asymmetric synthesis of a-alkylated amines (see Scheme 1.3.3a).21 Immobilisation 
o f enantiopure sulfinamide fragment 49 was achieved via hydroboration of the alkene 
moiety and Suzuki coupling of the resulting boronic acid onto bromo-polystyrene resin. 
Complexation of aldehydes with Ti(OEt)4 as a Lewis acid, with subsequent addition of 
ethylmagnesium bromide, afforded a-branched amines 51 which were then cleaved as their 
hydrochloride salts by treatment with HC1 in a mixed DCM / n-BuOH solvent. Chiral 
products 52 were obtained in near quantitative yield (90 -  95%) based on the calculated 
loading of the auxiliary fragment onto the resin (although this value was not disclosed) and 
high ee (74 -  94%). However, it should be noted that the stereochemistry of the polymer- 
supported auxiliary 53 is destroyed in the product cleavage step, so the polymer-supported 
chiral auxiliary could not be readily recycled for subsequent asymmetric reactions.
■\PO -B r 2 *  ' \ P  ORCHO ^  •; O E,
V ' ' • P  I I  V  Ti/OFH. I 1 V
' NH * 5  % P d (P P h 3) X ^ N H j ' B
4 9  '  '  2M  N a 2C 0 3 50 51
R -  /-Pr, P h . B n, p -M e O P h
HCI
DCM / n-BuOH 
BL E s • :  O gt
X  * AOH CIH H2N R
53 52
Y ield = 9 0 - 9 5  %  
e e  = 7 6  - 9 4  %
Scheme 1.3.3a: Immobilisation o f an enantiopure sulfinamide 49 onto solid support and application o f  the 
resulting resin 50 as a chiral auxiliary fo r  asymmetric synthesis o f  a-alkylated amines 52 (as HCI salts), as 
described by Ellman et al.
Torn et al. reported the asymmetric conjugate addition of resin-bound chiral p- 
(trimethylsilyl)ethyl sulfoxide 54 to a,p-unsaturated carbonyl compounds (see Scheme 
1.3.3b).22 Resin bound sulfoxide 54 was treated with LDA at -78 °C and methyl cinnamate 
added. Cleavage of functionalised resin 55 was achieved by heating in benzene to afford 
methyl-3-phenyl-5-trimethylsilylpent-4-enoate 57 in 51% yield and 90% ee. The presence
16
of the P-silyl group both accelerated elimination of the resin-bound sulfoxide fragment and 
controlled the regioselective formation of the double bond of 57. Alternatively, treatment 
of the resin 55 with TBAF caused desilylsulfinylation to afford the vinyl analogue 56 in 
56% yield and 90% ee.
The stereoselectivity of the conjugate addition reaction was found to be dependant on the 
nature of the spacer. Reaction of the analogous phenyl spacer resin 58 under the same 
conditions afforded 57 in similar yield but a significantly lower ee of 75%, whereas the 
inclusion of a highly flexible alkyl chain spacer in resin 59 reduced the ee of 57 even 
further to just 52%.
Again, it should be noted that the cleavage of the product from the resin destroys the 
chirality of the polymer-bound sulfoxide moiety and therefore it is not possible to directly 
recycle this auxiliary.
M errifield






S iM e 3
Ph




55 C 0 2M e
TBA F




/ r \ -
56
Y ield  -  5 6  %  
e e  -  9 0  %
Ph
C 0 2M e S iM e 3 -C O zM e
M errifield





li) ph / ^ 5^ C 0 2Me 
iii) C 6H6f reflux
Ph
S iM e 3 - - C 0 2M e
57
57
Yield  = 51 %  
e e  = 9 0  %
Y ield  = 48%  
e e  = 7 5  %
Merrifield
C h \ i) LDA,
ii)
S iM e q '•') c 6h 6 . reflux
S iM e 3
Ph
57
- C 0 2M e
Yield  = 6 7 %  
e e  = 5 2  %
Scheme 1.3.3b: Torn’s polymer-bound chiral sulfoxide auxiliary in asymmetric conjugate addition reactions.
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1.3.4 Oxazolidin-2-one auxiliaries
By far the most common chiral auxiliary to be immobilised onto polymer support is the 
Evans oxazolidin-2-one. This is due to its immense popularity in solution phase synthesis 
that stems from the excellent levels of stereoselectivity observed in a wide variety of 
asymmetric reactions involving enolate intermediates.
Two different types of polymer supported oxazolidin-2-ones have been employed for 
asymmetric synthesis to date. These polymers are derived from either serine or tyrosine to 
create polymer-supported oxazolidin-2-ones 60 and 2 respectively, where the chiral 
auxiliary is attached to the polymer support via either their primary alcohol or phenolic 
functionalities respectively.
Q —d  \  / /  j  ff
O - o  h o
60 61 2 1
Fig 1.3.4a: Polymer-supported serine-derived (61) and tyrosine-derived (2) oxazolidin-2-ones and their 
retrosynthetic analysis.
The remainder of this chapter reviews the synthesis and applications of polymer-supported 
oxazolidin-2 -one derived auxiliaries reported to date, which illustrate the significant 
problems associated with the transferral of standard reaction conditions of oxazolidin-2 - 
ones from solution to solid phase.
Serine derived polymer-supported oxazolidin-2-ones
The first report on the synthesis and application of a polymer-supported Evans 
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Scheme 1.3.4a: Reported synthesis o f serine-derived oxazolidin-2-one 61 and its subsequent immobilisation 
onto solid phase.
Treatment of commercially available L-serine methyl ester hydrochloride 62 with phosgene,
moiety afforded oxazolidin-2-one 61 (see Scheme 1.3.4a). It was reported that this 
oxazolidin-2 -one fragment 61 was immobilised onto polymer support via its hydroxyl 
group, with subsequent deprotection to give polymer-bound TV-H oxazolidin-2-one 60. It 
was further claimed that polymer-supported oxazolidin-2 -one 60 was acylated with 
propionic anhydride under basic conditions to give TV-propionyl-oxazolidin-2-one 63. This 
species then underwent an asymmetric enolate alkylation reaction involving treatment with 
LDA and electrophilic quenching with benzyl bromide. Basic hydrolysis o f the resultant 
resin 64 was reported to afford (S,)-2-benzyl-propionic acid (S)-65 in 42% overall yield and
excellent enantioselectivity (ee = 96%) (see Scheme 1.3.4b).
0 0  o
Scheme 1.3.4b: Reported acylation and asymmetric enolate alkylation reaction o f polymer-supported
oxazolidin-2-one 60, as described by Allin and Shuttleworth.
However, the validity of this scheme was subsequently questioned by two other groups. ’
polymeric auxiliary 60 was in fact TV-bound polymeric auxiliary 66 , (see Scheme 1.3.4c).
24 followed by TV-Boc-protection of the oxazolidin-2-one nitrogen and reduction of the ester
M errifield 60 Merrifield 63 M errifield 64
Bew et al. 26 conducted studies that indicated that the material described as the O-bound
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This was attributed to a facile N -0  acyl exocyclic rearrangement that had occurred as the 
auxiliary was immobilised onto Merrifield resin .27 It was shown that upon deprotonation of 
the alcohol functionality of A)r-Boc-oxazolidin-2-one 61, the resulting alkoxide species 61b 
underwent intramolecular attack at the A-Boc-carbonyl, resulting in the transferral o f the 
Boc group from the nitrogen atom to the oxygen atom to form O-Boc-oxazolidin-2-one 67. 
Subsequent treatment of the A-anion with chloromethyl polystyrene (i.e. Merrifield resin) 
would then result in immobilisation of the oxazolidin-2-one fragment 67 via its nitrogen 
atom and not via the oxygen as originally reported by Allin and Shuttleworth. The resulting 
polymer-bound species after Boc-deprotection was therefore A-bound oxazolidin-2-one 66 
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Scheme 1.3.4c: N,0-Boc-exocyclic rearrangement o f N-Boc,0-H oxazolidin-2-one 61 under conditions
employed fo r  immobilisation onto Merrifield resin resulting in immobilisation via its nitrogen atom, not its 
oxygen atom as reported.
The occurrence of this rearrangement was confirmed by solution phase studies in which the 
chloromethyl polystyrene was replaced with benzyl bromide, thus producing A -benzyl-0- 
H-oxazolidin-2-one 6 8 . Importantly, it was then shown that acylation of solution phase A- 
benzyl-O-H oxazolidin-2-one 68 with propionic anhydride and use of the resulting species
69 for the asymmetric alkylation reaction using LDA and benzyl bromide did not produce 
any trace of the a-benzylated-propionyl oxazolidin-2-one 71, with only rearranged ketones
9 o
70 being produced in low yield (see Scheme 1.3.4d). It is therefore unclear how (S)-2- 
benzylated propionic acid (S)-65 could have been prepared from basic hydrolysis o f the 
corresponding solid-phase analogue as originally reported.
2 0
Scheme 1.3.4d: Attempted asymmetric a-alkylation of N-benzyl, O-propionyl oxazolidin-2-one 69.
Upon re-examination of their previous claims, Allin and co-workers confirmed the structure 
o f the polymer-bound species as A-bound oxazolidin-2-one 66  via magic-angle NMR and
9Qrecently withdrew their previous claims of success in this area.
No further examples of serine-derived auxiliaries have since been published, with all 
subsequent auxiliaries being synthesised from tyrosine.
Synthesis of tyrosine-derived polymer-supported oxazolidin-2-ones.
To date, with just one exception, the strategy employed for preparation of polymer- 
supported Evans oxazolidin-2-ones has involved synthesis of (S)-4-(4-hydroxybenzyl)- 
oxazolidin-2-one 1 in solution phase with attachment to the resin as a final step. Three
25types of resin have been used - Merrifield, W ang and less frequently Tentagel. 
Attachment to M errifield resin has been achieved via nucleophilic substitution reactions, 
with Burgess preparing an A-acylated oxazolidin-2-one resin using the phenolate anion of 
the auxiliary to displace chloride from chlorobenzyl M errifield resin under relatively harsh 
conditions (see Scheme 1.3.4e). Attachment to W ang resin (and Tentagel) has been 




72a M errifield - route i) 
72b W a n g  - ro u te  ii) or iii) 
72c T e n ta g e l - route ii)
Scheme 1.3.4e: Reagents and conditions: i) 'BuOK, cat. 18-crown-6 /  B114NI, DMF, 75 °C, 84 h, 30%  
loading; ii) E t0 2CNNC02Et, PPh3, 20 h, loading: 56% Wang, 60% Tentagel; iii) E t0 2CNNC02Et, PPh3 
THF, 0 °C  1 h then 25 °C, 72 h, loading 0.79 mmol/g.
An alternative strategy was employed by W inkler et al. who described the assembly o f the 
oxazolidinone ‘on bead’ using similar chemistry to that employed previously for solution 
phase synthesis.30 The commercially available methyl ester of A-Boc-L-tyrosine was 
attached to the resin (hydroxymethyl Merrifield and W ang) via a M itsonubu coupling. 
Reduction of the ester to the alcohol using LiAlH4, and subsequent cyclisation of the 
resulting alkoxide onto the A-Boc protecting group afforded the polymer-bound oxazolidin- 
2-one 72 according to scheme 1.3.4f.
o
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a) H ydroxym ethyl Merrifield '----' 72d H ydroxym ethyl Merrifield
b > W an 9  72b W ang
Scheme 1.3.4f: Assembly o f oxazolidin-2-one ‘on-bead’, as described by Winkler and co-workers.
Applications of solid-supported oxazolidin-2-ones
Burgess and Lim investigated the asymmetric a-alkylation of a solid-supported oxazolidin- 
2-one 72, (see scheme 1.3.4g).25 Hence A-propionyl oxazolidin-2-one 73 was enolised with 
LDA then alkylated with benzyl bromide before LiBH4 cleavage to yield the chiral product 
as alcohol (/?)-65. Their report primarily focused on the differences in reactivity and 
selectivity that were found when the nature o f the polymer support (Wang, M errifield or 
Tentagel) was changed. Wang resin was found to be the preferred support in terms o f both 
yield and selectivity. However, irrespective of the resin used, in each case the yield and ee 
of the alcohol product formed were found to deteriorate with reaction time, a feature not
2 2
previously reported in solution phase. No explanations were offered for the deterioration in 
ee , although its loss was noted to be related to the number of equivalents of base used. It 
was tentatively suggested that the decrease in yield could be due to “loss of the propionyl 





















0 °C (h ) b
a
Time at 
25 °C (h )c
Yield of 74
(%)
ee of 74 
(%)
1 BnBr 3 0.5 0.33 66 90
2 BnBr 2 1.0 12 39 86
3 CH2CHCH2Br 3 0.5 0.33 25 81
4 CH2CHCH2Br 2 2.0 15 - 88
5 BnOCH2Cl 3 0.5 0.33 12 71
6 BnOCH2Cl 2 2.5 14 20 76
Table 1.3.4a: Optimisation o f reaction conditions using Wang resin- supported oxazolidin-2-one 72b. "
Polymer-supported 73b in THF at 0 °C treated with LDA fo r  30 min. b Specified alkylating agent added and 
reaction stirred at 0 °C fo r  stated period o f tim e,c Warmed to 25 °C fo r stated period o f  time
Conditions were optimised for benzyl bromide as the alkylating agent which gave (R)-65  in 
a respectable 66% yield and 90% ee (see Table 1.3.4a, entry 1). However, when the same 
reaction conditions were applied to other electrophiles (See Table 1.3.4a, entries 3-6), poor 
yields were gained implying that each reaction would require individual optimisation.
Purandare et al. demonstrated the first use of solid supported oxazolidin-2-one 72b (Wang 
resin) for the synthesis of chiral a-substituted P-hydroxyacid derivative 76 via an aldol 
condensation reaction (see Scheme 1.3.4h).31 The polymer bound auxiliary 72b was N- 
acylated with hydrocinnamoyl chloride and its aldol reaction with isovaleraldehyde 
investigated under varying conditions i.e. variation of reaction temperature, number of 
equivalents of boron reagent and Hunig’s base (see Table 1.3.4b). It was found that
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repeated treatment of the resin with each reagent (with removal of excess reagent and 
washing with DCM between treatments) gave the greatest conversions of starting material 
to product. Under optimised reaction conditions ester 76 was obtained along with 
hydrocinnamoyl ester 75 (derived from un-reacted starting material) in a 90:10 ratio after 
cleavage from the polymer support using sodium methoxide in THF. HPLC and 'H-NM R 
revealed that the product was predominantly a single syn diastereomer (2 0 :1), but no 
isolated chemical yield of cleaved ester product 76 was given.
.0 O i) n-Bu2BOTf
0 J {  LHMDS, THF n J l  ,0  DIPEA, DCM
NH O | N— x >') O
Wang Vi A
iii) H20 2, DMF
Wang ^  ^
O - o
Scheme 1.3.4h: Asymmetric aldol reaction o f polymer-supported N-hydrocinnamoyl-oxazolidin-2-one with 













1 2.0 2.0 4.0 -78 15:85
2 2.0 2.0 4.0 -20 60:40
3 4.0 4.0 8.0 -20 50:50
4 2 x 2.0 * 2 x 2.0 * 4.0 -20 90:10
Table 1.3.4b: Optimisation o f  reaction conditions fo r aldol reaction o f N-acylated oxazolidin-2-one 
derivative with isovaleraldehyde. * Indicates multiple treatments. Resin treated with reagent, washed three 
times with anhydrous DCM, then treated with 2nd batch o f  reagent.
Phoon et al. also reported the use of solid supported auxiliary 72d in various aldol reactions 
(see Scheme 1.3.4j) and achieved yields and enantioselectivity comparable to the
'VJcorresponding reactions in solution phase.' However severe problems were noted in 
transferral o f experimental conditions from solution to solid phase, and the need for flexible 
experimental design was highlighted. Despite the well-known advantage of solid-phase 
chemistry providing the option to use an excess of soluble reagents to drive reactions to 
completion, this was reported not to be feasible in this case. It was reported that in this 
situation a reversal of stereochemistry was observed when two equivalents of n-
24
dibutylboron triflate were employed. To circumvent such issues, the formation of the 
enolate was first driven to completion using an excess of rc-dibutylboron triflate (13 
equivalents) and triethyl amine, with the excess reagents then being washed away. Again, a 
strategy involving multiple treatments of resin with reagents (with draining and rinsing in 
between), was employed. Thereafter, the resin was re-suspended in dichloromethane and 
cooled to -7 8  °C before benzaldehyde was added to form resin-bound product 77. 
Additionally the cleavage of the aldol product from polymer support proved problematic. 
The standard conditions used in solution phase reactions (lithium hydroperoxide) resulted 
in the product being “heavily contaminated with unidentifiable impurities” which appeared 
to originate from destruction of the resin. Consequently, cleavage was carried out using 
lithium hydroxide in THF, which produced a cleaner cleavage product sytt-78, however 
with the possibility of partial endocyclic cleavage of the polymer supported auxiliary 
having occurred. The syn diastereomer of the acid product was formed with a 
diasteromeric excess of greater than 98% and in 63% chemical yield overall (based on 




Scheme 1.3.4j: Asymmetric aldol reaction o f  polymer-supported N-propionyl-oxazolidin-2-one 73d with 
benzaldehyde as reported by Phoon et al.
Phoon et al also explored the use of A-propionylated Evan’s chiral auxiliary 73d for 
asymmetric conjugate addition on solid phase (see Scheme 1.3.4k). a-m ethylated 3-cyano 
butyric acid 79 was found to be the major product, being formed in an enantiomeric ratio of 
89:11 and 52% overall yield (based on loading o f chiral auxiliary on resin). In the 
corresponding solution phase reaction, the enantiomeric ratio is reported to be 98:2,34 hence 
in this case, the polymer-supported version results in a decrease in stereoselectivity.
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Scheme 1.3.4k: Firs/ example o f  asymmetric conjugate addition on polymer support, as reported by Phoon 
et al.
W inkler et al. investigated the use of polymer-supported A-crotonyl-oxazolidinones 80a 
(on M errifield resin) and 80b (on Wang resin) in Diels Alder cycloaddition reactions (see 
Scheme 1.3.4m).30 The attempted Lewis acid catalysed Diels Alder reaction between 
cyclopentadiene and Wang supported A-crotonyl oxazolidinone 80b at low temperature did 
not lead to any desired reaction presumably due to the instability of the Wang resin to 
Et2AlCl. The Merrifield resin 80a proved more robust to the Lewis acidic conditions and 
the desired reaction proceeded to form 81 in 26% overall yield (including synthesis of 
polymer-bound auxiliary) and in 86% ee, (endo/exo ratio of 21:1). These results are 
comparable to the solution-phase counterpart, which yielded 81 in 42% yield (not including 











Scheme 1.3.4m: Diels Alder cycloaddition o f cyclopentadiene and polymer-supported N-crotonyl-
oxazolidin-2-one 80a, as reported by Winkler et al.
Faita and Quadrelli reported the use of a resin-bound Evans’ auxiliaries 80a,b for 1,3- 
dipolar cycloaddition reactions with either mesitonitrile oxide (MNO) or diphenylnitrone 
(DPN) as 1,3-dipoles (see schemes 1.3.4n and 1.3.4p), 35,36 to form isomeric cycloadducts 
82 and 83 (for MNO) and 84 and 85 (for DNP). The products were subsequently released 
from the resin via NaBFL cleavage. Generally the reactions with mesitonitrile were more 
successful than those with diphenylnitrone, the latter being sluggish and affording low
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yields of the desired products. In all cases, the reactions on solid support (both Merrifield 
and W ang) were inferior to those performed in solution phase, both in terms o f yield and 
stereoselectivity. The polymer support was shown to interfere significantly with the action 
o f the magnesium catalyst and in some cases resulted in reversal of the stereocontrol, both 
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Scheme 1.3.4n: Asymmetric 1,3-dipolar cycloaddition o f polymer-supported N-crotonyl oxazolidin-2-ones 
80a/b with mesonitrile oxide (MNO) as the 1,3-dipolar species.
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Scheme 1.3.4p: Asymmetric 1,3-dipolar cycloaddition o f polymer-supported N-crotonyl oxazolidin-2-ones 
80a/b with diphenylnitrone (DPN) as the 1,3-dipolar species.
Overall, this study highlighted the sensitivity of solid-supported auxiliaries and the ensuing 
asymmetric reaction to the nature o f the solid support. With reduced (and seemingly 
unpredictable) yields and enantioselectivities relative to the solution phase analogue and
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extremely long reaction times (minimum four days), these protocols were inferior to 
existing solution phase reactions. The authors later reported the use o f a soluble polymer 
(non-cross-linked polystyrene) to support the oxazolidin-2 -one and its use in cycloaddition
'in
reactions. This soluble polymer helped to alleviate many o f the problems o f the solid 
phase system, and resulted in faster reaction rates and more efficient complexations 
between the metal catalysts and co-ordinating substrates. However, the results obtained 
were still inferior compared to the solution phase version.
Fluorous synthetic methodologies are similar to polymer-supported synthesis techniques in 
that the physical properties o f the fluorine-containing product are used to simplify product 
purification. In this regard, a fluorous version o f an oxazolidin-2-one auxiliary has been 
reported by Hein and Hultin and used in asymmetric a ld o l3 9  and 1,3-dipolar cycloaddition 
reactions (see Scheme 1.3.4q ) . 4 0  Fluorous oxazolidin-2-ones 87 and 8 8  were prepared from 
L-phenylalanine methyl ester in poor yield due to several issues arising from the presence 
o f the fluorous group. Firstly, the reaction o f the ester with the fluoroalkyllithium species 
was low yielding due to the latter reagents’ instability, even when formed in-situ. 
Furthermore, attempts to acheive diasteroselective reduction o f the resulting ketone resulted 
in mixtures o f the syn- and anti- alcohols syn - 8 6  and an ti - 8 6  respectively. This is 
presumably a consequence o f the electron-withdrawing nature o f the perfluoroalkyl chain 
which reduces the Lewis basicity o f the fluoroketone and hence alters the transition state o f 
the subsequent reduction reaction. The ketone was therefore simply reduced with NaBH 4  
with chromotographic separation o f the two resulting diastereomers. However, unwanted 
jyn-alcohol syn - 8 6  could be converted directly into desired oxazolidin-2 -one 8 8  by 
treatment with triflic anhydride, which caused cyclisation with inversion o f the secondary 
alcohol centre. Recently, an improved synthesis o f fluorous oxazolidin-2-ones addressing 
these issues has been reported. 41
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Scheme 1.3.4q: Synthesis o f fluorous oxazolidin-2-one 88 from (L)-phenylalanine methyl ester, as reported 
by Hein and Hultin.
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The jjn-A^-propionyl fluorous oxazolidin-2-one 89 was converted to its titanium enolate via 
treatment with TiCU and DIPEA, then reacted with several aldehydes (see Scheme 1.3.4r). 
After hydrolysis, the syn-hydroxy acids 91 were isolated in 74 - 94% yield with greater than 
99% ee, comparable to the results gained from the analogous solution phase version using 
classical Evans oxazolidin-2-one auxiliaries. The use of fluorous auxiliary 88 allowed the 
products to be easily and rapidly purified via fluorous solid phase extraction (FSPE). The 
crude reaction mixtures 90 were evaporated and the residues dissolved in n-propanol and 
passed down a column charged with perfluoroalkyl-modified silica gel. Washing with a 
fluorophobic solvent mixture (e.g. 3:7 water:n-propanol) rapidly stripped all organic and 
inorganic materials from the column. THF or acetone then eluted the fluorous products in 
excellent yield and purity.
OH
LiOOH
0 J I TiCU.










0  OH 
h o '^ y ^ r
90 91
Yield = 7 4 - 9 4  %  
ee = > 99 %
R = Ph, i-Pr
Scheme 1.3.4r: Asymmetric aldol reaction employing fluorous oxazolidin-2-one 89, as reported by Hein and 
Hultin.
29
The authors claim this fluorous oxazolidin-2-one 8 8  represents an ideal combination o f the 
benefits o f solution and solid phase supports. Like solid supported auxiliaries, the physical 
properties o f the fluorous oxazolidin-2 -one allows facile purification o f reaction products. 
However, ultimately, the fluorous oxazolidin-2-one remains a solution-phase auxiliary and 
hence retains many o f the inherent advantages including compatibility with classical 
enolate reaction conditions, conventional characterisation, and the option to conduct 
purification (e.g. separation o f diastereomers) if  required.
1.4 Conclusions
This brief literature review has demonstrated that efficient asymmetric synthesis using a 
polymer-supported chiral auxiliary is possible. Occasionally, the reaction conditions for 
the analogous solution phase reaction can be directly transferred successfully to the solid 
phase reaction. However, in most cases, reaction conditions need to be re-optimised for 
application to solid phase systems since the presence o f the polymer support can have a 
significant effect on the reactivity and stereoselectivity o f the chiral auxiliary fragment. In 
some cases, this effect can be beneficial, for example, both Kawana3 and Schore4  developed 
polymer-supported chiral auxiliaries which gave products o f  highereethan the 
corresponding solution phase reaction.
Some key points o f the literature review are summarised below.
•  A variety o f different chiral auxiliaries have been immobilised on polymer support, 
however many more remain to be investigated.
• There has not been much variety in the choice o f polymer support used for 
immobilisation. In the vast majority o f cases, commercially available cross-linked 
polystyrene supports have been employed, however, some success has been  
achieved with non-crosslinked soluble polystyrene supports and the emerging 
fluorous support.
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• In an attempt to minimise steric interactions between the polymer support and the 
chiral auxiliary, some groups have incorporated a linker molecule between the two 
components.
• The inclusion o f an orthogonal cleavage strategy within the linker or chiral auxiliary 
fragment allows for easy characterisation o f polymer-supported intermediates via 
selective cleavage and solution-phase characterisation.
• Large excesses o f reagents are often not essential but can be useful to drive 
polymer-supported asymmetric reactions to completion. Alternatively, multiple 
treatments o f resins with reagents (with filtration between each treatment) has also 
shown some utility.
• Isolated yields o f products are often significantly lower than the corresponding 
solution phase reactions, but rarely have explanations been given for this reduction.
•  It has been shown that in some cases, the polymer supported chiral auxiliary can be 
recycled with little loss in yield and /  or stereoselectivity.
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A  solid supported oxazolidin-2-one chiral auxiliary requires three main components: a 
polymer support, a chiral auxiliary unit and a suitable linker to attach the two fragments
2.1 Selection of chiral auxiliary for solid-supported system
together (see Fig. 2.1a).
polymer support
Fig 2.1a: Essential components o f  a solid supported chiral auxiliary.
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As reviewed in the preceding chapter, a variety of different chiral auxiliaries have been 
immobilised onto solid support over the years, including carbohydrate-based auxiliaries, 
chiral amines and sulfoxides (for recent review see reference 7). However, the most 
common chiral auxiliary to be immobilised has been the Evans oxazolidin-2-one auxiliary, 
because of its efficiency, versatility and popularity in solution phase asymmetric synthesis. 
The parent auxiliaries 100 are available as both enantiomers in two high yielding steps from 
inexpensive a-am ino acid starting materials (see Fig 2.1b).
100
Fig. 2.1b: Common examples o f Evans-type oxazolidin-2-one auxiliaries
A representative asymmetric reaction cycle employing an oxazolidin-2-one auxiliary is 
portrayed in Figure 2.1c. The attachment of the auxiliary to the substrate is generally 
achieved via an A-acylation reaction employing an acid chloride, anhydride or carboxylic 
acid which ensures applicability to a wide variety of substrates. Once constructed the N- 
acyl oxazolidin-2 -one is highly versatile and has been shown to provide excellent levels of 
diastereoselectivity in a wide variety of reactions including enolate alkylations, Michael 
additions, aldol condensations, Diels Alder cycloadditions and 1,3-dipolar cycloadditions. 
It has also been found that any diastereomeric products formed are generally easy to 
separate via column chromatography or recrystallisation. The oxazolidin-2-one auxiliary 
can then be easily cleaved by a variety of nucleophiles (allowing for the introduction of a 
further point of diversity) to afford enantiopure products and the intact, robust chiral 
auxiliary that can be recycled as required.
R
R =  'Pr (v a lin e )
R = B n (p h e n y la la n in e )
R = Ph (an d  R , = M e) (n o re p h ed r in e)  
(u n le s s  o th e r w ise  s ta te d , R , «  H)
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Fig. 2.1c: Representative asymmetric synthesis using an oxazolidin-2-one chiral auxiliary
Given the fact that the oxazolidin-2-one chiral auxiliaries have proven remarkably efficient, 
versatile and popular for solution phase synthesis, and that they have also been employed 
with some success in previous solid phase systems, it was decided to employ an oxazolidin- 
2-one fragment as the chiral auxiliary in our solid-supported reactions. The strategy chosen 
for selection of the polymer support and linker are discussed in the following chapter.
A review of the published accounts of solid-supported oxazolidin-2-ones revealed two 
common features.
1) The most popular oxazolidin-2-one fragment for immobilisation is (S)-4-(4- 
hydroxybenzyl)-oxazolidin-2-one 1 derived from L-tyrosine, (see Fig 2. Id). This fragment 
is sterically and electronically similar to the commonly used solution phase auxiliary (S)-4- 
benzyloxazolidin-2-one 101 yet the presence o f the phenol moiety allows attachment to a 
variety of different linkers. As described, the serine-derived (S)-4- 
(hydroxymethyl)oxazolidin-2 -one 102  has been shown to be unsuitable for immobilisation 
onto polymer support (for details see Chapter l ).29
H O
1 101 102
Fig 2 .Id: Examples o f  Evans oxazolidin-2-one auxiliary fragments, 1 and 102 previously proposed fo r  
immobilisation onto polymer support.
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2) To date, with just one exception ,30 the preparation of solid-supported oxazolidin-2-ones 
has involved construction of the oxazolidin-2 -one fragment in solution phase with 
subsequent immobilisation onto the solid support. This appeared to be the simplest and 
most reliable route as solution phase intermediates are easily characterised via conventional 
methods unlike their solid phase counterparts.
2.2 Synthesis of chiral auxiliaries
In this section, the syntheses of three oxazolidin-2-one chiral auxiliary fragments are 
described. Oxazolidin-2-one 1 was needed for immobilisation onto resin and subsequent 
solid supported reactions whilst oxazolidin-2-ones 103 and 101 were required to conduct 
preliminary solution phase studies (see Fig 2.2a). The two solution phase auxiliaries were 
deemed necessary in order to carry out a full investigation into analogous solution phase 




(S )-4 -(4 -h y d r o x y b e n z y l)o x a z o lid in -2 -o n e  (S )- 4 -(4 -(b e n z y lo x y )b e n z y l)o x a z o lid in -2 -o n e  (S )-4 -b e n z y lo x a z o lid in -2 -o n e
Fig 2.2a: Oxazolidin-2-one auxiliaries to be prepared and used in this study.
Benzyloxybenzyl-oxazolidin-2-one 103 was intended to be a solution phase mimic of the 
forthcoming solid phase system with the O-benzyl group mimicking the polystyrene 
support. However, its use as a chiral auxiliary had not been reported previously so the 
commonly used oxazolidin-2-one auxiliary 101 (from L-phenylalanine) was also prepared 
in parallel to ensure that the performance of 103 would conform to the high standards 
typical o f an Evans oxazolidin-2-one. These solution phase reactions would serve to 
identify any features of solution phase reactions that might be relevant to its transferral to
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solid support e.g. any unwanted by-products formed. The results gained would also allow  
direct comparison between traditional solution phase routes and any new solid-phase 
methods developed.
2.2.1 Synthesis o f (S)-4-(4-benzyloxybenzyl)-oxazolidin-2-one (103) and (S)-4-(4- 
hydroxybenzyl)oxazolidin-2-one (1).42
W e required a synthesis o f (S)-4-(4-hydroxybenzyl)-oxazolidin-2-one 1 that was both high 
yielding and amenable to scale up. A review o f the literature revealed that five routes (A- 
E) to 1 had been reported previously, the details o f which are described in Scheme 2.2.1a.
Routes A 3 5  and B 4 3  involved a strategy in which the carboxylate and amino groups o f  L- 
tyrosine were protected as an ester and carbamate respectively. Subsequent reduction o f the 
ester group with NaBH* afforded an alkoxide that underwent intramolecular cyclisation  
onto the carbonyl o f the carbamate protecting group yielding oxazolidin-2-one 1. Faita et 
al. (route A) 3 5  employed a two step reduction /  thermal cyclisation procedure whereas 
Sudharshan et al. (route B) 4 3  developed a ‘one-pot’ operation to affect this transformation 
employing Lil to facilitate cyclisation in situ.
Route C (described by Phoon et a l . ) 3 2  was the shortest approach employing a variation o f 
Evans’ original conditions 4 4  involving borane mediated reduction o f the acid functionality 
o f L-tyrosine to afford L-tyrosinol 104 that was then converted to oxazolidin-2-one 1 via 
treatment with diethyl carbonate under basic conditions.
The synthesis o f  Purandare et al. (route D ) 31 commenced from commercially available O- 
Benzyl-L-tyrosine and proceeded via reduction o f the carboxylate to the corresponding 
alcohol by treatment with LiAIKU, followed by treatment with phosgene to afford an O- 
benzyl oxazolidin-2-one 103 that was deprotected to give 1 via hydrogenolysis.
Finally, in route E Burgess et al. 2 5  employed O-benzyl-A-Boc-L-tyrosine as the starting 
material that was reduced to its A-Boc-amino-alcohol, followed by A-Boc deprotection and
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treatment of the resulting amino alcohol with phosgene to afford an O-benzyl oxazolidin-2 - 
one 103 that was once again deprotected to 1 under hydrogenolytic conditions.
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(iii) (A) (iv) (B)
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Scheme 2.2.1a: Literature routes for preparation o f (S)-4-(4-hydroxybenzyl)-oxazolidin-2-one 1.
Reagents and conditions: (i) SOCl2, MeOH, 95%, (A); or EtOH, HCI, (B), (ii) (a) K2C 0 3, (b) EtOCOCl, 
NaHCOj, 95%, (A); or BnOCOCl, Na2C 0 3 (aq), CHCl3, (B); (iii) (a) NaBH4, THF, A, 82%, (A); (b) K2C 0 3, 
toluene, A, 50%, (A); (iv) NaBH4, Lil, THF, 4  90%, (B); (v) (a) BH3.SMe2, BF3.OEt2, THF, A; (b) 5M  
NaOH(aq.), A; (c) 6M HCl(aq), 83% (three steps) (C); (vi) (a) N aH C03 (aq), (b) (EtO)2CO, K2C 0 3, 125 V , 
8 6 % (two steps) (C); (vii) (a) LiAlH4, THF, 60 V ; (b) COCl2, toluene, 82% (two steps) (D); (viii) (a) 
PrOCOCl, Et3N, THF, (E); (b) NaBH4 (E); (ix) HCI, Et20-EtOAc, 25 °C, 93% (E); (x) COCl2, K 0H -K 2C 0 3 
(aq.), toluene, 0-25 °C, 98% (E); (xi) H2, cat Pd-C, EtOH (D); (xii) H2, cat Pd-C, MeOH-EtOAc, 25 V , 96%  
(E).
However, no single route appeared to fulfil all the requirements of this project. Routes A-C 
proceeded via intermediates which, due to the presence of an unprotected phenol group, 
had proven to be non-crystalline and highly polar leading to purification issues that reduced 
both yield and reproducibility .45 W hilst these polarity problems could be overcome in 
routes D and E using O-benzyl-L-tyrosine derivatives in which the phenol group was 
protected as a benzyl ether, the prospect of employing highly toxic phosgene as a reagent 
for oxazolidin-2 -one ring formation on a large scale was unattractive.
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Consequently, an alternative synthesis of (5')-4-(4-hydroxybenzyl)oxazolidin-2-one 1 was 
devised that combined the relatively non-polar O-benzyl-L-tyrosine intermediates 
employed in routes D and E, with the intramolecular alkoxide/A^-carbamate cyclisation 
strategy for oxazolidin-2-one ring formation used in routes A and B. This approach 
allowed 1 to be prepared in five steps from (L)-tyrosine, without the necessity of using 
phosgene as a reagent for oxazolidin-2-one ring formation (see Scheme 2.2.1b). This route 
also allowed the simultaneous preparation of large quantities of (S)-4-(4-benzyloxybenzyl)- 
oxazolidin-2-one 103, that was also required as a chiral auxiliary for preliminary solution 
phase studies.
.N H B o c N H B o c(B o c )20 ,  Et3N 
Bu„NI
D io x a n e  /  H20
N H B o c
M eO H  /  E tO A c
Scheme 2.2.1b: Synthesis of(S)-4-(4-benzyloxybenzyl)-oxazolidin-2-one 103 and (S)-4-(4-hydroxybenzyl)- 
oxazolidin-2 -one 1.
The first step involved protection of the primary amine of L-tyrosine with a tert- 
butoxycarbonyl (Boc) moiety. This not only prevented possible side reactions in the 
following steps due to the presence of an unprotected amino group but would also serve as 
a crucial sacrificial carbonyl donor in the oxazolidin-2-one cyclisation step. Therefore, 
treatment of L-tyrosine with triethylamine and di-rm -butyl dicarbonate in a dioxane:water 
(1:1 ratio) mixed solvent at room temperature according to the method of Jung ,46 afforded 
A-Boc-L-tyrosine 105 in variable yield. However, addition of tetrabutylammonium iodide 
as a phase transfer agent consistently increased the quantity and quality of product isolated 
affording 105 in 85% yield.
38
Protection o f the phenolic hydroxyl group o f  105 as a benzyl ether was necessary to ensure 
the ensuing cyclisation proceded in a chem oselective fashion. A  benzylic ether protecting 
group was chosen due to the mild and selective catalytic hydrogenation conditions that 
could be employed for its deprotection. A lso the presence o f an O-benzyl group was 
reported to produce crystalline intermediates 31 which would greatly facilitate subsequent 
purification steps. In protecting the phenolic hydroxyl group as an O-benzyl ether, the 
carboxylic acid moiety was simultaneously protected as its benzyl ester. However this 
benzylic ester would be reduced in subsequent synthetic steps, so had no detrimental effect 
on the overall synthesis. To achieve perbenzylation, 105 was treated with K2 CO3 and 
excess benzyl bromide in DMF to afford O-benzyl-A-boc-L-tyrosine benzyl ester 106 after 
recrystallisation in 87% overall yield .4 7
Reduction o f the benzylic ester o f 106 to afford the alcohol functionality necessary for the 
subsequent intramolecular cyclisation reaction was achieved via  treatment with LiAIR* in 
THF following the method o f Dondoni (THF, 0 C to 25 C ) 4 8  affording (5)-A-Boc-L- 
tyrosinol 107 in 8 8 % yield.
Treatment o f A-Boc-aminoalcohol 107 with NaH in THF afforded a sodium alkoxide 
intermediate that underwent an intramolecular cyclisation reaction via attack o f its alkoxide 
functionality at the jV -B oc carbonyl to afford O-benzyl-oxazolidin-2-one 103 in 78% yield. 
The IR spectrum of 103 showed a characteristic new carbonyl stretch at 1754 cm ' 1 and 103 
was sufficiently crystalline to allow X-ray structural analysis to be carried out (see 
Appendix). An 0 Cd value comparable to that o f the literature suggests that the integrity o f  
the stereogenic centre o f 103 had been conserved [(x ]d  -85.1 ( c  = 5.0, EtOAc), literature 
value 4 9  [oc]Drt= -84.8).
(S)-4-(4-hydroxybenzyl)-oxazolidin-2-one 1 was then easily prepared in 92% yield by 
debenzylation of 103 using the catalytic hydrogenation conditions described by Burgess et 
al.25 involving treatment with palladium on carbon in a mixed solvent system o f methanol /  
ethyl acetate.
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Finally, it should be noted that all o f the intermediates in this synthetic protocol were 
crystalline enabling purification at each step of the synthesis to be achieved via simple 
recrystallisation of crude reaction products with no need for chromatography.
2.2.2 Synthesis of (S)-4-benzyloxazolidin-2-one (101).
(SM -benzyloxazolidin^-one 101 is a classic Evans oxazolidin-2-one chiral auxiliary that 
was prepared according to the original method of Evans (see Scheme 2.2.2a).44
(E tO )2C O ,
k 2c o 3
ii) 5M N aO H  (aq .) 
T H F , A
7 1%  7 5 %
Scheme 2.2.2a: Synthesis o f (S)-4-benzyl-oxazolidin-2-one 101 according to the method o f Gage and 
Evans.44
Hence, L-phenylalanine was reduced to L-phenylalanol 108 in 71% yield via borane- 
mediated reduction of its acid functionality. The resulting amino alcohol was then treated 
with diethylcarbonate under basic conditions to form the oxazolidin-2-one 101 in 75% 
yield. An a D value for 101 comparable to that of the literature demonstrated that the 
integrity of the stereogenic center had once again been conserved [ocJd11 5.1 (c 0.77, EtOH), 
literature value 44 [a ]Drt 4.9 (c 1.10, EtOH).
2.3 Solution phase N-acylation studies
The first step of any oxazolidin-2-one mediated asymmetric reaction is attachment of the 
substrate to the oxazolidin-2-one via /V-acylation. The conventional method of achieving 
A-acylation is via reaction of its lithium anion (generated with n-BuLi at -78 °C) with an 
acyl chloride (see Scheme 2.3a). This method was used successfully to acylate oxazolidin-
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2-ones 101 and 103 with both N-propionyl and N-hydrocinnamoyl side-chains being 
attached in excellent 87-92% yields (see Table 2.3a).
NH  i) n-BuLi, THF  
- 7 8  “C
ii) Q  
-7 8  °C to  rt
101 R = H
103 R = OBn
Scheme 2.3a: N-acylation o f  oxazolidin-2-ones 101 and 103 employing an acid chloride as the acyl source.
Entry Oxazolidin-2-one Acid chloride Product and (yield %)
0 109 (92)
1 101
(R = H, R, = Me)
0 110 (89)
2 103 a A ^ (R = OBn, R, = Me)
0 111 (89)
3 101
(R = H, R, = Bn)
0 112 (87)
4 103
CI'^Ss— (R = OBn, R, = Bn)
Table 2.3a: N-acylation o f oxazolidin-2-ones 101 and 103 employing an acid chloride as the acyl source.
However, this N-acylation procedure does have some limitations, since it is not applicable 
to carboxylic acids that do not form stable acid halides, or substrates that are incompatible 
with the basicity of the lithiated oxazolidin-2-one. Although this was not the case for the 
N-propionyl side-chain, alternative, milder conditions were also investigated in case 
incompatible acyl substrates were encountered in the future.
One such method introduced by Ho and Mathre 50 employs a LiCl-activated anhydride as 
the acyl source, using triethylamine (Et3N) as the base. Again, this reaction proceeded well 
with both oxazolidin-2-ones, affording 109 and 110 in essentially identical yields (83-89%) 





LiCI, Et3N  
THF, 5 0  °C
R
101 R = H
103 R = O B n
109 R = H ( 8 9 %  y ield )
110 R = O B n  ( 8 3 %  yield)
Scheme 2.3b: N-acylation o f oxazolidin-2-ones 101 and 103 employing an anhydride as the acyl source.
2.4 Solution phase asymmetric enolate alkylation reactions
One of the most common applications of the Evans oxazolidin-2-one chiral auxiliaries is 
the asymmetric alkylation of chiral enolates of A-Acyl-oxazolidin-2-ones. In solution 
phase, chiral oxazolidin-2 -one mediated asymmetric enolate alkylations have been found to 
proceed with excellent levels of diastereoselectivity .51
2.4.1 Mechanism of diastereocontrol
The success of chiral oxazolidin-2-ones in achieving such an efficient transfer o f chirality is 
due to their ability to control crucial aspects of the asymmetric enolate alkylation reaction.
Selective enolisation is achieved due to 1,3-allylic strain between the oxazolidin-2-one ring 
and the substituent at the a-position where deprotonation occurs. In the case of enolisation 
of A-propionyl oxazolidin-2-one 113 with a non-nucleophilic base such as LDA or 
LHMDS at low temperatures (typically -78 °C) (see Fig 2.4.1a), conformer II is 
destabilised relative to conformer I due to 1,3-allylic strain between the methyl group at the 
a- position of the acyl chain and the bulky nitrogen substituents of the chiral auxiliary 
fragment. Hence an enolate is formed in which the methyl group and the nitrogen are 
positioned on opposite sides of the molecule thus affording the cis- or (Z)-enolate 113b. It 
has been found for various jV-Acyl-oxazolidin-2-ones that this process is generally highly 
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Fig. 2.4.1a: Geometry o f enolate formation controlled by 1,3-allylic strain between bulky nitrogen
substituents o f  the oxazolidin-2-one ring and the a-substituent o f the acyl side chain. Conformer I highly 
favoured due to minimisation o f allylic strain and as a consequence get selective formation o f  the (Z)-enolate 
113b.
With the geometry of the enolate defined, the R substituent of the oxazolidin-2-one 
auxiliary then provides a steric bias between the two faces of the enolate. Coordination of 
the lithium ion between the two carbonyl groups creates a planar, six-membered chelate 
ring that prevents rotation about the C-N bond. This fixes the bulky R group in a position 
such that the steric demand on the bottom face (as drawn in Fig. 2.4.1b) is large when 
compared to that of the top face. With inequivalent steric bias between the two faces of the 
enolate, the electrophile is more likely to attack the less-hindered top face and hence one 
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Fig. 2.4.1b: Mechanism o f diastereoselective control in enolate alkylation reaction.
2.4.2. Solution phase asymmetric enolate alkylation reactions.
A typical reaction for the exploration of the potential of an Evans oxazolidin-2-one type 
chiral auxiliary is the asymmetric alkylation o f the enolate of its A-propionyl derivative 
(see Scheme 2.4.2a).53
B nB rB a s e
e .g .  LD A , L H M D S  
or N a H M D S
109 R =  H
110 R  -  O B n
109b R - H  
110b R - O B n
114 R - H
115 R = O B n
Scheme 2.4.2a: Asymmetric enolate alkylation o f  N-propionyl oxazolidin-2-ones 109 and 110 with benzyl 
bromide.
A review of the literature revealed that asymmetric enolate alkylation reactions o f this type 
are prone to competing tem perature-dependant enolate decom position .54 At temperatures 
above 0 °C, it has been reported that lithium enolates 113b undergo extensive 
decomposition (see Scheme 2.4.2b, red arrow) to form TV-lithiated oxazolidin-2-one of the 
form 117 and ketene 118. The N-lithiated oxazolidin-2-one 117 is then quenched with any 
excess electrophile present in the reaction to form Af-alkyl species 120, or reacts with water 
on aqueous quenching o f the reaction to form the parent N -H oxazolidin-2-one 119.





















N-H oxazolidin-2-one  
119
A/ alkyl oxazolidin-2-one  
120
Scheme 2.4.2b: Temperature-dependant lithium enolate decomposition. The green arrow shows the desired 
reaction pathway to form  N-alkylated oxazolidin-2 -one 116, wheresas the red arrow depicts the undesired 
side reaction involving decomposition o f  enolate 113b to form N-lithiated oxazolidin-2-one 117.
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Similar decomposition is reported to occur with the corresponding sodium enolate, which 
occurs at even lower temperatures, with temperatures of -78 °C being required for good 
yields of a-alkylated-./V-acyl-oxazolidin-2-ones 116 to be achieved.
Therefore, for the case of the asymmetric alkylation of the enolate of N-propionyl 
oxazolidin-2-ones 109 and 110 with benzyl bromide, there were five possible products each 
that could be present at the end of the reaction, see Figure 2.4.2a.
P h
121 R = H
,NH
101 R = H
110 R = OBn 103 R = OBn 122 R = OBn
A A p rop iony l-oxazo lid in -2 -on e W-H o x a z o lid in -2 -o n e  A A b en zy l-o x a zo lid in -2 -o n e
Ph
114 R = H 123 R = H
115 R = OBn 124 R = OBn
a -a lk y la ted  o x a z o lid in -2 -o n e  a -a lk y la ted  o x a z o lid in -2 -o n e
Fig 2.4.2a: Potential products o f  enolate alkylation reaction ofN-propionyl oxazolidin-2-one 109 and 110 
with benzyl bromide.
It was therefore decided to carry out a series of solution phase studies aimed at identifying 
any features of the asymmetric reactions in solution phase that might affect the 
performance of an analogous solid-supported system, where this competing enolate 
decomposition pathway had the potential to cause serious problems (see Chp. 3.1 for full 
discussion). Experiments were therefore conducted on solution phase oxazolidin-2-ones 
101 and 103 to determine whether this decomposition pathway could be minimised or 
eliminated by careful control of reaction conditions.
Therefore, a series of reactions were conducted in which solutions of oxazolidin-2-ones 109 
and 110 in THF were each treated with 1.5 equivalents of LHMDS at -78 °C for 30 minutes 
before addition of benzyl bromide. Each optimisation reaction was then stirred for a further
45
hour at -78 °C before being warmed slowly over 12 hours to a varied maximum 
temperature (see Scheme 2.4.2c).
i) 1 .5  e q u iv . L H M D S  
T H F , -78°C 
3 0  m in .
N H
ii) 3  e q u iv . B nBr 
- 7 8  °C to  
s ta t e d  te m p  Ft'
109 R = H 114 R = H 101 R = H 121 R = H
110 R = OBn 115 R = OBn 103 R = OBn 122 R = OBn



























1 109 rt 0 65 25 10 * 50
2 110 rt 0 57 28 15 * 46
3 109 0 0 87 8 5 > 9 5 81
4 110 0 0 85 9 6 > 9 5 73
5 109 -15 0 90 8 2 > 9 5 87
6 110 -15 0 93 5 2 > 9 5 89
Table 2.4.2a: Investigating the effect o f  temperature on the extent o f  enolate decomposition.
a LHMDS added to solution o f oxazolidin-2-one 109 and 110 in THF at -78 °C and stirred fo r  30 min, BnBr 
then added and reaction stirred a t -78 °C fo r  a further 1 hour then allowed to warm slowly to stated  
temperature over 12 hours. b Crude product composition determined by integration o f  the relevant signals in 
the 300 MHz 1H-NMR spectrum. c All diastereomeric ratios determined by integration o f  the relevant signals 
in the 300 MHz 1 H-NMR spectrum corresponding to the benzylic protons o f  the major and minor 
diastereomers. Where stated as > 95%, no trace o f  minor diastereomer was observed. * indicates de could not 
be reliably determined from analysis o f  the crude mixture or reaction products. d Isolated yield after 
recrystallisation.
The results gained demonstrated that enolate decomposition is a significant problem in 
these reactions. As expected, when warmed to room temperature, there was extensive 
enolate decomposition which served to reduce the yields o f alkylated product significantly
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(see Table 2.4.2a, entries 1 and 2). With a maximum temperature of 0 °C, the extent of 
decomposition was greatly reduced (approx. 13-15% A-H-oxazolidin-2-one and A-benzyl- 
oxazolidin-2 -one combined), resulting in improved yields of the desired alkylated product 
for both A-acyl-oxazolidin-2-ones 109 and 110 (see Table 2.4.2a, entries 3 and 4). This 
could be improved further by reducing the maximum permitted temperature to just -15 °C, 
where conversions of greater than 90% were observed for both oxazolidin-2-ones resulting 
in isolated yields of 87-89% of a-alkylated products 114 and 115 after recrystallisation (see 
Table 2.4.2a, entries 5 and 6 ). In all cases, the a-alkylated product was formed in high de , 
with no trace of the minor diastereomer being observed. It therefore appeared that 
maintaining the reaction temperature below -15 °C was sufficient to minimise the extent of 
enolate decomposition to an acceptable level without unduly compromising the reactivity 
of the system.
At this stage it was not deemed necessary to cleave the side-chain from the A-acyl- 
oxazolidin-2 -one to determine the ee o f the resulting chiral product, as a large number of 
non-racemising side-chain cleavage methods had been reported previously .51’55,56 It was 
therefore assumed that the ee of any side-chain cleaved product would be identical to the de 
o f the diastereomeric product before side-chain cleavage.
To assess the generality of these reaction conditions to other A-acyl-oxazolidin-2-ones and 
electrophiles, these conditions were used to react the enolates of both A-propionyl- 
oxazolidin-2-ones 109 and 110 with allyl iodide (see Table 2.4.2b, entries 1-2) and the 
enolates of both A-hydrocinnamoyl-oxazolidin-2 -ones 111 and 112 with methyl iodide (see 
Table 2.4.2c, entries 1-2).
i) 1 .5  e q u iv . LHM DS  
TH F , - 7 8 °C 
3 0  m in.
,NH
ii) 3  eq u iv . Allyl-I
-7 8  °C to  
-1 5  °C F
109 R = H 125 R = H 101R = H 127R = H
110 R = OBn 126 R = OBn 103 R = OBn 128 R = OBn
Scheme 2.4.2b: Application o f reaction conditions to N-propionyl-oxazolidin-2-ones 109 and 110 with allyl 
iodide.
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1 109 0 89 8 3 > 9 5 88
2 110 0 90 6 4 > 9 5 89
T a b l e  2 .4 .2 b :  Application o f reaction conditions to N-propionyl-oxazolidin-2-ones 109 and 110 with allyl 
iodide. Reaction conditions: LHMDS added to a solution o f  109 or 110 in THF at -78 °C and stirred fo r  30 
min., allyl iodide then added, stirred at -78 °C fo r  a further 1 hour then allowed to warm slowly to -15 °C 
over 12 hours. a Crude product composition determined by integration o f the relevant signals in the 300 MHz 
1H-NMR spectrum. b All diastereomeric ratios determined by integration o f  the relevant signals in the 300 
MHz 1 H-NMR spectrum corresponding to the benzylic protons o f the major and minor diastereomers. Where 
stated as >  95%, no trace o f minor diastereomer was observed. c Isolated yield after recrystallisation or 
column chromatography.
112 R = OBn
1 .5  eq u iv . LHM DS  
TH F. -7 8  °C 
3 0  m in.
ii) 3  e q u iv . M el
- 7 8  °C to  
- 1 5  °C
123 R = H
124 R = OBn
101 R = H





Scheme 2.4.2c: Application o f  reaction conditions to N-hydrocinnamoyl-oxazolidin-2-ones 111 and 112 with 
methyl iodide.
















1 111 0 86 8 6 91 83
2 112 0 84 11 5 93 82
T a b l e  2 .4 .2 c :  Application o f  reaction conditions to N-hydrocinnamoyl-oxazolidin-2-ones 111 and 112 with 
methyl iodide. Reaction conditions: LHMDS added to a solution o f  109 or 110 in THF at -78 °C and stirred 
fo r  30 min., allyl iodide then added, stirred at -78 °C fo r  a further 1 hour then allowed to warm slowly to -15 
°C over 12 hours. a Crude product composition determined by integration o f  the relevant signals in the 300 
MHz 'H-NMR spectrum. b All diastereomeric ratios determined by integration o f the relevant signals in the 
300 MHz 'H-NMR spectrum corresponding to the benzylic protons o f the major and minor diastereomers. 
Where stated as > 95%, no trace o f minor diastereomer was observed. c Isolated yield after recrystallisation 
or column chromatography.
Although yields were slightly less than the analogous benzyl bromide reactions, good 
results were demonstrated for the alkylation of A-propionyl oxazolidin-2-ones 109 and 110 
with allyl iodide (see Table 2.4.2b, entries 1 and 2) with a-allylated products 125 and 126
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being formed in excellent de (> 95%). Similarly, alkylation o f the enolates o f N- 
hydrocinnamoyl-oxazolidin-2-ones 111 and 112 with methyl iodide resulted in good yields 
of a-methylated products, albeit with their de slightly reduced to 91-93% (see Table 2.4.2c, 
entries 1 and 2). However, this reduced level o f diastereoselectivity when methyl iodide is 
employed as the electrophile has been reported previously54 and is likely to be attributed to 
the small steric demand o f this electrophile.
Gibson et al. had suggested previously that judicious choice o f appropriate work-up 
conditions for o f these types of enolate alkylation reactions could significantly increase 
yields o f a-alkylated products,57 with the most efficient system being achieved using 0.16 M  
pH 7 phosphate buffer. However, in my hands, parallel trials comparing this buffer to 
standard saturated ammonium chloride solution revealed no significant difference in 
product yields.
To conclude, the solution phase studies carried out have established conditions for the 
solution phase asymmetric enolate alkylation o f a small sample o f iV-acyl-oxazolidin-2- 
ones. It was found that conducting the alkylation reactions initially at -78 °C and then 
allowing them to warm slowly to -15 °C, minimised decomposition o f the enolate and 
hence increased yields o f a-alkylated products.
With the enolate decomposition pathway minimised, it was anticipated that the ‘solution 
phase’ conditions established for this type o f asymmetric enolate alkylation reaction would 
be suitable for transferral to solid support. Formation o f any side-products from competing 
enolate decomposition would complicate solid phase reactions, so it was hoped that careful 
control o f temperature could be used to minimise this pathway. It was also possible that the 
N-acyl-oxazolidin-2-one enolates might even be stabilised by their immobilisation onto 
solid support, since this would result in monomeric enolates that might be less prone to 
decomposition.
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2.5 Solution phase asymmetric aldol reactions.
The aldol condensation is a reaction of fundamental importance in synthesis since the 
resulting substitution pattern of the product is a common feature of many natural products. 
As a result, stereoselective aldol additions have been the subject o f intense study, however 
the diastereoselective synthesis of just one of four possible diastereomeric aldol products 
(see Scheme 2.5a) is not a trivial undertaking.
R M e R , 
Evans - s y n - 131
non-Evans-syn-131 non-Evans-a/itf-131
Fig. 2.5a: Four possible diastereomeric products o f the aldol reaction o f  N-propionyl-oxazolidin-2-one 113 
with an aldehyde (R/CHO).
However, A-acyl-oxazolidin-2-one-mediated aldol reactions have proven to be highly 
diastereoselective and it is possible to select for different aldol diastereomers simply by
CO
changing the reaction conditions. For example, aldol reactions of boron enolates of N- 
acyl oxazolidin-2-ones generally give ‘Evans-syn’-aldol products sy/i-132 in high de, yet 
reaction of the corresponding magnesium enolate gives the corresponding ‘Evans anti’- 
diastereomerawri-132 in high de 59 (see scheme 2.5b).
B u 2B O Tf, R 3N O'
PH
or TiCI4, R3NTM SCI






Scheme 2.5b: The diastereoselectivity o f  aldol reactions o f N-acyl-oxazolidin-2-ones is dependant on the 
reaction conditions.
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2.5.1 Mechanism of diastereocontrol of syn-aldol reactions of boron enolates of N-acyl- 
oxazolidin-2-ones
As for asymmetric enolate alkylation reactions, the success of an oxazolidin-2-one auxiliary 
in selectively preparing just one of four possible diastereomeric aldol products is due to its 
ability to firstly cause selective enolisation and secondly provide a stereofacial bias 
between the two faces of the enolate.
Ffe
Scheme 2.5.1a: General conditions fo r the aldol reaction o f  N-acyl-oxazolidin-2-one.
Unlike enolate alkylation reactions where the lithium counter-ion acts as the Lewis acid for 
chelation of the transition state, Evans-syn-aldol reactions generally employ a di-substituted 
boron triflate as Lewis acid, with a separate non-nucleophilic base such as 
diisopropylethylamine (DIPEA) for enolisation (see Scheme 2.5.1a).
In order for the aldol reaction to proceed with high yyn-diastereoselectivity, the enolate 
must first be formed with high levels of selectivity. Enolisation of A-acyl-oxazolidin-2- 
ones generally favours the (Z)-enolate due to allylic strain considerations (see Fig. 2.4.1a). 
The (Z)-geometry o f the enolate then preferentially defines the relative stereochemistry of 
the two new stereocentres of the aldol product as syn- according to the Zimmerman Traxler 



























Fig 2.5.1a: Zimmerman-Traxler transition states fo r  translation o f enolate geometry into stereochemistry in 
the aldol reaction.
This Zimmerman-Traxler model postulates that the aldol reaction proceeds via a pericyclic 
‘chair-like’ transition state. For (ZJ-enolates, it is reasoned that T2 is destabilised relative to 
Ti due to unfavourable Rj<-»R2 1,3-diaxial interactions as well as L<->R2 pseudo-1,3-diaxial 
interactions. Hence Tj is the thermodynamically favoured transition state and the syn 
product is selectively formed. Likewise, for f^ -eno la tes, T4 is favoured over T3 and hence 
the an/i-aldol product is formed preferentially.
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Dialkylboron enolates (formed by enolisation with DIPEA in the presence o f stoichiometric 
dialkylboron triflate) maximise R.2 <-»L steric interactions within the transition state due to 
relatively short boron-oxygen and boron-carbon (i.e. boron-ligand) bond lengths o f 1.36-
o o
1.47 A  and 1.5-1.6 A respectively, and this effect may be increased further by increasing 
the steric demand o f the ligands co-ordinated to the boron centre. This results in the two 
transition states Ti and T2  having very different energies and hence results in a highly 
diasteroselective syn-aldol reaction. Furthermore, the use o f a bulky dialkylboron reagent as 
Lewis acid ensures that Ri<-*R.2 interactions are small relative to the size o f R2 +-+L 
interactions, thus rendering the aldol reaction independent o f the steric requirements o f the 
enolate substituents Ri.
As discussed above, the enolate geometry determines the relative stereochemistry o f  the 
product so that potentially two syn diastereomers could be formed. However, in order to 
prepare just one diastereomer selectively, the absolute stereochemistry must be controlled 
by the chirality o f the oxazolidin-2-one auxiliary introducing a steric bias between the two 
faces o f the enolate. Upon addition o f the aldehyde to a (Z)-dialkylboryl-enolate, the boron 
centre becomes associated with the aldehyde carbonyl group, rather than with the 
oxazoldin-2-one carbonyl. In the absence o f chelation with the boron centre, the 
oxazolidin-2-one and its side-chain are not fixed in a rigid transition state. Rotation occurs 
around the carbon-nitrogen bond so that the oxazolidin-2-one carbonyl is sy/i-periplanar to 
the alkene functionality o f the enolate. This results in the bulky R group o f the oxazolidin- 
2-one projecting downwards (as drawn in Scheme 2.5.1b) and hence the aldehyde 
approaches preferentially from the opposite face to afford the observed syn-aldol 
diastereomer.
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Scheme 2.5.1b: Determination o f absolute stereochemistry controlled by the bulky R group o f  the oxazolidin- 
2 -one chiral auxiliary.
2.5.2 Solution phase asymmetric syn-aldol reactions
A brief investigation into oxazolidin-2-one mediated .syn-aldol reactions was then carried 
out in order to assess their suitability for transferral to solid support. Using reaction 
conditions optimised within the SDB research group,62’63 /V-propionyl-oxazolidin-2-ones 
109 and 110 were enolised via treatment with 1.1 equivalents o f 9-BBN-OTf and DIPEA, 
followed by addition of either isobutyraldehyde or benzaldehyde (see Scheme 2.5.2a) to 
form syn-aldol products in acceptable yield after column chromatography and in excellent 
de.
J  «
109 R = H
110 R = O B n
OXi) 9-BBN -O Tf DIPEA ,
ii) Hz0 2. M eOH
syn-133 r  =  h ,  r ,  « ‘Pr 
S yn --\  34 R = O B n , R , = 'Pr 
Sy/7-135 R = H, R , = Ph  
syn-136 R = O B n , R , = Ph
OH
a n t i -  1 3 3 r  = h ,  R , -'Pr 
a n t i - l  34 R =  O B n , R, = 'Pr 
a n t i -135 R = H, R, = Ph 
a n t i -136 r  = O B n , r ,  = Ph
Scheme 2.5.2a: Solution phase oxazolidin-2-one mediated syn-aldol reactions. 1.1 equiv. o f 9-BBN-OTf 
added to N-propionyl oxazolidin-2-one 109 or 110 in DCM at 0 °C, and stirred fo r  10 minutes before 1.2 
equiv. o f  DIPEA added. Reaction stirred fo r  a further 30 min before cooling to -78 °C and addition o f 1.3 
equiv. o f  isobutyraldehyde or benzaldehyde. Reaction stirred at -78 °C fo r  lh r  then allowed to warm to room 
temperature over two hours before quenching with pH 7 phosphate buffer, methanol and H2C>2 to cleave the 
boron-oxygen bond.
Entry Oxazolidin-2-one Aldehyde Product and yield (%)a de (%)*
1 109
O
“V syn-133 (71) (R = H, R, = 'Pr) > 9 5
2 110
o
"Y syn- 134 (73)(R = OBn, Rj = 'Pr) > 9 5
3 109 A syn- 135 (75) (R = H, R, = Ph) 90
4 110 A syn-136 (69)(R = OBn, R, = Ph) 87
Table 2.5.2a: Solution phase aldol reactions o f  N-propionyl-oxazolidin-2-ones 109 and 110 with
isobutyraldehyde and benzaldehyde. a Isolated yield after column chromatography. b De determined by 
integration o f the relevant signals in the 300 MHz 1 H-NMR spectrum corresponding to the CHOH protons o f  
the syn and anti aldols. Where stated as > 95%, no trace o f  anti-diastereomer was observed.
W hile the 69-75% yields of aldol products formed were acceptable, it was clear from 
analysis of the 'H-NM R spectra of the crude reaction product that some unreacted starting 
material remained. The propensity of this class of aldol reaction to not proceed to 
completion has been noted previously within the SDB group and is generally thought to be 
related to the quality of the boron reagent employed in the reaction.
These findings indicated that this type of syn-aldol reaction was a suitable candidate for 
transferral to solid support, however a review of the literature revealed that the use of an 
excess of boron reagent could, in some cases, cause reversal o f the stereochemistry of the 
aldol products formed.33 The use of an excess of reagents is a commonly used technique in 
solid-phase chemistry to force reactions to completion, therefore this feature could 
potentially limit the reaction conditions available.
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2.6 Conclusions
This chapter has described the first steps towards the development of an optimal solid- 
supported chiral auxiliary system for asymmetric synthesis. An Evans oxazolidin-2-one 
was selected to act as the chiral auxiliary due to its proven excellence in achieving 
consistently high levels of diastereoselectivity in a wide variety o f solution phase reactions. 
To allow facile attachment to a variety of linkers, a phenol moiety was included as part of 
the stereocontrolling R group and a new, convenient synthetic strategy to oxazolidin-2-one 
fragment 1 was established.
NH
103
Fig 2.6a: Preparation o f  oxazolidin-2-one auxiliaries 1, 103 and 101 described in this chapter, with 103 and 
101 employed in subsequent asymmetric reactions.
In addition, two oxazolidin-2-one auxiliaries (103 and 101) suitable for solution phase 
optimisation studies were prepared and subsequently A-acylated with two different side 
chains. The resulting jV-acyl-oxazolidin-2-ones were then subjected to asymmetric enolate 
alkylation and aldol reactions. In the case of enolate alkylation reactions, it was found that 
a temperature-dependant enolate decomposition pathway could occur to afford undesirable 
by-products, however these could be minimised by maintaining the reaction temperature 
below -15 °C. The a-alkylated products formed were produced in good yield and excellent 
de. For diastereoselective aldol reactions, syn-aldol products were formed in acceptable 
yield and with high levels of diastereoselectivity.
Importantly, there appeared to be no significant difference between the functioning of the 
conventional 4-benzyl-oxazolidin-2-one 101 and benzyloxybenzyl-oxazolidin-2-one 103. 
103 was intended to act as a solution phase mimic of the solid phase system with the O-
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benzyl protecting group mimicking the polystyrene support, so its successful use as a chiral 
auxiliary represented a promising starting point for development o f a solid-supported 
oxazolidin-2-one.
With multigram quantities o f oxazolidin-2-one 1 available for immobilisation, the next step 
towards the development o f a polymer-supported chiral auxiliary was the selection of the 
other components o f the system. Therefore, my next goal was to identify a suitable 
polymer support and linker for immobilisation and establish a series o f basic reactions on 
solid support.
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Chapter 3: Developing a system for polymer-supported
asymmetric synthesis.
Overview
3.1 Selection of resin
3.2 Immobilisation of auxiliary onto 2-chlorotrityl chloride resin
3.3 Acylation ‘on-bead’
3.4 Cleavage
3.4.1 TFA cleavage of entire auxiliary from 2-chlorotrityl chloride resin
3.4.2 Nucleophilic side-chain cleavage 
3.4.2a Nucleophilic side-chain cleavage employing LiOH 
3.4.2b Nucleophilic side-chain cleavage employing LiOOH 
3.4.2c Nucleophilic side-chain cleavage employing LiOBn 
3.4.2d Nucleophilic side-chain cleavage employing NaBH4 
3.4.2e Nucleophilic side chain cleavage -  conclusions
3.5 Summary
Introduction
Chapter 2 discussed the selection o f an Evans-type oxazolidin-2-one chiral auxiliary for use 
in our polymer-supported system, primarily due to its efficiency, versatility and popularity 
in solution phase asymmetric reactions. In addition, the synthesis o f key oxazolidin-2-one 
fragments was described and the subsequent use o f these oxazolidin-2-ones as chiral 
auxiliaries demonstrated in solution phase asymmetric enolate alkylation and aldol 
reactions. This chapter describes the crucial selection o f the other components o f the solid- 
supported chiral auxiliary system, namely the polymer support and the linker which plays a 
key role in attaching the chiral auxiliary to the polymer support. In addition, this chapter 
discusses the optimisation o f some fundamental solid supported reactions essential to the 
development o f a polymer-supported chiral auxiliary. These include immobilisation o f the 
chiral auxiliary onto the chosen polymer support and the subsequent cleavage o f various 















3.1 Selection of Resin
A solid supported chiral auxiliary requires three main components: a chiral auxiliary unit, a 
polymer support and a suitable linker to attach the two fragments together.
Evans auxiliary
Fig 3.1a: Essential components o f  a solid supported chiral auxiliary.
The chiral auxiliary fragment must function efficiently and reliably for a range of 
asymmetric reactions and must also be tolerant of the presence of the solid support. The 
polymer support itself must be both mechanically and chemically stable whilst also inert to 
a range of reaction and cleavage conditions. If these conditions are not met then the 
polymer support will not be recyclable and will lose reactivity between each reaction cycle. 
The linker is a crucial component - it acts as a double-ended protecting group that attaches 
the chiral auxiliary to the solid support. Principally, the linker must be robust towards the 
reaction conditions, however it would be greatly advantageous if the linker could also be 
engineered to allow orthogonal cleavage of the chiral auxiliary fragment from the polymer 
support under mild conditions. This would allow polymer-supported reaction products and 
intermediates to be analysed easily in solution phase. The selection of each of the key 
components of this orthogonal cleavage strategy will now be discussed individually.
The decision to use a phenol-functionalised oxazolidin-2-one fragment derived from L- 
tyrosine, as a chiral auxiliary has been discussed in the previous chapter. To summarise, 
this fragment is relatively cheap and convenient to prepare in 4 steps from commercially 
available A-Boc-L-tyrosine (see Chapter 2) and there is precedent for its attachment to 




The polymer support plays a crucial role in solid supported reactions and picking the right 
support was likely to be fundamental to the success o f this project. Although there are many 
different types o f insoluble supports available, there are two main classes that dominate the 
literature. The first type is the traditional cross-linked polystyrene support that is widely 
used for polymer supported synthesis o f peptides and small organic compounds. The 
second class, TentaGel™-type supports, are based on polystyrene cores grafted with 
polyethylene glycol (PEG) chains. The PEG chains dramatically affect the swelling 
properties o f  the resulting polymer support and can offer advantages for selected reaction 
scenarios.
Polystyrene resins (ps-resins), similar to those first developed by Merrifield in 1963 for 
peptide synthesis,64 are the mainstay o f solid supported chemistry. Advances in 
polymerisation techniques have resulted in the commercial availability o f resins with 
predictable, reproducible and high loadings, and excellent mechanical and chemical 
stability profiles. They are readily and cheaply available from a multitude o f commercial 
sources with a huge variety o f pre-attached functional groups and different degrees o f  
crosslinking available.65 It is therefore becoming increasingly possible to cheaply purchase 
a polystyrene support o f precise specifications to suit the requirements o f a given project.66 
However, polystyrene supports are not without their limitations, notably the inherent 
hydrophobicity o f the polystyrene core that can render them incompatible with polar 
solvents due to restricted swelling o f the polymer bead limiting accessibility o f reagents to 
the reaction sites located within the polymer.
PEG-grafted polystyrene resins (e.g TentaGel™) were designed to overcome this issue by 
attaching highly hydrophilic PEG chains to the resin, see Fig 3.1b.
Fig 3.1b: Schematic representation o f  PEG resin, a composite o f  cross-linked hydroxyethylpolystrene and  
3000-4000 M.W. polyethylene glycol, which has been terminally functionalised.
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These side chains comprise approximately 75% o f the resin mass, and afford resins that 
display excellent compatibility with polar solvents. However, the use o f PEG-resins has its 
limitations, since uncontrolled swelling can afford polymers that are unsuitable for solid 
phase organic synthesis, resulting in resins that are ‘sticky’ and difficult to manipulate. 
Furthermore, these resins also suffer from a lower loading o f functional groups and are 
considerably more expensive than their polystyrene counterparts.
Considering the specific chemical requirements o f our polymer-supported chiral auxiliary 
system, the nature o f the chemistry to be performed dictates the use o f relatively non-polar 
solvents (CH2 CI2 and THF) that will induce high levels o f swelling in ps-resins. Also, 
much o f the chemistry carried out using Evans’ auxiliaries relies fundamentally on 
complexation o f the oxazolidin-2-one to a Lewis acid. With TentaGel™-type resins the 
potential exists for the long PEG chains to also complex with Lewis acids, thus interfering 
with the mechanism of these types o f asymmetric reactions. Therefore, considering all 
these factors, a decision was made to employ a polystyrene resin as a polymer support for 
immobilisation o f the chiral oxazolidin-2-one fragment.
Selection o f the final component, the linker, was perhaps the most crucial factor in 
designing the system. There were a number o f factors to be considered, however the issue 
o f characterisation was uppermost in our minds. In the past one o f the major pitfalls o f  solid 
phase synthesis has been the difficulty o f monitoring the progress o f solid phase reactions 
and characterising the nature o f solid phase species. Consequently, much work has been 
focused towards developing methods to characterise polymer supported intermediates ‘on- 
bead’ and many useful methods have now been developed for this purpose.
Magic angle spinning (M AS) NMR is now a well developed technique.68 By rotating the 
sample o f swollen polymer beads at the ‘magic’ angle o f 54° to the direction o f the 
magnetic field, the signals arising from the solid support are minimised and the line widths 
narrowed which allows reasonable spectra o f the solid-supported species to be obtained 
(especially for 13C-NMR). Also, specially designed high resolution probes have now been 
developed to further increase the speed and sensitivity o f this technique. Another 
frequently used technique is single-bead FT-IR where a single resin bead is placed onto the
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window o f an IR microscope and analysed. However, both these techniques require 
specialised (and expensive) equipment which is not readily available to the wider chemical 
community and as a consequence these methods o f analysis were not considered.
Alternative procedures for on-bead analysis include IR analysis o f the resin beads crushed
and suspended in KBr discs. This technique has been used in a quantitative manner using a
polystyrene resin signal as an internal reference (e.g. the C=C-C peak at 1450 cm'1) that is
then compared with the intensity o f a peak corresponding to an emerging or disappearing
characteristic functional group.69 However, this technique obviously suffers from the same
limitations o f IR in solution phase, as it can only give information on a few key functional
groups with little information being available on the finer structure o f a compound. Another
possibility that was considered was the use o f gel-phase NMR since Lorge et al. have
1reported that slight modifications o f the conditions used for acquisition in C-NMR  
experiments can provide adequate spectra o f well-swollen polystyrene beads without the 
need for specialised probes.70 However, visualisation o f quaternary carbonyls was difficult 
without the addition o f a relaxation agent and analysis times were reasonably lengthy. The 
authors themselves claim the technique might not allow determination o f the exact structure 
o f a resin-bound species but would be a powerful complement to IR. It was therefore 
concluded that the non-destructive, on-bead analysis techniques readily available to us 
would not be sufficient to provide the detailed characterisation needed for optimisation o f 
diastereoselective reactions ‘on-bead’. A  review o f the literature revealed many other 
research groups had also reached this conclusion with by far the most widely used method 
for solid-phase reaction analysis being small-scale cleavage o f polymer-supported 
intermediates and analysis by conventional solution phase methods.
It was therefore concluded that it would be considerably more convenient and efficient to 
incorporate an orthogonal cleavage strategy into our polymer-supported chiral auxiliary 
system. Thus, at any stage in a sequence o f polymer supported reactions, cleavage o f a 
portion o f resin would allow solution phase characterisation o f the auxiliary species, thus 
enabling unequivocal identification o f any intermediates or side products produced ‘on- 
bead’ .
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On consideration of such a strategy, it became apparent that it was highly unlikely that a 
single linker would be suitable for use in all the oxazolidin-2-one auxiliary-controlled 
asymmetric reactions that could be envisaged. Initially the focus of this study was to be the 
optimisation of solid phase asymmetric enolate alkylation reactions, therefore a solid phase 
system was targeted with this reaction in mind. In the course of an enolate alkylation 
reaction (see Scheme 3.1a), the linker would be exposed to a base (e.g. LDA, LHMDS or 
NaHM DS) and electrophiles (e.g benzyl bromide, allyl iodide), hence the linker would 
need to be stable to both classes of reagent. Additionally, in the subsequent nucleophilic 
side chain cleavage reaction (see Scheme 3.1a), the linker would need to be robust to 
nucleophilic (and basic) species such as hydroxide ions. Consideration of these chemical 
requirements resulted in selection of an acid-labile linker which would be robust under the 




Scheme 3.1a: Model transformation to be investigated: alkylation o f the enolate o f solid-supported N-acyl- 
oxazolidin-2 -one with an electrophile, followed by nucleophilic side chain cleavage.
A wide variety of acid-labile functionalised resins are commercially available that are 
capable of immobilising phenols.71 These include chloromethyl polystyrene (Merrifield), p- 
benzyloxybenzyl alcohol (Wang), 2-chlorotrityl-chloride polystyrene and 4- 
(methoxyphenyl)-diisopropylsilyl propyl polystyrene. The extent of acid-lability, loading 






Structure and Name Details
Loading 1.0 - 1.6 mmolg 
(£14 for 5 g)
NaH / KH + phenol, 
then 18-crown-6. 50-95% TFA or HF
Merrifield
'OH
Phenol + PPh3 + 
DIAD.Loading 0.5 - 1.3 mmolg' (£22 for 5 g) 15 -5 0 %  TFA
Wang
Phenol + DIPEA / 
pyridineLoading 0.8 -1.6 mmolg (£64 for 5 g)
2-chlorotrityl chloride
.OMe
Resin + TFMSA 
(to prepare silyl 
triflate) 
then 2,6-lutidine + 
phenol.
Loading 1.2 -1.6 mmolg 
(£245 for 5 g)




Table 3.1a: Possible acid-labile resins considered fo r use in this work, showing structure and details of
loading, cost and conditions required fo r  acid cleavage. All prices from NovaBioChem (Merck BioSciences). 
a All resins are 1% divinylbenzene-crosslinked and 100-200 mesh except 4-(methoxyphenyl)-diisopropylsilyl 
propyl polystyrene which is 50-100 mesh. b General conditions required to immobilise a phenol onto the solid 
support, according to NovaBiochem technical notes c General conditions required to cleave a phenol from  
the solid support, according to NovaBiochem technical notes. d TFMSA = Trifluoromethanesulfonic acid
Although it is possible to cleave M errifield resin, it is rarely demonstrated as the harsh 
conditions required often have adverse effects on both the polymer support and the attached 
substrate molecule. Wang resin (the preferred support of Burgess)25 was also considered, 
although once again relatively harsh acidic cleavage conditions were likely to limit the 
range of compatible substrates. 4-(methoxyphenyl)-diisopropylsilyl propyl polystyrene, 
has desirable cleavage properties, however it requires pre-activation before use involving 
treatment with TFM SA to produce a polymer-bound silyl triflate, whilst it is also
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prohibitively expensive. From consideration of these issues, 2-chlorotrityl chloride resin 
(1% DVB) (100-200 mesh) was selected as the polymer support of choice for our 
immobilisation studies since its mild acidic cleavage conditions would allow its use for the 
analysis o f a wide variety of functionalised side-chain products.
The orthogonal cleavage system that would be produced by the use of 2-chlorotrityl 
chloride resin to immobilise the oxazolidin-2-one is described in Scheme 3.1b.
1%  TFA LiOBn
140





so lu tio n  p h a s e





P y > °
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° ~ A  //Cl
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143
Scheme 3.1b: Two possible orthogonal cleavage routes fo r  functionalised resin 140, showing both solution 
and solid phase products.
Cleavage of reaction products from the resin could therefore be effected chemoselectively 
at two different locations to afford either the acyl side-chain fragment 142, or the intact N- 
acyl oxazolidin-2-one fragment 141.
Conventional nucleophilic side chain cleavage would release the side chain product 142 
whilst leaving the chiral auxiliary fragment still attached to polymer support. This method 
o f cleavage would therefore be used in an optimised system for the preparation of libraries 
o f chiral side-chain products. The resin-bound auxiliary 2 would then be re-acylated and 
reused as required. Alternatively, for the purposes of method development, treatment with
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TFA could be employed as an alternative cleavage strategy to release the entire A-acyl 
oxazolidin-2-one fragment 141 from polymer support. This would then enable polymer 
supported products to be readily characterised by comparison with authentic standards 
prepared previously via established solution phase methodology (see Chapter 2).
The utility of the two-point cleavage strategy can be illustrated by considering the potential 
products arising from alkylation of the enolate of TV-propionyl oxazolidin-2-one 145 with 
benzyl bromide. Earlier solution-phase studies (see Chapter 2) had shown that a competing 
enolate decomposition pathway could account for the competing formation of parent N -H 
oxazolidin-2-one 2 and A-benzyl oxazolidin-2-one 149 (see Scheme 3.1c). It was therefore 
reasonable to assume that the corresponding solid-supported species would also be formed 
in these types o f enolate alkylation reactions.
1 % TFA O H
2-CI-Trt144 145
HO'



















Scheme 3.1c: Possible products o f  solid-phase alkylation reactions and their cleavage products.
Conventional nucleophilic side chain cleavage of the acyl fragment from polymer support 
using LiOH would only reveal the presence of propionic acid 146 and a-methyl
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hydrocinnamic acid (R)-65  with no products derived from //-B enzyl oxazolidin-2-one 150 
or parent N -H oxazolidin-2-one 2 being cleaved. However, cleavage o f the resin using 1% 
TFA solution would result in four species, A-propionyl oxazolidin-2-one 144, a- 
benzylated-oxazolidin-2-one 147, N -H oxazolidin-2-one 1 and A-Benzyl oxazolidin-2-one 
149. Therefore this dual cleavage strategy would enable a true picture o f what was 
occurring on polymer support to be ascertained, which would prove invaluable for reaction 
optimisation.
The ability to cleave the newly formed chiral products as diastereomers containing the 
chiral auxiliary fragment would also offer an advantage to reaction scenarios where poor 
levels o f diastereoselectivity were achieved. If cleavage o f  a small portion o f resin revealed 
that a poor de had been achieved, it would be considerably easier to enrich a diastereomeric 
product (via chromatography, recrystallisation etc.), than it would be to enrich a 
corresponding enantiomeric product resulting from nucleophilic side chain cleavage. 
Subsequent nucleophilic cleavage o f the enriched diastereomer could then be employed to 
afford the enriched enantiomeric product. Although this scenario is by no means an 
efficient or desired solution, it does represent another potential advantage o f the use o f a 2- 
chlorotrityl-bound chiral auxiliary during the asymmetric reaction condition optimisation 
process.
W hilst 2-chlorotrityl chloride resin represents an incredibly useful development resin, it is 
reasonably expensive when compared to alternative ps-resins. The ultimate aim o f this 
study was to develop an efficient, cheap and user-friendly system for the synthesis o f  
libraries o f enantiopure carboxylic acid derivatives. Consequently it was our intention to 
transfer this methodology to robust Merrifield resin once it had been optimised on the 2- 
chlorotrityl chloride development resin (see Chapter 5.3).
3.2. Immobilisation of auxiliary onto 2-chlorotrityl chloride resin
Initial attempts to immobilise the auxiliary fragment onto 2-chlorotrityl chloride resin 
employed A-propionyl oxazolidin-2-one 144 rather than N -H oxazolidin-2-one 1. Although
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it should be possible to attach jV-H-oxazolidin-2-one 1 selectively via its phenol moiety 
(pKa approx. 10) rather than the carbamate NH (pKa approx. 12) via judicious choice of 




Fig 3.2a: Estimated pKa values o f Junctional groups o foxazolidin-2-one auxiliary fragments 1 and 144. 72
Early literature examples describing the immobilisation of functionalised phenols onto 2- 
chlorotrityl chloride resin involved heating the resin and a functionalised phenol at 50 °C 
for 18 h in the presence of a large excess of pyridine.73 However,this route was found to be 
highly unreliable, with later reports claiming that these conditions resulted in pyridine 
reacting with the chlorotrityl group.74 Alternative conditions employed the more hindered 
base diisopropylethylamine (DIPEA) at 25 °C in a mixed DCM/THF solvent.75'77 Hence 
phenolic auxiliary fragment 144 (3 equiv.) was stirred with 2-chlorotrityl-chloride resin (1 
equiv.) with DIPEA (10 equiv.) in a mixture of DCM and THF for 24 h. This method was 
found to immobilise the phenolic auxiliary fragment in a reliable and reproducible manner 
with highest yields achieved when heating the reaction at 60 °C for 18 h.
,0
DIPEA (1 0  eq u iv .)
® - o
1 eq u iv . I
r e p r esen te d  a s•Cl
THF/ DCM 
6 0 °C , 18  h
.Cl
3  eq u iv .
oHO 145144 145
2-CI-Trt2-CI-Trt-CI
Scheme 3.2a: Immobilisation o f  N-propionyl auxiliary 144 onto 2-chlorotrityl chloride resin.
The excess auxiliary fragment was easily recovered at the end of the immobilisation 
reaction by sequential washing of the resin with DCM, DCM / MeOH and MeOH, and 
evaporation o f solvent in vacuo to afford impure /V-propionyl oxazolidin-2-one 144 that
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was then redissolved in ethyl acetate followed by a simple acid wash to remove residual 
DIPEA.
In this way two batches o f resin 145 were prepared with loadings o f 1.11 mmolg'1 and 0.99  
mmolg'1 (as estimated by mass o f recovered material after TFA cleavage (vide infra)). IR 
analysis (KBr disc) o f the resin revealed two characteristic carbonyl peaks at 1780 cm'1 and 
1700 cm'1. The stereochemical integrity o f the auxiliary was not compromised during the 
immobilisation reaction as shown by measurement o f the (Xd values o f the chiral N- 
propionyl oxazolidin-2-one 144 recovered from reaction washings and from TFA cleavage 
o f the functionalised resin.*
The preparation o f a versatile AMI auxiliary-functionalised resin that could later be acylated 
with the side-chain o f choice was next investigated as this would represent a more efficient 
(and potentially commercially viable) route to a variety o f different A-acyl-oxazolidin-2- 
one resins. Examination o f the pKa values o f DIPEA (pKa ~  14) and the two functional 
groups o f auxiliary 1 (phenol pKa - 1 0 ,  carbamate pKa ~  12) suggested that the polymer 
derivatisation method described above could also be employed to selectively immobilise 
unprotected 1 onto 2-chlorotrityl-chloride resin through its phenolic group. This was 
confirmed by solid phase studies whereby 2-chlorotrityl chloride resin was first 
functionalised by treatment with 10 equiv. DIPEA and 3 equiv. oxazolidin-2-one 1 to 
afford a polymer that was then treated with 10 equiv. LDA and 20 equiv. BnBr. Cleavage 
o f this ‘benzylated’ polymer with 1% TFA in DCM resulted in exclusive formation o f N- 
benzyl-oxazolidin-2-one 149, with no evidence o f any O-benzyl-oxazolidin-2-one 103 
having been formed. Therefore this cleavage experiment clearly revealed that oxazolidin- 
2-one 1 had been exclusively immobilised onto polymer support via its phenolic group.
* 144 before any treatment: aD 42.5° (c 0.4, CHC13), 144 recovered from reaction washings: aD 41.9° (c 0.5, 
CHC13), 144 recovered after TFA cleavage o f functionalised resin: aD 43.2° (c 0.4, CHC13).
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1 equ iv.
10  equ iv. LDA 
2 0  equ iv. BnBr
Not formed
Scheme 3.2b: Solid phase studies into selectivity o f immobilisation o f  NH, OH auxiliary 1, showing selective 
immobilisation via phenol group. For details o f  TFA cleavage reaction to remove entire auxiliary fragment 
from resin see Section 3.4.1. (TIS = Triisopropylsilane).
Optimisation of the previous immobilisation method was then carried out due to the 
increased polarity of the parent oxazolidin-2-one fragment 1 relative to its A-propionyl 
analogue 144. It was found necessary to aid the solvation of 1 during the immobilisation 
reaction by the addition of a small amount of DMF (typically 2 mL per g of resin). The 
procedure for recovery of the excess auxiliary fragment was also altered slightly due to the 
increased water solubility of 1 that lead to poor yields when an acidic aqueous work-up was 
employed. Therefore, the filtrate recovered from the washing of the resin was evaporated to 
dryness, then redissolved in MeOH and purified by passing through a solid phase extraction 
column (SCX-2). This column, packed with supported propylsulfonic acid residues, 
scavenged the excess basic DIPEA allowing the non-basic oxazolidin-2-one 1 to be eluted 
in an essentially pure form.
Again, the batches of chiral oxazolidin-2-one resin 2 produced were of good yield, typically 
between 0.96-1.16 m m olg'1, 8 0 - 96% yield, based on mass recovery of 1 after TFA 
cleavage, (vide infra). Measurement of ao values confirmed that the configuration of the 
stereocentre of auxiliary 1 had been conserved throughout the immobilisation/cleavage
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process.* Importantly, IR analysis (KBr disc) of the resin showed a characteristic broad 
peak at 1752 cm '1 corresponding to the oxazolidin-2-one carbonyl.
3.3 N-Acylation of the oxazolidin-2-one fragment ‘on-bead’
A review o f the literature revealed that the most common method for TV-acylating a solid- 
supported oxazolidin-2-one auxiliary is via the use of an anhydride acyl donor. In previous 
solution phase work (vide supra), conditions employing the use o f anhydride, lithium 
chloride and triethylamine in THF (based on the method of Burgess) 25 had been found to 
afford A-acyl oxazolidin-2-ones in excellent yield. Consequently, these conditions (five 
equivalents of each reagent) could be used to drive the A-acylation reaction to completion, 
producing a range of A-acyl oxazolidin-2-ones in essentially quantitative yield. Therefore 
this anhydride approach was employed to prepare a variety of polymer-supported A-Acyl- 
oxazolidin-2-ones, including A-propionyl-145, AMsovaleryl-151, A-hexanoyl-152 and N- 
crotonyl-oxazolidin-2-one-153 in good yields.







Scheme 3.3a: N-acylation o f N-H oxazolidin-2-one functionalised resin 2 employing the appropriate
anhydride, triethylamine and lithium chloride. Loading established by mass recovery o f  the product o f 
cleavage o f  the entire oxazolidin-2-one fragment from the resin with 1% TFA (see Section 3.4.1).
* 1 before any treatment: aD -12.3° (c 0.65, MeOH), 1 recovered from reaction washings: aD -12.0° (c 0.6, 






Yield b (%) Loading of /V-Acyl oxazolidin-2-one resin
. A /
145 144 88 - 9 6  * 1 .0 1 -1 .1 5  mmolg'1 c
J U 151 154 91 1.10 mmolg'1
o
152 155 75 0.91 mmolg'1
153 156 85 1.05 mmolg'1
Table 3.3a: Preparation o f  N-Acyl oxazolidin-2-one functionalised resins (2-chlorotrityl chloride resin) via 
N-acylation with the corresponding anhydride. Xc indicates a polymer-bound oxazolidin-2-one. a Solution 
phase N-acyl- oxazolidin-2-one prepared by TFA cleavage o f  N-acyl-oxazolidin-2-one resin. b Yield 
calculated by mass recovery o f solution phase oxazolidin-2-one after TFA cleavage o f 20 mg resin, based on 
original loading o f resin (1.2 mmolg'1). c Multiple batches o f  functionalised resin prepared.
However, the general applicability of this A-Acylation method is restricted due to the 
limited availability of anhydrides. Although this issue could potentially be circumvented 
by in-situ formation of a mixed anhydride, it was concluded that it would be more
efficient to develop a method that would allow ‘on-bead’ acylation directly from the 
appropriate carboxylic acid.
There were two reported cases of achieving A-acylation via deprotonation of the polymer 
supported oxazolidin-2-one with /i-BuLi or LHMDS followed by treatment with the acid 
chloride.31,32 However, repeating these conditions resulted in only partial success in my 
hands. Polymer supported N -H oxazolidin-2-one 2 was treated with LHMDS (2 
equivalents) at -20 °C for 2 hours before addition of hydrocinnamoyl chloride. The reaction 
was stirred at -20 °C for a further 2 hours then warmed slowly to room temperature for 12 
hours. TFA cleavage of the resulting resin revealed some A-acylation had occurred, but the 
resultant !H-NMR spectra were swamped by unidentifiable impurities, some of which were 
clearly derived from an oxazolidin-2-one fragment.
As an alternative method of achieving A-acylation directly from the carboxylic acid, 
conditions were employed using the peptide coupling reagent DCC and catalytic DMAP in 
DCM in a variation of a solution phase literature procedure.79 Again, an excess of reagents
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was used since the solid phase nature of the reaction allowed facile removal o f the urea by­
product by repeated washing of the resin with DMF. Hence N-hydrocinnamoyl oxazolidin- 
2-one resin 157 was prepared in good yield.
HO'
NH
1%  TFA , 5%  TIS
DCM1 0  eq u iv . D C C  




Scheme 3.3b: N-Acylation o f solid-supported N-H oxazolidin-2-one 2 with hydrocinnamic acid mediated by 
DCC and DMAP.
Side chain Resin Yield (%) Loading of N-Acyl oxazolidin-2-one resin
0
157 80 0.96 mmolg'1
W
Table 3.3b: Acylation o f solid-supported N-H oxazolidin-2-one with hydrocinnamic acid mediated by DCC  
and DMAP. In this case, Xc indicates polymer-bound oxazolidin-2-one. a Yield calculated by mass recovery 
o f  auxiliary fragment after TFA cleavage o f 20 mg resin, based on original loading o f resin (1.2 mmolg'1).
To summarise, in my experience, the most reliable, mildest and high yielding method for 
achieving N-acylation of our polymer supported N-H-oxazolidin-2-one 2 was by use of an 
anhydride approach. However, in those cases where the anhydride is not readily available, 
the DCC / DMAP route represents a viable alternative.
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3.4 Cleavage from resin
Preliminary experiments were then undertaken on A-propionyl and A-isovaleryl 
functionalised resins 145 and 151 respectively to confirm that the proposed orthogonal 
cleavage methods were both viable and high-yielding.
3.4.1 TFA cleavage of the entire N-acyl-oxazolidin-2-one fragment from 
polymer support.
The extremely acid labile trityl linkage was easily cleaved by treatment with 1% TFA in 
DCM at room temperature (30 min.). The addition of triisopropylsilane (TIS) (5%) is 
reported to enhance the rate of the cleavage reaction due to its stabilising effect on the 
resulting trityl cation.77 After treatment the resin was washed thoroughly with DCM and 
MeOH, with all washings collected and evaporated in vacuo to remove all residual traces of 
TFA. To confirm that initial treatment with TFA was sufficient to effect complete 
cleavage, the above process was repeated on the same sample of resin, but upon filtration 
and evaporation of this second cleavage reaction, no additional material was recovered, 
implying complete cleavage in the first round of treatment. IR analysis (KBr disc) of the 
TFA-treated resin also revealed a complete absence of carbonyl peaks, again suggesting 
complete release of the auxiliary from polymer support.
Scheme 3.4.1: TFA cleavage to remove entire oxazolidin-2-one fragment from the 2-chlorotrityl-chloride 
resin.
The mass recovery of non-volatile A-acyl-oxazolidin-2-one 144 from this TFA cleavage 
reaction was used to calculate the loading of the resin 145. This procedure represents a 
reliable and relatively quick characterisation method using readily available equipment with 
accurate analysis being achieved from cleavage of just 20 mg of functionalised resin.
,0 o
2-C I-Trt 2-C I-Trt-O H
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3.4.2 Nucleophilic side chain cleavage
The traditional method of removing the derivatised, chiral side chain product from the 
auxiliary is via nucleophilic cleavage. In solution phase syntheses, after the cleavage 
reaction, the side chain product is separated from the auxiliary by a variety of different 
methods including chromatography, distillation or acid/base extraction. In the case of a 
solid-supported system, the side-chain product would be released into solution with the 
auxiliary remaining immobilised. Product retrieval should then be achieved via simple 
filtration o f the residual polymer and removal of the solvent in vacuo. By judicious choice 
o f an appropriate nucleophile, this cleavage step could serve to introduce an extra point of 
diversity, thus enabling the preparation o f a number of different derivatives such as 
carboxylic acids, esters, thioesters, amides, Weinreb amides and alcohols. However, the 
choice of nucleophile is not limitless as there are two important factors that must be 
considered. Firstly, the nucleophile must not cause racemisation of the newly formed chiral 
centre. Secondly, the nucleophile must attack the exocyclic carbonyl selectively and leave 
the endocyclic carbonyl of the polymer supported oxazolidin-2-one intact. The elimination 
o f the endocyclic cleavage pathway is crucial both for the retention of high yields of side 
chain product and also to enable recycling and reuse of the polymer supported auxiliary.
H
Fig 3.4.2 : Two competing pathways fo r  nucleophilic cleavage o f N-acyl-oxazolidin-2-one.
In the absence of significant steric crowding around the exocyclic carbonyl, electronic 
factors generally direct nucleophilic attack in the desired exocyclic fashion. However, as 
the steric requirements of the R ’ group are increased, there is increased competition from 
the less sterically hindered endocyclic pathway.
o
e x o c y c lic
R
R e n d o c y c lic
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3.4.2a Nucleophilic side chain cleavage employing LiOH.
A commonly used cleavage technique o f A-acyl-oxazolidin-2-ones is basic hydrolysis to 
afford their corresponding carboxylic acids.53 However, the use o f small, hard nucleophiles 
such as LiOH and NaOH for these type o f hydrolysis reactions has been reported to cause 
significant endocylic cleavage.55 To ascertain the sensitivity o f  our system to endocyclic 
cleavage, A-isovaleryl oxazolidin-2-one functionalised resin 151 (loading 1.10 mmolg'1) 
was treated with varying amounts o f LiOH in a THF /  D 20  solvent system* for 6 hours. The 
extent o f cleavage was measured in two ways. Firstly, the side chain product (lithium 
isovalerate 159) produced was collected via filtration o f the resin after completion o f the 
reaction and thorough washing with DCM and THF. The washings were evaporated on a 
cool waterbath and the resulting residue dissolved in D 20  for !H-NMR analysis. A known 
amount o f crotonic acid was added to the !H-NMR sample to act as an internal standard to 
allow accurate quantification o f the yields gained via comparison o f appropriate intergrals. 
In addition, the residual LiOH-cleaved resin was subsequently treated with TFA in order to 
cleave the remaining auxiliary fragment. This approach enabled quantification o f any N- 
isovaleryl-oxazolidin-2-one 154 and N-H oxazolidin-2-one 1 present, as well as enabling 
identification o f any A-acyl-p-amino alcohol 161 formed by the endocyclic cleavage 
pathway.
* It should be noted that polar, non-swelling solvents such as water can be used as part o f a mixed solvent 


















Scheme 3.4.2a: Nucleophilic cleavage o f N-isovaleryl-oxazolidin-2-one 151 using LiOH, to form desired 
exocyclic cleaved products 2 and 159, and unwanted endocyclic cleaved product 160. Resulting resin then 
treated with 1% TFA to remove the auxiliary fragment and to establish extent and nature o f  cleavage.
To allow accurate determination of the ratio of the three possible species, 154, 1 and 161 
formed in this TFA cleavage reaction, it was necessary to use ^ 3-MeCN as a solvent for ’H- 
NM R studies, since it enabled full solvation of the whole sample and resulted in *H-NMR 
spectra with non-overlapping characteristic peaks for each component.
LiOH used Yield of A cid fl(%) Ratio" 154 : 1 :161
2 equiv. 21 7 : 2.5 : 0.5
5 equiv. 45 2 : 6 .2 :  1.8
10 equiv. 70 0 : 7.2 : 2.8
Table 3.4.2a: Investigation o f LiOH-mediated side chain cleavage o f polymer-supported N-Isovaleryl
oxazolidin-2-one auxiliary 151. “ Isolated yield determined by 1H-NMR in dj-MeCN with 0.025 mmol crotonic 
acid as internal standard, based upon previously determined loading o f  functionalised N-Isovaleryl 
oxazolidin-2-one resin. b Ratio o f products observed after TFA cleavage o f remaining resin-bound auxiliary 
fragment after LiOH treatment.
It was found that 10 equiv. LiOH was required to ensure complete cleavage of the 
isovaleryl side chain so that no isovaleryl-oxazolidin-2-one 154 was recovered after the 
cleavage reaction. However, at these concentrations, there was clearly a high incidence of 
the undesirable endocyclic cleavage pathway occurring, with the identity of A-acyl-P- 
amino alcohol product 161 being confirmed after isolation via column chromatography,
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characterisation by !H- and 13C-NMR analysis and comparison against similar literature 
compounds. Solution phase studies, employing O-benzyl-protected auxiliary 162 showed 
that the use of a large excess of LiOH (5 equivs.) also caused a significant degree of 
exocyclic cleavage in solution phase, with 33% of endocyclic cleavage product N- 
isovaleryl-P-amino alcohol product 163 being recovered (see Scheme 3.4.2an)-
162B nO
NH








v o la tile
Scheme 3.4.2a/i: Exocyclic cleavage o f  solution phase oxazolidin-2-one 1 6 2  upon treatment with 5 equiv. 
LiOH fo r 6  h at rt.
It was clear therefore, that LiOH cleavage was not suitable as a nucleophile to cleave this 
polymer as the significant presence of the endocyclic pathway would result in low yields of 
the desired acid and also result in destruction of the oxazolidin-2 -one ring system thus 
rendering the polymer non-recyclable.
Alternative cleavage systems have been developed to circumvent this endocyclic cleavage 
problem. For example, lithium hydroperoxide (LiOOH) has been reported to hydrolyse the 
exocyclic amide functionality of A-acyl-oxazolidin-2 -ones selectively under similar 
conditions (LiOOH, THF / H20 )  with no endocyclic cleavage occurring .55 Consequently, 
we next explored the use of LiOOH as an alternative nucleophile for cleavage of our 
polymer supported oxazolidin-2-one.
3.4.2b Nucleophilic cleavage of N-acyl-oxazolidin-2-ones using LiOOH.
Nucleophilic cleavage with lithium hydroperoxide (LiOOH) has been reported to cause no 
endocyclic cleavage of A-acyl-oxazolidin-2 -ones 55 and has consequently been used 
extensively in solution phase for this purpose. The reasons for the insensitivity of LiOOH 
to steric hindrance in carboxamide hydrolysis are not fully understood, but may be related
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to the alpha effect which is responsible for the enhanced nucleophilicity of HOO" compared
81to HO". It may also be due to the sm aller size o f the HOO" anion in solution making it 
less prone to steric effects.
Phoon et al. had commented that the use o f LiOOH to cleave an acyl side chain from a 
W ang-resin supported aldol product had resulted in the cleavage product being “heavily 
contaminated with unidentified impurities” . Therefore, a sample of un-derivatised 2- 
chlorotrityl-chloride resin was treated with 5 equivalents of LiOOH in THF / H2O (8:1) at 0 
°C to rt over 18 hours. After removal of the filtrate, thorough washing of the polymer 
support (DCM, DCM/MeOH, MeOH) and evaporation of the combined organic extracts, 
no significant impurities were found. Treatment of N-H  oxazolidin-2-one functionalised 
resin in a similar manner also showed no sign of decomposition products being formed. 
Therefore, AMsovaleryl oxazolidin-2-one functionalised resin 151 was treated with LiOOH 
under the same conditions to afford isovaleric acid 159 in an acceptable 65% yield. 
Subsequent cleavage of the residual LiOOH-treated resin with TFA revealed that complete 
endocyclic cleavage of the acyl fragment had occurred with only jV-H auxiliary 1 being 
observed in the !H-NMR spectrum and no sign of any endocyclic cleavage having 
occurred. Therefore, these LiOOH cleavage conditions had resulted in no endocyclic 
cleavage.
Scheme 3.4.2b: Nucleophilic cleavage o f  N-isovaleryl-oxazolidin-2-one 151 using LiOOH, to form the 
desired exocyclic cleaved products 159 and 2 with no sign o f  any unwanted endocyclic cleavage. Resulting 
resin then treated with 1% TFA to remove the auxiliary fragment and to establish extent and nature o f 
cleavage.
3.4.2c Nucleophilic side chain cleavage of N-acyl-oxazolidin-2-ones using 
LiOBn.
Cleavage of the side chain of chiral //-acyl-oxazolidin-2-ons using LiOBn has been 
reported to proceed in good yields, with no endocyclic cleavage and no racemisation
LiOOH 
(H20 2 + LiOH)
2-CI-Trt 2-C I-Trt
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occurring.51 LiOBn was generated in-situ (rc-BuLi (5 equiv.) + BnOH (6 equiv.)), and
added to functionalised N-Isovaleryl resin 151 (1 equiv.) at 0 °C followed by stirring at rt 
for 18 h.
Scheme 3.4.2c: Nucleophilic cleavage o f N-isovaleryl-oxazolidin-2-one 151 using LiOBn, to form desired 
exocyclic cleaved products 2 and 164, with no sign o f any unwanted endocyclic cleavage occurring. Resulting 
resin then treated with 1% TFA to remove the auxiliary fragment and to establish extent o f  cleavage.
Upon completion of the reaction, the resin was washed thoroughly and all washings 
collected and evaporated. Unfortunately, the resultant ^ -N M R  spectra were dominated by 
the presence of excess benzyl alcohol and hence reliable yields based on mass recovery 
could not be calculated. However addition of a known amount of crotonic acid to the ]H- 
NM R sample as an internal standard did allow the isolated yield to be estimated for 
reactions involving 1.5 and 2.5 equivalents LiOBn. However, the amount of BnOH present 
in the reaction involving 5 equivalents LiOBn was too great to allow any useful 
interpretation of the *H-NMR spectrum and in this case, column chromatography was used 
to isolate the benzyl ester 164 in 79% yield.
Fortunately, the success of the cleavage reaction could also be monitored by examining the 
ratio of oxazolidin-2-one fragments produced on TFA cleavage from polymer support. 
Again, it was found that an excess of LiOBn (5 equiv.) was required to cause complete 
endocyclic cleavage of the acyl fragment from polymer support.
LiOBn  
(n-BuLi + B nO H ) + Excess 
BnOH
2-CI-Trt 2-CI-Trt
1 % TFA  
5  % TIS  
DCM
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LiOBn used Yield o f Ester 164 a% Ratio" 1 :1 6 1
1.5 equiv. 43 1 : 1
2.5 equiv. 54 1 :0 .6
5.0 equiv. 79c 1 : trace
Table 3.4.2c: Investigation o f  LiOBn-mediated side chain cleavage o f  polym er-supported N-isovaleryl
oxazolidin-2-one auxiliary 151. a Isolated yield determined by IH-NMR in d3-MeCN using crotonic acid as an 
internal standard, based upon the initial loading o f  functionalised N-isovaleryl oxazolidin-2-one resin 151. b 
Ratio o f  products observed after TFA cleavage o f  residual resin-bound auxiliary fragm ent after LiOBn 
treatment. c Isolated yield  after column chromatography to remove excess BnOH.
In order for this LiOBn cleavage method to be useful, it was necessary to develop a method 
for removing the excess benzyl alcohol from the ester product after the cleavage reaction 
was complete. The high boiling point o f benzyl alcohol (205 °C) renders evaporation 
conditions reasonably harsh, raising concerns about the volatility and thermal stability o f 
the product ester. Also, benzyl alcohol is not sufficiently aqueous soluble to allow  
complete removal by successive washing, even as its alkoxide. As had been shown, 
removal o f residual benzyl alcohol could be easily achieved by column chromatography 
however it was our aim to make the whole process o f  synthesis and purification as 
amenable to automated systems as possible. Hence a generic, universal purification method 
was desired.
Consideration o f the protecting group chemistry o f benzyl alcohol led to the development 
o f a technique to remove the excess benzyl alcohol via  the use o f a solid-phase scavenging 
resin. In solution phase, benzyl alcohol can be protected as its tosylate by treatment with 
tosyl chloride in the presence o f pyridine. It was therefore reasoned that addition o f an 
excess o f polymer-supported tosyl chloride and pyridine to the crude reaction product 
arising from the LiOBn cleavage reaction, would result in scavenging o f the benzyl alcohol 
by the tosyl chloride resin. 66 Any remaining pyridine could then be easily removed via an 
acidic wash, or via evaporation in vacuo (pyridine b.p 115 °C). Hence, the LiOBn cleavage 
reaction was repeated according to the method described above where 5 equivalents o f  
LiOBn (prepared from n-BuLi (5 equiv.) and BnOH (6 equiv.) in THF), was added to N- 
isovaleryl resin 151(1 equiv.). After 18 hours, the resin was washed thoroughly with DCM  
and THF and the solvent removed in vacuo. The resulting oily residue was redissolved in 
DCM and pyridine (2:1) and ps-tosyl chloride resin (loading 2.4 mmolg'1)(3 equivs. with
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respect to BnOH) added and the whole reaction mixture agitated at room temperature for 12 
hours on an orbital shaker (see Scheme 3.4.2c//).
p p A A  - (T*p0H I5,<1‘"v \
Pyridine /  DCM o '  * 0
1 eq u iv . 5 eq u iv .
164 164 re m o v ed  via filtration
Scheme 3.4.2ci i : Solid phase scavenging o f excess BnOH by ps-tosyl chloride after LiOBn cleavage.
After filtration of the resin and thorough washing with DCM, the organic layer was washed 
with 1.0 N HC1 and brine and solvent removed in vacuo to yield benzyl ester 164 in good 
yield (81%) and in excellent purity with no traces of either benzyl alcohol or pyridine 
remaining.
It was anticipated that this scavenging method would also be applicable to the cleavage of 
chiral esters from polymer support since pyridine is a weak base that would not cause 
racemisation of the side-chain stereocentre.
3.4.2d Reductive cleavage of N-acyl-oxazolidin-2-ones using NaBH4.
In solution phase, reductive cleavage o f A-acyl oxazolidin-2-ones with sodium borohydride 
(NaBH4) has been reported to proceed with no racemisation to afford their corresponding 
alcohols in good yield .56 Hence, polymer-supported A-Isovaleryl oxazolidin-2-one resin 
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Scheme 3.4.2d: Nucleophilic cleavage o f N-isovaleryl-oxazolidin-2-one 151 using NaBH4, to form desired 
exocyclic cleaved products 2  and 165, with no sign o f any endocyclic cleavage occuring. Resulting resin then 
treated with 1% TFA to remove the auxiliary fragment and to establish extent o f  cleavage.
Unfortunately, upon filtration of the resin and evaporation of the washings, 3-methyl-butan-
l-o l 165 could not be isolated, presumably due to its inherent volatility (b.p. 130 °C) that 
lead to its loss on solvent evaporation. However, cleavage of the remaining resin with 1% 
TFA in DCM revealed the exclusive formation o f N-H  oxazolidin-2-one 1 suggesting that 
reductive side-chain cleavage had proceeded quantitatively and that no endocyclic cleavage 
had occurred.
3.4.2e Nucleophilic side chain cleavage -  conclusions
The preceeding sections have described the development of three methods of side-chain 
cleavage, employing LiOOH (to produce carboxylic acids), LiOBn (to prepare benzyl 
ethers) and NaBH4 (to prepare alcohols). In each case the reaction conditions have been 
optimised to ensure complete side-chain removal and in each case there was no sign of the 
competing endocyclic cleavage pathway acting to destroy the oxazolidin-2-one ring. 
However, yields of the side-chain cleaved products were disappointingly low (with the 
exception of the ester product obtained from LiOBn cleavage). It is anticipated that this is 
due to problems isolating the small, volatile and water-soluble compounds, and thus yields
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should be improved in a real reaction scenario where the asymmetric reaction would have 
increased the mass o f the side-chain product. Each o f the three methods has its merits and 
as such, it was decided to test and compare all three methods for the nucleophilic side-chain 
cleavage o f the resin resulting from a polymer-supported asymmetric reaction (see Chapter 
4).
3.5 Summary
In this chapter, the fundamental synthetic protocols for the development o f a solid- 
supported chiral auxiliary have been established. Commercially available 2-chlorotrityl- 
chloride functionalised polystyrene resin was selected as a low-cross-linked polystyrene 
support with an acid-labile linker already pre-attached. The use o f an acid-labile linker was 
designed to allow orthogonal cleavage o f key-solid supported intermediates by offering an 
alternative cleavage site to the nucleophilic A-acyl-side-chain cleavage traditionally used in 
oxazolidin-2-one chemistry. It was anticipated that this approach would greatly facilitate 
characterisation o f side-products and intermediates and therefore aid optimisation o f  
reaction conditions for future solid-supported asymmetric reactions.
Reaction conditions for the immobilisation of oxazolidin-2-one auxiliary fragments onto 2- 
chlorotrityl-chloride polystyrene resin were then established and functionalised resins o f  
reasonable loading (approx. 1 mmolg'1) have been achieved. In addition, various methods 
o f A-acylating the polymer-supported oxazolidin-2-one were established, allowing a range 
o f A-acyl-oxazolidin-2-ones to be prepared ‘on-bead’.
Finally, four different methods o f cleaving polymer-supported A-acyl-oxazolidin-2-ones 
have been optimised. Firstly, treatment o f the resin with 1% TFA results in cleavage o f the 
entire oxazolidin-2-one fragment with its A-acyl side-chain intact. Alternatively, three 
different methods to effect nucleophilic cleavage o f the A-acyl side chain from the 
polymer-supported oxazolidin-2-one were developed, each proceeding efficiently and with 
no sign o f any endocyclic cleavage occurring.
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With reliable conditions for these fundamental reactions in hand, it was now possible to 
begin the development o f efficient polymer-supported oxazolidin-2-one-mediated 
asymmetric reactions, as will be discussed in Chapters 4 and 5
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4.1 introduction
In the preceding chapter, reaction conditions were developed and optimised to allow  
fundamental reactions essential to the development o f a polymer-supported chiral auxiliary 
to be conducted. These consisted o f immobilisation o f the chiral auxiliary onto polymer 
support, N-acylation o f the solid-supported oxazolidin-2-one and orthogonal cleavage o f  
the acid-labile linker attaching the oxazolidin-2-one fragment to the resin as well as 
conventional side-chain cleavage o f the N-acyl fragment. These reactions constituted the 
basic tools necessary to develop solid-supported asymmetric reactions, commencing with 
the solid-supported asymmetric enolate alkylation protocol described in this chapter.
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4.2 Characterisation
A typical reaction for the exploration of the potential of an Evans oxazolidin-2-one type 
chiral auxiliary is the asymmetric alkylation of the enolate of its A-propionyl derivative 
(see Scheme 4.2a). As discussed in Chapter 2, this model reaction was investigated and 
optimised in solution phase and it was therefore planned to apply these findings to the 
corresponding solid phase system.
BnBrBase
e.g. LDA, LHMDS 
or NaHMDS
o -
145  1 4 5 b  148
Scheme 4.2a: Model transformation to be investigated: alkylation o f  the enolate o f solid-supported N- 
propionyl oxazolidin-2-one 145 with benzyl bromide.
Before attempting to perform asymmetric enolate alkylation reactions on oxazolidin-2-one 
functionalised resin 2, it was deemed wise to prepare authentic samples of the reaction 
products using conventional solution phase chemistry (see Fig. 4.2a). This would allow 
unambiguous identification of species in potentially complex mixtures of crude reaction 
products since solution phase studies had suggested up to five structurally similar 









Fig 4.2a: Potential products o f solid phase enolate alkylation reaction o f  N-propionyl-oxazolidin-2-one 145 
with benzyl bromide after TFA cleavage.
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N-H oxazolidin-2-one 1 and N-propionyl oxazolidin-2-one 144 had been prepared 
previously and characterised (see Chapter 3). N-benzyl oxazolidin-2-one 149 was prepared 
by catalytic hydrogenation of N-benzyl auxiliary 122, which had been formed by treatment 
of N-H oxazolidin-2-one 103 with LDA and benzyl bromide (see Scheme 4.2b).
NH Hz, Pd/CLDA, BnBr




Scheme 4.2b: Preparation o f  149 via solution phase alkylation o f  the enolate o f N-H oxazolidin-2-one 103 
and subsequent catalytic hydrogenation o f  122 to remove the benzyl ether protecting group.
Similarly, the major diastereomeric product o f the enolate alkylation reaction 147 was 
prepared by catalytic hydrogenation of its parent O-benzyl-product 115 (again prepared in 
solution phase) (see Scheme 4.2c).






Scheme 4.2c: Preparation o f  147 via solution phase asymmetric alkylation o f the enolate o f N-acyl
oxazolidin-2-one 110 and subsequent catalytic hydrogenation o f  115 to remove the benzyl ether protecting 
group.
A 1:1 mixture of 147and 166 was achieved by acylation o f N-H auxiliary 103 with racemic
2-benzylpropanoic acid that was converted to its acid chloride in situ via refluxing with 
thionyl chloride in DCM (see Chapter 5.1 for details), followed by catalytic hydrogenation 
of the 1:1 mixture of N-acyl-oxazolidin-2-one diastereomers 115 and 124 (see Scheme 
4.2d). No attempts were made to separate the resulting two diastereomers since the peaks 
corresponding to 166 in the ’H-NMR spectrum of a 1:1 mixture of 147 and 166 could 
easily be identified by comparison with the !H-NMR spectrum of a pure sample of 147 (For 












Scheme 4.2d: Preparation o f a 1:1 mixture o f  147 and 166 via solution phase acylation ofN -H  oxazolidin-2- 
one 103 with rac-2-benzylpropanoyl chloride and subsequent catalytic hydrogenation o f  a 1:1 mixture o f  115 
and 124 to remove the benzyl ether protecting group.
In order to develop optimal conditions for the solid-supported enolate alkylations, it was 
proposed that three aspects of the reaction would need to be monitored. Firstly, the 
composition of the crude product mixture would have to be established, with the ultimate 
aim of achieving a high conversion of starting N-propionyl oxazolidin-2-one 144  to a- 
benzylated product 147  with minimal formation of the two decomposition products jV-H- 
oxazolidin-2-one 1 and /V-benzyl-oxazolidin-2-one 149 . Secondly, the extent of the 
system ’s diastereoselectivity would need to be determined by measurement of the de of the 
a-benzylated product 147  by HPLC (after cleavage of an aliquot of resin with TFA). 
Finally, the e.e. of the side-chain cleaved product as its carboxylic acid, alcohol or benzyl 
ester would need to be determined, again by HPLC. It should be noted that the latter two 
methods should result in identical numerical values since the side-chain cleavage methods 
proposed were reported to be non-racemising and therefore the ee should be a direct 
consequence of the de. However, it was decided to measure and compare both values 
against each other as a safeguard against any unforseen epimerisation / racemisation events 
caused by the presence of the polymer support.
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4.2.1 Determination of crude product mixture composition
Determination o f the composition o f the crude product mixture required a rapid, high-
throughput method o f analysis. Initially ^ -N M R  spectroscopy was proposed as a potential
method, however, the structural similarity o f the species produced in the cmde reaction
product afforded a complicated spectrum with overlapping signals that were difficult to
interpret. However, analysis o f the cmde product o f TFA cleavage by LC/MS gave good
separation o f the product peaks with the exception o f the two diastereomers o f the a-
♦
alkylated product which were resolved but did not quite achieve baseline separation.
This analytical approach also had the advantage o f allowing accurate characterisation of  
each compound peak by mass-spec analysis and could be performed on a small quantity o f  
cmde product (1 mg). Concurrent analysis o f the same sample on a LC/UV instrument 
(same solvent system) allowed quantitative analysis o f  the mixture composition after 
calibration to account for differences in the UV chromophore o f the acyl substituent o f each 
o f the components (see Appendix).
4.2.2. Determination of d.e.
A crucial aspect o f this investigation was the accurate determination o f the 
diastereoselectivity o f the asymmetric reaction. Preparation o f both possible diastereomers 
(147 and 166) via solution phase synthesis allowed conditions for this determination to be 
developed. ^ -N M R  analysis o f a 1:1 mixture o f the two diastereomers (147 and 166) 
revealed that a number o f their resonances were coincident. However, there were some 
characteristic differences between the two spectra that were diagnostic, notably the CHN  
multiplets at 5 4.40 ppm and 4.55 ppm (see Fig. 4.2.2a).
*3pm ABZ+ column, Solvent systems used were 0-100% gradient o f 0.1% formic acid +10mM  
ammonium acetate and 95% acetonitrile + 0.05% formic acid. jV-H oxazolidin-2-one 1 (tR = 1 . 7  min), N- 
propionyl oxazolidin-2-one 144 (tR = 2.4 min), //-benzyl oxazolidin-2-one 149 (tR = 2.7 min), a-benzylated 
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Fig. 4.2.2a: /H-NMR o f a 1:1  mixture o f diastereomers 147 and 166 in d4-MeOD.
However, again there were concerns that these resonances might be coincident with 
resonances of other reaction products present in the complicated crude reaction product 
spectrum, particularly as the high de’s expected would make the minor diastereomer signals 
very weak in comparison with those of the major diastereomer. Therefore, an additional 
method, allowing greater sensitivity was sought. As previously discussed, the available 
open-access LCMS/LCUV system did not achieve baseline separation between the two 
peaks, with the major diastereomer peak that eluted first tailing into the minor diastereomer 
peak which made the de value obtained appear considerably lower than it actually proved to 
be.*
A normal-phase HPLC method was therefore developed to separate the two diastereomers 
of the a-benzylated product; with a ChiralCel AD column resulting in excellent separation 
(90% hexane, 10% propan-2-ol, 1 mL per min, major diastereomer 147 tR = 15 min, minor 
diastereomer 166 tR = 23 min). In fact, this ChiralCel column afforded good separation of 
all compounds present in the crude reaction m ix ture/ However, it must be noted that this 
method could not be used to quantitatively ascertain the composition of the crude mixture
* Analysis o f 1:1 mixture of 147and 166 by this method gave d.e.errors o f 15% in favour of the second eluting 
minor diastereomer.
f a-benzylated product (major diastereomer) 147 tR = 15 min, a-benzylated product (minor diastereomer) 166 
tR = 23 min, A-propionyl oxazolidin-2-one 144 tR = 26 min, A-benzyl oxazolidin-2-one 149 tR = 38 min, 7V-H 
oxazolidin-2-one 1 tR = 50 min.
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due to poor solubility of the N-U  oxazolidin-2-one 1 in the eluent which resulted in removal 
of a significant quantity upon filtration prior to injection onto the column.
4.2.3 Determination of e.e.
Authentic racemic samples of the side-chain cleaved products were prepared by cleavage 
(using the appropriate nucleophile) of solution phase alkylated product 167 and separation 
o f the product from the auxiliary by column chromatography. Hence a 1:1 mixture of 
diastereomers 147 and 166 was cleaved with LiOBn to give racemic benzyl-2- 
benzylpropanoate rac-168 (see Scheme 4.2.3a), and by NaBH4 to give racemic 2-methyl-3- 
phenylpropan-l-ol rac-169 (see Scheme 4.2.3b) Cleavage of the resin with LiOOH 
cleavage was not necessary since the acid product 2-benzylpropionic acid was 
commercially available in its racemic form.
1:1 mixture of 
1 4 7  and 1 6 6
Scheme 4.2.3a: Preparation o f an authentic sample o f racemic benzyl-2-benzylpropanoate rac-168 via
solution phase cleavage o f  167 with LiOBn.
1:1 mixture of 
1 4 7  and 166
Scheme 4.2.3b: Preparation o f an authentic sample o f racemic 2-methyl-3-phenylpropan-1 -ol rac-169 via 
solution phase cleavage o f  167 with NaBH4.
LiOBn
NaBH,
Chiral HPLC conditions were then developed to achieve baseline separation of the 
enantiomers of each o f the compounds (see Table 4.2.3a).










« U 97% hexane, 3% propan-2-ol 1 mL min'1 10.3 12.8 *
rac-169
0
ChiralCel OJ-R column **
60% MeCN, 40% H20 15.7 18.3
0.5 mL min'1
rac-168
Table 4.2.3a: HPLC conditions for determination o f  e.e. o f side-chain cleaved products.
Where known, * indicates enantiomer later identified as the major enantiomer. ** rac-168 had poor retention 
on normal-phase systems so was analysed on a reverse-phase system -  method developed at 
GlaxoSmithKline, Stevenage by Eric Hortense.
Analytical techniques required to develop optimal conditions for a polymer-supported 
asymmetric enolate alkylation had therefore now been established.
To summarise:
1) The composition of the crude product mixture arising from cleavage o f the entire 
A-acyl-oxazolidin-2-one fragment from the alkylated resin using 1 % TFA, could be 
established by simultaneous LCMS and LC-UV analysis that enabled compound 
characterisation and quantification respectively.
2) The de of the alkylated product could be determined via HPLC analysis of the 
crude reaction mixture arising from cleavage of the entire oxazolidin-2-one 
fragment from the alkylated resin using 1 % TFA.
3) The ee of alkylated products could be determined via HPLC analysis of the 
products arising from nucleophilic cleavage o f the A-acyl side-chain from polymer 
support using LiOOH, LiOBn or NaBH4.
The optimal method of side chain cleavage was not firmly established before the start o f the 
enolate alkylation optimisation process. Conditions for three different cleavage reactions
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were established (see Chapter 3.4.2) but the use of LiOBn (generated from n-BuLi and 
benzyl alcohol) for library development was ruled out at an early stage due to the additional 
step necessary to remove the excess benzyl alcohol after reaction. Additionally, the reverse- 
phase HPLC required to determine the ee o f the benzyl ester products produced by LiOBn 
cleavage was not readily available at Bath. Both the LiOOH and NaBH4 cleavage methods 
were shown to be suitable for our purposes with the carboxylic acid products formed from 
LiOOH cleavage being easily purified by acidic aqueous extraction, whilst the NaBH4 
method was more convenient to carry out at ambient temperature. It was anticipated that 
any issues arising from volatility and/or water solubility o f the side chain cleavage products 
would be reduced by the extra mass of the electrophile introduced in the actual alkylation 
reaction. It was therefore decided that the efficiency of each method would be compared 
for the cleavage of an actual solid-supported enolate alkylation reaction product.
4.3 Optimisation of reaction conditions using model system
As previously discussed, a typical transformation to explore the potential o f a chiral 
auxiliary for asymmetric enolate alkylation reactions involves treatment of the enolate of 
polymer-supported A-propionyl auxiliary with benzyl bromide (see Scheme 4.3a). ’ ’
Scheme 4.3a: Model transformation to be investigated: alkylation o f the enolate o f solid-supported N- 
propionyl oxazolidin-2-one 145 with benzyl bromide, followed by nucleophilic side chain cleavage. (Base 
typically LDA, LHMDS or NaHMDS).
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i) Variations of existing literature method
At the time of commencing this work, only one reliable report of the application of a solid- 
supported oxazolidin-2-one chiral auxiliary for enolate alkylation reactions had been 
published.25 Employing the model transformation described above, Burgess et al. reported 
the use of a W ang-supported oxazolidin-2-one 73b for the preparation of chiral alcohol (R )- 
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Scheme 4.3b: Burgess’ enolate alkylation o f  solid-supported N-propionyl oxazolidin-2-one 73b with benzyl 
bromide and subsequent LiBH4 cleavage to afford alcohol (/?)-169.
These conditions were therefore used as a starting point for our investigation. Hence, our 2- 
chlorotrityl polymer supported oxazolidin-2-one 145 was treated with 3 equivalents of 
freshly prepared LDA and 5 equivalents of benzyl bromide. However, in our hands, 
disappointing results were achieved (see Table 4.3a, entry 1) with TFA cleavage affording 
a sample comprised of 26% unreacted A-propionyl oxazolidin-2-one 144, 33% alkylated 
product 147 and 41% A-H-oxazolidin-2-one 1. Due to the complex nature of the 
diastereomeric products cleaved from the resin, a poor isolated 28% yield of alcohol (R )- 
169 was recovered after NaBH4 side-chain cleavage of the alkylated resin. The 
stereocontrol achieved (85% de for 147, 90% ee for (/?)-169) was comparable to that 
reported by Burgess for (/?)-169 of 90% ee. Importantly, the two values determined for the 
de and ee were comparable with each other, when allowances were made for statistical 
errors between the two different methods of analysis.
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v o la tile
Scheme 4.3c: Solid phase enolate alkylation o f 150 mg o f solid-supported N-propionyl oxazolidin-2-one 145, 
with subsequent cleavage o f  a 20 mg portion o f resin with 1% TFA and 5% TIS in DCM to give crude 
reaction products that were analysed via LC/UV and HPLC analysis to determine product composition and 
de respectively. Remaining 120 mg alkylated resin treated with either NaBH4 to give alcohol (/?)-169, or 
LiOOH to give acid  (/?)-65, with the ee o f chiral products being determined by chiral HPLC.
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Entry
Reaction conditions" Crude product from TFA cleavage composition (% )b
De of 
1 4 7 c
(%)
Method d, y ie ld e 
and ee^ of chiral 











(3 equiv.) 0 °C 33




2 LDA  (3 equiv.)
0 ° C *  












Table 4.3a: Investigating variations o f  existing literature methods.
a All reactions (except entry 4) conducted as follows: 3 equiv, o f base added to 150 mg pre-swollen resin 145 
in 6 ml dry THF at stated temperature and stirred fo r  30 min. before addition o f  5 equiv. BnBr. Reaction 
stirred fo r  a further 30 mins at stated temperature then removed from  ice-bath and stirred fo r  a further 20 
min before quenching. b Crude product decomposition determined by LCMS and LC-UV analysis. c De 
determined by HPLC analysis o f  crude product o f  TFA cleavage o f 20-50 mg portion o f  resin after alkylation 
reaction. d Side-chain cleavage reaction employed either LiOOH or NaBH4 as nucleophile. e Isolated yield  
after appropriate work-up based upon the calculated loading o f  N-H  oxazolidin-2-one on 2-CI-Trt resin 
representing the combined yield  over three steps -  N-acylation, enolate alkylation and side-chain cleavage. f  
Ee determined by HPLC analysis o f  side-chain cleaved product after appropriate work-up. 8 Reaction 
conditions as fo r  a) however after removal o f  the reaction from an ice-bath, the reaction was stirred fo r  an 
additional 3 hours a t room temperature. h Nucleophilic cleavage not undertaken due to poor yields o f  a- 
benzylated product 147.
In an attempt to drive the reaction to completion, the enolate alkylation reaction was 
repeated but left for an extended duration o f 4 hours at 0 °C (see Table 4.3a, entry 2). 
Perhaps unsurprisingly considering our previous solution phase studies, this resulted in 
extensive enolate decomposition with 48% N-H  oxazolidin-2-one 1 and 26% //-benzyl 
oxazolidin-2-one 149 being isolated. Both the percentage conversion and de o f the 
alkylated product 147 were poor (18% and 51% respectively).
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In solution phase enolate alkylations, LHMDS is often used as an alternative to LDA since 
LHMDS is commercially available in THF solution and retains its activity on storage. It 
therefore represented a more convenient and reliable alternative to the in-situ preparation o f  
LDA or the use o f unreliable commercially available solutions.
Hence the enolate alkylation reaction was repeated following an identical procedure, 
employing LHMDS as base (see Table 4.3a, entry 3). This was found to achieve superior 
conversions, with no starting material 144 recovered and 64% a-benzylated product 147 
being detected with levels o f stereocontrol comparable to that achieved using LDA (87% 
de, 83% ee o f (/?)-169 after NaBH 4  cleavage). However, once again there was a significant 
amount o f N -H oxazolidin-2-one 1 recovered and also some A-Benzyl oxazolidin-2-one 
149 implying significant enolate decomposition had occurred.
ii) Selection of LiOOH as the preferred method of side-chain cleavage
At this stage it was decided to employ LiOOH cleavage as the preferred method of  
cleavage o f the A-Acyl side chain from polymer supported products. Cleavage o f the same 
batch o f a-benzylated resin via three different methods (see scheme 4.3d) had confirmed 
that all three cleavage methods had afforded comparable de/ee values for the products 
obtained. However it was clear that the acidic products resulting from LiOOH cleavage 
were generally cleaner and easier to analyse than the alcohol products obtained from 
NaBRt cleavage, presumably due to the acidic aqueous extraction method used for workup, 
and as a consequence this method o f side-chain cleavage was employed in subsequent 
optimisation reactions.
o °
1%  TF  
5%  Tl 
DCV
2-CI-Trt 5  eq u iv . N aB H 4 
TH F /  HzO
5  e q u iv  LiOOH  
(rvBuLi + B nO H )
\  t h f / h 2o
OH O
147 ^
85 % d e
b (R)-169
82 % e e
(R)-65
87 % e e
HO
Scheme 4.3d: Cleavage o f a-benzylated resin via three different methods to allow comparison o f  the de and 
ee values.
iii) R ed u c in g  the reaction tem perature ...
From earlier solution phase studies it was known that enolate decomposition of A-acyl- 
oxazolidin-2-ones was temperature dependant, with temperatures above 0 °C causing 
appreciable decomposition. However, it had been found that such decomposition could be 
essentially eliminated by keeping the reaction below -15 °C. It was reasoned that the same 
reduction in temperature might help reduce the decomposition occurring on solid phase 
systems, and hence the reaction was again repeated, using LHMDS at -15 °C (see Table 
4.3a, entry 4). This alteration to the method was partially successful, with fewer 
decomposition products formed (15% A-H-oxazolidin-2-one 1 and 3% A-Benzyl 
oxazolidin-2-one 149) however, the lower temperature also resulted in a reduced reaction 
rate with 20% M-propionyl oxazolidin-2-one 144 being recovered. Despite this, the 
conversion to a-benzylated product 147 was comparable to that achieved at 0 °C (table 
4.3b, entry 3) which had been formed with similar levels o f stereocontrol (85% de and 83% 
ee after LiOOH cleavage). However, it was clearly desirable to identify conditions that 
would result in the alkylation reaction proceeding to completion, not only to improve 
isolated yields of 147 but also because any residual A-propionyl oxazolidin-2-one 144 
would lose its propionyl side-chain in the subsequent cleavage step and hence contaminate 
the desired chiral acid product (R )-65 . Although in this model transformation the resulting
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propionic acid was volatile and could therefore be removed upon work-up, in other cases 
where larger N-acyl side-chains were employed this would not be the case.
It was therefore necessary to try to identify conditions to drive the enolate alkylation 
reaction to completion. Maintaining the temperature at -15 °C throughout and employing 
LHMDS as the base, the reaction duration was increased to 12 hours in an attempt to 
encourage complete benzylation of all the N-propionyl enolate species (see Table 4.3b, 
entry 1). However, despite all the starting material being consumed, there was a slight 
decrease in the percentage of a-benzylated product 147 produced as well as a decrease in 
the diastereoselectivity of the asymmetric enolate alkylation reaction, affording a de of just 
74% (70% ee after LiOOH cleavage). Furthermore, significant levels of N-H oxazolidin-2- 
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Scheme 4.3e: Solid phase enolate alkylation o f  150 mg o f solid-supported N-propionyl oxazolidin-2-one 145, 
with subsequent cleavage o f a 20 mg portion o f resin with 1% TFA and 5% TIS in DCM to give crude 
reaction products that were analysed via LC/UV and HPLC analysis to determine product composition and 
de respectively. Remaining 120 mg alkylated resin treated with LiOOH to give acid  (/?)-65, with the ee of 
chiral products being determined by chiral HPLC.
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Entry
Reaction conditions ° Composition o f crude product from TFA 
cleavage ( % ) b
D e of 
1 4 7 c
(%)
Method d, yield e 














2 hr with 
LHMDS 
then 12 hr 
with BnBr.





30 min with 
LHMDS, 






3 10 LHMDS then 12 hr 
with B nB r/
57 38 0 5 68 Not cleaved
Table 4.3b: Investigating the effect o f  reducing the reaction temperature, increasing the excess o f
reagents used and increasing the duration.
a Reaction conducted as follows: Stated equiv. o f  LHMDS added to 150 mg pre-swollen resin 145 in 6  mL dry 
THF at -15 °C and stirred fo r  the stated amount o f  time before addition o f  BnBr (when 3 equiv. o f  LHMDS 
employed then 5 equiv. o f  BnBr used, when 10 equiv. o f  LHMDS employed then 20 equiv. o f  BnBr used). 
Reaction stirred fo r  a further stated period o f  time a t -15 °C then quenched. b Crude product decomposition 
determined by LCMS and LC-UV analysis. c De determined by HPLC analysis o f  crude product o f  TFA 
cleavage o f  20-50 mg portion o f  resin after benzylation reaction. d Side-chain cleavage reaction employed  
LiOOH as the nucleophile. e Isolated yield  after appropriate work-up, based upon calculated loading o f  N-H  
oxazolidin-2-one 1 onto 2-CI-Trt resin with y ield  quoted over three steps -  N-acylation, enolate alkylation 
and side-chain cleavage. * Ee determined by HPLC analysis o f  side-chain cleaved product after appropriate 
work-up. g Reaction conducted as before but resin sealed within an IRORI mini-Kan™ in 10 mL dry THF.
iv) Increasing the excess of reagents...
As increasing the reaction duration appeared to give inferior yields, an alternative method 
o f driving the enolate alkylation reaction to completion was attempted. One o f the 
frequently quoted advantages o f using solid phase chemistry for synthesis is the 
opportunity to use a large excess o f reagents to drive a reaction to completion using excess 
reagents that are removed by simple filtration o f the polymer supported products. Hence, 
following a slight variation o f the method of Burgess, A-propionyl oxazolidin-2-one resin 
145 was treated with 10 equivalents o f LHMDS at -15 °C for 30 min. before addition o f 20 
equivalents o f benzyl bromide and subsequent stirring at the same temperature for a further 
50 minutes (see Table 4.3b, entry 2). A s seen previously for short duration reactions at -15 
°C, there was still a significant amount o f unreacted A-propionyl oxazolidin-2-one 144
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remaining (15%), indicating that despite the large excess o f reagents, the reaction had once 
again not proceeded to completion. Despite this, the diastereoselectivity o f  the reaction 
was very high, with a de o f 90% (85% ee after LiOOH cleavage). A lso pleasingly the 
levels o f N-H  oxazolidin-2-one 1 and A-benzyl-oxazolidin-2-one 149 arising from these 
conditions were greatly decreased.
v) Increasing the reaction duration...
Repetition o f these reaction conditions for a longer duration (12 hours) (see table 4.3b, 
entry 3) resulted in complete consumption o f all the A-propionyl starting material 144, but 
did not result in increased levels o f a-benzylated product 149 being produced with a 
dramatic decrease in the observed levels o f diastereoselectivity (68% de). It should be noted 
that for this reaction (and subsequent ones) the enolate alkylation reaction procedure 
needed to be altered. Previously, the A-propionyl oxazolidin-2-one functionalised polymer 
had been reacted by stirring loose resin in a 25 mL flask using a magnetic flea. For short 
duration experiments this was acceptable, however excessive magnetic stirring o f cross- 
linked polystyrene resins was not advisable for prolonged periods because it resulted in 
‘grinding’ o f the resin beads.
vi) The use of Irori Kans ™
In order to protect the resin beads, during these prolonged duration experiments, IRORI 
mini-Kan™ reactors were used for synthesis. IRORI Kan™ microreactors are a fam ily o f  
small polypropylene capsules with polypropylene mesh side walls and cap. The resin is 
placed inside the Kan whose mesh walls are designed to encapsulate the resin yet still allow  
solvated reagents to enter and react with the resin-bound reagents in a normal manner. In 
this way the resin is kept away from the magnetic stirrer bar and hence normal laboratory 
glassware and magnetic stirring facilities can be used (see Fig 4.3a). These Kans were 
originally designed to be used with a radiofrequency ‘tag’ encased within them however in 
this work the reactions were conducted individually and therefore this means o f
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identification was not required. It should be noted that in order to fully submerge the resin- 
filled Kan it was necessary to use an additional 4 ml of THF as solvent (10 ml in total). 
Therefore, the concentration of LHMDS in the reactions involving 10 equivalents LHMDS 
using IRORI Kan™ technology was actually only twice that of the reactions employing 3 
equivalents of LHMDS conducted previously with ‘loose’ resin in 6 mL of THF.
Fig 4.3a: Structure o f IRORI kan ™ reactor and its use with magnetic stirring equipment.
From the above experiments it was noted that a significant amount of N-H oxazolidin-2-one 
1 was being formed, presumably from enolate decomposition, and as a consequence 
concerns were raised over the conditions used to quench the reaction. Previously, solid 
phase enolate alkylations had been quenched by addition of 2 mL saturated ammonium 
chloride solution with no fixed time period observed between the quench and filtration of 
the resin. It was proposed that the addition of water to excess LHMDS present at the end of 
the alkylation reaction might produce LiOH that could inadvertently result in nucleophilic 
side chain cleavage on prolonged contact with the resin. Although never observed in 
solution phase, there was a possibility that this might explain the greater than expected 
amount of N-H oxazolidin-2-one auxiliary 1 being observed in our polymer-supported 
enolate alkylation reactions. It was therefore decided to quench all subsequent enolate 
alkylation reactions with 0.16 M pH 7 phosphate buffer to limit the effects of any LiOH 
formed and also to filter, wash and dry the alkylated resin immediately after quenching. 
However, repetition of some of the experiments described above, employing this new 
quench method did not result in any significant alteration in either the crude product 
composition, or the diastereoselectivity observed.
At this stage, it became apparent that extensive reaction optimisation would be required to 
develop optimal reaction conditions for solid supported asymmetric enolate alkylation
Mesh side walls 
allow resin to react 
with reagents in 
solution
Resin sealed inside kan
I
Resin in kan can be reacted in 
round bottomed flask with 
magnetic stirrer bar
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reactions. The results already gained had demonstrated a good correlation between the 
measurements o f the de o f 147 and ee o f (.R)-65 , so it was concluded that it was no longer 
necessary to perform both measurements. Therefore, the stereoselectivity o f all subsequent 
enolate alkylation optimisation reactions was determined using TFA cleavage o f a small 
portion of resin enabling the de o f 147 to be determined in the usual manner.
vii) Changing the order of reagent addition...
To further explore the unwanted occurrence o f enolate decomposition on polymer support, 
the effect o f changing the order o f addition o f reagents was investigated. In all the reactions 
previously described, the enolate had been preformed before addition o f the electrophile 
(benzyl bromide) since this was the procedure favoured for solution phase enolate 
alkylations. This order is generally employed to avoid prolonged contact between the base 
and electrophile as some electrophiles can undergo unwanted elimination reactions under 
strongly basic conditions. However, this method relies on the enolate being sufficiently 
stable to survive the ‘deprotonation’ period before addition o f  the electrophile. Although 
this was the case in the solution phase enolate alkylation reactions o f A-acyl-oxazolidin-2- 
ones previously investigated, it was not necessarily the case on solid phase since it was 
possible that the solid-supported enolate was decomposing before addition o f the 
electrophile. It was therefore reasoned that formation of the enolate in the presence o f the 
electrophile might be beneficial since the electrophile would be present to intercept the 
enolate the instant it was formed, thus hopefully preventing the competing enolate 
decomposition pathway. As benzyl bromide is not a base-sensitive electrophile the model 
transformation could be conducted in this manner without any concerns regarding reagent 
compatibility.
Oxazolidin-2-one functionalized resin 145 (in an IRORI mini-Kan™) in a solution o f THF 
and 20 equivalents o f benzyl bromide was treated with 10 equivalents o f LHMDS at -15 °C 
followed by stirring for 12 hours (see Table 4.3c., entries 1 and 2). However, there was no 
sign o f any reduction in the occurrence o f enolate decomposition as demonstrated by N-H
104
oxazolidin-2-one 1 comprising around 40% of the crude product mixture. Furthermore 
there was no significant change in the diastereoselectivity of 147 suggesting there is no 
significant difference between pre-formation of the enolate and generating the enolate in 
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Scheme 4.3f: Solid phase enolate alkylation o f  150 mg o f solid-supported N-propionyl oxazolidin-2-one 145, 
with subsequent cleavage o f a 20 mg portion o f resin with 1% TFA and 5% TIS in DCM to give crude 
reaction products which were analysed via LC/UV and HPLC analysis to determine product composition and
Entry
Reaction conditionsa Composition of crud cleavag















20 equiv. BnBr 
first, then LHMDS 
12 h
50 43 0 7 68
2 10
20 equiv. BnBr 
first, then LHMDS 
12 h
58 42 0 0 76
Table 4.3c: a Reaction conducted as follows: 10 equiv. LHMDS added to 150 mg pre-swollen resin 145 in 
IRORI mini-Kan™ in solution o f  20 equiv. BnBr and 10 mL dry THF at -15 °C. Reaction stirred fo r  12 hours 
at -15 °C then quenched. b Crude product decomposition determined by LCMS and LC-UV analysis. c De 
determined by HPLC analysis o f crude product following TFA cleavage o f 20-50 mg portion o f  resin after 
alkylation reaction.
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viii) Investigating enolate decomposition and N-benzyi formation.
However, whilst these experiments (and those previously discussed) revealed that enolate 
decomposition is prevalent in these polymer-supported enolate alkylation reactions, the 
amount of W-benzyl auxiliary 149 formed was always significantly smaller than the amount 
o f A'-H oxazolidin-2-one 1 and rarely comprised more than 7% of the crude product 
mixture. Consideration of the proposed mechanism for decomposition o f enolates of N- 
acyl-oxazolidin-2-ones (see Scheme 4.3g) reveals that removal of the side chain fragment is 
proposed to occur via loss of ketene 118 to afford an oxazolidin-2-one fragment with an 
anionic nitrogen atom. The lithiated anion o f the parent oxazolidin-2-one 170 is then free to 
react with excess benzyl bromide to form the yV-benzyl species 150, or it may react with a 
proton source (presumably upon aqueous quenching of the alkylation reaction) to form the 
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Scheme 4.3g: a) Formation and decomposition o f  enolate o f  N-propionyl oxazolidin-2-one to afford N- 
lithiated oxazolidin-2-one 170 and ketene 118. b) Quenching o f  N-lithiated oxazolidin-2-one 170 with BnBr to 
form N-benzyl-oxazolidin-2-one 150 or protonation to afford N-H-oxazolidin-2-one 2.
Under the reaction conditions investigated so far, there had always been an excess of 
benzyl bromide present. Therefore, it appears that the yV-lithiated oxazolidin-2-one 170 
does not react readily with benzyl bromide under these conditions and persists unreacted
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until quenched by water at the end o f the alkylation reaction. This suggests that 170 is 
relatively stable at low temperatures and hence alkylation with benzyl bromide is slow. A  
review o f the literature supports this observation since A-benzylation o f lithium anions o f 
oxazolidin-2-ones generally requires reaction at room temperature.83,84
This feature is advantageous for the potential recycling o f the solid-supported chiral 
auxiliary. As discussed earlier, whilst the formation of A-H oxazolidin-2-one 2 in the 
enolate alkylation reaction is clearly not desirable as it reduces the yield o f alkylated 
product, it is not disastrous as it does no permanent damage to the auxiliary fragment which 
can simply be re-acylated and reused in the resin’s next cycle. However, formation of the 
A-benzyl oxazolidin-2-one 150 results in irreversible alkylation o f the polymer supported 
oxazolidin-2-one fragment which results not only in a decrease in the yield o f a-benzylated 
product 148 in the current reaction cycle, but also a decrease in the amount o f chiral 
auxiliary available for subsequent reactions using that batch o f resin. As the ultimate aim 
o f this study was to create a reusable solid-supported chiral auxiliary, significant levels o f  
A-benzyl formation would be highly detrimental to the system’s success. Therefore, the 
observation that A-benzyl-oxazolidin-2-one 150 formation is slow, even with a large excess 
o f benzyl bromide was highly encouraging.
ix) Summary to date...
Considering all the results discussed above, the following conclusions were drawn.
1) Enolate decomposition is occurring extensively, even at -15 °C over short durations, 
resulting in significant amounts o f A-H oxazolidin-2-one 2. Fortunately A- 
benzylation o f the lithium anion o f 2 is slow therefore only a small amount o f A- 
benzyl-oxazolidin-2-one is formed even when extensive enolate decomposition 
occurs.
2) Both the yield and de o f  the alkylated product appear to diminish with time.
3) The use o f large excesses o f reagents appears to consume all o f the A-propionyl 
oxazolidin-2-one 145 starting material, and encourage the alkylation reaction to 
proceed to completion.
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x) Multiple treatments with reagents
The next strategy investigated aimed to use multiple treatments involving sequential 
treatments with LHMDS and BnBr, in the hope that all the starting material would be 
reacted over a series of short reaction times. This strategy had been reported to have been 
employed successfully for solid-supported oxazolidin-2-one mediated aldol reactions. 
Hence, /V-propionyl resin 145 in an IRORI kan™ was treated with 10 equivalents of 
LHMDS for 30 minutes at -15 °C before addition of 20 equivalents of benzyl bromide, and 
the reaction stirred for a further 60 minutes. The reaction solution was then removed from 
the reaction vessel via cannula, the resin re-suspended in fresh, pre-chilled THF and the 
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Scheme 4.3h: Solid phase enolate alkylation o f 150 mg o f solid-supported N-propionyl oxazolidin-2-one 
145, with subsequent cleavage o f a 20 mg portion o f  resin with 1% TFA and 5% TIS in DCM to give crude 


















1 10 then BnBr,60 min.
(3 x treatment)
LHMDS, 30 min.
63 25 7 5 81
2 10 then BnBr, 60 min.
(3 x treatment)
22 59 13 7 78
Table 4.3d: Investigating effect of multiple treatments of resin with reagents.
a Reaction conducted as follows: 10 equiv. LHMDS added to 150 mg pre-swollen resin 145 in IRORI mini- 
Kan™ in 10 mL dry THF at -15 °C. Reaction stirred fo r 30 minutes before addition o f BnBr follow ed by 
stirring fo r  60 minutes at -15 °C. Reaction solution then removed from vessel via cannula and resin 
resuspended in 10 mL fresh, dry THF that had been pre-chilled to -15 °C. Reaction cycle repeated a further 2 
times. b Crude product decomposition determined by LCMS and LC-UV analysis. c de determined by HPLC 
analysis o f crude product o f TFA cleavage o f 20-50 mg portion o f resin after alkylation reaction.
Initially these modified conditions appeared relatively successful with 63% of the crude 
product being the desired a-benzylated product 147 with a relatively good de (81%) (see 
Table 4.3d, entry 1). There was still a significant amount of N-H oxazolidin-2-one 1 
present (25%) but only trace amounts of the undesired N-benzyl 149 and N-propionyl 144 
auxiliaries. However, upon repetition of this reaction (see Table 4.3d, entry 2), 
dramatically different product composition results were achieved, with a very poor 
conversion to a-benzylated product (22%) and extensive enolate decomposition. Further 
repetitions of this experiment revealed that although these conditions were capable of 
producing good results, it was very capricious, presumably due to the high level of physical 
manipulation involved over the three cycles of this protocol. This afforded many 
opportunities for contamination of the reaction which was already known to be temperature 
and moisture sensitive. So, although with care this procedure might prove to be effective, a 
simpler experimental procedure was clearly desirable.
xi) Epimerisation of the N-alkylated product?
These results again suggested that short reaction durations were required to ensure high 
levels of diastereoselectivity as the de of the alkylated product appeared to decrease with
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time. This trend was also briefly commented on by Burgess et al.25 but no reference was 
made to the relevant time-scale or any explanation offered for this loss of stereocontrol. As 
the de of the a-benzylated product 147 is high after a short duration, the enolate alkylation 
reaction must be proceeding with high diastereoselectivity. This suggests that the decrease 
in de of the a-benzylated product 147 that occurred over longer durations might be due to 
epimerisation of the newly formed chiral centre of the benzylated product 148 rather than 
poor diastereoselectivity in the initial enolate benzylation reaction. It would therefore 
appear that the excess base used to effect enolate formation was also causing epimerisation 
of the a-benzylated product over time. Under normal solution phase conditions, it is 
reported that a-alkylated products are stable to the presence of excess base remaining after 
enolate formation. This is because the a-alkylated oxazolidin-2-one has to adopt a 
conformation that positions its a-proton orthogonal to the exocyclic carbonyl group for 
enolate formation to occur, as depicted in Fig. 4.3b. W hilst conformers B and C meet the 
stereoelectronic requirement for enolisation to occur, they are much higher in energy than 
conformer A due to 1,3-allylic strain interactions between the oxazolidin-2-one fragments 
and Ri and R2 substituents of the acyl fragment. Therefore, the energetically more 
favourable conformer A predominates in solution, and as a consequence enolisation does 
not occur and the a-stereocentre is stable under basic conditions.
A V    AV' _  A V
 ^  ^ H R2 ^ R 2 ^ H  R2
R 171 R 171b R rac-171
A  cM caA
A B C
Fig. 4.3b: Epimerisation via enolisation o f the a-stereocentre o f  171 is unlikely to occur due to allylic strain. 
Conformers B and C meet the stereoelectronic requirement fo r  enolisation but are higher in energy than 
conformer A which disfavours enolisation.
A comprehensive review of the literature could find no reports on epimerisation of a- 
alkylated A-acyl-oxazolidin-2-ones by excess base present in enolate alkylation reactions. 
However, most solution phase reactions of this type only employ a small excess o f base 
(typically 1.1 to 1.5 equivalents) and it is possible that the large excess of base (3 or 10
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equivalents) used to drive my solid phase alkylation reaction to completion, could also 
result in epimerisation occurring despite unfavourable interactions caused by allylic strain.
If this theory was correct, and the excess o f base was indeed causing epimerisation o f the a- 
benzylated product on solid phase, then it was reasoned that a simple alteration to the 
reaction protocol should eliminate this problem. Therefore it was reasoned that simply 
removing excess base from the reaction vessel after formation o f the solid-supported 
enolate, but before addition o f the electrophile, would prevent the excess base from ever 
being in contact with the a-benzylated product 148. If successful, this would still allow a 
large excess o f reagents to be used to drive the reaction to completion but would eliminate 
the epimerisation problem.
A-Propionyl oxazolidin-2-one resin 145 encased in an IRORI mini-kan™ was therefore 
treated with 10 equivalents o f LHMDS at -15 °C for 2 hours. After this time, the reaction 
solvent containing the excess base that surrounded the Kan was removed via cannula. The 
resin was then resuspended in fresh, dry THF pre-chilled to -15 °C and treated with 20 
equivalents o f benzyl bromide for 12 hours. Gratifyingly, the de o f the a-benzylated 
product 147 was high (89% de) (see Table 4.3e, entry 1) and comparison o f this result with 
those obtained in control reactions under similar conditions, but without removal o f the 
excess base (see Table 4.3e, entries 2 and 3), demonstrated that removal o f the excess base 
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Scheme 4.3j: Solid phase enolate alkylation o f  150 mg o f solid-supported N-propionyl oxazolidin-2-one 145, 
with subsequent cleavage o f a 20 mg portion o f resin with 1% TFA and 5% TIS in DCM to give crude 
reaction products which were analysed via LC/UV and HPLC analysis to determine product composition and
Entry Reaction conditionsa
Composition of crud 
cleavae














1 10 LHMDS, 2 h, drain then BnBr, 12 h. 65 26 3 6 89
2 10 LHMDS, 2h. then BnBr, 12 h. 55 38 0 7 74
3 10 BnBr, then LHMDS, 12 h. 50 43 0 7 68
Table 4.3e: Investigating the order the addition o f  reagents and the effect o f  removing excess base from  
the reaction solution before addition o f  the electrophile
a Reaction conducted as follows: 10 equiv. LHMDS added to 150 mg pre-swollen resin 145 in IRORI mini- 
Kan™ in 10 mL dry THF at -15 °C. Reaction stirred for stated period o f time before removal o f reaction 
solution via cannula. Resin resuspended in 10 mL fresh, dry THF that had been pre-chilled to -15 °C, BnBr 
added and reaction stirred fo r  a further time period as stated. b Crude product decomposition determined by 
LCMS and LC-UV analysis. c De determined by HPLC analysis o f  crude product o f  TFA cleavage o f 20-50 
mg portion o f  resin after alkylation reaction.
To confirm that the decrease in the de of the alkylated product with time was indeed due to 
epimerisation o f the newly formed chiral centre of 148 by excess LHMDS, a control 
experiment was conducted. Diastereomerically pure (>99% de) N-alkylated oxazolidin-2- 
one fragment 147 that had been prepared in solution phase was immobilised onto 2- 
chlorotrityl chloride resin under standard conditions, albeit in a poor 33% yield (Scheme
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4.3k). Collection and evaporation of the washings after filtration of the resin yielded 
impure a-benzyl-147 contaminated with DIPEA, which after washing with 1.0 M HC1 (aq) 
afforded pure a-benzyl-147. ’H-NMR and HPLC analysis of 147 confirmed a >99% de, 
showing that the a-benzylated fragment had not been epimerised under the immobilisation 
conditions. Additionally, in order to calculate the loading and to again confirm that no 
epimerisation had occurred upon immobilisation, a portion of resin 172 was cleaved via 















Scheme 4.3k: Immobilisation o f a-benzylated oxazolidin-2-one 147 onto 2-chlorotrityl chloride resin.
This diasteromerically pure functionalised resin 172 (in an IRORI mini-kan™ ) was then 
treated with 10 equivalents of LHMDS at -15 °C in THF for 12 hours, under analogous 
conditions to those of the extended enolate alkylation reactions (see Scheme 4.3m). The 
resin 173 was then cleaved (1% TFA, 5% TIS, DCM) to afford diastereomeric product 147, 
which HPLC analysis revealed a de of 75%. This reaction therefore confirms that excess 














147 Ratio 9 :  1
Scheme 4.3m: Treatment o f  functionalised resin 172 with 10 equivalents LHMDS at -15 °C fo r 12 hours and 
subsequent TFA cleavage o f  resulting resin 173 demonstrates that enolisation o f  alkylated product 172 results 
in both epimerisation o f  147 and enolate decomposition to N-H oxazolidin-2-one 1.
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In addition to the partially epimerised a-benzylated product 147, some N-H  oxazolidin-2- 
one 1 was observed. Again, this indicates that enolisation of the alkylated product has 
occurred, with a small proportion of the enolate decomposing to its parent oxazolidin-2-one 
(see Fig 4.3c).
R R
Fig. 4.3c: Mechanism o f enolisation o f alkylated product by excess LHMDS with subsequent enolate
decomposition and formation ofN -H  oxazolidin-2-one and ketene.
xii) Solution phase enolate epimerisation and decomposition studies...
To investigate the epimerisation reaction further and to confirm that its occurrence was not 
purely associated with the solid phase nature of the enolate alkylation reactions studied 
herein, solution phase time-course studies were then conducted.
Hence diasteromerically pure a-benzyl-oxazolidin-2-one 115 was treated with 10 
equivalents of LHMDS in THF at -15 °C over a period of 12 hours (see Scheme 4.3n) and 
aliquots of the reaction mixture taken at regular intervals and quenched with pH7 phosphate 
buffer. !H-NMR analysis of the crude reaction product allowed the relative amounts of 
epimerised-A-alkylated product 174 and N -H oxazolidin-2-one 103 to be determined. The 
crude reaction product was then cleaved with LiOOH (generated in situ from H2O2 and 
LiOH) in THF / H2O solution. The crude product, consisting of both N -H oxazolidin-2-one 
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-1 5  °C, THF 
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Scheme 4.3n: Solution phase decomposition studies: Diasteromerically pure oxazolidin-2-one 115 was
treated with 10 equiv. LHMDS at -15 °C in 8  mL dry THF fo r  12 hours with the crude product composition 
o f aliquots sampled over time determined by 'H-NMR spectroscopy. Crude reaction product then cleaved 
using LiOOH and the ee o f the resulting 2-benzylpropanoic acid 65 determined by HPLC.
Time (min.) ee of acid (% )a a-benzylated oxazolidin-2-one 174 remaining (% )b
A^-H-oxazolidin-2-one 103 
formed (%)
0 100 100 0
15 93 83 17
30 90 82 18
60 81 82 18
120 74 78 22
240 65 78 22
480 62 74 26
Table 4.3f: Solution phase decomposition studies. Diastereomerically pure a-benzyl-oxazolidin-2-one 115 
treated with 10 equiv. LHMDS and subsequent epimerisation /  enolate decomposition monitored. a Ee o f acid 
determined by HPLC. b Percentage o f crude product as determined by 1H-NMR.
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Fig 4.3d: Graph to show epimerisation o f  a-benzylated-115 with time upon treatment with 10 equivalents o f  
LHMDS at -15 °C, as demonstrated by determination o f  the ee o f  2-benzyl-propionic acid  65 recovered after 
LiOOH treatment o f epimerised-a-benzylated-Yl4.
These solution phase studies clearly demonstrate that the ee of the acid product formed was 
decreasing, indicating epimerisation of the newly formed stereogenic centre of a-benzyl- 
oxazolidin-2-one 174 over time (see Fig. 4.3d). It would appear that initially the rate of 
epimerisation (which is itself indicative of the rate of enolisation) is relatively fast, but that 
it decreases with time until a constant level is achieved. This implies an equilibrium is 
reached between the two diastereomers, in which the ‘m ajor’ diastereomeric product of the 
enolate alkylation reaction is more thermodynamically favoured (see Fig. 4.3e).
Fig 4.3e: Epimerisation o f the diastereomeric product o f  enolate alkylation favours the ‘m ajor’
diastereomeric product as it minimises steric repulsion between the bulky R group and the electrophile.
In an additional solution phase experiment, a 1:1 mixture of the two diastereomers 115 and 
124 were treated with 10 equivalents o f LHMDS for 12 hours at -15 °C, which upon work­
up afforded a mixture of diastereomers with a de of 16% in favour of the major 
diastereomer.
'Major' d ia s te r e o m e r
R R
'Minor' d ia s te r e o m e r
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9 o o o
A.-V A -V
1 0  eq u iv .
115 R/  LHM D S 115 .
5 0 %  T H F , 1 2  h +  5 8 %
-15<C
124
5 0 % 4 2 %
Fig 4.3f: Epimerisation o f a 1:1 mixture o f diastereomers o f  a-alkylated oxazolidin-2-one results in a 
diastereoenriched product mixture.
Any consideration of the de obtained in these epimerisation reactions must consider the fact 
that lithium enolates generally exist as aggregates. Lithium is usually tetra-coordinated, 
however it is reported that the degree of aggregation depends less upon the particular
o c
enolate structure than upon solvent and the presence of other complexing reagents.
In the epimerisation reactions under consideration (see Scheme 4.3f), there are several 
different species capable of participating in a higher order aggregation state (see Fig 4.3g). 
It should also be noted that the enolate o f the a-alkylated product is also prone to 
decomposition to afford the lithiated oxazolidin-2-one and ketene, further complicating the 
nature of the potential aggregation species.
O  OLi O  O<vv <yv* m * »“»* a. i4  * M, K  * thf w  x
H R R V, r 2 Ri
Fig 4.3g: Species present in solution phase epimerisation o f a-alkylated product reaction that could be 
involved in aggregation states.
These species are capable of forming various pure and mixed aggregates, with the potential
o c
for each aggregate having a different reactivity / decomposition profile. It is possible 
therefore that the ratio of products reached in the deprotonation (and hence epimerisation) 
of a-alkylated-oxazolidin-2-one is due to the formation of stable heterochiral aggregates 
corresponding to the ratio of diastereomers obtained. Furthermore, the formation of 
different ‘m ixed’ aggregation states may account for the propensity of the a-alkylated
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product to undergo deprotonation in the presence of an excess of LHMDS, yet remain 
configurationally stable with one equivalent of base.
This decomposition study therefore explains the observation that removal of the excess 
base before addition of the electrophile is beneficial to the solid-supported enolate 
alkylation reactions because it prevents enolisation of the a-benzylated product, 
consequently preventing epimerisation and enolate decomposition. However, the issue of 
/V-propionyl enolate decomposition still remained and as a consequence, N-propionyl 
oxazolidin-2-one 110 was treated with 10 equivalents o f LHMDS at -15 °C for 8 hours, 
with aliquots being removed at intervals and quenched (see Scheme 4.3p).
110
NH
1 0  e q u iv . LHM DS
- 1 5 ° C ,  THF  
1 2  h.
110 103
Scheme 4.3p: Solution phase decomposition studies: N-propionyl oxazolidin-2-one 110 treated with 10 equiv. 
LHMDS and subsequent enolate decomposition to N-H oxazolidin-2-one monitored over time.








Table 4.3g: Solution phase decomposition studies. N-propionyl oxazolidin-2-one 110 treated with 10 equiv. 
LHMDS and subsequent enolate decomposition monitored by ‘H-NMR analysis.
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Fig. 4.3h: Graph to show percentage o f N-propionyl oxazolidin-2-one 110 remaining at a given time when N- 
propionyl oxazolidin-2-one is treated with 10 equivalents o f  LHMDS at -15 °C.
Unsurprisingly, it was found that the enolate formed by deprotonation of the /V-propionyl 
oxazolidin-2-one 110 by LHMDS was prone to decomposition (see Table 4.3g, Fig. 4.3h), 
with a trend being observed in which decomposition occurred very quickly in the initial 
stages of the reaction, then appeared to stabilise at around 75%. Again, this could be due to 
the formation of a stable aggregation state involving the anions of /V-propionyl and N -H 
oxazolidin-2-ones in a 7:1 ratio, with other possible complexing species present being the 
eliminated ketene fragment and the secondary amine formed from protonation of LHMDS.
In both the solution phase enolisation reactions investigated in this section, aggregates of 
lithium enolates and other complexing reagents have been proposed to be directly involved 
in the reaction and reactivity and stereoselectivity of the lithium enolates of /V-acyl- 
oxazolidin-2-one. However, the situation with solid phase lithium enolates is more 
complicated. It is often reported that immobilisation of a species onto a rigid, cross-linked
o z
polymer support results in reactive site isolation. This approach has been proposed to be 
useful as an alternative to the solution phase ‘high-dilution’ effect for the synthesis of 
molecules prone to polymerisation. Conversely, it has also been demonstrated that site-site
o<7 o o
interactions on polymer support can occur to some extent Rapoport and Scott both 
demonstrating that the majority of functionalised sites on 1% and 2% DVB-crosslinked 
polystyrene can interact. It is therefore feasible that aggregation between polymer-
119
supported lithium enolates could be achieved. Regardless o f site-site interactions, it is 
certainly possible for solid-supported enolates to form aggregated states with solution phase 
components, however it is possible that these interactions may not be identical to those 
formed in the corresponding solution phase system due to the presence o f the polystyrene 
support. Overall, it must be concluded that proof o f the nature o f any higher-order, 
aggregated states in solution and solid phase reactions, cannot be made without a great deal 
o f further experimentation and analysis in this area.
xiii) Bringing it ail together...
In order to develop optimal reaction conditions for the model asymmetric enolate alkylation 
reaction, it was necessary to reconsider the information discovered in these studies.
The key observations were
1) Both the yield and de o f the alkylated product diminished with time due to 
enolisation o f the alkylated product by the excess LHMDS present. However, both 
issues could be avoided by removal o f the excess LHMDS solution from the resin 
after enolate formation before addition o f the electrophile.
2) Partial decomposition o f the enolate o f the N-propionyl oxazolidin-2-one appears 
inevitable due to the large excesses of base required for efficient enolate formation, 
even at -15 °C over short durations
Following on from the previous optimisation reaction investigating the effect o f removal o f  
the excess base (see Table 4.3h, entry 1), it was found that a 65% yield o f a-benzylated 
product 147 could be achieved with a de o f 89% when the polymer-supported N-acyl- 
oxazolidin-2-one 145 was treated for 2 hours with LHMDS which was then drained 
followed by a 12 hour reaction o f the enolate with benzyl bromide. However, this resulted 
in 26% N -H oxazolidin-2-one 1 being formed by enolate decomposition and it was 
reasoned that this might be further reduced by decreasing the duration o f the enolate 
formation step. Indeed decreasing the enolate formation period to 30 minutes and 
decreasing the total reaction duration to a total o f 80 minutes (Table 4.3h, entry 2), did 
result in a slight decrease in the amount o f N -H oxazolidin-2-one 1 formed, although it also
120
resulted in some starting material jV-propionyl oxazolidin-2-one 144 remaining. This result 
was very encouraging as the yield and de of the alkylated product were high (63% and 95% 
respectively). To confirm these values, LiOOH side chain cleavage was also conducted 
and 2-benzylpropionic acid (R )~65 isolated in good yield (59%) and excellent ee (96%).
1452-CI-Trt
LDA or 
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Scheme 4.3q: Solid phase enolate alkylation o f 150 mg o f solid-supported N-propionyl oxazolidin-2-one 
145, with subsequent cleavage o f a 20 mg portion o f  resin with 1% TFA and 5% TIS in DCM to give crude 
reaction products which were analysed via LC/UV and HPLC analysis to determine product composition and 
de respectively. Remaining 120 mg alkylated resin treated with LiOOH to give acid (R)-6S, with the ee o f 
chiral products being determined by chiral HPLC.
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Entry
Reaction conditions a Composition o f crude product from TFA 
cleavage (% )b
De o f  















( R ) - 65
1 10
LHMDS, 2 h at 
-15 °C, drain, then 
BnBr for 
12 h at -15 °C.
LHMDS, 30 min at 
-15 °C, drain, then
65 26 3 6 89 Notcleaved
59%
2 10 BnBr for 30 min at 
-15 °C, then 20 min 
warming from -15 °C 
to rt
LHMDS, 30 min at 
0 °C, drain then BnBr











3 10 for 5 min at 0 °C, 
then 20 min warming 
from 0 °C to rt.
LHMDS, 30 min at 
0 °C, drain then BnBr
77 20 0 2 96
4 3 for 5 min at 0 °C, 
then 20 min warming 
from 0 °C to rt
70 24 2 3 95
Table 4.3h: Investigating the effect o f  removing the excess o f  base, raising the temperature and decreasing 
the reaction duration.
a R e a c t i o n  c o n d u c t e d  a s  f o l l o w s :  1 0  e q u i v .  o f  L H M D S  w a s  a d d e d  t o  1 5 0  m g  p r e - s w o l l e n  r e s i n  145 s e a l e d  i n t o  
I R O R I  m i n i - k a r i ™  i n  8  m L  d r y  T H F  a t  s t a t e d  t e m p e r a t u r e  a n d  s t i r r e d  f o r  t h e  s t a t e d  a m o u n t  o f  t i m e  b e f o r e  
r e m o v a l  o f  t h e  r e a c t i o n  s o l u t i o n  v i a  c a n n u l a .  T h e  r e s i n  w a s  r e s u s p e n d e d  in  8  m L  f r e s h ,  d r y  T H F  a n d  B n B r  
a d d e d  ( w h e n  3  e q u i v .  o f  L H M D S  u s e d  t h e n  5  e q u i v .  o f  B n B r  u s e d ,  w h e n  1 0  e q u i v .  o f  L H M D S  u s e d  t h e n  2 0  
e q u i v .  o f  B n B r  u s e d ) .  R e a c t i o n  s t i r r e d  f o r  a  f u r t h e r  s t a t e d  p e r i o d  o f  t i m e  a t  s t a t e d  t e m p e r a t u r e  t h e n  
q u e n c h e d .  b C r u d e  p r o d u c t  d e c o m p o s i t i o n  d e t e r m i n e d  b y  L C M S  a n d  L C - U V  a n a l y s i s .  c D e  d e t e r m i n e d  b y  
H P L C  a n a l y s i s  o f  c r u d e  p r o d u c t  o f  T F A  c l e a v a g e  o f  2 0 - 5 0  m g  p o r t i o n  o f  r e s i n  a f t e r  a l k y l a t i o n  r e a c t i o n .  d 
I s o l a t e d  y i e l d  a f t e r  a p p r o p r i a t e  w o r k - u p ,  b a s e d  u p o n  t h e  c a l c u l a t e d  l o a d i n g  o f N - H  o x a z o l i d i n - 2 - o n e  o n t o  2 -  
C l - T r t  r e s i n  r e p r e s e n t i n g  y i e l d  o v e r  t h r e e  s t e p s  -  N - a c y l a t i o n ,  e n o l a t e  a l k y l a t i o n  a n d  s i d e - c h a i n  c l e a v a g e .  e 
E e  d e t e r m i n e d  b y  H P L C  a n a l y s i s  o f  s i d e - c h a i n  c l e a v e d  p r o d u c t  a f t e r  a p p r o p r i a t e  w o r k - u p .
In an effort to drive the enolate alkylation reaction to completion without extending the 
reaction time, the reaction was repeated at 0 °C rather than -15 °C (see Table 4.3h, entry 3). 
It was hoped that the elevated temperature, although likely to cause an increase in the rate 
o f enolate decomposition, would also result in an increase in the rate o f the desired 
alkylation reaction. Therefore, resin 145 was treated with 10 equivalents o f LHMDS at 0 
°C for 30 minutes, the solvent and excess base removed via cannula, and then 20  
equivalents o f BnBr added at 0 °C. The reaction was stirred for a further 5 minutes at 0 °C
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and then allowed to warm to room temperature over a period of 20 minutes. Gratifyingly, 
excellent results were achieved with a-benzylated product 147 comprising a high 77% yield 
o f the crude product of TFA cleavage and a very high de of 96% achieved. There was no 
evidence of a decreased diastereoselectivity due to the increase in temperature or an 
increase in the amount of A-benzyl oxazolidin-2-one 149 formed. Again LiOOH side-chain 
cleavage was conducted to afford 2-benzylpropionic acid (R )-65 in 69% yield and 95% ee. 
In a final attempt to further improve the conditions, the excess of base (and hence the 
concentration) was reduced to establish whether this would result in less enolate 
decomposition at the elevated temperatures being used. However, repeating the previous 
reaction with 3 eq LHMDS gave results that were similar to those obtained when 10 
equivalents of LHMDS were employed (see Table 4.3h, entry 4) but with a slightly lower 
yield of a-benzylated product 147 (70% of crude product mixture, corresponding to 63% 
isolated yield after LiOOH cleavage).
These results were now deemed satisfactory -  a-benzylated product 147 could be prepared 
cleanly (see Fig. 4.3j) and in reasonable conversions considering the apparently inevitable 
decomposition of the enolate 145b to A-H oxazolidin-2-one with excellent levels of 
diastereoselectivity (see Scheme 4.3r).
1 0  eq u iv . LHM DS  
0  °C , 3 0  min. 
Drain
2 0  equ iv . BnBr 
0  °C , 5  min then  
2 0  min, 0  °C to  rt
8  mL THF
77  %  conv. 
9 6  %  de2-CI-Trt 2-CI-Trt
145 148
NH





69  %  yield 
95  %  ee
(/?)-65
Scheme 4.3r: Optimised reaction conditions developed fo r  model transformation. 10 equivalents o f  LHMDS 
added to 150 mg N-propionyl resin 145 in IRORI mini-kan (resin preswollen in 8mL THF) at 0 °C and stirred 
at this temperature fo r  30 min. Reaction solution then removed via cannula and resin re-suspended in 8  mL 
fresh, pre-chilled THF. 20 equivalents o f BnBr added and reaction stirred at 0 °C fo r  5 minutes, then 
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Fig 4.3j: 2-benzylpropionic acid (R)-65 prepared via asymmetric enolate alkylation o f solid supported N- 
propionyl-oxazolidin-2-one 145 with benzyl bromide, with subsequent cleavage o f  the acid product via 
LiOOH hydrolysis.
4.4 Conclusions
To conclude, as depicted in Scheme 4.3r, reaction conditions had been developed that 
allowed an a-benzylated carboxylic acid to be prepared in acceptable yield and excellent 
de. It should be noted that although 10 equivalents of LHMDS and 20 equivalents of 
benzyl bromide were employed in these small scale reactions, only slightly reduced yields 
were gained using 3 equivalents of LHMDS and 5 equivalents of benzyl bromide. 
Therefore, if the use of such large excesses was undesirable, either due to safety concerns 
or reagent cost, the method could be easily adapted to use lower concentrations of reagents 
with relatively small losses in yield.
In developing these conditions, an understanding of the factors affecting solid-supported 
asymmetric enolate alkylation reactions was gained, including the conflicting temperature 
and time requirements for enolate reactivity versus enolate decomposition. It was found 
that enolate decomposition was inevitable if complete enolisation was to occur and hence 
quantitative yields of a-alkylated products were unlikely to be obtained. In addition the
124
discovery was made that excess base can cause epimerisation o f the newly formed chiral 
centre o f the a-alkylated product.
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Chapter 5: Application of solid-phase enolate alkylation reaction 
conditions to other systems
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5.5 An alternative polymer-supported oxazolidin-2-one for asymmetric enolate
alkylations. 152
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5.1 Alternative N-acyl-oxazolidin-2-ones and electrophiles
Having optimised reaction conditions for the asymmetric alkylation o f the enolate o f a 
polymer-supported N-propionyl oxazolidin-2-one 145 with benzyl bromide (see Scheme 
4.3r), it was necessary to determine whether these conditions could be applied successfully 
to other types o f polymer-supported iV-acyl-oxazolidin-2-ones and electrophiles.
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Benzyl brom ide Allyl iodide Methyl iodide
Scheme 5.1a: Proposed array o f  enolate alkylation reactions to be conducted according to the previously 
optimised protocol (see Section 4.3)
The proposed array (depicted in Scheme 5.1a) was comprised of four different N-acyl 
oxazolidin-2-ones (N-propionyl, N-isovaleryl, N-hexanoyl and N-hydrocinnamoyl) and 
three different electrophiles (benzyl bromide, allyl iodide and methyl iodide). This 
selection of reactive components aimed to explore the scope and limitation of the solid 
supported asymmetric enolate alkylation reaction conditions developed for the model 
reaction.
In order to establish the diastereoselectivity of the reactions it was necessary to have 
authentic samples of the two possible a-alkylated diastereomers in each case. In this array, 
it was decided that analysis of the diastereomeric products would be carried out by cleavage 
o f the alkylated product resin with 1% TFA since this would afford chiral products 
containing a 4-benzyl-oxazolidin-2-one fragment with a chromophore that was easily 
detectable by HPLC with UV detection.
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It was therefore necessary to prepare authentic 1:1 mixtures of two possible diastereomeric 
products of each alkylation reaction in solution phase. The general strategy was to prepare 
racemic a-alkylated acid corresponding to the desired side-chain, activate it as an acid 
chloride by refluxing with thionyl chloride (SOCI2) and then use it to A-acylate an O- 
benzyl-protected N-U  oxazolidin-2-one followed by O-benzyl deprotection to expose the 
phenol moiety (scheme 5.1b).
0  i) LDA (2.1 eq u iv .) 0
-dSr -°V
E
SOC I2, DCM  
0 °C  to reflux







Scheme 5.1b: General strategy fo r preparation o f  1:1 mixtures o f  diastereomeric products o f enolate
alkylation reactions. Appropriate carboxylic acid a-alkylated via treatment with 2.1 equiv. LDA and 
appropriate electrophile. Racemic a-alkylated acid then activated as acid chloride by refluxing with SOCI2 in 
DCM and added to lithium anion o f  N-H oxazolidin-2-one, followed by O-deprotection via catalytic 
hydrogenation.
In cases where the electrophile was either benzyl bromide or methyl iodide, the standard O- 
benzyl protected oxazolidin-2-one 103 was employed with the protecting group being 
removed in a facile, chemoselective manner by catalytic hydrogenation. However, when 
the electrophile employed was allyl iodide, this protecting strategy could not be employed 
as the O-deprotection conditions would also cause hydrogenation of the alkene 
functionality. For these substrates, an alternative TBDM S-protected oxaolidin-2-one 179 
was prepared by treatment of 1 with TBDMS-C1 using imidazole and DMAP as 
nucleophilic catalysts. Deprotection was achieved highly selectively by brief treatment 
with terabutylammonium fluoride (TBAF) (see Scheme 5.1c).
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Scheme 5.1c: Strategy fo r  the preparation o f  1:1 mixtures o f diastereomeric products o f  enolate alkylation
treatment with 2.1 equiv. LDA and appropriate electrophile. Racemic a-alkylated acid then activated as acid 
chloride by refluxing with SOCl2 in DCM and added to lithium anion o f  O-TBDMS-oxazolidin-2-one, 
followed by O-deprotection with TBAF.
The 1:1 mixtures of diastereomers thus gained (see Fig 5.1a) were then used to develop 
HPLC conditions that caused baseline separation of the two peaks (see experimental 
procedure for compound-specific details).
Fig 5.1a: Pairs o f  diastereomers that were prepared in 1:1 ratio via solution phase techniques described 
above, with yield over two steps -  N-acylation o f  protected oxazolidin-2-one with racemic acid and 
deprotection. NB: Diastereomers all have configuration 4(S)-2-rac-.
reactions where the reaction products included an allyl moiety. Appropriate carboxylic acid a-alkylated via
r a c -1 8 0  r  = o h  
r a c -1 4 7  R » X c
Previously prepared
r a c - 1 81 r  = o h  
r a c -1 9 4  r  = x c
64 % yield
r a c -1 82  r  = o h  
r a c -1 9 5  R = X c
70 % yield
r a c - 1 83  R = OH  
r a c - 1 9 6  R = x c
66 % yield
r a c -1 8 4  r  = o h  
r a c -1 9 7  R -  Xc
75 % yield
O r\
r a c A  8 5  R = OH 
r a c -1 9 8  R = Xc
72 % yield
r a c -1 8 0  r = o h  r a c -1 8 6  r = oh
ra c - 1 4 7  r  = x c  r a c -1 9 9  r = Xc
Previously prepared 72 % yield
r a c -1 8 7  r  = o h  
ra c -2 0 0  R -  Xc
68 % yield
r a c -1 8 8  r  = o h  
ra c -2 0 1  R = Xc
66 % yield
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Confident that the diastereoselectivity of each polymer supported alkylation reaction could 
now be determined by HPLC analysis of the mixture of a-alkylated diastereomers resulting 
from cleavage of the resin with 1% TFA, a series of solid phase asymmetric enolate 
alkylation reactions were then conducted. Each experiment was carried out using the 
conditions previously optimised for the A-propionyl / benzyl bromide combination (see 
Scheme 5 .Id) with the results being described in Table 5.1a. In each case the reaction was 
conducted on 150 mg A-acyl-oxazolidin-2-one resin and for characterisation purposes 
following the alkylation reaction, a 20 mg portion o f each alkylated resin was treated with 
1% TFA and 5% TIS in DCM to cleave the diastereomeric products of the polymer- 
supported enolate alkylation reaction and allow determination of the de of the alkylated 
products via HPLC analysis. The remaining resin (approx. 130 mg) was then treated with 
LiOOH (made in situ from H2O2 and LiOH) in THF / H2O to hydrolyse the side-chain and 
afford the corresponding a-alkylated acid that was recovered after acidic aqueous 
extraction, thus allowing the isolated yield of the reaction to be determined.








,0 10 eq u iv . LHM DS  
0°C , 3 0  min. 
Drain■R
2 0  eq u iv . E-X 
0°C , 5  min then  
2 0  m in, 0°C  to rt
a m L T H F
2-CI-Trt 2-CI-Trt
Scheme 5.Id: Reaction conditions fo r  array o f enolate alkylation reactions, employing four different solid- 
supported N-acyl oxazolidin-2-ones and three different electrophiles.
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45% yie ld c
Table 5.1a: Table to show de o f  each o f the products o f  the array o f  asymmetric solid-supported enolate 
alkylation reactions and the yield o f  acid recovered after LiOOH cleavage. Reaction conditions as detailed 
in Scheme 4.3r. Yield o f acid calculated from mass o f acid recovered and based upon the calculated loading 
o f N-H oxazolidin-2-one onto 2-CI-Trt resin thus representing yield over three steps -  N-acylation, enolate 
alkylation and side-chain cleavage. De determined by HPLC analysis o f  the crude reaction product after TFA 
cleavage o f 20 mg resin with 1% TFA. Where de  = 99%, no trace o f minor diastereomer could be observed. a 
No splitting o f  the peak fo r the two diastereomers could be achieved so de was not determined. b HPLC 
dominated by unidentified impurity, so no de could be gained. c Acid product contaminated with 3-phenyl- 
propionic acid, arising from LiOOH cleavage o f unreacted starting material.
Overall, the results from the array of ten polymer-supported enolate alkylation reactions 
were successful with each of the acid products being formed in acceptable yields. 
Although the ee o f the resulting acids was not measured due to the lack o f UV 
chromophore in some products rendering them ‘invisible’ to the UV detector of the HPLC 
instrument, the de of the preceding diastereomeric products were generally found to be high 
(87 -  99% de). As it has been shown that the LiOOH cleavage method used proceeds 
without epimerisation, it can be concluded that the ee values of the acids would be 
correspondingly high. The reactions employing methyl iodide as electrophile gave slightly 
lower levels of diastereoselectivity (87 -  95% de) than the analogous reactions employing 
allyl iodide or benzyl bromide, as expected given its lower steric demands.
W hilst this series of experiments employed a carefully selected array of /V-acyl fragments 











97% de 99% de 90% de
69% yield 52% yield 48% yield
194 196 200
a 99% de 99% de
61% yield 60% yield 58% yield
197 201
N/A 90% de 95% de
42% yield 53% yield
131
supported N-isovaleryl-oxazolidin-2-one and the relatively unreactive electrophile methyl 
iodide is particularly noteworthy. It is proposed therefore that the conditions developed for 
these enolate alkylation reactions should also be applicable to more complex //-acyl 
fragments and more functionalised electrophiles.
To conclude, my optimal reaction conditions developed for the model N-propionyl /  benzyl 
bromide system have been shown to be applicable to the enolate alkylation reactions o f four 
different N-acyl oxazolidin-2-ones with three different (reactive) electrophiles. A s a result 
nine a-alkylated carboxylic acids were prepared in acceptable yield with good levels o f  
stereocontrol. The results gained here would therefore allow the preparation o f useful 
amounts o f chiral a-alkylated products o f high ee in quantities adequate for screening 
purposes.
5.2 Recycling of resin
An important feature o f any successful solid-supported chiral auxiliary is its ability to be 
recycled. This helps to make the overall system more cost-effective after the initial 
expense o f preparing the polymer-supported oxazolidin-2-one is factored into the equation. 
It had already been demonstrated that recycling o f the polymer-supported oxazolidin-2-one 
2 should be possible. Reaction conditions had been developed to allow high yielding N- 
acylation, and asymmetric enolate alkylation reactions, with final LiOOH to remove the 
entire side-chain fragment via an exocyclic pathway, regenerating the solid-supported N -H 
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Scheme 5.2a: Theoretical recycling o f solid-supported oxazolidin-2-one 2, including unwanted formation o f  
N-alkyl oxazolidin-2-one 205 which cannot be recycled
However, one issue that was likely to have a detrimental effect on the recycling process 
was the possibility of competing formation of N-alkyl oxazolidin-2-one 205 from reaction 
o f excess electrophile with the N-lithiated oxazolidin-2-one product arising from enolate 
decomposition. The N-alkyl bond of 205 would not be cleaved during the nucleophilic 
cleavage reaction so would permanently ‘cap’ the oxazoldin-2-one preventing it from 
participating in any further enolate alkylation reactions thus reducing the total number of 
chiral auxiliary fragments available for reaction.
Formation of this type of N-alkyl-oxazolidin-2-one species had been minimised by the 
optimisation process, but as enolate decomposition could not be completely eliminated it 
was inevitable that a small amount of the N-alkyl oxazolidin-2-one (typically < 5 %  per 
cycle) would be formed.
A recycling scheme (as represented in Scheme 5.2a) was therefore proposed in which the 
same batch of resin would be subjected to four sequential reaction cycles. Three of these
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cycles would combine a different A-acyl-oxazolidin-2-one with a different electrophile, 
thus allowing any cross-contamination between sequential reaction cycles to be identified. 
These combinations were selected from the array o f enolate alkylation reactions 
investigated in the previous section as this would allow comparison o f yields and de values 
between the reactions performed on ‘recycled’ resin and those carried out previously on 
‘fresh’ resin. Additionally, the first and final cycle would employ identical reagents thus 
allowing for a direct comparison between two identical reactions on the first and fourth 
cycle o f the same batch o f resin.
Hence a series o f  four solid-supported asymmetric enolate alkylation reactions cycles 
(comprising A-acylation, alkylation and side chain cleavage) were conducted on the same 
batch  o f 2-Cl-Trt-supported oxazolidin-2-one resin, according to the reaction protocols 
described in Scheme 5.2b and Table 5.2a. Characterisation o f the oxazolidin-2-one species 
was achieved at each stage by cleaving a 20 mg portion o f resin with 1% TFA and 5%  TIS 
in DCM. The de o f the alkylation reactions was determined by HPLC analysis o f  the crude 
diastereomeric oxazolidin-2-one species after cleavage and comparison with authentic 
samples o f 1:1 mixtures o f the two possible diastereomers.
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O - 0  205
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Q - °  204
Cl-Trt
1 % TFA,
5 equiv. LiOOH 
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S id e -c h a in  not c le a v a b le  
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Scheme 5.2b: R e s i n  r e c y c l i n g  i n v e s t i g a t i o n .  Four successive enolate alkylation reaction cycles (comprising 
N-acylation, enolate alkylation and LiOOH side-chain cleavage) conducted on the same batch o f 2-Cl-Trt- 
supported oxazolidin-2-one 2 with different combinations o f N-Acyl-oxazolidin-2-ones and electrophiles. N- 
acylation reactions employed either the appropriate acid or the anhydride according to the standard method 
detailed in Section 3.3. Enolate alkylation reactions conducted according to the conditions optimised fo r  the 
model N-propionyl /  benzyl bromide reaction, described in Scheme 4.3r. LiOOH side chain cleavage 
reactions conducted according to Section 3.4.2b. Identification o f  the oxazolidin-2-one species at each step 
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Table 5.2a: Identity o f  N-acyl-oxazolidin-2-ones and electrophiles in the four cycles o f  the resin recycling 
investigation and the corresponding results. Four successive enolate alkylation reaction cycles (comprising  
N-acylation, enolate alkylation and LiOOH side-chain cleavage) conducted on the same batch o f  2-Cl-Trt- 
supported oxazolidin-2-one 2 with different combinations o f  N-Acyl-oxazolidin-2-one and electrophile. 0 D e  
determined by HPLC analysis o f  the crude reaction product after cleavage o f  20 mg resin with 1% TFA. b 
Previous de obtained fo r  identical reaction on fresh oxazolidin-2-one resin, see Section 5.1. c Isolated y ie ld  o f  
acid after work-up, based upon the calculated loading o f  N-H oxazolidin-2-one onto 2-CI-Trt resin 
representing yield  over three steps -  N-acylation, enolate alkylation and side-chain cleavage. d Previous yield  
obtained fo r  identical reaction on fresh oxazolidin-2-one resin, see Section 5.1. e HPLC dominated by  
unidentified impurity so de could not be determined.
From the results gained (see Table 5.2a) it appears that 2-Cl-Trt-supported oxazolidin-2- 
one 2 can be recycled four times with no apparent loss in diastereoselectivity in the enolate 
alkylation step. In each case, the de obtained was similar to that obtained previously using 
‘fresh’ oxazolidin-2-one resin. To highlight this, the first and fourth cycle employing 
identical reagents produced essentially identical de values for the production o f 147. 
However, the yield o f the reaction did decrease between each progressive cycle with the 
combined reactions o f the fourth cycle producing a 38% yield for formation o f (R )-65  
compared to the identical reactions o f the first cycle which gave a 69% yield o f (R)-65. 
Analysis o f the N-H  oxazolidin-2-one 1 after cleavage o f a 20 mg portion at the end o f  each 
cycle by 1 H-NMR, showed an increasingly more complex spectrum between each reaction. 
The 1 H-NMR spectra o f the N-H  oxazolidin-2-one fragments cleaved after the first and 
fourth cycles are shown in Figs. 5.2a,b. The principle impurities introduced appear to 
produce peaks in the aromatic region and also between 5 1.0 and 1.5 ppm, which are likely  
to be a result o f resin decomposition. It is also likely that some o f the reduction in purity 
observed was due to the accumulation o f small quantities o f A-alkyl oxazolidin-2-one 
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Fig. 5.2a: 1 H-NMR spectrum o f  N-H oxazolidin-2-one fragment 1 cleaved from 2-CI-Trt resin after first 
reaction cycle i.e. N-acylation, enolate alkylation and LiOOH side-chain cleavage.
NH
HO
7.5 7 .0 6.5 6.0 5.0 3 .5 3 .0 2.5 2.0 1.5 1.0 0.5 ppm5.5 4.5 4.0
Fig 5.2b: 1H-NMR spectrum o f N-H oxazolidin-2-one fragment 1 cleaved from 2-CI-Trt resin after four 
reaction cycles. Each cycle consists o f N-acylation, enolate alkylation and LiOOH side-chain cleavage.
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Importantly there was no evidence of any cross-contamination between products arising 
from different cycles (see Figs 5.2c,d,e,f). However, the 1 H-NMR spectrum of (/?)-2- 
benzyl propionic acid (R)-65  produced after the fourth cycle (Fig. 5.21) was clearly less 
pure than that produced after the first cycle (Fig. 5.2c). This may imply that even with 
efficient side-chain cleavage between each cycle, some side-products / contaminants 
accumulate on polymer-support between each cycle that can contaminate the acidic product 
o f LiOOH side-chain cleavage. However, this effect was not noted until after the third 
cycle, and the extent of contamination was not large.
HO'
(R)-65
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 2.0 1.5 0.53.0 2.5 1.0
Fig. 5.2c: 'H-NMR spectrum o f  (R)-2-benzylpropionic acid produced in first cycle o f  recycling scheme.
HO'
(S)-184
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Fig 5.2e: 'H-NMR spectrum o f (S)-2-benzylpent-4-enoic acid produced in the third cycle o f the recycling 
scheme.
HO'
0.5 ppm7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
Fig. 5.2f: ‘H-NMR spectrum o f (R)-2-benzylpropionic acid produced in the fourth cycle o f the recycling 
scheme.
To conclude, it had been shown that the polymer-supported oxazolidin-2-one 2 could be 
recycled at least four times without a reduction in stereoselectivity. However, possibly due 
to the slow accumulation of N-alkyl oxazolidin-2-one (as a result o f enolate 
decomposition), the purity of the products produced from polymer-supported oxazolidin-2- 
one decrease with each cycle. This also leads to a progressive reduction in the isolated 
yield of the side-chain cleaved acid products between each cycle due to reduction in the
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number of N -H oxazolidin-2-one fragments available for reaction on polymer support. A  
reduction in purity o f the acid product prepared after the fourth cycle was also observed, 
however acceptable results were gained for the first three cycles o f the resin. Therefore, it is 
proposed that polymer-supported oxazolidin-2-one 2 may be used at least three times thus 
increasing its cost-effectiveness significantly.
5.3 Development of a Merrifield resin supported oxazolidin-2-one auxiliary
The ultimate aim o f this work was to develop a synthetically useful solid-supported 
oxazolidin-2-one chiral auxiliary that was efficient and user-friendly. In order to decrease 
the cost even further, it was proposed that the relatively expensive and highly acid-sensitive 
2-chlorotrityl-chloride resin might be replaced with cheap, robust Merrifield resin.
As discussed earlier (see Chapter 3.1), Merrifield resin was not considered ideal for the 
optimisation o f reaction conditions as the intermediate a-benzyl-A-acyl-oxazoldin-2-one- 
diastereomers (or enolate decomposition products) could not be easily cleaved for analysis 
due to the harsh acidic conditions required to cleave the benzylic ether linker o f this type o f  
resin. Hence, the only method available to establish the success o f the asymmetric enolate 
alkylation would be via side-chain cleavage and determination o f the isolated yield and ee 
o f the resulting side chain fragment. It was proposed that the conditions optimised for the 
2-chlorotrityl-chloride supported chiral auxiliary 2 might also be applicable to Merrifield 
supported auxiliary and therefore a second round of extensive method development would  
not be necessary. However, Burgess had previously reported significantly inferior results 
when employing a Merrifield-supported oxazolidin-2-one auxiliary for asymmetric enolate 
alkylation reactions in comparison to a Wang-supported oxazolidin-2-one (50-55% for 
Merrifield, 85-90% for Wang), thus implying that resin type could dramatically affect the 
performance o f the entire system.25
Hence a Merrifield resin supported oxazolidin-2-one auxiliary 72a was prepared by 
immobilisation o f A-H oxazolidin-2-one fragment 1 onto Merrifield resin according to the
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method of Hallman et al. (see Scheme 5.3a).89 It should be noted that attempts to employ 
/V-propionyl oxazolidin-2-one fragments for immobilisation by this method resulted in N- 
acyl side-chain cleavage under the reaction conditions.
K2C 0 3 (3  e q u iv .)  
18 -c ro w n -6
r e p r e s e n te d  a s
/ DM F ~ " 0
\ 6 0 °C , 1 8 h rs 0 ~  0'' 3  eq u iv .
L /  7 2 a
1 eq u iv .
Merrifield
Scheme 5.3a: Immobilisation o f  oxazolidin-2-one auxiliary 1 onto Merrifield resin.
M errifield
7 2 a
IR analysis (KBr disc) o f the resin revealed a characteristic carbonyl peak at 1754 cm ' 
indicating that oxazolidin-2-one had been immobilised onto the resin, but determination of 
the loading of oxazolidin-2-one auxiliary onto the M errifield resin was, as anticipated, 
difficult to establish. Previously the loading of 2-chlorotrityl-chloride resin-bound 
oxazolidin-2-one had been estimated by the mass of recovered oxazolidin-2-one fragment 
after acidic cleavage of the linker attaching the auxiliary to the resin. However, for 
Merrifield resin, the conditions required for complete cleavage of the oxazolidin-2-one 
fragment were significantly harsher than for 2-chlorotrityl chloride resin. Treatment of 
oxazolidin-2-one functionalised Merrifield resin 72a with 50% TFA in DCM for 30 
minutes did result in cleavage o f some oxazolidin-2-one 1 corresponding to a loading of 
0.21 m m olg'1 (20%) that was estimated by 1 H-NMR analysis after addition of a known 
amount of crotonic acid as an internal standard. This very low value implied either a low 
loading of the oxazolidin-2-one onto the resin or incomplete cleavage of the benzylic ether 
linker. Indeed, repetition of the cleavage process on the same batch of resin afforded more 
oxazolidin-2-one 1 (approx. 0.014 mmol) giving a total resin loading of 33%. In fact it was 
found that 1 could still be recovered in low yields after a fourth treatment of the resin with 
TFA in DCM for 30 minutes. Employing lengthier reaction times involving treatment of a 
fresh batch of functionalised resin with 50% TFA in DCM for two hours did cleave a 
greater proportion of oxazolidin-2-one from the polymer, but also gave a significant
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quantity of resin-derived impurities. It was therefore concluded that resin loading could not 
be determined reliably using this cleavage method.
Hence resin loading was estimated roughly by gravimetric analysis involving measurement 
of the mass gained by the resin in the immobilisation reaction after thorough drying in a
calculated. However, it is important to note that the optimised reaction conditions for the 
subsequent solid-phase reactions (/V-acylation, enolate alkylation and side chain cleavage) 
were such that a large excess of reagents were always employed and hence it was not vital 
to determine the exact loading of the oxazolidin-2-one fragment onto M errifield resin.
Acylation of Merrifield supported oxazolidin-2-one 72a was achieved according to the 
same procedure described previously for 2-chlorotrityl chloride resin (see Section 3.3) 
employing propionic anhydride, triethylamine and lithium chloride in refluxing THF (see 
Scheme 5.3b). Analysis of the resin by IR (KBr disc) revealed the presence of two 
carbonyl groups (1704 cm '1 and 1784 cm '1) indicating that A-acylation had occurred.
Scheme 5.3b: N-acylation ofN -H  oxazolidin-2-one functionalised resin 72a employing propionic anhydride, 
triethylamine and lithium chloride
Alkylation of the enolate of Merrifield-bound A-propionyl oxazolidin-2-one with benzyl 
bromide under the optimised conditions established for the 2-chlorotrityl-supported 
oxazolidin-2-one 2 (see Scheme 5.3c) afforded 2-benzylpropionic acid in a disappointing 
38% yield and 35% ee after LiOOH cleavage. Further repetitions of this experiment did 
not result in any improvement on these results.
vacuum oven for 24 hours at 40 °C. In this way resin loadings of 0.75 -  0.95 m m olg'1 were
M errifield M errifield
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Scheme 5.3c: Model enolate alkylation reaction performed on Merrifield-supported oxazolidin-2-one 73a.
It therefore appears that the type of resin employed as a polymer-support for the A-acyl- 
oxazolidin-2-one fragment has a profound effect on the diastereoselectivity o f the 
asymmetric enolate alkylation reaction. It should be noted that in this investigation, the 
Merrifield resin employed was 2% DVB-crosslinked rather than the usual 1% DVB- 
crosslinked resin. It is known that the extra degree of cross-linking in 2% DVB resins 
results in increased rigidity yet this is normally considered beneficial as it allows more 
stringent reaction conditions to be used and often results in more reproducible results.66 
However, in hindsight, this extra rigidity may also have interfered with the ability o f the 
polymer-supported enolate to adopt the correct conformation required to attain good levels 
of diastereoselectivity. Unfortunately no details were provided by Burgess et al. as to the 
degree o f cross-linking of the Merrifield resin employed in their study.
Although it was disappointing that the reaction conditions developed for 2-chlorotrityl- 
resin were not directly transferable to Merrifield resin, the 2-chlorotrityl-supported 
oxazolidin-2-one system still represents a useful polymer for the preparation of a-alkylated 
carboxylic acids and their derivatives in acceptable yields.
5.4 Development of a polymer-supported SuperQuat auxiliary
The 2-chlorotrityl polymer-supported Evans oxazolidin-2-one chiral auxiliary described 
allowed for the preparation of a-alkylated V-acyl-oxazolidin-2-ones in high de with 
subsequent nucleophilic cleavage of the side-chain giving chiral a-alkylated products in 
high enantiopurity. In order to prepare the carboxylic acid products, it was found necessary
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to use LiOOH as the nucleophile rather than LiOH as the latter was found to cause a 
significant amount of endocyclic cleavage on solid support. Not only did this competing 
pathway reduce yields of the desired product, the LiOH also destroyed the oxazolidin-2-one 
ring rendering the chiral auxiliary fragment non-recyclable. It was also possible that 
repeated treatment of the functionalised resin with LiOOH might be responsible for the 
accumulation of contaminants observed after 4 reaction cycles on the same batch o f resin, 
as seen during the recycling study (see Chapter 5.2). Additionally, the products prepared in 
this study were relatively simple structures, and the proportion of cleavage proceeding via 
the endocyclic cleavage pathway is known to increase as the steric demand of the acyl 
fragment increases, particularly when bulky substituents are present at the a-position.
It was reasoned that a polymer-supported SuperQuat auxiliary might address this potential 
issue. The family o f SuperQuat auxiliaries which includes 5,5-dimethyl oxazoldin-2-one 
211, (see Fig. 5.4a) were originally designed to act as chiral auxiliaries in much the same 
way as Evans oxazolidin-2-one auxiliaries, but are less prone to endocyclic cleavage. This 
is due to the C-5 geminal dimethyl substituents blocking the Burgi-Dunitz angle of attack 
of nucleophiles at the endocyclic carbonyl. The approaching nucleophile is therefore more 
likely to attack the relatively less-hindered exocyclic carbonyl (see Fig. 5.4a).
Fig. 5.4a: a) SuperQuat auxiliary 211 and b) SuperQuat auxiliary discourages cleavage at endocyclic 
carbonyl due to unfavourable steric interactions between the gem-dimethyl substituents at C-5 and the 
incipient nucleophile.
Solution phase studies have shown that A-acyl-oxazolidin-2-ones derived from the
onSuperQuat auxiliary do not exhibit any sign o f endocyclic cleavage, even for aggressive 
nucleophiles such as LiOH or NaOH. The use of a polymer-supported SuperQuat- 
oxazolidin-2-one auxiliary would therefore potentially eliminate the need to use LiOOH in
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the preparation of carboxylic acids and ensure complete selectivity during nucleophilic 
cleavage for the exocyclic carbonyl. A further advantage of SuperQuat auxiliaries is their 
ability to be cleaved using DIBAL-H to allow direct preparation of aldehyde side-chain
DIBAL-H cleavage results in extensive endocyclic cleavage. Finally it has been claimed 
that higher diastereoselectivities can be gained using SuperQuat auxiliaries for enolate 
alkylation reactions in solution phase when compared to their Evan’s-style counterparts. 
For example, comparative studies involving methylation of the enolates of A-acyl-5,5- 
dimethyl-4-isopropyloxazolidin-2-one 212 and the corresponding Evans-type analogue 213 
(see Scheme 5 .4 a )92 revealed a significantly higher de for the SuperQuat system.
corresponding Evans-type analogue 213 in which a higher level o f  diastereoselectivity is achieved for  
SuperQuat 212 compared to Evans-type auxiliary 213.
It was shown by nOe studies, that in SuperQuat derived A-acyl-oxazolidin-2-ones, steric 
interactions between its C-5 dimethyl substituent and the methyl groups of the C-4 
isopropyl substituent, results in one of the methyl groups of the isopropyl group being 
orientated directly beneath the plane o f the enolate (conformer II) (see Fig. 5.4b). This 
effect is more pronounced than in the corresponding Evans-type auxiliary where there is 
reduced steric interaction due to the smaller C-5 substituents and hence conformer II is less 
favoured. In both cases, conformer II is more effective at blocking electrophilic attack 
from the bottom face and therefore the SuperQuat chiral auxiliary results in improved
o 9
diastereoselectivity.
products.91 This is in contrast to Evans oxazolidin-2-ones, where attempts to perform
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Fig 5.4b: Rationale behind the improved diastereoselectivity that has been observed for 5,5-dimethyl
oxazolidin-2-one (SuperQuat) auxiliaries when compared to their Evans oxazolidin-2-one counterparts. 
Steric hindrance between the C-5 syn methyl group and the C-4 methyl substituents o f the isopropyl group 
results in positioning o f  the methyl groups directly beneath the enolate, thus providing greater steric 
hindrance to the approaching electrophile and increasing diastereoselectivity.
However, it has also been reported that the enolate of 5,5-dimethyl-oxazolidin-2-one was 
less stable than that of the corresponding Evans oxazolidin-2-one and was therefore more 
prone to decomposition which would result in lower yields of desired a-alkylated product 
on polymer support. Therefore, in order to investigate these effects, a polymer-supported 
SuperQuat auxiliary was prepared and its application to enolate alkylation reactions 
investigated.
A SuperQuat auxiliary fragment 217 suitable for immobilisation onto resin was easily 
prepared (Scheme 5.4b) by variation of the procedure previously used for the preparation of 
the Evans oxazolidin-2-one fragment 1 (see Section 2.2.1). Hence, bis-benzylated /V-Boc 
tyrosine 106 was prepared by treatment of A-Boc tyrosine 105 with an excess of benzyl 
bromide and potassium carbonate. The introduction of a gem -dimethyl groups was easily 
achieved by treatment of the benzyl ester with 4 equiv. of methylmagnesium bromide to 
form gem-dimethyl alcohol 215. As before, attack of the alkoxide (formed by 
deprotonation of the alcohol with NaH) onto the carbonyl of the Boc group results in 
formation o f the oxazolidin-2-one ring 216. Finally, catalytic hydrogenation to remove the
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benzyl ether protecting group exposes the phenol group necessary for immobilisation to 
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Scheme 5.4b: Synthesis o f SuperQuat (5,5-dimethyl oxazolidin-2-one) auxiliary fragment.
Immobilisation of 217 onto 2-chlorotrityl chloride resin proceeded as before (see Section 
3.2) with a loading of 1.06 m m olg1 (88% yield) being determined as described previously 
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Scheme 5.4c: Immobilisation o f  SuperQuat auxiliary fragment 217 onto 2-chlorotrityl chloride resin.
Loading estimated by mass o f recovered auxiliary after TFA cleavage o f  an aliquot o f  resin.
Acylation of the polymer bound 5,5-dimethyl oxazolidin-2-one with propionic or isovaleric 
anhydride (with triethylamine and lithium chloride) or hydrocinnamic acid (with DCC and 
DMAP) (Scheme 5.4d) also proceeded smoothly and in comparable yield to the Evans 
oxazolidin-2-one analogue described previously (219 92% yield, 220 90% yield, 221 85% 
yield).
4  eq u iv . 









LiCI, Et3N , THF
or c)
HO''^v / ^ > h  
D C C , D M A P, DCM
2-CI-Trt
219 R = Me
220 R = CH(CH3)2
221 R = Bn
Scheme 5.4d: N-acylation o f 5,5-dimethyl-oxazolidin-2-one with a) propionic anhydride or b) isovaleric 
anhydride, triethylamine and lithium chloride or c) 3-phenylpropionic acid, DCC and DMAP.
To confirm that the solid-supported N-acyl-5,5-dimethyl oxazolidin-2-one was not prone to 
endocyclic cleavage, a nucleophilic side chain cleavage reaction employing 10 equivalents 
of LiOH was conducted. Under these conditions it had previously been noticed that the 
solid-supported Evans-type N-isovaleryl-oxazolidin-2-one 151 underwent significant 
endocyclic cleavage resulting in reduced yields of the acid product and destruction of the 
oxazolidin-2-one ring (see Scheme 5.4e).
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Scheme 5.4e: Nucleophilic side chain cleavage o f solid-supported N-isovaleryl-oxazolidin-2-one 151 with 10 
equivalents o f LiOH.
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Scheme 5.4f: Nucleophilic side chain cleavage o f  solid-supported N-isovaleryl-5,5-dimethyloxazolidin-2-one 
220 with 10 equivalents o f  LiOH.
Therefore, solid supported A-isovaleroyl 5,5-dimethyloxazolidin-2-one 220 was prepared 
by yV-acylation of 5,5-dimethyloxazolidin-2-one 218 using isovaleric anhydride (see 
Scheme 4.6.2d) with TFA cleavage of an aliquot of the resin showing A-acylation had 
proceeded with 90% yield. Resin 220 was then treated with 10 equivalents o f LiOH for 12 
hours to afford isovaleric acid in 80% yield (see Scheme 5.4f). Cleavage of the residual 
resin with 1 % TFA in DCM to remove the entire oxazolidin-2-one fragment from the resin 
revealed the exclusive presence of 5,5-dimethyloxazolidin-2-one with no sign of any N- 
acyl-P-amino alcohol 223 resulting from endocyclic cleavage. Therefore this provides 
conclusive evidence that SuperQuat derived A-acyl-oxazolidin-2-ones afford superior 
cleavage properties to their corresponding Evans’ type oxazolidin-2-ones
Alkylation of the enolate of polymer-supported SuperQuat-A-propionyl-oxazolidin-2-one 
with benzyl bromide, according to the conditions optimised for the polymer-supported 
Evans-type oxazolidin-2-one (see Scheme 5.4g) afforded (/?)-2-benzylpropionic acid (R )- 
65 in poor yield (27%) but good ee (92%). Examination of the crude reaction product from 
1% TFA cleavage of an aliquot of the alkylated resin revealed predominantly jV-H 
SuperQuat-oxazolidin-2-one 217 (approx. 60%) with a trace of A-propionyl SuperQuat- 
oxazolidin-2-one 219 starting material and approximately 35% of the desired a-benzylated 
product 224.
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Scheme 5.4g: Enolate alkylation reaction o f solid supported N-propionyl-5,5-dimethyl-oxazolidin-2-one 219 
with benzyl bromide, according to the method optimised earlier fo r  the model transformation.
This reaction clearly demonstrated a considerably greater proportion of N-H  oxazolidin-2- 
one (60%) than for the corresponding Evans-type oxazolidin-2-one reaction (20%) 
suggesting that the enolate of the solid-supported SuperQuat 5,5-dimethyl-oxazolidin-2-one 
was less stable and more prone to decomposition (as had been reported previously in 
solution phase).92 However, the stereoselectivity achieved was similar for the two 
examples, (92% ee for SuperQuat and 95% ee for Evans), hence there is no evidence in this 
case of an improved diastereoselectivity for SuperQuat chiral auxiliary 218 arising from the 
presence of its gem-dimethyl C-5 substituents (see Fig. 5.4b)
To further examine the issue of improved diastereoselectivity, a second reaction was 
attempted using methyl iodide that had been shown to proceed with the lowest 
diastereoselectivity using our 2-chlorotrityl immobilised Evans-type oxazolidin-2-one. 
Hence, the enolate of polymer-supported N-3-phenylpropionyl 5,5-dimethyl-oxazolidin-2- 
one 221 was alkylated under similar conditions using methyl iodide, and the de/ee of the 
resultant polymer-supported products analysed in the usual manner (see Scheme 5.4h).
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Scheme 5.4h: Enolate alkylation reaction o f solid supported N-3-phenylpropionyl-5,5-dimethyl-oxazolidin-2- 
one 2 2 1  with methyl iodide, according to the method optimised earlier fo r  the model transformation.
Again, there appeared to be no significant difference in the level o f stereocontrol observed 
(SuperQuat 88% ee, Evans 87% ee) with the isolated yield obtained for (S)-2- 
benzylpropionic acid being lower for the SuperQuat-style chiral auxiliary (SuperQuat 35% 
yield, Evans 45% yield), once again implying a greater extent of enolate decomposition. 
This was confirmed by examination of the crude reaction product arising from 1% TFA 
cleavage of an aliquot of the a-benzylated SuperQuat resin revealed that a large amount of 
N-H  SuperQuat-oxazolidin-2-one 218 (approx. 50%) with a trace of A-3-phenylpropionyl 
SuperQuat-oxazolidin-2-one 221 starting material with only 40% of the desired alkylated 
product 225.
These initial results suggest that a polymer-supported SuperQuat chiral auxiliary e.g. 5,5- 
dimethyl-oxazolidin-2-one 218 can be applied to asymmetric enolate alkylation reactions 
and result in high levels of diastereoselectivity. However, it appears that the yields of 
chiral products obtained are lower than those achieved for the corresponding solid- 
supported Evans oxazolidin-2-one discussed earlier, presumably due to increased enolate 
decomposition of the SuperQuat based system. Early results would therefore suggest that 
the use of a polymer-supported SuperQuat does not represent an improvement to the solid- 
supported Evans oxazolidin-2-one system developed earlier. However, the solid-supported 
SuperQuat auxiliary would potentially have an advantage in some applications if the 
polymer supported a-alkylated A-acyl-oxazolidin-2-one product has a tendency to undergo 
endocyclic cleavage under nucleophilic side chain cleavage conditions. In addition, the 
option of using LiOH hydrolysis for side chain removal could offer advantages if the intent 
was to recycle the functionalised resin, as LiOH cleavage is reported to cause less
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decomposition of the polymer support and hence cleaner products compared to LiOOH 
hydrolysis.
5.5 An alternative polymer-supported oxazolidin-2-one for asymmetric enolate 
alkylations
W hilst this work was underway, an account on the use of an alternative polymer-supported 
oxazolidin-2-one auxiliary 226 for enolate alkylation reactions was reported by Kotake et 
a l,93 Initially a brief communication on this work appeared which was shortly followed by 
a full paper.94 Kotake et al. proposed that the difficulties experienced by others in 
achieving high levels of diastereoselectivity in asymmetric enolate alkylation reactions was 
due to the attachment of the oxazolidin-2-one auxiliary to the polymer support via the 
“critical chiral discriminating unit”, i.e. the bulky C-4 substituent. Hence they proposed a 
novel polymer-supported oxazolidin-2-one in which the C-4 substituent was liberated from 
the polystyrene backbone of the resin by attachment of the oxazolidin-2-one to the polymer 









Fig 5.5a: Design o f  a new oxazolidin-2-one auxiliary anchored at the 5-position developed by Kotake et al.
The reaction conditions employed for the solid-supported asymmetric enolate alkylation of 
oxazolidin-2-one 226 changed completely between their two published reports. In the 
earlier communication a Wang-supported oxazolidin-2-one resin 227 was treated with 2 
equivalents of LDA at 0 °C for 30 minutes before addition of 10 equivalents of the 
electrophile and stirring at 0 °C for a further three hours (see Scheme 5.5a, i). In the second 
paper, 3 equivalents of NaHMDS were employed for enolate formation at -78 °C for 1 
hour, before addition of 10 equivalents of the electrophile and stirring for 12 hours with 
gradual warming to 0 °C (see Scheme 5.5a, ii).
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Scheme 5.5a: N-acylation o f solid-supported oxazolidin-2-one 226 followed by i) Is' generation enolate 
alkylation employing 2 equivalents o f LDA at 0 °C fo r  3.5 hours 93 and ii) 2nd generation enolate alkylation 
employing 3 equivalents o f NaHMDS at -78 °C to 0 °C fo r  12 hours.94
Entry Ri R2X
Yield (% )a 
1st Gen. 2nd Gen.
ee (% )b 
1st Gen. 2nd Gen.
1 Bn Mel 48 61 85 85
2 Bn EtI - 50 8 8
3 Bn Allyl I 54 6 8 96 96
4 Me BnBr 40 70 97 97
5 Me 4-N 0 2BnBr - 55 97
Table 5.5a: Selected solid-phase enolate alkylation results from both 1st (2004) and 2" (2005) generation 
reactions. a Combined yield o f three steps starting from oxazolidin-2-one resin 226. b Determined by chiral 
HPLC analysis after conversion to the corresponding (S)-a-methylbenzylamine-derived amides.
Significantly higher yields were reported for the revised conditions employing NaHMDS, 
presumably because the sodium enolates of Af-acyl-oxazolidin-2-ones 227 at -78 °C were 
less prone to decomposition than the corresponding lithium enolates at 0 °C. However, the 
sodium enolates were still prone to enolate decomposition as demonstrated by the 
observation of approximately 8% N-allyl oxazolidin-2-one in the allylation reaction o f N-3- 
phenylpropionyl oxazolidin-2-one with allyl iodide, after cleavage of the auxiliary fragment
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from the resin via  methanolysis (see Table 5.5a, entry 3). The de values gained were also 
very high and roughly in accordance with the values observed in our studies.
In conclusion, Kotake et al. have reported on a successful polymer-supported oxazolidin-2- 
one with a novel anchoring strategy. However, the unnatural amino acid phenylnorstatine 
from which this oxazolidin-2-one is prepared is very expensive and not readily available, 
making this polymer-supported oxazolidin-2-one expensive to prepare. In addition, 
formation o f the unwanted A-alkyl oxazolidin-2-one during the enolate reaction (as in our 
system) reduces the ability to recycle the resin. Excellent levels o f diastereoselectivity 
were gained, although the assessment that this was due to attachment through the 5-position  
does not appear to be accurate since their de values are similar to those observed in our 
studies employing an oxazolidin-2-one attached to the polymer through its 4-position. It 
would therefore be interesting to investigate whether alkylation o f the enolate o f this 
oxazolidin-2-one 226 with removal o f excess base before addition o f electrophile might 
enable even better diastereoselectivities to be achieved for small electrophiles such as 
methyl iodide.
5.6 Conclusions
Following the successful development o f reaction conditions for the asymmetric alkylation 
o f the enolate o f polymer-supported iV-propionyl-oxazolidin-2-one 145 with benzyl 
bromide (as described in Chapter 4), this chapter focused on exploring and expanding the 
scope o f this reaction.
Firstly it was demonstrated that the optimised reaction conditions could also be applied to 
other A-acyl-oxazolidin-2-ones and other electrophiles. A  small array o f nine a-substituted 
acids was prepared, each in reasonable yield and high de, suggesting that this method could 
allow the preparation o f useful amounts o f chiral a-alkylated carboxylic acid derivatives in 
quantities sufficient for screening purposes.
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It was further demonstrated that iV-H-oxazolidin-2-one resin 2 could be reused in 
asymmetric enolate alkylation reactions three times without loss in diastereoselectivity. 
However, there was a slight decrease in yields between the cycles, presumably due to the 
build up o f non-cleavable /V-alkyl oxazolidin-2-one ‘blocking’ reactive sites. There was 
also a decrease in purity o f the acid products gained, although acceptable purities were 
achieved in the first three cycles. The potential to recycle the iV-H-oxazolidin-2-one resin 
significantly increases its cost-effectiveness.
In a further effort to increase the cost-effectiveness o f the polymer-supported chiral 
auxiliary system, inexpensive Merrifield resin was used as the polymer support. However, 
disappointing results were achieved with levels o f stereocontrol greatly decreased 
compared to the chlorotrityl-supported analogue. It was therefore concluded that direct 
transfer o f the optimised conditions for the chlorotrityl-supported resin was not possible 
and further studies would be needed to develop a successful Merrifield-supported version.
Finally, it was demonstrated that polymer-supported SuperQuat oxazolidin-2-ones could 
also be applied to asymmetric enolate alkylation reactions and achieve high levels o f  
diastereoselectivity. However, the yields gained were inferior to those afforded by the 
analogous Evans-oxazolidin-2-one auxiliary, seemingly due to an increased propensity 
towards enolate decomposition in the SuperQuat system. Despite this, a polymer-supported 
SuperQuat might prove useful in cases where its superior cleavage properties (i.e a 
resistance to endocyclic cleavage) were required.
Overall, this chapter has shown that the solid-supported iV-H-oxazolidin-2-one system  
developed in Chapter 4 has the potential to be a useful method to synthetic chemists 
interested in preparing small quantities o f small, chiral compounds in high ee. The 
potential for resin recycling greatly increases the cost-effectiveness o f the system.
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Chapter 6 Novel strategies for asymmetric synthesis employing 
oxazolidin-2-one auxiliaries.
Overview
6.1 Introduction -  novel strategies for asymmetric synthesis. 156
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6.2.1 An efficient, solution phase asymmetric synthesis of Grenadamlde 159
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6.4 Application to solid phase 177
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6.4.2 Solid phase aldol /  directed cyclopropanation 183
6.4.3 Solid phase aldol /  directed epoxidation 185
6.5 Conclusions 187
6.1 Introduction
There is currently ongoing research within the SDB research group into new strategies for 
the use o f chiral auxiliaries. One such strategy is the use o f ‘temporary’ stereogenic centres 
as stereodirecting groups to create remote stereocentres using substrate-directable reactions. 
In this approach, a chiral auxiliary is first employed to create a chiral intermediate 
containing a new stereogenic centre in high de. This new stereocentre is subsequently used 
to control the facial selectivity o f a second, substrate-directable asymmetric reaction thus 
creating further stereogenic centres. The second chiral intermediate can then either be 
cleaved to afford the chiral auxiliary and a chiral product or the auxiliary can be left in 
place to act as a protecting group for a number o f subsequent synthetic steps. In this way, 
the chiral auxiliary acts to create a remote stereocentre beyond its usual sphere o f influence.
One example o f this reaction strategy employs an oxazolidin-2-one-mediated asymmetric 
aldol reaction to create a stereodefined hydroxyl group with generally high levels o f
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diastereoselectivity, with subsequent use of this hydroxyl group to direct further 
asymmetric reactions. One such example was recently reported by Cheeseman et al. in 
which a novel aldol/cyclopropanation/retro-Aldol strategy for the asymmetric synthesis of
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Fig 6.1a: Aldol/cyclopropanation /  retro-aldol strategy for the asymmetric synthesis o f chiral cyclopropane 
carboxaldehydes.
In this strategy, chiral auxiliary 230 reacts with an a,p-unsaturated aldehyde 231 to afford a 
jy/i-aldol product 232 that incorporates a chiral allylic alcohol functionality (Step 1). The 
‘temporary’ (3-hydroxyl functionality is then used to control facial selectivity in a directed 
cyclopropanation reaction to afford cyclopropane 233 in very high de (Step 2). Retro-aldol 
cleavage of cyclopropane 233 results in destruction of the ‘tem porary’ P-hydroxyl
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stereocentre, affording the chiral auxiliary fragment 230, and the desired enantiopure 
cyclopropane carboxaldehyde 234 in high de. (Step 3).
Following the success o f this example, further research was undertaken within the group to 
investigate the scope of this strategy. It was noted that chiral intermediate 235 was a 
versatile substrate that could be employed in other asymmetric substrate-directed reactions, 
for example substrate-directed hydrogenations and epoxidations, as well as 
cyclopropanations.
Fig 6.1b: Substrate-directed asymmetric reactions possible on substrate 235.
It was also reasoned that further diversity could be achieved by variation of the cleavage 
method (see Fig. 6.1c). The original concept involved the destruction of the p-hydroxyl 
moiety via a retro-aldol reaction to afford the chiral aldehyde. However, conventional 
nucleophilic side-chain cleavage could also be used to create a wide variety of carboxylic 
acid derivatives of use for natural product or drug discovery applications.
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Fig 6.1c: Alternative cleavage methods to remove chiral side-chain product.
In this way, a wide variety of chiral products could be prepared as substrates for subsequent 
reactions which could introduce a variety of functional groups beyond those which would 
normally be accessible.
This chapter therefore describes further investigations into both the cyclopropanation and 
epoxidation reactions of these types of allylic alcohols, applies new synthetic strategies to 
the asymmetric synthesis of the cyclopropane-containing natural product Grenadamide and 
finally reports on preliminary investigations into the transfer o f this methodology to 
polymer support.
6.2 Directed cyclopropanations
6.2.1 An efficient asymmetric synthesis of chiral cyclopropane-containing natural 
product -  Grenadamide.
Grenadamide 240, debromogrenadadiene 241 and grenadadiene 242 are natural products 
that were isolated from the marine cyanobacterium Lyngbya majuscula, by Sitachitta and 
Gerwick in 1998 96 (see Figure 6.2.1a). These structurally unique cyclopropyl fatty acid 
derived metabolites were shown to demonstrate cannabinoid receptor binding activity, as 
well as cytotoxicity towards cancer cells. Baird and co-workers subsequently confirmed the 
absolute configuration of the cyclopropane fragment of grenadamide 240 as (R,R) via total
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synthesis. Their synthesis required more than fifteen linear steps, with an enzymatic kinetic 
resolution being employed to introduce the stereogenic centres of the cyclopropane 
fragment.97
P h . / - v
^  ' S J  ' c 7h 15
G r e n a d a m id e 241 R «  H - D e b r o m o g r e n a d a d ie n e  
240 242 R = Br - G r e n a d a d ie n e
Fig 6.2.1a: Structures o f Grenadamide 240, debromogrenadadiene 241 and grenadadiene 242.
Retrosynthetic analysis.
A consideration of the structure o f grenadamide highlighted the key chiral 8,y-cyclopropane 
amide moiety that could be easily prepared by the ‘tem porary’ stereocentre / substrate 
directed reaction strategy described above. An initial retrosynthesis showing the key 
structural components (see Scheme 6.2.1a) is described below. In this proposal, (5-hydroxy 
alkene 243 could be prepared from the asymmetric reaction of chiral auxiliary 241 with 
a,|5-unsaturated aldehyde 242. This stereodefined hydroxyl group could then be used to 
direct a subsequent cyclopropanation reaction to form cyclopropane 244. Removal of the 
hydroxyl functionality, followed by substitution of the chiral auxiliary fragment with the 
desired phenylethylamine fragment would afford grenadamide 240.
P h . P h .
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Scheme 6.2.1a: Initial retrosynthesis fo r  preparation o f grenadamide 240 employing ‘tem porary’ 
stereocentre /substrate directed reaction strategy.
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Analysis of this initial retrosynthesis revealed two key issues. Firstly, aldol reactions 
employing the boronates of A-acetyl-oxazolidin-2-ones were known to proceed with poor 
levels of diastereoselectivity, and hence the presence of substituents at the a-carbon is
circumvented by the use of a bromoacetyl-oxazolidin-2-one in a Reformatsky-type process 
since the resultant zinc enolates had been shown to proceed with high levels of 
diastereoselectivity in aldol reactions, albeit in often poor yields.
However, even if this issue of diastereoselectivity could be resolved, subsequent removal of 
the isolated p-hydroxyl group of 244 after cyclopropane formation would not be a trivial 
matter. Conventional methods for removing such a group generally rely on the formation 
o f a carbocation or radical intermediate, however the presence of either of these features 
adjacent to a cyclopropane ring would lead to its destruction.
Therefore, it was proposed that the use of chloroacetyl-oxazolidin-2-one 246 would address 
both these issues. Firstly, the presence o f an a-substituent would ensure high levels of 
diastereoselectivity in the initial aldol reaction. In addition, the presence of an a-chloro- 
substituent would facilitate cleavage of the P-hydroxy group via a p-elimination mechanism 
in which both the chloro- and hydroxyl- functionalities are removed in a single step,
QO
according to the method of Concellon et al.(see scheme 6.2.1b).
It was also decided to employ a SuperQuat auxiliary rather than a classic Evans-oxazolidin-
cleavage minimised by the use of a SuperQuat auxiliary, it was proposed that the chiral 
auxiliary fragment could be cleaved in good yield via direct aminolysis with 
phenylethylamine.
The refined retrosynthetic analysis is therefore shown in Scheme 6.2.1c. Grenadamide 240 
would be prepared by direct aminolysis o f the oxazolidin-2-one fragment of 247 using
essential to achieve the aldol product in good yield. It is possible this issue could be
o  OH o
H al R 2
Scheme 6.2.1b: Synthesis o f (E)-a,f-unsaturated amides from p-hydroxy amides with Sml2 as reported by 
Concellon.
2-one due to the more versatile cleavage profile of the former. With the risk of endocyclic
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phenylethylamine as a nucleophile. 247 would be prepared by reduction of a,(3-unsaturated 
cyclopropane 248, which could be derived from (3-elimination of a-chloro-(3-hydroxy- 
cyclopropane 249. The cyclopropane ring of 249 could be introduced stereoselectively via a 
hydroxyl directed cyclopropanation reaction on syn-aldol 250 that would be prepared from 
aldol reaction of the (Z)-boron-enolate o f Af-chloroacetyl-5,5-dimethyl-oxazolidin-2-one 
246 with (£> d ec-2-enal 242.
Scheme 6.2.1c: Refined retrosynthetic analysis o f Grenadamide 240.
Synthesis of Grenadamide’
The first task was to employ the syrc-aldol / directed cyclopropanation methodology 
described earlier (see Fig 6.1a) for the asymmetric synthesis of cyclopropane 249 in high 
de.
Therefore, (/?)-4-benzyl-5,5-dimethyl-oxazolidin-2-one 211 was first prepared in 72% yield 
from unnatural D-phenylalanine, according to the method of Bull et al. (Scheme 6 .2 .I d ) .99 
Hence D-phenylalanine underwent esterification with MeOH to protect the acid 
functionality with N-Boc protection of the amine to afford 252 in 94% yield. 252 was then 
treated with four equivalents of methyl magnesium bromide (MeMgBr) to introduce the 
gem dimethyl groups, forming 253 in 84% yield. Finally, base-promoted cyclisation of the 
alkoxide of 253 gave (fl)-4-benzyl-5,5-dimethyl-oxazolidin-2-one 211 in 90% yield after 
recrystallisation, corresponding to an overall 72% yield from D-phenylalanine.
Part of this work was carried out in conjunction with final year project student Sarah Duffill and Matt 
Cheeseman.
o o n  O
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Fig 6.2.1d: Synthesis o f SuperQuat auxiliary 211 from unnatural (D)-phenylalanine, according to the method 
o f Bull et al.
Treatment of (/?)-211 in THF at -7 8  °C with 1.1 equivalents of n-BuLi, followed by 
addition of 1.1 equivalents of chloroacetyl chloride gave a-chloroacetyl-oxazolidin-2 -one 
246 in 78% yield after recrystallisation (see scheme 6 .2 .le). 246 was then subjected to syn- 
aldol conditions developed within the SDB group ,95 modified from the method of Caddick 
et al.63 Treatment of 246 with 1.1 equivalents o f 9-BBN-OTf and lPr2NEt in CH2CI2 at 0 
°C, followed by cooling to -7 8  °C and addition of (E)-dec-2-enal resulted in syn-aldol 250 
in 92% de, which was purified to >95% de in 74% yield following silica chromatography. 
The syn-stereochemistry of aldol 250 was confirmed from the small 7(2’,3’) coupling 
constant o f 3.5 Hz observed in the ]H NMR spectrum.*
o  0  0  O O OH
II n-BuLi 11 0 ') 9 -B B N -O T f, D IPE A  11 U I ✓
c / ^ N H  CICOCH2CI DCM.O^C
T H F  /. Cl II) O
Ph P h  H ^ ^ ^ C tH w  p tf
8 8 %  yield
(R)-211 246 250
Scheme 6.2.1e: Acylation o f SuperQuat-oxazolidin-2-one auxiliary (R)-211, follow ed by diastereoselective 
aldol reaction to give syn-aldol 250.
Reaction of a-chloro-|3-vinyl syn-aldol 250 with 5 equivalents o f Et2Zn and CH2I2 in 
CH2CI2 at -1 0  °C, resulted in a highly stereoselective cyclopropanation reaction, to afford
* a«n'-a-alkyl-p-hydroxy-Ar-acyl-oxazolidin-2-ones normally exhibit J(2\ 3-) coupling constants o f >  7.0 Hz, see 
reference (59) Evans, D. A.; Tedrow, J. S.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2002,
124, 392-393.
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s;y«-cyclopropyl aldol 249 in >95% de and in 98% yield, see Scheme 6 .2 .If. 100 
Cyclopropanations under this type of modified Furukawa conditions are normally syn- 
selective (for reasons discussed below) and as a consequence the absolute configuration of 
249 was assigned accordingly. In addition, the configuration of similar substrates has been 
confirmed by X-ray crystallography.
Scheme 6.2.1f: Directed cyclopropanation o f syn-aldol 250 under modified Furukawa conditions.
The diastereoselectivity of this reaction is determined by minimisation of allylic strain in 
the transition state (see Scheme 6.2. lg). The carbenoid cyclopropanating species (formed 
from CH2I2 and Et2Zn) coordinates to the stereodirecting hydroxyl group which then 
determines which of the diastereotopic faces of the olefin is cyclopropanated. For trans- 
allylic alcohol 254, transition state 255a is energetically favoured in comparison to 
transition state 255b due to smaller A 1,3 strain resulting from the H-H interaction in 255a 
compared to the Ri-H interaction in 255b. The reactive conformation o f the lower energy 
transition state 255a therefore leads to formation of syn-cyclopropyl alcohol 256a in high 
de.
> 9 5  % d e
250 249
254 255a 255b
D isfa v o u re dF a v o u red
F a v o u red
256a
OH
D isfa v o u re d
256b
O H




Attempts to perform p-elimination on 249 and thus simultaneously remove both the chloro-
QO
and hydroxyl- substituents, employed Sm l2, according to the method of Concellon. 
Treatment of 249 with 2.5 equivalents of a solution of commercially available Sm l2 in THF 
at room temperature for 30 minutes afforded a mixture of products consisting of the desired 
a,p-unsaturated cyclopropane 248 (40%), starting material 249 (20%) and the two products 
of retro-aldol elimination, A-chloroacetyl-oxazolidin-2-one 246 (20%) and cyclopropyl- 
aldehyde 257 (20%) as shown in Scheme 6.2. lh.
pathway to afford 246 and 257.
The mechanism for the samarium diiodide mediated p-elimination mechanism is not fully 
established but one possible mechanism is shown below in scheme 6 .2 .lj. Samarium (II) is 
oxidised to samarium (III) with the release of a single electron that reacts with the 
exocyclic carbonyl of 258 to afford radical anion intermediate 259, which is then further 
reduced by another equivalent of samarium to form anionic intermediate 260. Elimination 
of the a-chloro-substituent then affords samarium (III) enolate 261. Finally, elimination of 
the P-hydroxyl group via a cyclic mechanism affords (£)-a,p-unsaturated-oxazolidin-2-one 
262. The chelated six-membered ring transition state is thought to be responsible for the 
high diastereoselectivity observed in this reaction.
p athw ay
2 .5  eq u iv . 
S m l2
re fro a ld o l
pathw ay
P -elim in ation  O  O
 II II
Ph 246 257
Scheme 6.2. lh: Two possible reaction pathways in the attempted f-elimination reaction o f  249, one 
preparing the desired a,p~unsaturated cyclopropane 248 and the other involving an unwanted retro-aldol
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S m l2CI H S m lz(O H ) H
261 262 Ph
Scheme 6.2.1 j: Proposed mechanism fo r Sml2-mediated p-elimination reaction o f  a-chloro-p-hydroxyl-258
However, this mechanism does not account for the competing retro-2\do \ pathway observed 
in this reaction. Again, the mechanism of this step is not clear, but literature precedent 
suggests the retro-aldol pathway is likely to be mediated by the Sm(III) that is generated as 
a result of the elimination pathway, e.g. retro-aldol process observed by Molander et al. as 
shown in Scheme 6.2.1k. 101
S m ^ O  C O O E t R C O O E t
S m 3+0 "
Scheme 6.2.1k: Retro-aldol -  aldol process results in equilibration o f the initially form ed aldol products as 
reported by Molander et. al.
The occurrence of a retro-aldol reaction was not noted in Concellon’s original work on the 
P-elimination reactions of simple amides, esters and ketone products. It was therefore 
proposed that the presence of the oxazolidin-2-one fragment in 249 must have been 
responsible for promoting this unique retro-aldol reaction pathway. It was reasoned that 
this issue could be circumvented be replacing the oxazolidin-2 -one fragment with a simple 
amide, which would then hopefully undergo a clean p-elimination reaction.
It had previously been shown by Davies et al. that A-acyl-SuperQuat auxiliaries underwent
9 0clean aminolysis reactions with primary amines, see scheme 6 .2 .1m.





Scheme 6.2.1m: Direct aminolysis ofN-acyl-SuperQuat-oxazolidin-2-one, as reported by Davies et al.
Hence a-chloro-cyclopropyl-jyn-aldol 249 was dissolved in neat phenylethylamine and 
stirred overnight, which resulted in cleavage of the oxazolidin-2 -one auxiliary to afford the 
desired a-chloro-cyclopropyl amide 263 as the only product in 89% yield after column 
chromatography, (see Scheme 6.2.In). Fortunately, no competing side products from 
nucleophilic displacement of the a-chloro group by the amine or competing nucleophilic 
attack at the endocyclic carbonyl were observed in this reaction.
O O OH
cAVxT'OH,, p ^ NH’ Ph J  f  ,
i j  ci
Ph 8 9  %  yield
249 263
Scheme 6.2.In: Aminolysis o f  a-chloro-cyclopropyl-syn-aldol 249 with phenylethylamine.
This new a-chloro-cyclopropyl amide 263 was then treated with samarium diiodide in THF 
to afford the desired vinylcyclopropane 264 in 85% yield and >95% de, with no competing 
products arising from the retro-aldol reaction being observed (see Scheme 6.2. Ip)
O OH O
II I  3  e q u iv .S m I2 m
Cl
8 5  % yield
263 264 > 9 5  % d e
Scheme 6.2.Ip: Samarium diiodide mediated fl-elimination reaction o f  a-chloro-cyclopropyl amide 263.
Reduction of double bond
The final step of the synthesis of Grenadamide was the reduction of the alkene moiety. 
However, the need to reduce the double bond of vinylcyclopropane 264, whilst leaving the 
adjacent cyclopropyl group intact, meant that catalytic hydrogenation methods could not be 
used. It is well established that transition metals such as palladium, rhodium, platinum and
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mercury can promote cyclopropane ring opening reactions and Barrett et al. have 
demonstrated the regioselective ring opening of vinylcyclopropanes under catalytic 
hydrogenation conditions (Pd / C, EtOH) that were intended to cause hydrogenation of the
double bond (see scheme 6 .2 . lq). 102
b
C O O R '-
b o n d  'a' c le a v e d
P d /C , 
H2 , EtOH
R * P h , vinyl
b o n d  'b' c le a v e d
,C O O R ‘
C O O R ’
R =  P h , vinyl
Scheme 6.2.1q: Regioselective ring opening o f vinylcyclopropanes upon treatment with H2 and Pd/C in 
EtOH.
Therefore, an alternative method involving conjugate reduction of 264 with NaBH4 and 
C 0 C I2 was employed according to the method of He and Deng .103 As depicted in Scheme 
6 .2 .  lr, vinylcyclopropyl amide 264 was treated with excess NaBH4 with catalytic C 0 C I2 in 
MeOH / DMF to afford grenadamide 240 in 88% yield and >95% de.
o  4  eq u iv . N aB H 4,
Ph 11 x .  2 0  m ol % C oC I2 Ph ^
Ph^ ^ N ^ ^ ^ t - CjH,s ------------------ ^
DM F, M eO H , TH F
8 8  %  yield
264 240 >95 % de
G r e n a d a m id e  [ a i o 25 = - 1 1 °
Scheme 6.2.1r: Reduction o f  vinylcyclopropyl amide 264 with NaBH4 and CoCl2.
The spectroscopic data of this sample of (7?,jR)-Grenadamide 240 matched that previously 
published for this natural product. The specific rotation of [a]Dht = -11 ([a]o25 = -11) 97 
confirmed the correct enantiomer of this natural product had been prepared. The 
asymmetric synthesis of Grenadamide 240 had therefore been completed in six steps and 
42% overall yield from oxazolidin-2-one (J?)-211
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6.3 Directed epoxidations
The most widely exploited substrate directable transformation to date has been the hydroxyl 
directed epoxidation of chiral allylic alcohols. A popular method of achieving this 
transformation is via the use of a vanadium catalyst, due to its significant rate enhancement 
effect. In the catalytic cycle described in Fig. 6.3.1a,104 the lower-valent VO(acac)2 
complex is oxidised by t-BuOOH to afford a catalytically active d° vanadate ester which 
undergoes rapid ligand exchange to afford intermediate 267. Bidentate coordination of the 
alkylperoxide activates intermediate 268, with loss of a further alkoxide ligand. The alkene 
then initiates nucleophilic attack of the oxygen atom of 268 in the rate- and 
stereochemistry-determining step to afford epoxy alcohol complex 269. Upon dissociation 
of the epoxy alcohol and t-BuOH side product, the active site on the vanadium centre is 
regenerated, thus completing the catalytic cycle.
f-BuO O H
V O (O R 3)
V O (O R 3)
♦ f-BuO H + f-BuO O H
O R  p t -Bu
268
Fig 6.3.1a: Proposed mechanism fo r the vanadium catalysed epoxidation o f allylic alcohols.
In cases where chiral allylic alcohols are employed, the diastereoselectivity of these types 
o f allylic epoxidation reactions arises from minimisation of A 1,3-strain in the transition 
state, as previously discussed for directed cyclopropanation of allylic alcohols (see Section
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6.2.1). Evans and co-workers have achieved good results employing this reaction for the 
synthesis of macrolide antibiotics (see scheme 6.3.1a). 105 In this example, excellent levels 
of diastereocontrol were achieved for the hydroxyl-directed epoxidation of a 1, 1- 
disubstituted chiral allylic alcohol, despite the presence of many surrounding stereocentres 
that could potentially influence the stereocontrol of the reaction.
OH OH QTIPS
B enzene * c 
25 °C
OH OH OTIPS
Me Me Me 11 Me Me "  ^  Me Me M e0 ^  Me Me
Scheme 6.3.1a: Hydroxyl-directed epoxidation fo r  the synthesis o f  macrolide antibiotics.
91% yield 
> 90%  de
Previous work within the SDB group had sought to test this hydroxyl-directed epoxidation 
reaction on our substrates, and hence 1,1-disubstituted unsaturated syn-aldol 270 was 
prepared. The boron enolate of (5>Af-propionyl-4-benzyl-oxazolidin-2-one 230 was treated 





-78 to 25 X:
Ph 230
Scheme 6.3.1b: Aldol reaction o f solution phase N-propionyl oxazolidin-2-one 230 with 2-ethylacrolein to 
afford syn-aldol product 270.
270 was then treated with 10 mol% VO(acac)2 and one equivalent of tert-butyl hydrogen 
peroxide in benzene at room temperature, followed by aqueous work-up (see Scheme 
6.3.1c.) However, examination of the ’H-NMR spectrum of the reaction product revealed 





Scheme 6.3.1c: Proposed epoxidation o f syn-aldol 270, however epoxy-aldol 271 was not formed.
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Instead the !H-NMR spectrum revealed only the presence of N-H oxazolidin-2-one (S)-211, 
with no products derived from the syn-aldol side-chain. However, subsequent saturation of 
the aqueous layer generated during work-up with sodium chloride, followed by back- 
extraction with ethyl acetate, resulted in isolation of lactone 272 in 78% yield and >95% de 
(see scheme 6 .3 .Id)
o
Scheme 6.3.1d: Treatment ofsyn-aldol 270 according to standard directed epoxidation conditions leads to 
formation ofN -H  oxazolidin-2-one (S)-211 and lactone 272.
Following this discovery, I sought to further investigate this useful, if not entirely 
unexpected, synthesis of chiral hydroxyl-garama-lactones. The proposed mechanism for 
the formation of lactone 272 is shown in Scheme 6 .3 .le. It is proposed that hydroxyl- 
directed epoxidation occurs on the 1, 1-disubstituted alkene to afford the ^yn-epoxy-aldol 
271. The configuration of this step was assigned on the basis of literature precedent of 
similar 1,1-disubstituted alkenes as attempts to isolate the epoxy-aldol intermediate were 
not successful. It is then proposed that the exocyclic carbonyl o f the side-chain, facilitated 
by the electron-donating effect o f the adjacent nitrogen, acts as an intramolecular 
nucleophile to attack the epoxide and cause ring-opening with inversion of stereochemistry 
to form iminium intermediate 273. Hydrolysis of the iminium intermediate, presumably 
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Scheme 6.3.le: Proposed mechanism fo r  the intramolecular cyclisation o f  epoxy aldol to form lactone 274.
Based on the literature precedent, this intramolecular cyclisation pathway appeared to be 
the most likely mechanism. M iller et al. recently reported a mild, non-transition metal 
catalysed deprotection of N-allyloxycarbonyl amines using iodine in wet acetonitrile which
was proposed to proceed via a similar mechanism (see scheme 6 .3 .If). 106
o
I H < X
Scheme 6.3.1f: Proposed mechanism ofN -alloc deprotection via iodination /  hydrolysis mechanism.
However, there was also a possibility that direct hydrolysis of the intermediate epoxide 
with water could result in formation of a lactone product. In this pathway, water would 
attack the epoxide at the least sterically hindered end thus producing diol 275, which would 
then cyclise via nucleophilic attack of the exocyclic carbonyl with the /V-H-oxazolidin-2- 
one fragment being released as a stable leaving group (see scheme 6 .3 .lg )
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o O OH n O
V O (a c a c )2
t-B uO O H
B e n z e n e A
O H  2 7 6
P h  270 Ph ('S)-211
Ph Ph
271 275
Scheme 6.3.1g: Alternative possible mechanism for lactone formation, resulting in gamma- lactone 276.
In an attempt to establish which of these two mechanisms was operating in this reaction, 
further experiments were conducted to investigate the possibility of an external nucleophile 
opening the epoxide. It was proposed that under strictly anhydrous conditions, repetition of 
this reaction with addition of an alternative nucleophile might result in incorporation of that 
nucleophile into the lactone product. Hence, syn-aldol 270 was treated with VO(acac)2 and 
r-BuOOH in anhydrous benzene under strictly anhydrous conditions before addition of an 
excess of ethanethiol, see scheme 6 .3 .lh.
mixture does not result in its incorporation into the lactone product implying the mechanism does not proceed 
via opening o f  the epoxide with an external nucleophile.
However, this reaction resulted in the original lactone 274 being formed with no sign of any 
products arising from incorporation of the thiol nucleophile. As ethanethiol is a better
n O
P h H O
(S)-211
Scheme 6.3.1h: Investigating the reaction mechanism: Addition o f  ethanethiol to the anhydrous reaction
Not formed
V O (a c a c )2
f-BuO OH
B e n z e n e
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nucleophile than water and would therefore be expected to undergo such a nucleophilic 
substitution reaction more readily, this result therefore implies that gamma-lactone 
formation does not proceed via opening of the interm ediate epoxide by an external 
nucleophile.
It was also noted that the two possible mechanisms proposed above would result in the 
formation of lactones o f opposite configuration at the quaternary centre. It was therefore 
reasoned that confirming the stereochemistry o f the lactone product (as 274 or 276) would 
help to confirm  which o f the two mechanisms was operating. It is notoriously difficult to 
assign the configuration o f stereocentres within gamma-lactones via analysis o f ’H-NMR 
coupling constants, 107 so it was therefore necessary to obtain an X-ray crystal structure of 
the lactone 274 (see Figure 6.3.1b). This established the configuration o f the quaternary 
centre o f lactone 274 as (45), thereby supporting the theory that the intram olecular ring 
opening mechanism proposed in Scheme 6 .3 .le , involving nucleophilic attack on the 
epoxide by the exocyclic carbonyl, and resulting in ring-opening with inversion o f 
stereochemistry at C-4.
274
Fig 6.3.1b: X-ray crystal structure o f  lactone 21A confirming the stereochemistry o f  the C-4 quaternary 
centre as (S).
To further investigate the scope o f this reaction, further substrates were prepared via aldol 
condensation of A-propionyl-oxazolidin-2-one 230 with the corresponding aldehyde 
(according to Scheme 6.3.1b). All aldol products were achieved in good yield and >95% 
de after column chromatography, see Table 6.3.1a.
These substrates were then subjected to the epoxidation conditions described earlier and 
reacted for 2-4 hr at rt, followed by aqueous quench. The resulting lactones were often
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found to be water-soluble, so were generally obtained by saturation of the aqueous layer 
and back-extraction into ethyl acetate. In all cases, there was some indication of the 
reaction occurring, although it was not always possible to isolate the lactone product in
pure form.
Yield of yyn-aldol 
substratea (%)












Only NH aux 
isolated, plus 











Table 6.3.1a: Epoxidation /  cyclisation reaction with alternative aldehydes to produce N-H oxazolidin-2-one
(S)-211 and lactones 278, 280 and 283. Reaction conditions: 10mol% VO(acac)2, 1 equiv. t-BuOOH, 
benzene, 2 hrs, rt. a Isolated yield after column chromatography o f  the crude product. All aldols had de 
>95%  according to analysis o f their respective 1 H-NMR spectra b Isolated yield after column 
chromatography. c de determined by 1H-NMR. d Yield after reaction conducted for 12 hours a t room 
temperature to ensure all epoxide converted to lactone. e After recrystallisation.
Treatment of jy«-aldol 277 with VO(acac)2 and r-BuOOH, under the same conditions 
developed previously did not result in the direct formation of the lactone product 278 (see 
Scheme 6 .3 .lj). Instead a compound that was structurally similar to the starting aldol was 
recovered, which spectroscopic analysis revealed to be the epoxide intermediate 284. The 
stereochemistry of this epoxide was inferred from literature precedent and by minimisation
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of allylic strain in the transition state. Although stable for long enough to be characterised, 
epoxide 284 was found to decompose over a couple of days forming N -H oxazolidin-2-one 
(S)-211 and lactone 278. However, extending the duration of the epoxidation reaction to 12 
hours resulted in complete conversion to lactone 278 and jV-H-oxazolidin-2-one (S)-211 
with no trace of epoxide 284. The epoxide intermediates were not isolated in any of the 
other examples attempted and it is not entirely clear why this epoxide was more stable than 
any of the others, although it may be that the formation of the more hindered tertiary 











Scheme 6.3.1j: Epoxidation o f syn-aldol 277 to form epoxide 284, with subsequent cyclisation to form N-H 
oxazolidin-2-one (S)-211 and lactone 278.
The reaction with tra/ts-cinnamaldehyde-derived aldol 281 did yield N-H  oxazolidin-2-one 
(S)-211  but also afforded a complex mixture of products in which the lactone could not be 
identified. This may be due to competing side reactions being possible due to the potential 
o f this substrate to form a benzylic carbocation which could result in formation of 
competing products.
In summary, four lactones were prepared and isolated successfully, and in reasonable yield 
and high de. These lactones represent versatile chiral building blocks for further structural 
elucidation with three contiguous stereocentres having been easily formed in high de.
Recently, Dias et al. reported a similar route to diastereomeric y-butyrolactone products via 
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Scheme 6.3.1k: Synthesis o f y-butyrolactone via dihydroxylation /  lactonisation sequence.
However, further investigations by members of the SDB group have revealed 
inconsistencies between the spectral data of similar lactones prepared by the two groups, 
implying a possible mis-assignment of the lactone’s configuration. Further investigation 
into this issue is ongoing.
6.4 Application of methodology to solid phase.
Following the successful synthesis of a chiral cyclopropane containing natural product and 
some promising results towards the preparation of chiral gamma-hydroxy lactones in 
solution phase, the application of this strategy to a solid-phase system was investigated. 
Despite a number of examples of sol id-supported asymmetric reactions in the literature, it is 
rare to find examples in which two consecutive asymmetric reactions have been conducted 
‘on-bead’. It was proposed that this strategy would greatly expand the scope of the 
applications of solid-supported chiral oxazolidin-2 -one-type auxiliaries and allow a greater 
variety of chiral products to be formed.
As in the solution phase strategy, the first stage was construction of the stereodefined 
hydroxyl group which would later act to direct a second asymmetric reaction. It was 
therefore necessary to develop conditions for an efficient asymmetric solid-supported aldol 
reaction. It was anticipated that development of optimal conditions for a solid-supported 
aldol reaction would not represent as much of a challenge as for the solid-supported enolate 
alkylation reactions previously considered. Earlier studies investigating solution phase aldol 
reactions had revealed no signs of any unwanted by-products from the aldol reaction, a 
feature which, if also applicable to solid phase versions, would hopefully lead to high yields 
of the desired aldol product in high purity. In addition, two separate reports of asymmetric
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aldol reactions on solid-supported oxazolidin-2-one auxiliaries have previously been 
reported with aldol products of high de (90 -  98%) prepared .31,32
6.4.1 Optimisation of solid-phase asymmetric aldo! reaction conditions.
The first step in developing an efficient asymmetric solid-phase aldol reaction was selection 
o f the appropriate polymer support. Unfortunately, the use of 9-BBN-OTf or BuiBOTf as a 
reagent for the aldol reaction ruled out the use of a 2 -chlorotrity 1-chloride resin-supported 
chiral auxiliary as the chlorotrityl linker was not stable to the Lewis acidic reaction 
conditions. It was therefore necessary to employ the more robust M errifield-supported 
oxazolidin-2-one 72a, however, as previously discussed, the use of this resin limited the 
extent o f intermediate characterisation possible.
M errifield supported oxazolidin-2-one 72a was N-acylated with propionic anhydride under 
the standard reaction conditions optimised previously and described in Chapter 2.3, see 
scheme 6.4.1a. The approximate loading was determined as 0.82 mmolg ' 1 by gravimetric 
analysis o f the functionalised resin.
Scheme 6.4.1a: N-acylation o f Merrifield-supported N-H oxazolidin-2-one 72a with propionic anhydride.
The optimised conditions for solution phase syn-aldol reactions developed within the SDB 
group were described previously in Chapter 2.5, see Scheme 6.4.1b for brief details.
7 3 a 0 .8 2  m m olg'
M errifield M errifield
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ii) 1 .2  eq u iv . D IPEA
iii) 1 .3  eq u iv .
iv) H20 2, M eO H
1 )1 .1  eq u iv . 9 -B B N -O T f
 f t
R'i R2 90 - >95% de
Scheme 6.4.1b: Aldol reaction o f  solution phase N-acyl oxazolidin-2-one with an aldehyde.
It had been noted that under these conditions, the reaction did not always proceed to 
completion, with the extent of the reaction appearing to be dependant on the quality of the 
boron reagent. It was therefore reasoned that the situation in the analogous solid phase 
reaction was likely to be worse, and due to the heterogenous nature of the system the 
reaction could be even less prone to proceeding to completion. A frequently cited 
advantage of solid phase synthesis is the option to use an excess of reagents to drive a 
sluggish reaction to completion with facile removal of the excess reagent from the product 
by simply filtering off the functionalised resin. This approach was therefore an obvious 
consideration in this example, where the presence of any starting material at the end of the 
reaction would result in contaminated products. However, Heathcock et al. had noted that 
the presence of excess Bu2BOTf in some syn-aldol reactions (including those involving 
aromatic aldehydes) resulted in a reversal o f diastereoselectivity with anti-aldols being 
formed (see scheme 6.4.1c). The authors proposed that this was due to the formation of 
different aggregation states depending on the number of equivalents of the boron reagent 
used and the nature of the base employed.
Scheme 6.4.1c: Syn products formed when slight excess o f  boron reagent present, but with two-fold excess o f  
born reagent, anti product formed. Selectivity highest when R contains aryl or S.
who had shown that an excess of boron reagent could be employed if the excess boron 
reagent was then drained away and the reaction solution replaced with fresh solvent. A
q  2 .0  e q . B u2BOTf 1.1 e q . B u2BO Tf 
1 .3  e q . 'PrN Et3
O  O H A
R C H O
anti
R C H O
syn
However, this issue had previously been addressed on solid-phase by Phoon and Abell,32
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similar strategy had been successfully employed in my previous work with solid-supported 
enolate alkylation reactions where an excess of LHMDS was required to force the reaction 
to completion.
Therefore, A-propionyl oxazolidin-2-one resin 73a in an IRORI Kan, suspended in DCM at 
0 °C was treated with 5 equivalents of 9-BBN-OTf for 1 hour, after which time the reaction 
solution was removed via cannula. After the addition of fresh, pre-chilled DCM, 5 
equivalents of DIPEA was added and the reaction stirred for a further hour. The entire 
reaction was then cooled to -78 °C before addition of 7 equivalents of benzaldehyde. The 
reaction was then allowed to warm to room temperature slowly and stirred for a further 12 
hours, see Scheme 6 .4 .Id.
i) 5 eq u iv . 9 -B B N -O T f, 0 °C , 1 hr th en  drain P
O'N
ii) 5  e q u iv . D IPEA, 0 °C , 1 hr I N
iii) 7  eq u iv . P h C H O , -7 8  - 0 “C, 1 2  hrs L iO O H
W \ DCM {\ 1
M errifield M errifield \L
o i l—1o °
73a 287 288
Scheme 6.4.1d: Solid phase syn-aldol reaction o f Merrifield-supported N-propionyl-oxazolidin-2-one 73a 
with benzaldehyde, followed by LiOOH side chain cleavage to form syn-aldol acid  288.
Subsequent cleavage of the washed, dried resin with LiOOH, according to the procedure 
described earlier in Chapter 3.4.2b. resulted in cleavage of yyn-aldol acid 288 in 58% 
yield*, 90% de and excellent purity (see Fig. 6.4.1a). The relative stereochemistry of the 
aldol product was assigned by the small 7^,3) coupling constant of 4.0 Hz.
* Yield based upon estimated original loading of auxiliary onto Merrifield resin, hence represents yield over 
three steps i.e. N-acylation, aldol reaction and finally LiOOH cleavage (with aqueous extraction).
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Fig. 6.4.1a: 1 H-NMR o f syn-aldol acid 288 prepared via syn-aldol reaction o f  polymer supported N-propionyl 
oxazolidin-2-one 73a with benzaldehyde, followed by LiOOH-mediated side-chain cleavage.
Further experiments were conducted including varying the temperature of the reaction and 
varying the duration of treatment of the resin with each reagent. However no significant 
improvements to either the yield or the de of the syn-aldol-acid product were observed.
Both the de and the yield of this reaction were slightly lower than those achieved in the 
corresponding solution phase reaction. However, these results are comparable to those 
previously reported for solid phase systems of this type 31,32 and still result in formation of 
chiral products with good levels of stereocontrol. The reduced yield is disappointing, 
however it must be noted that the yield stated was calculated based on the estimated 
loading of the auxiliary fragment onto M errifield resin so encompasses three separate 
reactions, N-acylation, an asymmetric aldol reaction and finally LiOOH cleavage (with 
aqueous extraction). The main losses in yield are thought to be due to the aldol reaction not 
being driven to completion despite the presence of excess reagents, and incomplete 
recovery of the acid product in the final acidic aqueous extraction.
Polymer-supported SuperQuat auxiliary 289 was also tested in this solid-phase aldol 
reaction. Hence Merrifield-supported N-propionyl SuperQuat oxazolidin-2-one 290 was 
treated with 9-BBN-OTf, diisopropylethylamine and benzaldehyde according to the method
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described above (see scheme 6.4. le). Subsequent LiOOH cleavage of the polymer-bound 
product afforded syn-aldol acid 288 in 57% yield and 93% de, an essentially identical result 
to that obtained using the polymer-supported Evans oxazolidin-2-one.
i) 5 equiv. 9-BBN-OTf. 0°C, 1 hr then drain
, 0
ii) 5 equiv DIPEA, 0°C , 1 hr
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Scheme 6.4.1e: Solid phase syn-aldol reaction o f Merrifield-supported N-propionyl-5,5-dimethyl-oxazolidin- 
2-one 290 with benzaldehyde, followed by LiOOH side chain cleavage to form syn-aldol acid  288.
It was then decided to investigate alternative aldehydes in this reaction. The procedure 
detailed above was repeated using E vans’ N-propionyl-oxazolidin-2-one 73a with 
isobutyraldehyde, cyclohexanecarboxaldehyde and octyl aldehyde in turn, see Table 6.4.1a.















Table 6.4.1a: Solid phase aldol reactions employing alternative aldehydes.
These results suggest that the reaction conditions optimised for the aldol reaction of 73a 
with benzaldehyde were broadly applicable to other aldehydes. Reaction of 73a with 
isobutyraldehyde, another commonly used aldehyde for optimising new aldol reaction 
conditions, resulted in similar results to those achieved with benzaldehyde. Superior results 
were achieved with the bulkier aldehyde cyclohexanecarboxaldehyde with no sign o f the 
rwft'-diastereomer detectable in the ^ -N M R  spectrum. Perhaps unsurprisingly, the reaction 
employing octyl aldehyde resulted in a lower yield of syAi-aldol acid (50%), albeit in a
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respectable 90% de. This is likely to be due to the aldol reaction itself being sluggish due 
to the less reactive long chain aldehyde and is a feature also seen in solution phase aldol 
reactions of this type.
Further optimisation of the solid-phase asymmetric aldol reaction conditions for each 
individual aldehyde would of course be possible and it is likely that higher yields could be 
gained. However, time restraints did not allow for further optimisation and therefore the 
current conditions for the solid-phase asymmetric aldol reaction were carried through to the 
next stage of research into a second, substrate-directed asymmetric reaction on the 
polymer-bound substrate.
6.4.2 Solid phase asymmetric aldol /  directed cyclopropanation strategy
W ith conditions for a polymer-supported asymmetric aldol reaction in hand, preliminary 
investigations into the second asymmetric reaction were commenced. Following the 
success in solution phase of this strategy for the synthesis of the natural product 
Grenadamide, solid-phase directed cyclopropanations were initially investigated.
Firstly, it was necessary to prepare an appropriate polymer-supported syn-aldol product. 
Although previous solution phase studies towards the synthesis o f Grenadamide had 
employed the long chain aldehyde trans-2 decenal, it was decided to use a simpler, more 
reactive aldehyde for these preliminary solid-phase reactions. Hence, the boron enolate of 
polymer-supported A-propionyl oxazolidin-2-one 73a was treated with trans- 
cinnamaldehyde to form syn-aldol 292 according to the reaction conditions developed in 
Section 6.4.1, (see Scheme 6.4.2a). Subsequent side-chain cleavage employing N aBH 4 
afforded syn-aldol alcohol 293 in 65% yield and 90% de.
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Scheme 6.4.2a: Solid phase syn-aldol reaction o f  Merrifield-supported N-propionyl-oxazolidin-2-one 73a 
with trans-cinnamaldehyde, followed by NaBH4 side chain cleavage to form syn-aldol alcohol 293.
Confident that the syn-aldol reaction had proceeded with good diastereoselectivity, the 
second asymmetric reaction was performed on functionalised resin 292. In a similar 
procedure to that employed in solution phase, polymer-supported syn-aldol 292 was 
suspended in dry DCM at -10 °C and five equivalents each of diethylzinc and 
diiodomethane added. The reaction was then agitated for two hours, whilst allowing it to 
warm to 0 °C. Subsequent NaBH4 cleavage of the thoroughly washed resin afforded syn- 
cyclopropane-alcohol 294 in approximately 90% de and 73% yield (after column 
chromatography) (see Scheme 6.4.2b). A trace of alkene starting material was also 
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Scheme 6.4.2b: Directed cyclopropanation o f polymer-supported vinyl-syn-aldol 292 with subsequent
NaBH4 cleavage to form syn-cyclopropane-alcohol 294.
This reaction provided proof that the concept of a solid-supported asymmetric aldol / 
directed cyclopropanation reaction was not only possible, but could proceed in high 
diastereoselectivity and moderate yields (47% over two steps). Further work is required to 
investigate this reaction further, firstly aiming to improve the yield of the reaction 
considerably and later to explore the scope and limitations of these reactions.
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6.4.3 Solid phase asymmetric aldol /  directed epoxidation/lactonisation strategy
Following on from the successful solid phase directed cyclopropanation reaction, 
preliminary studies into a polymer-supported directed epoxidation/lactonisation reaction 
were conducted.
A significant feature of this reaction on solid phase is that cyclisation/lactonisation of the 
side chain would result in self cleavage o f the lactone product from the polymer-supported 
oxazolidin-2-one. Whilst this is in some ways desirable as it eliminates the need for a 
separate cleavage step, it could also prove problematic since uncontrolled self-cleavage at 
inopportune times would lead to contamination of the lactone product with the reagents 
present in the reaction solution, thus negating the purification benefits of the solid-phase 
system.
Once again, the first step was synthesis o f the appropriate polymer-supported jy/i-aldol 
substrate. The boron enolate of polymer-supported /V-propionyl oxazolidin-2-one 73a was 
treated with 2-ethylacrolein to form .sy/i-aldol 295 according to the reaction conditions 
developed in Section 6.4.1, (see Scheme 6.4.3a). Subsequent side-chain cleavage 
employing NaBH4 afforded syrc-aldol alcohol 296 in 62% yield and > 95% de.
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Scheme 6.4.3a: Solid phase syn-aldol reaction o f Merrifield-supported N-propionyl-oxazolidin-2-one 73a 
with 2-ethylacrolein, followed by NaBH4 side chain cleavage to form syn-aldol alcohol 296.
Functionalised resin 295 suspended in benzene was then treated with an excess of 
V0 (acac)2 and r-BuOOH in a variation o f the solution phase method described in Section 
6.3.1, (see Scheme 6.4.3b)
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Scheme 6.4.3b: Directed epoxidation o f polymer-supported vinyl-syn-aldol 295 followed by cyclisation /  
lactonisation to afford lactone 21A in solution phase and polymer supported N-H oxazolidin-2-one 295.
In solution phase it had been found that the cyclisation /  lactonisation step appeared to 
occur spontaneously after epoxidation, with no sign of any epoxide remaining even after 
just 30 minutes. It was unclear whether or not this would also occur on solid phase, but to 
ensure the lactone product was recovered, the filtrate and washings of the resin were 
collected and evaporated. In order to remove the excess o f vanadium, the residue was 
redissolved in DCM and passed through a plug of silica. Analysis of the resulting 
colourless oil revealed the presence of lactone 274 albeit in a moderate 58% yield and in 
90% de. This result clearly shows that the concept o f polymer-supported substrate- 
directable reactions is viable with some lactone 274 being prepared in high de. It is 
unfortunate that the self-cleavage step in this case resulted in the product being released 
into the reaction mixture thus complicating the purification procedure. It must be noted 
however, that this still represents an improvement when compared to the corresponding 
solution phase reaction where the lactone has to be separated not only from the excess 
vanadium but also from the A-H-oxazolidin-2-one which often has a similar Rf value. It is 
anticipated that other substrates might allow a more practical experimental procedure since 
in solution phase it was found that some substrates afforded an intermediate epoxide that 
was stable and could be isolated. If this could be repeated on solid-phase systems, then it 
might allow the removal of the excess vanadium before intramolecular cyclisation and self­
cleavage of the lactone from the polymer occurs, thus simplifying the work-up procedure. 
Furthermore, it is anticipated that with further optimisation of both this reaction and the 
preceding aldol reaction, and a greater understanding of the epoxidation / lactonisation 
mechanism, improvements to the overall yield could be achieved. Unfortunately time 
restraints prevented further investigation into this area.
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6.5 Conclusions
This chapter has described early attempts to develop new strategies for the use o f Evans 
oxazolidin-2-one type chiral auxiliaries, both in solution and solid phase. The overall 
strategy involves the use o f a chiral oxazolidin-2-one to induce chirality in an asymmetric 
reaction in a conventional manner. The newly formed chiral centre is then used to induce 
chirality to a second asymmetric reaction. The oxazolidin-2-one fragment is thus used 
indirectly to induce chirality at a site remote to its normal area o f influence and hence the 
variety o f enantiopure chiral products that can be formed from oxazolidin-2-one chemistry 
is greatly increased.
This strategy was demonstrated in the synthesis o f the chiral cyclopropane-containing 
natural product Grenadamide. In this case, an asymmetric syrt-aldol reaction was used to 
introduce a temporary stereogenic hydroxyl group, which was used to direct a substrate- 
directed cyclopropanation reaction. Further manipulations afforded the natural product in 
good yield and excellent de.
A  variation o f this strategy involving substrate-directed epoxidation o f a chiral allylic 
alcohol was also investigated where it was found that an intermediate epoxide species was 
unstable and underwent self-cleavage to form the parent N -H oxazolidin-2-one and a chiral 
lactone in high de.
Attempts to apply these strategies to polymer-supported systems were promising. Firstly, 
conditions for a polymer-supported asymmetric .yyn-aldol reaction were developed to allow  
the formation o f a syn-aldol substrate with a stereodefined hydroxyl group, in high de. 
Subsequent attempts to perform substrate-directed cyclopropanations and epoxidation /  
lactonisation reactions were successful, with products o f good de being obtained albeit in 
moderate yields. Unfortunately, time restraints prevented further optimisation o f these 
systems, but it is anticipated that further investigation would allow the overall yields o f the 
chiral products to be increased thus affording practical solid-phase systems for the 
asymmetric synthesis o f libraries o f chiral products.
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Chapter 7 Synthetic procedure and spectroscopic data
7.1 General Experimental
All solvents were either distilled before use and stored in the presence o f 3 A  molecular 
sieves (tetrahydrofiiran and diethyl ether were distilled from sodium wire, acetonitrile, 
dichloromethane and DMF were distilled from calcium hydride) or obtained from an 
MBraun solvent purification system. Methanol was obtained in anhydrous form from 
Fluka. A ll commercial reagents were used without purification unless stated otherwise.
TLC using aluminium backed plates precoated with Macherey-Nagel Sil G, monitored all 
reactions. Visualisation o f these plates was by 254 nm U V  light and/or KMn0 4 , PMA or 
vanillin dips followed by gentle warming.
Flash chromatography was carried out using Davisil LC 60A silica gel (35-70 micron) 
purchased from Flurochem. Samples were either pre-absorbed onto silica or loaded as 
saturated solutions in an appropriate solvent.
Proton (]H) and carbon (13C) NMR spectra were recorded on a Bruker 300MHz 
spectrometer. Chemical shifts are quoted in parts per million and are referenced to the 
residual solvent peak or to SiM e4  (5 = 0.00 ppm) as an internal standard. Coupling 
constants (J) are given in Hz to the nearest 0.5 Hz and multiplicities are denoted as singlet 
(s), doublet (d), triplet (t), quartet (q), unresolved multiplet (m) or broad (br.). All 
structural assignments o f both proton and carbon spectra were achieved with the aid o f  
COSY, HMQC, HMBC and PENDANT experiments wherever possible and with 
comparisons from analogous literature compounds. In all 1 H-NMR spectra, the aromatic 
protons derived from the original tyrosine molecule (i.e. C6H4  moiety) represent an 
A A ’B B ’ system due to magnetic inequivalence. The signals are thus described as apparent 
doublets (app. d) although in reality this is a significant simplification.
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IR spectra were recorded from thin films or KBR disc on a Perkin-Elmer 1600 series FT-IR 
spectrophotometer in the range 600-4000 cm'1, with internal calibration. Selected 
absorbances are quoted as u in cm'1.
M ass spectra, including high-resolution spectra, were run by the EPSRC mass spectrometry 
service, Swansea. Electron impact (El) and chemical ionisation (Cl) analyses were 
performed in positive ionisation mode.
Elemental analyses were performed with an Exeter analytical, INC. CE-440 elemental 
analyser in the Chemistry Department o f the University o f Bath.
Melting points were measured on a Buchi 535 series instrument and are uncorrected.
Optical rotations were performed on an Optical Activity LTD: AA-10 automatic 
polarimeter.
High pressure liquid chromatography was carried out using a TSP Thermo Separation 
products spectra SERIES and Spectra Physics Systems using Chiralcel OD®, AD® and OJ® 
columns obtained from Fisher Scientific Supplies.
Diastereomeric excess (de) values were determined by ^ -N M R  and HPLC unless stated 
otherwise.
Reactions requiring anhydrous conditions were performed under nitrogen in flame-dried 
apparatus. A ll temperatures quoted are external.
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Triethylamine (11.54 mL, 82.8 mmol), Boc anhydride (13.27 g, 60.8 mmol) and 
tetrabutylammonium iodide (2.55 g, 6.9 mmol) were added to a solution of L-tyrosine (10 
g, 55.2 mmol) in dioxane:H20  (1:1, 100 mL) at 0 °C. The mixture was warmed to room 
temperature and stirred for 12 hours. The solvent was removed in vacuo, and the residue 
partitioned between water and ethyl acetate. The aqueous layer was washed with ethyl 
acetate, acidified to pH 1.0 with 2N HC1, and then back-extracted with the same ethyl 
acetate. The combined organic fractions were washed with brine, dried over magnesium 
sulphate, filtered and concentrated in vacuo yielding 105 as an off-white foam (13.24 g,
47.0 mmol, 85%). [oc]D21 + 3.9° (c 2.0, MeOH); NMR (CDC13, 300 MHz): 5 l .4 2 (9 H , 
s, C //3), 3.02 (2H, m, CH2A i ), 4.55 (1H, m, CHN), 5.14 (1H, br. s, NH), 5.97 (1H, br. s, 
OH), 6.70 (2H, app. d, J  8.5 Hz, o-OArH), 6.99 (2H, app. d, J  8.5 Hz, m-OAxH). 13C NMR 
(CDC13, 75.5 MHz): 8 28.6 (CH3), 37.8 (CH2), 57.8 (CH), 80.5 (C), 116.1 (CH), 129.1 
(CH), 131.2 (C), 157.1 (C =0), 157.7 (C), 175.5 (C =0). Spectroscopic data identical to 
literature com pound .46
(S)-3-(4-Benzyloxy-phenyl)-2-tert-butoxycarbonyl amino-propionic acid benzyl ester,
Potassium carbonate (29.59 g, 214.48 mmol), benzyl bromide (20.4 mL, 171.58 mmol) and 




protected L-tyrosine 105 (12.1 g, 42.91 mmol) in anhydrous DMF (150 mL). The mixture 
was stirred for 48 hour at room temperature followed by addition of water and extraction 
(three times) with ethyl acetate. The organic fractions were combined, washed with IN  HC1 
and brine, dried over sodium sulphate, and the solvent removed in vacuo to afford a dark 
orange oil that was recrystallised (Et20 /petrol) to afford the crystalline solid 106 (17.23 g, 
37.33 mmol, 87%). m.p. 85-86 °C; [cx]D21 -7.9 (c 2.97, EtOAc); *H NM R (CDC13, 300 
MHz): 8 1.41 (9H, s, C //3), 2.98 (2H, d, J  5.6 Hz, C //2Ar), 4.52 (1H, m, C //N ), 4.95 (2H, s, 
A rO C //2Ar), 5.02 (1H, d (as part of ABquartet) J  12.0 Hz, (CO )O C//A H BAr), 5.11 (1H, d, 
(as part of AB quartet, J  12.0 Hz, (CO )O C//A H BAr), 6.76 (2H, app. d, J  8.5 Hz, o-OAxH), 
6.87 (2H, app. d, J  8.5 Hz, m-OArH), 7.21 - 7.38 (10H, br. m, ArH)\ 13C-NMR (CDC13,
75.5 MHz): 8 28.3 (CH3), 37.4 (CH2), 54.5 (CH), 67.0 (CH2), 70.0 (CH2), 79.9 (C), 114.9 
(CH), 127.7 (CH), 127.9 (CH), 128.5 (CH), 129.5 (CH), 129.8 (CH), 130.5 (CH), 131.2 
(C), 132.3 (CH), 135.2 (C), 137.0 (C), 155.1 (C =0), 157.8 (C), 171.8 (C =0); IR (KBr) 
v max (cm '1): 3423 (N-H), 1729 (C =0), 1701 (C =0); MS (CI+) m/z (%) 462 (41) [M+H+], 
479 (100) [M+NH4+]. Spectroscopic data identical to literature reference .109
(S)-[l-(4-Benzyloxy-benzyl)-2-hydroxyethyl]-carbamic acid terf-butyl ester, 107
Y Yo 1
HO'
A solution of ester 106 in THF (40 mL) (9.72 g, 21.06 mmol) was added to a vigorously 
stirred solution of LiAlH4 (31.59 mL, 1.0 M, 31.59 mmol) in THF at 0 °C over a period of 
45 minutes, (CAUTION evolution of hydrogen). The reaction mixture was then stirred at 
room temperature for one hour before quenching via dropwise addition of aqueous 
potassium hydroxide solution (85 mL, 10%). The resulting solution was then filtered 
through a pad of Celite® to remove the gelatinous white precipitate, before being extracted 
with ethyl acetate. The organic layers were combined, washed with brine, dried with 
magnesium sulphate, and the solvent removed in vacuo to afford 107 (6.62 g, 18.53 mmol, 
8 8 % )  as a cream-coloured powder, m.p. 102-103 °C; Lit. 108-109 °C 110; [ c c ] d 2 1  -18.0 (c 
1.74, EtOAc); Lit. -17.0 n0; *H NM R (CDC13, 300 MHz): 8 1.33 (9H, s, CH3), 2.68 (2H,
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d, J  6.8  Hz, C //2Ar), 3.43 (1H, dd, J  10.9, 5.3 Hz, CHAHBOH), 3.55 (1H, dd, J  10.9, 3.8 
Hz, CHaHbOU), 3.72 (1H, m, CHN), A l l  (1H, br. s, NH), 4.95 (2H, s, O C //2Ar), 6.83 
(2H, app. d, J  8.5 Hz, o-OArH), 7.04 (2H, app. d, J  8.5 Hz, m-OAiH),  7.18-7.37 (5H, br. 
m, A t//); 13C NM R (CDC13, 75.5 MHz): 5 28.3 (CH3), 37.5 (CH2), 54.6 (CH), 67.1 (C),
71.1 (CH2), 79.9 (CH2), 114.9 (CH), 130.5 (CH), 128.8 (CH), 128.5 (CH), 127.7 (CH),
135.2 (C), 137.0 (C), 157.9 (C =0), 160.0 (C); IR (KBr) v max (cm '1): 3367 (broad O-H), 
3257 (broad N-H), 1688 (C =0); MS (CI+) m/z (%) 358 (27) [M+], 319 (93) [M- 
lBu+NH4+], 301 (100) [M-lBu+], 240 (39) [M-NHBoc+]; HRMS (ES+) for C2iH27N 0 4 
[M +H]+ Calc. 358.2013, Found 358.2015.
(4S)-4-(4-Benzyloxy-benzyl)-oxazolidin-2-one, 103
,NH
A solution of alcohol 107 in THF (5.2 g, 14.54 mmol) was added to a suspension of 
sodium hydride (1.45 g, 36.35 mmol) in THF (200 mL) over a period of 20 minutes, 
stirred for 12 hours, then quenched with saturated ammonium chloride (70 mL). The 
reaction mixture was then extracted with ethyl acetate (3 x 25 mL)), the organic phase 
combined, washed with aqueous hydrochloric acid (100 mL, 5% solution), saturated 
N aH C 03 solution (100 mL), and brine (100 mL), and then dried over magnesium 
sulphate. Solvent was then removed in vacuo to yield 103 (3.12 g, 78%) as a white 
crystalline solid, m.p. 133-134 °C; Lit. 136-138 °C 43; [a ]D21 -85.1 (c 5.05, EtOAc) 
Lit. - 84.8 43; !H NMR (CDC13, 300 MHz): 5 2.82 (2H, m, CHaH bAv), 4.05 (1H, m, 
CHN), 4.15 (1H, dd, J  8.5, 5.5 Hz, CHaHbO), 4.39 (1H, app. t, J  8.3 Hz, CHa/ / bO ),
4.98 (2H, s, A rO C //2Ar), 5.05 (1H, br. s, NH), 6.87 (2H, app. d, J  8.5 Hz, o-OAxH),
7.02 (2H, app. d, J  8.5 Hz, m-OAxH), 1 2 5  -  7.38 (5H, br. m, Ar//); 13C NMR (CDC13,
75.5 MHz): 5 41.2 (CH2), 54.6 (CH), 70.3 (CH2), 70.8 (CH2), 116.7 (CH), 128.3 (CH),
128.8 (CH), 129.0 (CH), 129.4 (CH), 130.9 (C), 137.7 (C), 158.7 (C =0), 160.6 (C); 
IR (KBr) v max (cm '1): 3245 (broad N-H), 1753 (C =0); MS (CI+) m/z (%) 301 (100)
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[M+NH4+]. CHN Found C, 71.90, H, 6.05, N, 4.79. C i7H 17N 0 3 requires C, 72.07, H,
6.05, N, 4.94. For X-ray crystallography structure, see Appendix.
General Procedure 1: Catalytic hydrogenation
Oxazolidin-2-one (1 equiv.) and Pd/C (0.1 equiv.) were placed in a round-bottomed flask 
and purged with nitrogen. A mixture of methanol/ ethyl acetate (1:1) was added via syringe 
and the flask placed under 1 atm of hydrogen. The reaction was stirred at room temperature 
for 18 hours (unless stated otherwise), then filtered through celite and washed thoroughly 




According to General procedure 1 using oxazolidin-2-one 103 (2.00 g, 7.1 mmol), Pd/C 
(5%) (744 mg, 0.35 mmol) and methanol/ ethyl acetate (1:1, 20 mL), 1 was prepared (1.25 
g, 6.49 mmol, 92%) as a white powder, m.p. 179-181 °C; Lit. 175-178 °C 43; [a]o21 -12.3 
(c 0.65, MeOH), Lit. -1 1.8 35; 'H  NMR (d4-MeOD, 300 MHz): 8 2.67 (2H, m, CHAHBA r ),
4.01 (2H, m, CHaH bO, CHN), 4.27 (1H, m, CUaH bO), 6.64 (2H, app. d, J  8.5 Hz, o- 
OArH), 6.95 (2H, app. d, J  8.5 Hz, m-OArtf); 13C NM R (d4-MeOH, 75.5 MHz): 5 41.4 
(CH2), 55.6 (CH), 70.8 (CH2), 116.8 (CH), 128.6 (CH), 130.9 (C), 157.9 (C), 162.7 (C =0); 
IR (KBr) v max (cm '1): 3331 (broad O-H), 3140 (broad N-H), 1731 (C =0); MS (CI+) m/z 





L-phenylalanine (5.00g, 30.3 mmol) was placed in a dry 3-necked flask fitted with a reflux 
condenser and 30 mL dry THF added with the resulting suspension stirred at room 
temperature. BF3.Et20  (3.80 mL, 30.3 mmol) was added dropwise over 15 minutes, and 
the suspension stirred for a further 15 minutes, before heating at reflux for two hours until 
the reaction became a colourless and heterogenous solution. BH3.SMe2 (3.6 mL, 37.8 
mmol) was then added over 90 minutes and the solution refluxed for a further 16 hours, 
before cooling to room temperature. To quench the reaction, THF/ MeOH (1:1, 5mL) and 
5M NaOH aq. solution (25 mL) were added dropwise, and the resulting biphasic mixture 
heated at reflux for six hours. The resulting white precipitate was removed by filtration and 
the bulk of the solvent removed in vacuo. The remaining slurry was extracted into DCM 
(x3), the combined organic extracts washed with brine and dried over magnesium sulphate. 
Removal o f the solvent yielded a pale yellow solid, which upon recrystallisation furnished 
108 (3.26 g, 21.5 mmol, 71%) as a cream-coloured crystalline solid, m.p. 84-85 °C; [ c c ] d 21  
-21.5 (c 1.73 , CHC13) ; *H NMR (CDC13, 300 MHz): 8 1.77 (3H, br. s, OH, NH2), 2.55 
(1H, dd, J  13.6, 8.7 Hz, C //AHBAr), 2.81 (1H, dd, J  13.6, 5.3 Hz, CHA/ / BPh), 3.13 (1H, m, 
C //N ), 3.39 (1H, dd, J  10.5, 7.2 Hz, CHAHBOH), 3.65 (1H, dd, J  10.5, 3.7 Hz, CHAtfBOH), 
7 .1 9 -7 .3 5  (5H, br. m, Ar//); 13C NMR (CDC13, 75.5 MHz): 541.1 (CH2), 54.6 (CH), 66.1 
(CH2), 126.8 (CH), 129.0 (CH), 129.6 (CH), 139.1 (C); IR (KBr) v max (cm '1): 3355 (broad 
O-H), 3298 (broad N-H); MS (FAB+) 152 (100) [M+H]+; HRMS (ES+) for C9H 13NO 
[M+H]+ Calc. 152.1070, Found 152.1072.
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(S)-4-Benzyl-oxazolidin-2-one, 101
(5)-phenylalanol 108 (3.50 g, 23.2 mmol), anhydrous potassium carbonate (320 mg, 2.32 
mmol) and diethyl carbonate (5.78 mL, 47.7 mmol) were placed into a round bottomed 
flask fitted with a Vigreux column, distillation head and receiving flask. The mixture was 
lowered into an oil bath preheated to 135 °C and stirred until dissolution was achieved. 
The distillation receiver was then cooled in an ice bath and ca. 2 mL ethanol was collected 
from the reaction over a five hour period. After the light yellow solution was cooled to 
ambient temperature, it was diluted with 50 mL DCM, washed with water (x2) and brine 
before drying over magnesium sulphate and removal of solvent in vacuo. Recrystallisation 
o f the resulting pale yellow solid (EtOAc, hexane) produced 101 (3.083 g, 17.4 mmol, 
75%) as a white solid, m.p. 84-85 °C, Lit 84.5-86.5 °C 44; [cc]D21 5.1 0 (c 0.77, EtOH), Lit 
[ a ]D21 4 .9 °  (c 1.10, EtOH)44; ‘H NMR (CDC13, 300 MHz): 5 2.88 (2H, m, CHAH BAr),
4.09 (1H, m, CHN), 4.17 (1H, m, CHAHbO), 4.50 (1H, app. t, J  8.5 Hz, CHa/ / bO), 5.04 
(1H, br. s, NH), 7.19 (2H, app. d, J  7.0 Hz, ArH), 7.28-7.39 (3H, br. m, ArH)\ 13C NMR 
(CDC13, 75.5 MHz): 541 .8  (CH2), 54.2 (CH), 70.0 (CH2), 127.6 (CH), 129.4 (CH), 129.5 
(CH), 136.3 (C), 160.1 (C =0); MS (FAB+) 178 (100) [M+H]+; HRMS (ES+) for 
C ioH nN 02 [M+H]+ Calc. 178.0863, Found 178.0864. Spectroscopic data identical to 
literature compound .44
General Procedure 2: Solution phase A-acylation employing acid chloride as acyl 
source
A solution of butyl lithium (1.05 equiv.) was added dropwise to a solution of N-H- 
oxazolidin-2-one (1 equiv.) in THF at -7 8  °C. The mixture was warmed to 0 °C then 
cooled back to -7 8  °C. Acid chloride (1.5 equiv.) was then added and the mixture stirred 
for 12 hours at room temperature before quenching with H20 .  The aqueous phase was then
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extracted into ethyl acetate, washed with H2O (x 2 ), and brine (x 2), dried over magnesium 
sulphate, solvent removed in vacuo to afford the A-acylated product.
General Procedure 3: Solution phase A-acylation employing anhydride as acyl source
Lithium chloride (1.2 equiv.), triethylamine (2 equiv.) and the appropriate anhydride (2 
equiv.) were added to a stirred solution of A-H-oxazolidin-2-one (1 equiv.) in THF at 0 °C. 
The mixture was then stirred at reflux for 12 hours, cooled to room temperature and 
quenched with saturated ammonium chloride solution. The solution was then extracted into 
ethyl acetate, the organic layer washed with brine, dried over magnesium sulphate and the 
solvent removed in vacuo to afford the A-acylated product.
(4S)-4-Benzyl-3-propionyl-oxazolidin-2-one, 109
According to General Procedure 2, 4-benzyl-oxazolidin-2-one 101 (401 mg, 2.28 mmol) in 
THF (10 mL) was treated with n-BuLi (0.926 mL, 2.58 M, 2.39 mmol) and propionyl 
chloride (0.298 mL, 3.41 mmol) to afford 109 (490 mg, 2.16 mmol, 92%) as a waxy, white 
solid, m. p. 41 -  42 °C; [oc]D21 + 58.4° (c 0.93, CHC13), !H NMR (CDC13, 300 MHz): 
5 1.20 (3H, t, J  7.0 Hz, CH3), 2.77 (1H, dd, J  13.5, 9.5 Hz, C //AHBAr), 2.95 (2H, m, CH2), 
3.30 (1H, dd, J  13.5 3.5 Hz, CHA/ / BAr), 4.20 (2H, m, CHAH BO), 4.67 (1H, m, CHN), 7.26 
-  7.37 (5H, br. m, A r//); 13C NMR (CDC13, 300MHz): 5 8.7 (CH3), 29.6 (CH2), 37.0 
(CH2), 55.6 (CH), 66.6  (CH2), 127.7 (CH), 129.3 (CH), 129.8 (CH), 135.7 (C), 153.9 
(C =0), 174.5 (C =0). IR (KBr) v max (cm '1): 1785 (C =0), 1700 (C =0); MS (CI+, NH 3) m/z 
(%) 251 (100) [M+NH4+], 234 (12) [M+H+]; HRMS (ES+) for C ,3H i5N0 3 [M+H]+ Calc. 
234.1125, Found 234.1121.
109 was also prepared according to General Procedure 3, in which A-H-oxazolidin-2-one 
101 (250 mg, 1.41 mmol) was treated with lithium chloride (71.6 mg, 1.69 mmol),
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triethylamine (0.393 mL, 2.82 mmol) and propionic anhydride (0.361 mL, 2.82 mmol) to 
afford 109 (293 mg, 1.25 mmol, 89%). Spectroscopic data identical to that reported above.
(4S)-4-(4-Benzyloxy-benzyl)-3-propionyl-oxazolidin-2-one, 110
According to general procedure 3, A-H-oxazolidin-2-one 103 (1.00 g, 3.53 mmol) was 
treated with lithium chloride (180 mg, 4.24 mmol), triethylamine (0.98 mL, 7.06 mmol) 
and propionic anhydride (0.91 mL, 7.06 mmol) to afford 110 as a cream solid (995 mg, 
2.93 mmol, 83%). m.p. 94-95 °C; [ a ]D21 + 57 ° (c 1.25, CHC13); *HNM R (CDC13, 300 
MHz): 5 1.20 (3H, t, J  7.3 Hz, CH/), 2.73 (1H, dd, J  13.5, 9.5 Hz, C //AHBAr), 2.96 (2H, 
m, CH2CH3), 3.22 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 4.20 (2H, m, CHaH bO), 4.63 (1H, 
m, CHN), 5.02 (2H, s, O C //2Ar), 6.94 (2H, app. d, J  8.5 Hz, o-OArH),  7.12 (2H, app. d, J
8.5 Hz, m-OArH), 7.32 -  7.45 (5H, br. m, A r//); 13C-NM R (CDC13, 75.5 MHz): 5 8.3 
(CH3), 29.2 (CH2), 37.0 (CH2), 55.2 (CH), 66.2 (CH2), 70.0 (CH2), 115.3 (CH), 127.4 
(CH), 127.5 (C), 128.0 (CH), 128.6 (CH), 130.5 (CH), 136.8 (C), 153.6 (C =0), 158.1 (C),
174.1 (C =0); IR (KBr) v max (c m 1): 1760 (C =0), 1699 (C =0); MS (CI+) m/z (%) 357 
(100) [M + N H /]. CHN: Found C, 70.8; H, 6.21; N, 4.11. C20H2iNO4 requires C, 70.78; H, 
6.24; N, 4.13.
110 also prepared according to general procedure 2, in which A-H-oxazolidin-2-one 103 
(500 mg, 1.76 mmol) treated with rc-BuLi (0.74 mL, 2.5 M, 1.85 mmol) and propionyl 
chloride (0.153 mL, 2.64 mmol) to afford 110 (532 mg, 1.56 mmol, 89%). Spectroscopic 
data identical to that described above.
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(S)-4-benzyl-3-(3-phenylpropanoyl)-oxazolidin-2-one, 111
According to general procedure 2, A-H-oxazolidin-2-one 101 (400.0 mg, 2.257 mmol) in 
THF (15 mL) was treated with n-BuLi (0.993 mL, 2.5 M, 2.483 mmol) and 3- 
phenylpropionyl chloride (0.435 mL, 2.934 mmol) to afford (5)-4-benzyl-3-(3- 
phenylpropionyl)-oxazo!idin-2-one 111 (607 mg, 1.96 mmol, 87%) as a white solid, mp 
106-107 °C; [ a ]D21 + 70 ° (c 1.0, CHC13), *HNM R (CDC13, 300 MHz): 5 2.71 (1H, dd, J
13.5, 9.5 Hz, CHAHBAr), 3.05 (2H, m, CHAH BPh), 3.20 (1H, dd, J  13.5, 3.5 Hz, 
CHA/ / BAr), 3.27 (2H, m, COCHAH B), 4.20 (2H, m, CH20 ) ,  4.68 (1H, m, CHN), 7.18-7.39 
(10H, br. m, A r//); 13C NMR (CDC13, 75.5 MHz): 5 30.6 (CH2), 37.3 (CH2), 37.5 (CH2),
55.6 (CH), 66.6  (CH2), 126.9 (CH), 127.8 (CH), 128.4 (CH), 128.6 (CH), 129.0 (CH),
130.2 (CH), 138.8 (C), 140.2 (C), 154.6 (C =0), 173.1 (C =0). Spectroscopic data identical 
to literature data. 111
(S)-4-(4-(benzyloxy)benzyl)3-(3-phenylpropionyl)-oxazolidin-2-one, 112
According to General procedure 2, A-H-oxazolidin-2-one 103 (500 mg, 1.765 mmol) in 
THF (20 mL) was treated with n-BuLi (0.777 mL, 2.5 M, 1.942 mmol) and 3- 
phenylpropionyl chloride (0.341 mL, 2.295 mmol) to afford (S)-4-(4-(benzyloxy)benzyl)3- 
(3-phenylpropionyl)-oxazolidin-2-one 112 (638.2 mg, 1.536 mmol, 87%) as a colourless 
oil. [a ]D21 + 66 0 (c 1.0, CHC13), *H NMR (CDC13, 300 MHz): 8 2.71 (1H, dd, J  13.5,
9.5 Hz, CHaH BAr), 3.02 (2H, m, CHAHBPh), 3.17 (1H, dd, J  13.5, 3.5 Hz, CU aHbA t), 3.27 
(2H, m, COCHaHb), 4.16 (2H, m, CH2Q), 4.61 (1H, m, CHN), 5.04 (2H, s, O C //2Ar), 6.92
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(2H, app. d, J  8.5 Hz, 0 -A1 H), 7.08 (2H, app. d, J  8.5 Hz, m-ArH),  7.18 -  7.45 (10H, br. m, 
A r//); 13C NM R (CDC13, 75.5 MHz): 5 30.6 (CH2), 37.3 (CH2), 37.5 (CH2), 55.6 (CH),
66.6 (CH2), 70.4 (CH2), 115.7 (CH), 126.7 (CH), 127.7 (C), 127.9 (CH), 128.4 (CH), 128.9 
(CH), 129.0 (CH), 129.1 (CH), 130.9 (CH), 137.2 (C), 140.9 (C), 153.9 (C = 0), 158.5 (C),
172.8 (C =0); IR (KBr) v max (cm '1): 1766 (C =0), 1693 (C =0).
General Procedure 4: Solution phase enolate alkylation reactions
LHMDS (1.0M in THF, 1.5 equiv.) was added dropwise via syringe to a solution of A-acyl- 
oxazolidin-2-one (1 equiv.) in anhydrous THF at -7 8  °C. After 30 minutes, the electrophile 
(3 equiv.) was added in one portion and the resulting solution stirred for two hours at -78 
°C, followed by 12 hours at -15 °C. The reaction was quenched by addition o f saturated 
ammonium chloride solution and extracted into ethyl acetate (x3). The combined organic 
fractions were washed with brine (x l), dried over MgSC>4 and solvent removed in vacuo to 
yield the product.
(4S)-4-Benzyl-3-((2/?)-2-methyl-3-phenyl-propionyl)-oxazolidin-2-one, 114
According to General procedure 4 using A-acyl oxazolidinone 109 (100 mg, 0.43 mmol), 
LHMDS (0.64 mL, 0.64 mmol) and benzyl bromide (0.25 mL, 2.14 mmol), a crude mixture 
containing the product was prepared as a pale yellow solid. Recrystallisation (ethyl acetate/ 
petroleum ether b.p. 40-60°C) afforded 114 as needles of white crystals (121 mg, 0.37 
mmol, 87%). m. p. 88-89 °C; [oc]D21 + 1 2  0 (c 0.40, CHC13); *H NM R (CDC13, 300 
MHz): 8 1.18 (3H, d, J  7.0 Hz, C //3), 2.55 (1H, dd, J  13.5, 9.5 Hz, C //AHBAr), 2.64 (1H, 
dd, J  13.0, 7.5 Hz, CH(CH3)C //AHB), 3.05 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 3.15 (1H, 
dd, J  13.0, 7.0 Hz, CH(CH3)CHA/ / B), 4.04 -  4.19 (3H, br. m, CHAH BO, C //C H 3), 4.65 (1H, 
m, C H N ), 7.03 (2H, app. d, J  7.5 Hz, AiH), 7.18 -  7.30 (8H, br. m, A r//); l3C NMR
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(CDC13, 75.5 MHz): 8 16.7 (CH3), 37.6 (CH2), 39.6 (CH), 39.8 (CH2), 55.1 (CH)), 65.9 
(CH2), 126.4 (CH), 127.3 (CH), 128.3 (CH), 128.9 (CH), 129.3 (CH), 129.4 (CH), 135.1 
(C), 139.2 (C), 153.0 (C =0), 176.5 (C =0); IR (KBr) v max (cm '1): 3022 ( C at- H ) ,  2912 (C- 
H), 1764 (C =0), 1700 (C =0), 1559 (Cat-Cat), 1454 (C-H), 1388 (C-H), 1240 (C-O), 746 
( C at- H ) ,  700 ( C at- H ) ;  MS (CI+, NH3) m/z (%) 341 (100) [M+NH4+], 324 (38) [M+H+].
(4S)-4-(4-Benzyloxy-benzyl)-3-((2/?)-2-methyl-3-phenyl-propionyl)-oxazolidin-2-one,
115
According to General procedure 4 using A-propionyl-oxazolidinone 110 (100 mg, 0.29 
mmol), LHMDS (0.44 mL, 1.0 M, 0.44 mmol) and benzyl bromide (0.105 mL, 0.89 mmol), 
a crude mixture of the product was prepared as an off-white solid. Column chromatography 
on silica using 10:1 petroleum ether (b.p.40-60°C)/ethyl acetate as the eluent yielded 115 as 
needles of a white crystalline solid (111 mg, 0.26 mmol, 89%). m. p. 123-124 °C; [ oc] d 21 
+13 ° (c 0.95, CHC13); 'H N M R  (CDC13, 300 MHz): 8 1.11 (3H, d, J  7.0 Hz, CH3), 2.44 
(1H, dd, J  13.5, 9.5 Hz, CHAHBAr), 2.59 (1H, dd„ J  13.0, 7.5 Hz, CH(CH3)C //AHB), 2.89 
(1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 3.0 (1H, dd, J  13.0, 7.0 Hz, CH(CH3)CHAHB), 3.98 -
4.11 (3H, br. m, CHAH BO, C //C H 3), 4.53 (1H, m, CHN),  4.94 (2H, s, A rO C //2Ar), 6.78 
(2H, app. d, J  8.5 Hz, o-OArH),  6.85 (2H, app. d, J  8.5 Hz, m-OAiH),  7.09 -  7.36 (10H, br. 
m, ArH)\ 13C NM R (CDC13, 75.5 MHz): 8 14.4 (CH3), 37.0 (CH2), 39.9 (CH), 40.1 (CH2),
55.4 (CH), 66.1 (CH2), 70.2 (CH2), 115.5 (CH), 126.7 (CH), 127.6 (C), 127.7 (CH), 128.2 
(CH), 128.6 (CH), 128.9 (CH), 129.7 (CH), 130.7 (CH), 137.2 (C), 139.6 (C), 153.4 (C =0), 
158.3 (C), 176.7 (C =0); IR (KBr) v max (cm '1): 1768 (C =0), 1688 (C =0); MS (CI+, NH3) 




Purification via column chromatography of the crude reaction product of the attempted 
alkylation of 109 with benzyl bromide at -78°C to room temperature afforded (4S)-3,4- 
dibenzyl-oxazolidin-2-one 121 (14.9 mg, 0.056 mmol, 13%) as a colourless oil. [a]o21 -
11.4 ° (c 1.0, CHC13); !H NMR (CDCI3, 300 MHz): 8 2.60 (1H, dd, J  13.5, 9.5 Hz, 
C C //AHBPh), 3.04 (1H, dd, J  13.5, 3.5 Hz, CCHA/ / BPh), 3.79 (1H, m, CHN), 4.01 (1H, dd, 
J  8.5, 5.5 Hz, CHaHbO), 4.11 (2H, m, CHa/ / bO, N C //AHBPh), 4.88 (1H, d J  15.0 Hz, 
NCH A/ / BPh), 7.02-7.10 (10H, br. m, A r//); 13C NM R (CDC13, 75.5 MHz): 5 38.5 (CH2),
46.6 (CH2), 55.8 (CH), 68.1 (CH2), 127.3 (CH), 128.4 (CH), 128.5 (CH), 128.9 (CH), 129.1 
(CH), 129.3 (CH), 135.8 (C), 137.2 (C), 158.6 (C =0). Spectroscopic data identical to 
literature compound 112
(4S)-3-Benzyl-4-(4-benzyloxy-benzyl)-oxazolidin-2-one, 122
Purification via column chromatography o f the crude reaction product of the attempted 
alkylation of 110 with benzyl bromide at -78°C to room temperature afforded (4S)-3- 
Benzyl-4-(4-benzyloxy-benzyl)-oxazolidin-2-one 122 (15.2 mg, 0.04 mmol, 14%) as a 
pale yellow oil. [ a ]D21 + 90.9° (c 0.7, CHC13); 'H N M R  (CDC13, 300 MHz): 5 2.57 (1H, 
dd, J  13.5, 9.5 Hz, C //AHBAr), 3.03 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 3.75 (1H, m, 
CHN), 3.99 (1H, dd, J  8.5, 6.0 Hz, C //aHbO), 4.10 (2H, m, CHa/ / bO, N C //AHB), 4.86 
(1H, d, J  15.0 Hz, NCHA/ / B), 5.04 (2H, s, O C //2Ar), 6.92 (2H, app. d, J  8.5 Hz, o-OArH), 
6.95 (2H, app. d, J  8.5 Hz, m-OArH), 7.23 -  7.44 (10H, br. m, A r//); 13C NMR (CDC13,
2 0 1
75.5 MHz): 5 37.5 (CH2), 46.3 (CH2), 55.3 (CH), 66.9 (CH2), 70.0 (CH2), 115.2 (CH),
127.4 (CH), 127.6 (CH), 127.9 (CH), 128.0 (C), 128.2 (CH), 128.6 (CH), 128.9 (CH),
130.0 (CH), 135.9 (C), 136.8 (C), 157.9 (C =0), 158.4 (C); IR (thin film) v max (cm '1): 1742 
(C = 0); MS (EI+) m/z (%) 374 (38) [M +]; HRMS (ES+) for C24H23N 0 3 [M+H]+ Caic. 
374.1751, Found 374.1752.
(S)-3-((/?)-2-methylpent-4-enoyl)-4-benzyl-oxazoIidin-2-one, 125
According to General procedure 4 using A-propionyl-oxazolidinone 109 (100.0 mg, 0.428 
mmol), LHMDS (0.64 mL, 1.0M, 0.64 mmol) and allyl iodide (0.195 mL, 2.14 mmol), a 
crude mixture containing the product was prepared as a pale yellow solid. Recrystallisation 
(ethyl acetate/ hexane) afforded (S)-3-((/?)-2-methylpent-4-enoyl)-4-benzyl-oxazoIidin-2- 
one 125 as needles of colourless crystals (102.9 mg, 0.376 mmol, 88%). [ o c ] d 2 1  92 ° (c 1.0, 
CHC13); 'H  NMR (CDC13, 300 MHz): 5 1.15 (3H, d, J  7.0 Hz, CH3), 2.20 (1H, m, 
CH(CH3)C //AHB), 2.49 (1H, m, CH(CH3)CHA/ / B), 2.60 (1H, dd, J  13.5, 9.5 Hz, 
C //AHBAr), 3.18 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 3.84 (1H, m, C //C H 3), 4.12 (2H, m, 
CHaH bO), 4.59 (1H, m, CHN), 5.05 (2H, m, C=CH2), 5.78 (1H, m, HC=CH2), 7.26 -  7.38 
(5H, br. m, A r//); 13C NMR (CDC13, 75.5 MHz): 5 16.6 (CH3), 37.3 (CH), 37.8 (CH2),
38.2 (CH2), 55.7 (CH), 66.0 (CH2), 117.5 (CH2), 127.8 (CH), 128.6 (C), 129.3 (CH), 134.8 




According to General procedure 4 using A-acyl-oxazolidinone 110 (80 mg, 0.24 mmol), 
LHMDS (0.35 mL, 1.0 M, 0.35 mmol) and allyl iodide (0.065 mL, 0.71 mmol), the crude 
product was prepared as a dark yellow oil. Column chromatography on silica using 4:1 
petroleum ether (b.p.40-60°C)/ethyl acetate as the eluent yielded 126 as a colourless oil 
(81.0 mg, 0.214 mmol, 89%). [ a ]D21 + 36.5° (c 1.02, CHC13); ’H N M R  (CDC13, 300 
MHz): 5 1.11 (3H, d, J  7.2 Hz, C //3), 2.16 (1H, m, CH(CH3)C //AHB), 2.45 (1H, m, 
CH(CH3)CHa//b), 2.57 ( 1H, dd, J  13.5, 9.5 Hz, C //AHBAr), 3.13 ( 1H, dd, J  13.5, 3.5 Hz, 
CH A/ / BAr), 3.78 (1H, m, C //C H 3), 4.08 (2H, m, C //aHbO), 4.56 (1H, m, CHN), 4.97 (2H, 
s, O C //2Ar), 5.03 (2H, m, C =C //2), 5.75 (1H, m, HC=CH2), 6.86  (2H, app. d, J  8.5 Hz, o- 
OArH), 7.06 (2H, app. d, J  8.5 Hz, m-OAiH),  7.23 -  7.37 (5H, br. m, ArH)\ 13C NMR
(CDC13, 75.5 MHz): 8 16.8 (CH3), 37.5 (CH), 37.6 (CH2), 38.4 (CH2), 55.9 (CH), 66.4 
(CH2), 70.5 (CH2), 115.7 (CH), 117.8 (CH2), 127.9 (CH), 128.0 (C), 128.4 (CH), 129.0 (C),
130.9 (CH), 135.7 (CH), 137.3 (C), 153.6 (C =0), 158.5 (C), 176.9 (C =0); IR (Thin film) 
Vmax (cm '1): 1770 (C =0), 1694 (C =0); MS (CI+, NH3) m/z (%) 397 (100) [M+NH4+], 380 
(38) [M+H+]; HRMS (ES+) for C23H25N 0 4 [M+NH4]+ Calc. 397.2122 , Found 397.2122.
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(45)-4-Benzyl-3-((25)-2-methyl-3-phenyl-propionyl)-oxazolidin-2-one, 123
According to general procedure 4, using /V-3-phenyl-propionyl-oxazolidin-2-one 111 (100 
mg, 0.323 mmol), LHMDS (0.484 mL, 1.0M in THF, 0.484 mmol) and methyl iodide
(0.060 mL, 0.969 mmol) to afford crude 123 as a yellow oil. Purification via column
0 1chromatography afforded 123 as a colourless oil (86.7 mg, 0.268 mmol, 83%). [a]o 63 0 
(c 1.0, CHC13); ]H NMR (CDCI3, 300 MHz): 5 1.23 (3H, d, J  7.0 Hz, CH3), 2.60 -  2.71 
(2H, m, C //AHBAr and CH(CH3)C //AHB), 3.05 (1H, dd, J  13.0, 7.5 Hz, CH(CH3)CHA/ / B),
3.14 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 3.89 (1H, app. t, J  8.5 Hz, C //aHbO), 4.08 (1H, 
dd, J  9.0, 2.0 Hz, CHa/ / bO), 4.13 (1H, q, J  7.0 Hz, CHCH3), 4.42 (1H, m, CHN), 6.99-7.32 
(10H, br. m, A r//); l3C NMR (CDC13, 75.5 MHz): 5 17.4 (CH3), 37.0 (CH2), 39.6 (CH),
39.9 (CH2), 55.4 (CH), 66.2 (CH2), 126.5 (CH), 128.0 (CH), 128.4 (CH), 128.7 (CH), 129.4 




According to General procedure 4, using 7V-3-phenyl-propionyl-oxazolidin-2-one 112 (100 
mg, 0.24 mmol), LHMDS (0.36 mL, 1.0M in THF, 0.36 mmol) and methyl iodide (0.044 
mL, 0.72 mmol) to afford crude 124 as a yellow oil. Purification via column 
chromatography afforded 124 as a colourless oil (84.5 mg, 0.197 mmol, 82%). [a]o21 + 70 
° ( c  1.7, CHCI3); 'H N M R  (CDCI3, 300 MHz): 8 1.24 (3H, d, J  7.0 Hz, CH3), 2.64 -  2.74 
(2H, m, CHaHBAr and CH(CH3)C //AHB), 3.03 (1H, dd, J  13.0, 7.5 Hz, CH(CH3)CHA/ / B),
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3.15 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 3.94 (1H, app. t, J  8.5 Hz, CAaHbO), 4.06 (1H, 
dd, J  9.0, 2.2 Hz, CHa/ / bO), 4.11 (1H, q, J  7.0 Hz, C //C H 3), 4.46 (1H, m, C //N ), 5.03 (2H, 
s, A rO C //2Ar), 6.92 (2H, app. d, J  8.5 Hz, o-OArH), 7.10 (2H, app. d, J  8.5 Hz, m-OArH),
7.15  _  7.44  (10H, br. m, ArH)\ 13C NM R (CDC13, 75.5 MHz): 8 17.5 (CH3), 37.4 (CH2),
39.9 (CH), 40.3 (CH2), 55.8 (CH), 66.4 (CH2), 70.4 (CH2), 115.6 (CH), 126.8 (CH), 127.8 
(C), 127.9 (CH), 128.4 (CH), 128.7 (CH), 129.0 (CH), 129.6 (CH), 130.9 (CH), 137.2 (C),
139.6 (C), 153.4 (C =0), 158.5 (C), 176.9 (C =0). IR and mass spec data identical to 45,2/?- 
115.
General Procedure 5: Solution phase syw-aldol reactions
9-BBN-OTf (0.5 M in DCM, 1.1 equiv.) was added dropwise via syringe to a stirred 
solution o f A-acyl oxazolidinone (1 equiv.) in DCM at 0 °C. After 30 minutes, DIPEA (1.2 
equiv.) was added and the solution stirred for a further 30 minutes before cooling to -78 °C 
and the addition of aldehyde (1.2 equiv.). The resulting solution was stirred at -78 °C and 
allowed to slowly warm to room temperature over the stated period of time. In order to 
quench the reaction, phosphate buffer pH 7 (0.1 M) was added, followed by a solution of 
H20 2 in MeOH (2:1 v/v) and the mixture was stirred for 6 hours. Finally the reaction was 
extracted into DCM (x3), the combined organic fractions were washed with saturated 
sodium bicarbonate solution (x2 ) and brine (x l), dried over magnesium sulphate and 
solvent removed in vacuo to afford the crude product.
(5)-4-Benzyl-3-((25,3/?)-3-hydroxy-2,4-dimethyl-pentanoyl)-oxazolidin-2-one, 133
P H
According to general procedure 5 employing A-propionyl-oxazolidin-2-one 109 (200 mg, 
0.857 mmol) in DCM (8 mL), 9-BBN-OTf (1.885 mL, 0.5 M, 0.943 mmol), 'Pr2NEt (0.179 
mL, 1.028 mmol) and isobutyraldehyde (0.094 mL, 1.028 mmol), the crude product was
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prepared as a pale yellow oil. Purification via column chromatography afforded (S)-4- 
benzyl-3-((2S,3*S)-3-hydroxy-2,4-dimethyl-pent-4-enoyl)-5,5-diinethyl-oxazolidin-2-one
133 (186 mg, 0.608 mmol, 71%) as a colourless oil. [ c x ] d 2 1  + 4 1  0 (c 1.0, CHCI3); *H 
NM R (CDCI3, 300 MHz): 6 0.98 (3H, d, J  7.0 Hz, C //3), 1.02 (3H, d, J  7.0 Hz, CH3),
1.21 (3H, d, J  7.2 Hz, CH3), 1.70 (1H, m, C //(C H 3)2), 2.78 (1H, dd, J  13.5, 9.5 Hz, 
C //AHBAr), 2.98 (1H, br. s, OH), 3.23 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 3.54 (1H, m, 
CHOU), 3.98 (1H, dq, J  3.0, 7.0 Hz, CHCH3), 4.21 (2H, m, CHaH bO), 4.69 (1H, m, CHN), 
7.28-7.39 (5H, br. m, A r//); 13C NM R (CDC13, 75.5 MHz): 5 9.8 (CH3), 18.7 (CH3), 19.2 
(CH3), 30.6 (CH), 37.6 (CH), 39.5 (CH2), 55.2 (CH), 66.0 (CH2), 77.8 (CH), 127.3 (CH),
128.9 (CH), 129.5 (CH), 135.0 (C), 152.8 (C =0), 177.7 (C =0); Spectroscopic data 




According to general procedure 5, employing A-propionyl-oxazolidin-2-one 110 (200 mg, 
0.589 mmol) in DCM (8 mL), 9-BBN-OTf (1.296 mL, 0.5 M, 0.648 mmol), ‘PrsNEt (0.123 
mL, 0.707 mmol) and isobutyraldehyde (0.064 mL, 0.707 mmol), the crude product was 
prepared as a pale yellow oil. Purification via column chromatography afforded (S)-4-(4-
Benzyloxy-benzyl)-3-((2S,3/?)-3-hydroxy-2,4-dimethyl-pentanoyl)-oxazoIidin-2-one
134 (176.9 mg, 0.430 mmol, 73%) as a colourless oil. [ c c ] d 21 + 48 0 ( c  1.26, CHCI3); !H 
NM R (CDCI3, 300 MHz): 8 1.00 (3H, d, J  7.0 Hz, C //3), 1.04 (3H, d, J  7.0 Hz, C //3),
1.22 (3H, d, J  7.0 Hz, C //3), 1.70 (1H, m, C //(C H 3)2), 2.80 (1H, dd, J  13.5, 9.5 Hz, 
C //AHBAr), 2.82 (1H, br. s, OH), 3.25 (1H, dd, J  13.5, 3.5 Hz, CH A/ / BAr), 3.56 (1H, m, 
CHOU), 3.99 (1H, dq, J  7.0, 3.0 Hz, CHCH3), 4.24 (2H, m, CHaH bO), 4.66 (1H, m, CHN),
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5.01 (2H, s, A rO C //2Ar), 6.89 (2H, app. d, J  8.5 Hz, o-OXxH), 7.00 (2H, app. d, J  8.5 Hz, 
m-OArH), 7.15-7.39 (5H, br. m, A r//); 13C NMR (CDC13, 75.5 MHz): 9.9 (CH3), 18.5 
(CH3), 19.4 (CH3), 30.8 (CH), 37.4 (CH), 38.9 (CH2), 55.4 (CH), 66.4 (CH2), 70.4 (CH2),
77.4 (CH), 115.7 (CH), 126.9 (CH), 127.4 (C), 128.3 (CH), 128.4 (CH), 130.9 (C), 137.4 
(C), 153.9 (C =0), 158.6 (C), 176.8 (C =0); IR (thin film) v max (c m 1): 3532 (broad O-H), 
1783 (C =0), 1688 (C =0).
(45)-4-Benzyl-3-((3S)-3-hydroxy-(2S)-2-methyl-3-phenyl-propionyl)-oxazolidin-2-one,
135
According to General Procedure 5 using A-acyl-oxazolidinone 109 (150 mg, 0.44 mmol), 
9-BBN-OTf (1.06 mL, 0.5 M, 0.53 mmol), DIPEA (0.100 mL, 0.58 mmol) and 
benzaldehyde (0.049 mL, 0.49 mmol), the crude product was prepared as a dark yellow oil. 
Column chromatography on silica using 10:1 petroleum ether (b.p.40-60 °C)/ethyl acetate 
yielded 135 as a colourless oil (112 mg, 0.33 mmol, 75%); [ a ]D21 + 54 0 (c 1.32, CHC13); 
‘H N M R  (CDC13, 300 MHz): 8 1.14 (3H, d, J  7.0 Hz, C //3), 2.68 (1H, dd, J  13.5, 9.5 Hz, 
C //AHBAr), 3.10 (1H, br. s, OH), 3.15 (1H, dd, J  13.5, 3.5 Hz, CHaH bAi),  4.01 (3H, m, 
CHCH3, CHaH bO), 4.49 (1H, m, CHN), 5.00 (1H, app. d, J  4.0 Hz, CHOU), 7.22 (10H, m, 
A r//); 13C NMR (CDC13, 75.5 MHz): 8 11.4 (CH3), 38.1 (CH2), 45.0 (CH), 55.6 (CH), 66.6 
(CH2), 74.2 (CH), 126.5 (CH), 127.8 (CH), 127.9 (CH), 128.6 (CH), 129.4 (CH), 129.8 
(CH), 135.4 (C), 141.7 (C), 153.3 (C =0), 177.1 (C =0); IR (thin film) v max (cm '1): 3507 
(broad O-H), 1770 (C =0), 1698 (C =0); MS (EI+) m/z (%) 339 (2) [M +], 57 (100); MS 
(CI+, NH3) m/z (%) 357 (5) [M+NH4+], 251 (100); HRMS (ES+) for C20H21NO4 [M+H]+ 




According to General Procedure 5 using A-acyl oxazolidinone 110 (200 mg, 0.59 mmol), 9- 
BBN-OTf (1.42 mL, 0.5 M, 0.71 mmol), DIPEA (0.133 mL, 0.77 mmol) and benzaldehyde 
(0.066 mL, 0.65 mmol), the crude product was prepared as a yellow oil. Column 
chromatography on silica using 10:1 petroleum ether (b.p.40-60 °C)/ethyl acetate as the 
eluent yielded 136 as needles of a white crystalline solid (157 mg, 0.35 mmol, 69%). m.p. 
102-103 °C; [a ]D21+ 5 0 ° (c 3 .3 3 ,  CHC13); 'H N M R  (CDC13, 300 MHz): 8 1.12 (3H, d, 7
7.0 Hz, CH3), 2.61 (1H, dd, 7 13.5, 9.5 Hz, C //AHBAr), 3.04 (1H, dd, 7 13.5, 3.5 Hz, 
CHA/ / BAr), 3.15 (1H, br. s, OH), 3.92 (1H, m, C //C H 3), 4.00 (2H, m, CH aH bO), 4.41 (1H, 
m, CHN), 4.93 (2H, s, ArOCH2Ar), 4.97 (1H, app. d, 7 4.0 Hz, C //O H ), 6.83 (2H, app. d, 7
8.5 Hz, o-OArH), 7.00 (2H, app. d, 7 8.5 Hz, m-OArH), 7.12-7.35 (10H, br. m, ArH); 13C 
NM R (CDCI3, 75.5 MHz): 5 11.4 (CH3), 37.2 (CH2), 45.0 (CH), 55.7 (CH), 66.6  (CH2),
70.5 (CH2), 74.3 (CH), 115.7 (CH), 126.6 (CH), 127.6 (C), 127.9 (CH), 128.0 (CH), 128.5 
(CH), 128.6 (CH), 129.0 (CH), 130.9 (CH), 137.3 (C), 141.8 (C), 153.4 (C =0), 158.5 (C),
177.1 (C =0); IR (KBr) v max (c m 1): 3540 (broad O-H), 1781 (C =0), 1689 (C =0); MS 
(CI+, NH3) m/z (%) 463 (100) [M+NH3]+, 446 (84) [M + H f; HRMS (ES+) for C27H27N 05 
[M+NH4]+ Calc. 463.2227, Found 463.2230. CHN: Found C, 72.6; H, 6.07; N, 2.97. 
C27H27N 0 5 requires C, 72.79; H, 6.11; N, 3.14.
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7.3 Compounds from Chapter 3
(4S)-4-(4-Hydroxy-benzyl)-3-propionyl-oxazolidin-2-one, 144
HO'
According to General procedure 1, using A-acyl oxazolidinone 110 (1.53 g, 4.50 mmol), 
Pd/C (5%) (237 mg, 0.23 mmol) and methanol/ethyl acetate (1:1, 20 mL), 144 was 
prepared (1.14 g, 4.59 mmol, 98%) as a white powder, m. p. 135 -  136 °C; [a]o21 + 43° (c 
0.40, CHC13); 'H N M R  (CDCI3, 300 MHz): 5 1.14 (3H, t, J  7.0 Hz, C //3), 2.66 (1H, dd, J
13.5, 9.5 Hz, C //AHBAr), 2.89 (2H, m, CH2CH3), 3.13 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr),
4.12 (2H, m, CHaH bO), 4.55 ( 1H, m, CHN), 4.78 (1H, br. s, OH), 6.73 (2H, app. d, J  8.5 
Hz, U-o-OArH),  7.00 (2H, app. d, J  8.5 Hz, m-OAr//); 13C NMR (d4-MeOD, 75.5 MHz): 
5 9.2 (CH3), 30.4 (CH2), 37.8 (CH2), 56.8 (CH), 68.1 (CH2), 116.9 (CH), 127.8 (C), 132.0 
(CH), 156.0 (C =0), 158.1 (C), 176.1(C=0); IR (KBr) v max (cm '1): 3331 (broad O-H), 
1756 (C =0), 1709 (C =0); MS (CI+, NH3) m/z (%) 267 (52) [M + N H /], 91 (100); HRMS 
(ES+) for C 13H 15NO4 [M+NH4r  Calc. 267.1339, Found 267.1343.
General Procedure 6: Immobilisation of phenolic oxazolidin-2-one fragments onto 2- 
chlorotrityl cloride resin.
2-chlorotrityl chloride resin (1 equiv.) was preswollen in DCM :THF (1:1 mixture) at 
ambient temperature in a vessel fitted with a reflux condenser. A solution of phenolic 
oxazolidin-2-one fragment (3 equiv.) in DCM / THF (1:1) (plus a minimum of DMF if 
necessary to ensure solvation) was added, followed by diisopropylethylamine (10  equiv.) 
and the reaction heated at 60 °C for 18 hours. After this time, the reaction was cooled to 
ambient temperature and the resin removed via filtration. The resin was washed thoroughly 
with DCM, THF and DCM / MeOH, with all washings collected. In order to recover the 
excess oxazolidin-2-one fragment, the combined washings were evaporated to dryness, 
redissolved in methanol and passed through a solid phase extraction column (SCX-2) with
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the resulting filtrate evaporated to yield pure oxazolidin-2-one. Meanwhile, the resin was 
dried thoroughly in a vacuum oven at 40 °C. A portion of the resultant resin (typically 
20mg) was cleaved with TFA solution, according to General Procedure 8 , and the mass of 
the recovered oxazolidin-2 -one fragment was used to calculate the loading of oxazolidin-2 - 
one onto the 2-chlorotrityl chloride resin.
2-Cl-Trt-supported A-propionyl-oxazolidin-^-one, 145
2-CI-Trt
According to general procedure 6 , 2-chlorotrityl-chloride resin (l.OOg, 1.20 mmol) 
preswollen in DCM / THF (80 mL) was treated with A-propionyl-oxazolidin-2-one 144 
(897 mg, 3.6 mmol) and DIPEA (2.090 mL, 12.0 mmol) to afford polymer-supported N- 
propionyl-oxazolidin-2-one 145.
To determine the loading of the resin: Functionalised resin 145 (20 mg) was treated with 
TFA cleavage solution, according to general procedure 8 . In this way the resin loading was 




According to general procedure 6 , 2-chlorotrityl-chloride resin (l.OOg, 1.20 mmol) 
preswollen in DCM / THF (80 mL) was treated with A-H-oxazolidin-2-one 1 (695 mg, 3.6 
mmol) and DIPEA (2.090 mL, 12.0 mmol) to afford polymer-supported A-H-oxazolidin-2- 
one 2.
2 1 0
To determine the loading of the resin: Functionalised resin 2 (20 mg) was treated with TFA 
cleavage solution, according to general procedure 8 . In this way the resin loading was 
found to be 1.16 mmolg ' 1 (97%).
General procedure 7: A-acylation of polymer-supported A-H-oxazolidin-2-one
employing anhydride as acyl source
A-H-oxazolidin-2-one functionalised resin (1 equiv.) encased in IRORI kans was 
preswollen in THF at room temperature. Lithium chloride (5 equiv.), triethylamine (5 
equiv.) and the anhydride (5 equiv.) were added and the reaction then heated at reflux for 
16 hours. After this time, the reaction was cooled to ambient temperature and the resin 
removed via filtration. The resin was then washed thoroughly with DCM, THF, DCM / 
MeOH and dried in a vacuum oven at 40 °C.
(S)-3-(3-methylbutanoyl)-4-(4-hydroxybenzyl)-oxazolidin-2-one, 154
HO
According to General procedure 7 employing A-H oxazolidin-2-one functionalised resin 2 
(1.00 g, 1.10 mmol/g, 1.10 mmol) in THF (300 mL), LiCl (233 mg, 5.5 mmol), 
triethylamine (0.767 mL, 5.5 mmol) and isovaleric anhydride (1.10 mL, 5.5 mmol), A- 
isovaleryl-oxazolidin-2-one functionalised resin 151 was prepared (structure not shown). 
TFA cleavage: According to General procedure 8 employing A-isovaleryl-oxazolidin-2-one 
functionalised resin 151 (50 mg, 0.055 mmol), TFA cleavage solution (5 mL) (S)-3-(3- 
methylbutanoyl)-4-(4-hydroxybenzyl)-oxazolidin-2-one 154 (13.9 mg, 0.050 mmol, 
91%) was prepared as a colourless oil. [cc]D21 + 36° (1.65, CHC13); *H NMR (CDC13, 300 
MHz): 5 1.02 (6H, app. t, J  6.5 Hz, C //3), 2.23 (1H, m, C //(C H 3)2), 2.71 (1H, dd, J  13.5,
9.5 Hz, CHaHBAr), 2.78 (1H, dd, J  16.0, 7.0 Hz, C O C //AHB), 2.89 (1H, dd, J  16.0, 6.5 Hz, 
COCHa//b), 3.21 (1H, dd, J  13.5, 3.5 Hz, CUaH bA t), 4.19 (2H, m, CHAH BO), 4.64 (1H,
2 1 1
m, CHN), 5.04 (br. s, OH), 6.80 (2H, app. d, J  8.5 Hz, o-OArH),  7.08 (2H, app. d, J  8.5 Hz, 
m-OArH)- 13C NM R (CDC13, 75.5 MHz): 5 22.8 (CH3), 22.9 (CH3), 25.4 (CH), 37.5 
(CH2), 44.4 (CH2), 55.6 (CH), 66.5 (CH2), 116.2 (CH), 127.7 (C), 131.0 (CH), 153.9 
(C =0), 155.3 (C), 175.1 (C =0); IR (thin film): v max (cm '1): 3362 (broad OH), 1763 (C =0), 
1710 (C =0); MS (CI+, NH3) m/z (%) 295 (70) [M+NH3]+, 278 (33) [M+H]+, 119 (100); 
HRMS (ES+) for C 15H i9N 0 4 [M+NH4]+ Calc. 295.1652, Found 295.1654.
(S)-4-(4-hydroxybenzyl)-3-hexanoyl-oxazolidin-2-one, 155
According to General procedure 7 (solid phase jV-acylation) employing A-H oxazolidin-2- 
one functionalised resin 2 (1.00 g, 0.91 mmol/g, 0.91 mmol) in THF (300 mL), LiCl (193 
mg, 4.55 mmol), triethylamine (0.634 mL, 4.55 mmol) and hexanoic anhydride (1.050 mL, 
4.55 mmol), A-hexanoyl-oxazolidin-2-one functionalised resin 152 was prepared (structure 
not shown). TFA cleavage: According to General procedure 8 (TFA cleavage) employing 
jV-hexanoyl-oxazolidin-2-one functionalised resin 152 (50 mg, 0.046 mmol), TFA cleavage 
solution (5 mL) (S)-4-(4-hydroxybenzyl)-3-hexanoyloxazolidin-2-one 155 (9.9 mg, 0.034 
mmol, 75%) was prepared as an off-white solid, m.p. 117-119 °C ; [ cx] d 21 + 52 ° (c 0.78, 
CHC13) ; yH NM R (CDC13, 300 MHz): 8 0.91 (3H, t, J  7.0 Hz, CH3), 1.35 (4H, m, 
CH2CH2C H3), 1.69 (2H, m, CH2(CH2)2CH3), 2.72 (1H, dd, J  13.5, 9.5 Hz, C tfAHBAr), 2.92 
(2H, m, COCH2), 3.17 (1H, dd, J  13.5, 3.5 Hz, CHA/ / BAr), 4.15 (1H, dd, J  9.0, 3.0 Hz, 
C //aHbO), 4.19 (1H, dd, J  16.5, 9.0 Hz, CHa/ / bO), 4.62 (1H, m, CHN), 5.58 (1H, br. s, 
OH), 6.79 (2H, app. d, J  8.5, o-OArH), 7.05 (2H, app. d, J  8.5 Hz, m-OArH ) ; 13C NMR 
(CDC13, 75.5 MHz): 8 14.3 (CH3), 22.8 (CH2), 24.4 (CH2), 31.7 (CH2), 35.9 (CH2), 37.4 
(CH2), 55.6 (CH), 66.6  (CH2), 116.2 (CH), 127.5 (C), 131.0 (CH), 154.0 (C =0), 155.4 (C),
174.0 ( C = 0 ) ; IR (KBr) v max (cm '1): 3308 (O-H), 1751 (C =0), 1708 (C =0); MS (CI+,
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NH3) m/z (%) 309 (100) [M+NH4]+, 292 (23) [M+H]+, 211 (25), 133 (39); HRMS (ES+) 
for C ,6H2iN04  [M+H]+ Calc. 292.1543, Found 292.1543.
(5)-3-((^)-but-2-enoyl)-4-(4-hydroxybenzyl)-oxazolidin-2-one, 156
HO
According to General procedure 7 (solid phase acylation) employing N-H  oxazolidin-2-one 
functionalised resin 2 (1.00 g, 1.05 mmol/g, 1.05 mmol) in THF (300 mL), LiCl (223 mg, 
5.25 mmol), triethylamine (0.732 mL, 5.25 mmol) and crotonic anhydride (0.778 mL, 5.25 
mmol), yV-crotonoyl-oxazolidin-2-one functionalised resin 153 was prepared (structure not 
shown).
TFA cleavage: According to General procedure 8 (TFA cleavage) employing A-crotonoyl- 
oxazolidin-2-one functionalised resin 153 (50 mg, 0.053 mmol), TFA cleavage solution (5 
mL) (S)-3-((Zs)-but-2-enoyl)-4-(4-hydroxybenzyl)-oxazolidin-2-one 156 (10.4 mg, 0.040 
mmol, 75%) was prepared as a colourless oil. [a]o21 + 64 ° (c 1.41, CHCI3) ; !H NMR 
(CDCI3, 300 MHz): 8 1.94 (3H, d, J  6.0 Hz, CH3), 2.74 (1H, dd, J  13.5, 9.5 Hz,
CHaHBAr), 3.21 (1H, dd, J  13.5, 3.5 Hz, CHAH BAr), 4.15 (2H, m, CH20 ), 4.65 (1H, m, 
CHN), 6.91 (2H, app. d, J  8.5 Hz, o-OArH), 7.07 (2H, app. d, J  8.5 Hz, m-OArH), 7.15-
7.23 (2H, br. m, HC=CH)\ 13C NMR (CDC13, 75.5 MHz): 8 18.9 (CH3), 37.4 (CH2), 55.8 
(CH), 66.5 (CH2), 115.7 (CH), 122.3 (CH), 127.9 (C), 128.6 (CH), 147.2 (CH), 153.6 
(C =0), 157.3 (C), 174,2 (C =0); IR (thin film) v max (cm '1): 3365 (broad O-H), 1785 




A-H-oxazolidin-2-one functionalised resin 2 (l.OOg, 1.10 mmol/g, 1.10 mmol) sealed into 
IRORI kans was pre-swollen in DCM (300 mL) at room temperature. DMAP (671.5 mg,
5.5 mmol) was added as a solid, followed by DCC (2.269 g, 11.0 mmol) and finally 3- 
phenyl-propionic acid (1.651 g, 11.0 mmol). The vessel was then purged with nitrogen 
before heating at reflux for 16 hours. After this time, the reaction was cooled and the resin 
filtered and washed thoroughly with DMF, DCM and DCM / MeOH. The functionalised 
resin 157 was then dried thoroughly in a vacuum oven at 40 °C.
TFA cleavage: According to General procedure 8 (TFA cleavage) employing functionalised 
resin 157 (50 mg, 0.055 mmol), TFA cleavage solution (4 mL) (S)-3-(3- 
phenylpropanoyl)-4-(4-hydroxybenzyl)-oxazolidin-2-one 158 (14.3 mg, 0.044 mmol, 
80%) was prepared as a white solid, m.p. 168 -169 °C; [ a ]D21 + 114 0 (c 0.72, MeOH); 
‘H NM R (d4-MeOD, 300 MHz): 5 2.83 (1H, dd, J  13.5, 7.5 Hz, C //AHBAr), 2.99 (2H, m, 
CHAH BPh), 3.15 (1H, dd, J  13.5 7.0 Hz, CHA/ / BAr), 3.30 (2H, m, COCHAHB), 4.25 (2H, 
m, CH2O), 4.59 (1H, br. s, OH), 4.65 (1H, 1H, m, CHN), 6.72 (2H, app. d, J  8.5 Hz, o- 
OArH), 6.96 (2H, app. d, J  8.5 Hz, m-OArH), 1.17-1.33 (5H, br. m, ArH)\ 13C NMR
(CDC13, 75.5 MHz): 5 31.8 (CH2), 37.7 (CH2), 38.7 (CH2), 56.8 (CH), 68.0 (CH2), 116.9 
(CH), 127.6 (C), 127.7 (CH), 129.9 (CH), 130.0 (CH), 132.1 (CH), 142.6 (C), 155.9 (C =0),
158.2 (C), 174.4 (C =0); IR (KBr) v max (cm '1): 3401 (broad O-H), 1782 (C =0), 1683 
(C =0); MS (CI+, NH3) m/z  (%) 343 (45) [M+NH4]+, 211 (100), 167 (90); HRMS (ES+) 
for C 19Hi9N 0 4 [M+H]+ Calc. 326.1387, Found 326.1392.
General Procedure 8: TFA cleavage of auxiliary from resin.
A solution of DCM / TFA / TIS (94:1:5) (4 mL) was added via syringe to a dry round 
bottomed flask containing the functionalised resin (typically 20 mg). The flask was swirled
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at 25 °C for 30 min. The resin was then filtered and washed thoroughly with DCM, THF 





AMsovaleroyl-oxazolidin-2-one resin 151 (200 mg, 0.95 mmol/g, 0.19 mmol) preswollen in 
THF (10 mL) then LiOH (79.8 mg, 1.90 mmol) (in 2.0 mL H2O) added and the reaction 
agitated on an orbital shaker for 6 hours. After this time, resin filtered and washed 
thoroughly (DCM, DCM / MeOH, THF) and dried in a vacuum oven at 40 °C. The resin 
then underwent TFA cleavage, according to General procedure 8 , employing functionalised 
resin 160 (not shown) (200 mg, 0.19 mmol) and TFA cleavage solution (12 mL) to afford a 
crude mixture of products. Purification via column chromatography afforded N-[2- 
hydroxy-l-(S)-(4-hydroxybenzyl)-ethyl]-3-methyI-butyramide 161 (12.4 mg, 0.05 
mmol, 26%) as a colourless oil. [a]o21 + 8.8 0 (c 0.225, MeOH); ]H NMR (d4-MeOD, 
300 MHz): 5 0.71 (3H, d, J  6.5 Hz, CH3), 0.76 (3H, d, J  6.5 Hz, CH 3), 1.75-1.92 (3H, br. 
m, COC //2  and C //(C H 3)2), 2.48 (1H, dd, J  13.5, 8.5 Hz, C tfAHBAr), 2.73 (1H, dd, J  13.5,
6.0 Hz, CHA/ / BAr), 3.40 (2H, d, J  5.5 Hz, C //2OH), 3.97 (1H, m, CHN), 4.90 (1H, br. s, 
NH),  6.59 (2H, app. d, J  8.5 Hz, o-OArH),  6.94 (2H, app. d, J  8.5 Hz, m-OAr//); 13C NMR 
(d4-MeOD, 75.5 MHz): 8 23.0 (CH3), 23.1 (CH3), 27.8 (CH), 37.6 (CH2), 46.9 (CH2), 54.6 
(CH), 64.9 (CH2), 116.5 (CH), 131.0 (C), 131.6 (CH), 157.2 (C), 172.3 (C =0); IR (Thin 
film) v max (cm '1): 3398 (broad O-H), 1665 (C =0); MS (CI+, NH3) m/z (%) 252 (11) 
[M+H]+, 52 (100); HRMS (ES+) for C i4H2iN 0 3 [M+H]+ Calc. 252.1594, Found 252.1595.
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(.S)-4-(4-Benzyloxy-benzyl)-3-(3-methyl-butyrl)-oxazolidin-2-one, 162
According to general procedure 3, lithium chloride (90.2 mg, 2.118 mmol), triethylamine 
(0.492 mL, 3.529 mmol) and isovaleric anhydride (0.599 mL, 3.00 mmol) were added to a 
A-H-oxazolidin-2-one 103 (500.0 mg, 1.765 mmol) in THF (15 mL) to afford crude 162. 
Recrystallisation (ether, hexane) yielded 162 as a white solid (551 mg, 1.500 mmol, 85%). 
m. p. 96-98 °C; [cc]D21 + 48 0 (c 0.65, CHC13) ; *H NMR (CDC13, 300 MHz): 5 1.00 (3H, 
d, J  6.0 Hz, CH3), 1.02 (3H, d, J  6.0 Hz, C //3), 2.22 (1H, m, C //(C H 3)2), 2.70 (1H, dd, J
13.5, 9.5 Hz, C //AHBAr), 2.77 (1H, dd, J  16.0, 7.0 Hz, CHAHBCO), 2.89 (1H, dd, J  16.0,
7.0 Hz, CHaHbCO), 3.23 ( 1H, dd, J  13.5, 3.5 Hz, CUaHbA i ), 4.16 (2H, m, CH2O), 4.63 
(1H, m, CHN), 5.04 (2H, s, A rO C //2Ar), 6.93 (2H, app. d, J  8.5 Hz, o-OAxH), 7.13 (2H, 
app. d, J  8.5 Hz, m-OArH), 7.32-7.45 (5H, br. m, ArH)\ 13C NM R (CDC13, 75.5 MHz): 5
22.9 (CH3), 23.0 (CH3), 25.4 (CH), 37.5 (CH2), 44.4 (CH2), 55.6 (CH), 66.5 (CH2), 70.4 
(CH2), 115.7 (CH), 127.9 (CH), 127.9 (C), 128.4 (CH), 129.0 (CH), 130.9 (CH), 137.3 (C),
153.9 (C =0), 158.5 (C), 173.1 (C =0); IR (KBr) v max (cm’1): 1761 (C =0), 1706 (C =0); 





Crude 163 isolated in 1:2 ratio with M l oxazolidin-2-one 103. Not purified further.
JH NM R (d4-MeOD, 300 MHz): 5 0.73 (3H, d, J  6.5 Hz, C //3), 0.79 (3H, d, J  6.5 Hz, 
CH3), 1.80-1.95 (3H, br. m, CH2CH(CH3)2), 2.54 (1H, dd, J  13.5, 8.5 Hz, C //AHBAr), 2.78 
(1H, dd, J  13.5, 6.0 Hz, CHA/ / BAr), 3.41 (2H, d, J  5.5 Hz, C tf2OH), 4.01 (1H, m, CHN),
4.98 (2H, s, O C //2Ar), 6.82 (2H, app. d, J  8.5 Hz, o-OAxH), 7.03 (2H, app. d, J  8.5 Hz, m- 
OArH), 7.14-7.35 (5H, br. m, ArH).
General procedure 9: LiOOH cleavage of solid-supported A-acyl-oxazolidin-2-ones.
Functionalised resin (1 equiv.) placed loose in flask and preswollen in THF for 30 minutes 
before cooling to 0 °C. H2O2(10 equiv.) added, followed by LiOH (5 equiv.) dissolved in a 
minimum volume of H20 . The reaction was agitated on an orbital shaker for 4 hours, then 
the resin filtered off and washed thoroughly with DCM and THF. All washings were 
collected and evaporated to dryness. The residue was then redissolved in EtOAc and H20 . 
The aqueous layer was acidified to pH 1 with 2.0 N HC1 (aq.) and saturated by the addition 
o f sodium chloride, before back-extracting into fresh EtOAc. The combined organic 
fractions were then dried with M gS 04, filtered and solvent removed in vacuo to afford the 
acid product.
General Procedure 10: LiOBn cleavage of side chain from auxiliary
rc-BuLi (5 equiv.) was added dropwise to a stirred solution of benzyl alcohol (6 equiv.) in
THF at 0 °C. An aliquot of the resulting solution was removed via syringe and injected 
into a flask containing functionalised resin (1 equiv.) pre-swollen in THF, also at 0 °C. The
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mixture was allowed to warm slowly to 25 °C and was stirred for 16 hours. The resin was 
then filtered and washed thoroughly with DCM and THF, with all washings collected, 
combined and solvent removed in vacuo.
3-methyl-butyric acid benzyl ester
According to general procedure 10, LiOBn was created in situ from rc-BuLi (0.226 mL, 
2.43 M, 0.55 mmol) and BnOH (0.683 mL, 0.66 mmol) in 2 mL THF, and added to N- 
isovaleryl-oxazolidin-2-one resin 151 (100 mg, 1.10 mmol/g, 0.11 mmol) in THF (5 mL) at 
0 °C. The reaction was then agitated on an orbital shaker for a further 16 hours, allowing to 
warm slowly to room temperature. The resin was then filtered and washed thoroughly with 
DCM and THF, with all washings collected and the solvent removed in vacuo to afford 
crude 164 (contaminated with excess BnOH) as a pale yellow oil.
Purification M ethod 1 (column chromatography): Crude 164 passed though a pad of silica 
to afford pure 3-methyl-butyric acid benzyl ester 164 (16.7 mg, 0.09 mmol, 79%).
Purification Method 2 (Removal of excess BnOH via solid phase scavenging): Crude 164 
redissolved in DCM and pyridine (2:1) (40 mL). ps-tosyl resin (3.437 g, 2.4 mmol/g, 8.25 
mmol) added and the reaction agitated for 16 hours on an orbital shaker. After filtration of 
the resin and thorough washing with DCM, the organic layer was washed with 1.0N HC1 
(aq.) and brine and the solvent removed in vacuo to afford 3-methyl-butyric acid benzyl 
ester 164 (21.1 mg, 0.445 mL, 81%). lU NMR (CDC13, 300 MHz): 5 0.98 (6H, d, J  7.0
7.14-7.36 (5H, br. m, ArH)\ 13C NMR (CDC13, 75.5 MHz): 8 22.8 (CH3), 22.9 (CH3), 25.6 
(CH), 44.5 (CH2), 66.4 (CH2), 126.4 (CH), 127.8 (CH), 128.6 (CH), 136.6 (C), 178.7 
(C =0). Spectroscopic data identical to literature compound. 115
o
Hz, 2 x CH 3), 2.14 (1H, m, CH(CH3)2), 2.30 (2H, d, J  7.0 Hz, CH2), 5.08 (2H, s, CH2Ph),
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General procedure 11: NaBH4 cleavage of solid-supported A-acyl-oxazolidin-2-ones.
Functionalised resin (1 equiv.) placed loose in flask and preswollen in THF. A solution of 
NaBH4 (5 equiv.) in a minimum volume of H2O was added and the reaction agitated on an 
orbital shaker for 4 hours. The resin was filtered off and washed thoroughly with DCM and 
THF, with all washings collected and evaporated to dryness. The residue was then 
redissolved in EtOAc and H2O and extracted into EtOAc. The combined organic fractions 
were then dried with M gS 04, filtered and solvent removed in vacuo to afford the alcohol 
product.
7.4 Compounds from Chapter 4
3-Benzyl-4-(4S)-(4-hydroxy-benzyl)-oxazolidin-2-one, 149
HO'
According to general procedure 1, using A-benzyl-oxazolidin-2-one 122 (100 mg, 0.267 
mmol), Pd/C (10%) (14 mg, 0.014 mmol) and methanol / ethyl acetate (1:1, 10 mL) 149 
was prepared as a colourless oil (66.6  mg, 0.235 mmol, 88%). [ a ]D21 + 14° (c 0.7, EtOH);
NM R (CDCI3, 300 MHz): 8 2.51 (1H, dd, J  13.5, 9.5 Hz, C //AHBAr), 2.92 (1H, dd, J
13.5, 3.5 Hz, CHA/ / BAr), 3.69 (1H, m, CHN),  3.94 (1H, dd, J  8.5, 6.0 Hz, C //aH bO), 4.05 
(2H, m, CHa/ / bO, NCH aHb), 4.80 (1H, d, J  15.0, NCHAH B), 6.71 (2H, app. d, J  8.5 Hz, 0 - 
OArH), 6.82 (2H, app. d, J  8.5 Hz, m-OArH), 7.16 -  7.33 (5H, br. m, ArH)\ 13C NMR 
(CDCI3, 75.5 MHz): 5 37.8 (CH2), 46.7 (CH2), 55.8 (CH), 67.5 (CH2), 116.3 (CH), 127.1 
(C), 128.5 (CH), 128.6 (CH), 129.3 (CH), 130.5 (CH), 136.1 (C), 155.8 (C =0), 159.2 (C); 
IR (Thin film) v max (cm '1): 3365 (broad O-H), 1742 (C =0); MS (CI+, NH3) m/z (%) 301 






According to General procedure 1 using oxazolidin-2-one 115 (1.56 g, 3.64 mmol), Pd/C 
(10%) (192 mg, 0.18 mmol) and methanol/ ethyl acetate (1:1, 20 mL), 147 was prepared 
(1.03 g, 3.02 mmol, 83%) as a white solid, m. p. 142-143 °C; [a ]o21 + 79° (c  1.35, 
MeOH); ]H NMR (CDC13, 300 MHz): 6  1.10 (3H, d, J  7.0 Hz, CH3), 2.44 (1H, dd, J
13.5, 9.5 Hz, C //AHBAr), 2.58 (1H, dd, J  13.0, 7.5 Hz, CH(CH3) / /AHB), 2.83 (1H, dd, J
13.5, 3.5 Hz, C H a / / b A t ) ,  3.06 (1H, dd, J  13.0, 7.0 Hz, CH(CH3)HA/ / B), 4.03 (3H, m, 
CHaH bO, CHCH3), 4.52 (1H, m, CHN), 5.83 (1H, br. s, OH), 6.65 (2H, app. d, J  8.5 Hz, o- 
OAxH), 6.75 (2H, app. d, J  8.5 Hz, m-OArH), 7.06-7.19 (5H, br. m, ArH)\ 13C NMR 
(CDC13, 75.5 MHz): 8 17.3 (CH3), 37.1 (CH2), 40.1 (CH), 40.3 (CH2), 55.6 (CH), 66.5 
(CH2), 116.3 (CH), 126.9 (C), 128.8 (CH), 129.6 (CH), 129.8 (CH), 131.0 (CH), 139.5 (C),
153.9 (C =0), 155.8 (C), 177.3 (C =0); IR (KBr) v max (cm '1): 3345 (O-H), 1771 (C =0), 
1667 (C =0); MS (CI+, NH3) m/z (%) 340 (100) [M+H+], 357 (98) [M+NH4+]; HRMS 
(ES+) for C20H21NO4 [M+H]+ Calc. 340.1543, Found 340.1542.
rac-Benzyl 2-benzylpropanoate, 168
o
Benzyl alcohol (0.133 mL, 1.287 mmol) in THF (1 mL) was cooled to 0 °C and /i-BuLi 
(0.429 mL, 2.5 M, 1.073 mmol) added dropwise. After stirring at 30 minutes, the entire 
reaction was transferred via cannula to a solution of oxazolidin-2-one 167 (100 mg, 0.429 
mmol) in dry THF (3 mL), also at 0 °C. The resulting mixture was stirred for a further two 
hours at 0 °C and then quenched by addition of saturated ammonium chloride solution and 
extracted into EtOAc. The combined organic extracts were washed with IN  HC1 (aq), 
brine, dried with M gS 04, filtered and solvent removed in vacuo. Column chromatography
2 2 0
afforded rac-Benzyl 2-benzylpropanoate rac-168 (46.2 mg, 0.182 mmol, 78%) as a 
colourless oil. ]H NM R (CDC13, 300 MHz): 8 1.18 (3H, d, J  7.0 Hz, C //3), 2.70 (1H, dd, J
13.0, 7.5 Hz, C //AHBPh), 2.82 (1H, app. q, J  7.5 Hz, CHA/ / BPh), 3.04 (1H, dd, J  13.0, 7.0 
Hz, C //C H 3), 5.08 (2H, s, O C //2Ph), 7.14-7.36 (10H, br. m, A r//); 13C NMR (CDC13, 75.5 
MHz): 5 17.3 (CH3), 40.4 (CH), 42.0 (CH2), 66.8  (CH2), 126.8 (CH), 128.4 (CH), 128.5 
(CH), 128.8 (CH), 129.0 (CH), 129.6 (CH), 136.5 (C), 139.9 (C), 176.5 (C =0). 
Spectroscopic data identical to literature reference .116
HPLC conditions: ChiralCel OJ-R column, 60% acetonitrile, 40% water, 0.5 ml/min. 
Enantiomer 1: tR 15.7 min, Enantiomer 2: tR 18.3 min.
rac-2-m ethyl-3-phenylpropan-l-ol, 169
Sodium borohydride (NaBH4) (35.2 mg, 0.932 mmol) in 1.5 mL H20  was added dropwise 
to a solution of oxazolidin-2-one 167 (lOOmg, 0.233 mmol) in THF (2.5 mL) and stirred for 
6 hours at room temperature. After this time the reaction was extracted into EtOAc (x3) 
and the combined organic layers washed with brine, dried with M gS04, filtered and 
evaporated to dryness. Purification via column chromatography yielded rac-2-methyl-3- 
phenylpropan-l-ol rac-169 (31.1 mg, 0.207 mmol, 89%) as a colourless oil. 'H  NMR 
(CDC13, 300 MHz): 8  0.91 (3H, d, J  7.0 Hz, C //3), 1.84 (1H, br. s, OH), 1.95 (1H, m, 
CHCH3), 2.41 (1H, dd, J  13.5, 8.5 Hz, CHAHBPh), 2.75 (1H, dd, J  13.5, 8.0 Hz, 
CHA/ / BPh), 3.50 (2H, m, C //2OH), 7.18-7.29 (5H, br. m, A r//); 13C NM R (CDC13, 75.5 
MHz): 8 16.5 (CH3), 38.2 (CH), 39.6 (CH2), 68.2 (CH2), 126.4 (CH), 128.3 (CH), 129.2 
(CH), 139.8 (C). Spectroscopic data identical to literature reference.117 
HPLC conditions: ChiralCel OD column, 97% Hexane, 3% isopropyl alcohol, 1 ml/min, 
(S)-169 tR 10.3 min, (R)-169 tR 12.8 min.
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2(/?)-methyl-3-phenylpropan-l-ol, (R)-169 (major product o f enolate alkylation 
employing (S)-2)
91
Spectroscopic data as for rac-169 described above, except [a]o + 12 ° (c 1.1, CHCI3).
rac-2-benzylpropionic acid, rac-65
o
(Commercially available product). *H NMR (CDC13, 300 MHz): 8 1.15 (3H, d, J  7.0 Hz,
C //3), 2.63 (1H, dd, J  13.5, 8.0 Hz, CHAHBPh), 2.73 (1H, m, CH), 3.05 (1H, dd, J  13.0, 8.0
Hz, CHA/ / BPh), 7.11-7.30 (5H, br. m, A r//); 13C NMR (CDC13, 75.5 MHz): 8 16.4 (CH3),
40.1 (CH2), 40.9 (CH), 126.3 (CH), 127.2 (CH), 128.8 (CH), 139.2 (C), 182.4 (C =0).
118Spectroscopic data identical to literature reference.
HPLC conditions: ChiralCel OJ column, 98% n-Hexane, 2% isopropyl alcohol, 0.1% TFA, 
1 ml/min. (/?)-65 tR 9.5 min, (S)-65 tR 10.8 min.
2(/?)-benzyl-propionic acid, (R)-65 (major product of enolate alkylation employing (S)-2)
o
Spectroscopic data as for rac-65 described above, except [cx]d21 - 25 0 ( c  1.0, CHCI3);
General procedure 12: Solid phase enolate alkylation reaction -  optimised method
Functionalised resin (150 mg, 1 equiv.) was sealed into an IRORI minikan and placed into 
an oven-dried round bottomed flask. THF (8 mL) was added to preswell the resin and the 
flask cooled to 0 °C. LHMDS (10 equiv., 1.0 M in THF) was added dropwise via syringe 
and the reaction was stirred for 30 minutes before the reaction solution was removed via
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cannula. The resin was then resuspended in fresh, pre-chilled THF and treated with an 
electrophile (20 equiv.) before being stirred for a further 5 minutes at 0 °C, then removed 
from the icebath and stirred for a further 20 minutes. The reaction was quenched by the 
addition of pH 7 phosphate buffer solution, the IRORI kan immediately removed from the 
reaction solution via filtration, and the resin washed thoroughly using DCM, DCM / MeOH 
and THF in alternate cycles. TFA cleavage of 20 mg o f the resulting resin was achieved 
according to general procedure 8 , with the remaining approximately 130 mg resin cleaved 
via LiOOH hydrolysis, according to general procedure 9.
7.5 Compounds from Chapter 5 
General procedure 13: Alkylation of acids.
Diisopropylamine in dry THF was cooled to 0 °C, and n-BuLi added dropwise. After 30 
minutes, acid in dry THF solution was added dropwise over a period of 20 minutes. The 
resulting solution was stirred at 0 °C for 40 minutes before dropwise addition of the 
electrophile. The reaction was allowed to warm slowly to room temperature and stirred for 
12 hours. The pH of the solution was adjusted to 2.5 with 2N HC1 solution. The organic 
layer was separated and extracted with saturated sodium bicarbonate solution. The aqueous 
layer was acidified with 2N HC1 solution to pH 2, saturated with sodium chloride, and 
extracted with ethyl acetate (3 x 20 mL). The combined extracts were dried over 
anhydrous M gS04, filtered, and evaporated in vacuo. The residue was purified by column 
chromatography.
rac-2-methylpent-4-enoic acid, 181
According to General procedure 13, propionic acid (0.373 mL, 5.0 mmol) was treated with 
LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and rc-BuLi (4.20 mL,
2.5 M, 10.5 mmol) and allyl iodide (0.549 ml, 6.0 mmol) to form rac-2-methylpent-4- 
enoic acid 181 as a colourless oil (519 mg, 4.55 mmol, 91%). *H-NMR (CDCI3, 300
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MHz): 5 1.17 (3H, d, J  7.0 Hz, CH3), 2.16 (1H, m, CHAHB), 2.36 (1H, m, CHA/ / B), 2.50 
(1H, m, C //C H 3), 5.01 (2H, m, =CH2), 5.75 (1H, m, HC=)\ 13C-NMR (CDC13, 75.5 MHz): 
5 16.6 (CH3), 37.8 (CH2), 39.4 (CH), 117.5 (CH2), 135.5 (CH), 182.5 (C =0). 
Spectroscopic data identical to literature compound. 119
rac-2-benzyl-3-methylbutanoic acid, 182
According to General procedure 13, isovaleric acid (0.552 mL, 5.0 mol) was treated with 
LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and /i-BuLi (4.20 mL,
2.5 M, 10.5 mmol) and benzyl bromide (0.714 mL, 6.0 mmol) to form rac-2- 
isopropylpent-4-enoic acid 182 as a colourless oil (855 mg, 4.45 mmol, 89%). 'H-NM R 
(CDC13, 300 MHz): 5 1.05 (6H, m, C //3), 1.91 (1H, m, C //(C H 3)2), 2.45 (1H, m, C //C H 2), 
2.80 (2H, br. d, J  6.5 Hz, CH2), 7.10 - 7.24 (5H, br. m, Ph); 13C-NMR (CDC13, 75.5 MHz): 
5 20.3 (CH3), 20.7 (CH3), 30.8 (CH), 35.7 (CH2), 54.6 (CH), 126.6 (CH), 128.8 (CH),
129.1 (CH), 140.0 (C), 180.5 (C =0). Spectroscopic data identical to literature 
com pound .120
rac-2-isopropylpent-4-enoic acid, 183
According to General procedure 13, isovaleric acid (0.552 mL, 5.0 mol) was treated with 
LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and n-BuLi (4.20 mL,
2.5 M, 10.5 mmol) and allyl iodide (0.549 mL, 6.0 mmol) to form rac-2-isopropy!pent-4- 
enoic acid 183 as a colourless oil (590 mg, 4.15 mmol, 83%). *H-NMR (CDC13, 300 
MHz): 5 1.0 (6H, d, J  7.0 Hz, C //3), 1.86 (1H, m, C //M e2), 2.10 -  2.29 (3H, m, CHCH2, 
CH2), 5.03 (2H, m, C =C //2), 5.76 (1H, m, T/C=C); 13C-NMR (CDC13, 75.5 MHz): 5 20.1
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(CH3), 20.2 (CH3), 30.0 (CH), 33.6 (CH), 52.1 (CH2), 116.7 (CH2), 135.6 (CH), 180.5 
(C =0). Spectroscopic data identical to literature compound. 121
rac-2,3-dimethylbutanoic acid, 184
According to General procedure 13, isovaleric acid (0.552 mL, 5.0 mol) was treated with 
LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and /i-BuLi (4.20 mL,
2.5 M, 10.5 mmol) and methyl iodide (0.374 mL, 6.0 mmol) to form rac-2,3- 
dimethylbutanoic acid 184 as a colourless oil (465 mg, 4.0 mmol, 80%). ’H-NMR 
(CDC13, 300 MHz): 5 0.92 (3H, d, J  7.0 Hz, CH3), 0.97 (3H, d, J  7.0 Hz, C //3), 1.10 (3H, 
d, J  7.0 Hz, CH3), 1.89 (1H, m, C //(C H 3)2), 2.29 (1H, m, C //C H 3); 13C-NMR (CDC13, 75.5 
MHz) 5 13.8 (CH3), 19.6 (CH3), 20.4 (CH3), 30.6 (CH), 46.5 (CH), 181.3 (C =0).
rac-2-Allyl-3-phenylpropionic acid, 185
o
According to General procedure 13, phenylpropionic acid (750 mg, 5.0 mol) was treated 
with LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and n-BuLi (4.20 
mL, 2.5 M, 10.5 mmol) and allyl iodide (0.549 mL, 6.0 mmol) to form rac-2-Allyl-3- 
phenylpropionic acid 185 as a colourless oil (856 mg, 4.50mmol, 90%). 'H-NM R 
(CDC13, 300 MHz): 5 2.29 -  2.46 (2H, m, C //2CH=CH2), 2.75 - 2.85 (2H, m, C //AHBPh, 
CHCO), 2.97 - 3.05 (1H, m, CHA/ / BPh), 5.08 - 5.15 (2H, m, C =C //2), 5.74 - 5.88 (1H, m, 
HC=C), 7.19 -  7.34 (5H, m, Ph) 10.04 (1H, br. s, OH) ; 13C-NM R (CDC13, 75.5 MHz) 5
36.0 (CH2), 37.7 (CH2), 47.4 (CH), 117.9 (CH2), 126.9 (CH), 128.9 (CH), 129.0 (CH),





According to General procedure 13, hexanoic acid (0.627 mL, 5.0 mol) was treated with 
LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and n-BuLi (4.20 mL,
2.5 M, 10.5 mmol) and benzyl bromide (0.714 mL, 6.0 mmol) to form rac-2- 
benzylhexanoic acid 186 as a colourless oil (886  mg, 4.30 mmol, 86%). ‘H-NMR (CDC13, 
300 MHz): 5 0.82 (3H, m, C //3), 1.22 -  1.68 (6H, br. m, (C //2)3), 2.62 (1H, m, CH), 2.75 
(1H, dd, J  13.5, 9.0 Hz, CHAHBPh), 2.98 (1H, dd, J 13.5, 9.0 Hz, CUAHB?h), 7.11 -  7.29 
(5H, br. m, Ar); 13C-NMR (CDC13, 75.5 MHz) 5 13.5 (CH3), 22.7 (CH2), 27.5 (CH2), 31.5 
(CH2), 39.3 (CH2), 48.2 (CH), 126.6 (CH), 128.6 (CH), 129.0 (CH), 140.3 (C), 182.1 
(C =0). Spectroscopic data identical to literature. 123
rac-2-AHyl-hexanoic acid, 187
According to General procedure 13, hexanoic acid (0.627 mL, 5.0 mmol) was treated with 
LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and /i-BuLi (4.20 mL,
2.5 m, 10.5 mmol) and allyl iodide (0.549 mL, 6.0 mmol) to form rac-2-Allyl-hexanoic 
acid 187 as a colourless oil (640 mg, 4.10 mmol, 82%). *H-NMR (CDC13, 300 MHz): 6 
0.82 (3H, m, C //3), 1.19-1.62 (6H, br. m, (C //2)3), 2.14-2.42 (3H, m, CHCHAH BCH=CU2), 
4.98 (2H, m, =CH2), 5.74 (1H, m, C //=C H 2); 13C NMR (CDC13, 75.5 MHz): 8 14.2 (CH3),
22.9 (CH2), 29.7 (CH2), 31.6 (CH2), 36.5 (CH2), 45.5 (CH), 117.3 (CH2), 135.6 (CH), 181.9 





According to General procedure 13, hexanoic acid (0.627 mL, 5.0 mmol) was treated with 
LDA (formed in situ from diisopropylamine (1.472 mL, 10.5 mmol) and n-BuLi (4.20 mL,
2.5 m, 10.5 mmol) and methyl iodide (0.374 mL, 6.0 mmol) to form rac-2-methylhexanoic 
acid 188 as a colourless oil (514 mg, 3.95 mmol, 79%). *H NM R (CDC13, 300 MHz): 
5 0.84 (3H, m, CH3), 1.11 (3H, d, J  7.0 Hz, CH3), 1.25-1.70 (6H, br. m, (C //2)3), 2.65 (1H, 
m, CH)-, 13C NMR (CDC13, 75.5 MHz): 8 13.7 (CH3), 14.2 (CH3), 20.4 (CH2), 23.0 (CH2),
27.9 (CH2), 48.6 (CH), 181.8 (C =0). Spectroscopic data identical to literature compound.
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(S)-4-[4-(/er/-Butyl-dimethyl-silanyloxy)-benzyl]-oxazoIidin-2-one, 179
A-H-oxazolidin-2-one (966 mg, 5.0 mmol) 1 was dissolved in dry DMF (75 mL) and 
stirred at room temperature. Imidazole (851 mg, 12.5 mmol) TBDMS-C1 (1.130g, 7.5 
mmol) and DMAP (122 mg, 1 mmol) were added sequentially to the reaction mixture and 
the reaction stirred for 8 hours. After this time the reaction was quenched with saturated 
ammonium chloride solution, and extracted into ether (x3). The combined organic extracts 
were then washed with saturated sodium bicarbonate, brine, dried with MgSCL, filtered and 
the solvent removed in vacuo. The resulting white solid was recrystallised (EtOAc, 
hexane) to afford (S)-4-[4-(terf-Butyl-dimethyl-silanyloxy)-benzyl]-oxazolidin-2-one 179 
as white needles, m.p. 102-104 °C; [ a ]D21 -4 8  ° (c 1.01, CHC13 ); *H NMR (CDC13, 300
MHz): 5 0.19 (6H, s, SiCH3), 0.98 (9H, s, C (C //3)3), 2.79 (2H, app. d, J  7.0 Hz, CH2Ar), 
4.03 (1H, m, CHN), 4.13 (1H, dd, J  8.5, 5.5 Hz, CHaHbO), 4.44 (1H, app. t, J  8.5 Hz, 
CHa/ / bO), 5.41 (1H, br. s, NH), 6.80 (2H, app. d, J  8.5 Hz, o-OAvH), 7.02 (2H, app. d, J
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8.5 Hz, m-OArtf); 13C NMR (CDC13, 75.5 MHz): 5 -4.0 (CH3), 18.6 (C), 26.0 (CH3), 41.1 
(CH2), 54.3 (CH), 70.1 (CH2), 120.9 (CH), 128.9 (C), 130.3 (CH), 155.3 (C = 0), 159.6 (C); 
IR (KBr) v max (cm"1): 3140 (broad N-H), 1730 (C =0); HRMS (+ESI) for Ci6H25N 0 3Si 
[M+H]+ Calc. 308.1682, Found 308.1694.
General procedure 14: Acylation of protected oxazolidin-2-one.
i) A  solution o f acid (2.0 mmol) in DCM (8 mL) was cooled to 0 °C and oxalyl chloride 
(2.0 mmol) added dropwise. The reaction mixture was refluxed for 2 hours then 
concentrated in vacuo to give the crude acyl chloride as a viscous oil.
ii) A  solution o f protected oxazolidin-2-one (1.0 mmol) in dry THF (8 mL) was cooled to - 
78 °C then n-BuLi (1.1 mmol) added dropwise. After the mixture was stirred for 30 
minutes, the above acyl chloride dissolved in dry THF (5 mL) was added dropwise. The 
resulting mixture was stirred for 2 hours at -78 °C, then quenched with saturated 
ammonium chloride and partitioned between ether and water. The combined ether extracts 
were washed with saturated sodium bicarbonate and brine, dried with MgSC>4 , filtered and 
evaporated in vacuo .
General Procedure 15: Removal of TBS-protecting group
A-acyl-oxazolidin-2-one (1 equivalent) was dissolved in THF and tetrabutylammonium 
fluoride (TBAF) (1.2 equivalents) added dropwise. The reaction was stirred at room 
temperature for 30 mins, before being quenched with saturated ammonium chloride and 
extracted into ether. The combined ether extracts were washed with brine, dried with 
M gS 04, filtered and evaporated in vacuo. Where necessary, the resulting residue was 




According to General Procedure 14, i) Acid 181 (228 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 179 (307 mg, 1.0 
mmol) was treated with rc-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-TBS-protected intermediate (not shown).
This residue was immediately treated according to General procedure 15, using TBAF (1.2 
ml, 1.2 mmol) in THF (10 mL), to afford the crude product which was filtered through a 
plug of silica to afford (5)-3-(2-methylpent-4-enoyl)-4-(4-hydroxybenzyl)oxazolidin-2- 
one 194 (185 mg, 0.64 mmol, 64%).
HPLC conditions could not be found that would resolve the two diastereomers. 
(5)-3-(2-benzyl-3-methylbutanoyl)-4-(4-hydroxybenzyl)-oxazolidin-2-one, 195
HO
According to General Procedure 14, i) Acid 182 (385 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 103 (283 mg, 1.0 
mmol) was treated with rc-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-Bn-protected intermediate (not shown).
This residue was immediately treated according to General procedure 1, using Pd / C (10%) 
(50 mg) in MeOH / EtOAc (1:1) (15 mL), to afford (5)-3-(2-benzyl-3-methylbutanoyl)-4- 
(4-hydroxybenzyl)oxazolidin-2-one 195 (257 mg, 0.70mmol, 70%).
HPLC conditions: ChiralCel AD column, 95% w-Hexane, 5% Isopropyl alcohol, 1.0 ml / 





According to General Procedure 14, i) Acid 183 (284 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 179 (307 mg, 1.0 
mmol) was treated with n-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-TBS protected intermediate (not shown).
This residue was immediately treated according to General procedure 15, using TBAF (1.2 
ml, 1.2 mmol) in THF (10 mL), to afford the crude product, which was filtered through a 
plug of silica to afford (S)-3-(2-isopropylpent-4-enoyl)-4-(4-hydroxybenzyI)oxazolidin- 
2-one 196 (209 mg, 0.66 mmol, 66%).
HPLC conditions: ChiralCel AD column, 97% n-Hexane, 3% Isopropyl alcohol, 0.6 ml / 




According to General Procedure 14, i) Acid 184 (232 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 103 (283 mg, 1.0 
mmol) was treated with n-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-Bn protected intermediate (not shown).
This residue was immediately treated according to General procedure 1, using Pd / C (10%) 
(50 mg) in MeOH / EtOAc (1:1) (15 mL), to afford (S)-3-(2,3-dimethylbutanoyl)-4-(4- 
hydroxybenzyl)oxazolidin-2-one 197 (218 mg, 0.75 mmol, 75%).
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HPLC conditions: ChiralCel OD column, 97% n-Hexane, 3% Isopropyl alcohol, 1.0 ml / 




According to General Procedure 14, i) Acid 185 (380 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 179 (307 mg, 1.0 
mmol) was treated with n-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-TBS-protected intermediate (not shown).
This residue was immediately treated according to General procedure 15, using TBAF (1.2 
ml, 1.2 mmol) in THF (10 mL), to afford the crude product which was filtered through a 
plug of silica to afford (S)-3-(2-benzylpent-4-enoyl)-4-(4-hydroxybenzyl)oxazolidin-2-
one 198 (263 mg, 0.72 mmol, 72%).
HPLC conditions: ChiralCel AD column, 99% n-Hexane, 1% Isopropyl alcohol, 0.6 ml / 
min. Diastereomer 1 tR 26.1 min. Diastereomer 2 tR 29.6 min. (Due to unknown impurity 




According to General Procedure 14, i) Acid 186 (412 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 103 (283 mg, 1.0
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mmol) was treated with n-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-Bn-protected intermediate (not shown).
This residue was immediately treated according to General procedure 1, using Pd / C (10%) 
(50 mg) in MeOH / EtOAc (1:1) (15 mL), to afford (S)-3-(2-benzyIhexanoyI)-4-(4= 
hydroxybenzyl)-oxazolidin-2-one 199 (250 mg, 0.66 mmol, 66%).
HPLC conditions: ChiralCel OD column, 95% n-Hexane, 5% Isopropyl alcohol, 1.0 mL / 




According to General Procedure 14, i) Acid 187 (412 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 179 (307 mg, 1.0 
mmol) was treated with n-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-TBS-protected intermediate, (not shown).
This residue was immediately treated according to General procedure 15, using TBAF (1.2 
ml, 1.2 mmol) in THF (10 mL), to afford the crude product which was filtered through a 
plug of silica to afford (5)-3-(2-allylhexanoyl)-4-(4-hydroxybenzyl)oxazolidin-2-one 200
(225 mg, 0.68 mmol, 6 8 %).
HPLC conditions: ChiralCel AD column, 97% n-Hexane, 3% Isopropyl alcohol, 1.0 ml / 





According to General Procedure 14, i) Acid 188 (260 mg, 2.0 mmol) in DCM treated with 
oxalyl chloride (0.174 mL, 2.0 mmol) and ii) A-H-oxazolidin-2-one 103 (283 mg, 1.0 
mmol) was treated with rc-BuLi (0.44 mL, 2.5 M, 1.1 mmol) in dry THF to form the N- 
acyl-O-Bn-protected intermediate (not shown).
This residue was immediately treated according to General procedure 1, using Pd /  C (10%) 
(50 mg) in MeOH / EtOAc (1:1) (15 mL), to afford (S)-3-(2-methylhexanoyl)-4-(4- 
hydroxybenzyl)oxazolidin-2-one 201 (218 mg, 0.72 mmol, 72%).
HPLC conditions: ChiralCel AD column, 99% n-Hexane, 1% Isopropyl alcohol, 0.7 ml / 
min. (5,5)-201 (major diastereomer) tR 133.4 min, (S,/?)-201 (minor diastereomer) tR 146.5 
min.
M errifield-supported A-H-oxazolidin-2-one, 72a
NH
M errifield
M errifield resin (l.OOg, 1.26 mmol) was preswollen in DMF (100 mL) at ambient 
temperature. 18-crown-6 (large crystal) and potassium carbonate (522 mg, 3.78 mmol) 
were added and the reaction vessel purged with nitrogen. Finally, a solution of A-H- 
oxazolidin-2-one 1 (730 mg, 3.78 mmol) in DMF was added via syringe and the reaction 
heated at 60 °C for 18 hours. After this time, the reaction was cooled to ambient 
temperature and the resin removed via filtration. The resin was washed thoroughly with 
DCM, THF and DCM / MeOH, with all washings collected. In order to recover the excess 
oxazolidin-2 -one fragment, the combined washings were evaporated to dryness, redissolved 
in methanol and passed through a solid phase extraction column (SCX-2) with the resulting
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filtrate evaporated to yield pure oxazolidin-2-one. Meanwhile, the resin was dried 
thoroughly in a vacuum oven at 40 °C. The loading of the resin was determined via 
gravimetric analysis of the resulting resin and comparison with the original mass of resin 
employed in the reaction. !n this way the resin loading was calculated as 0.95 mmolg ' 1 
(75%).
terf-butyl l-(4-(benzyloxy)phenyl)-3-hydroxy-3-methylbutan-2-ylcarbam ate, 215
HO'
A large 3-necked flask fitted with a reflux condenser and thermometer was charged with 
magnesium turnings (1.684 g, 69.30 mmol) and flushed with nitrogen. Diethyl ether (20 
mL) was added via cannula and the whole slowly stirred. In order to initiate the reaction, 
approximately 0.5 mL of iodomethane was added dropwise until the reaction was refluxing 
gently. The remainder of the iodomethane (in total, 4.314 mL, 69.30 mmol) was diluted in 
diethyl ether (40 mL) and added dropwise over 30 mins so as to maintain a gentle reflux. 
The newly formed solution of the Grignard reagent was then allowed to cool to room 
temperature before careful addition of a solution of ester 106 (7.996 g, 17.324 mmol) in 
THF (40 mL), again added dropwise so as to maintain a gentle reflux. After addition was 
complete, the reaction was allowed to stir at room temperature for a further 4 hrs. The 
reaction was quenched by careful addition of a saturated solution of potassium sodium 
tartrate, forming a pale grey, granular precipitate which was filtered through a pad of celite. 
The precipitate was washed with diethyl ether, and the filtrate evaporated to yield 215 as a 
white powder (5.009 g, 12.993 mmol, 75%). m. p. 138-139°C; [oc]D21 - 39° (c 1.02, 
CHC13) ; !H NM R (CDCI3, 300 MHz): 8 1.28 (9H, s, B oc-C //3), 1.30 (6H, s,
C (O H )(C //3)2), 2.54 (1H, dd, J  13.5, 9.5 Hz, C //AHBAr), 3.02 (1H, dd, J  13.5, 3.5 Hz, 
CHa//bA t), 3.64 (1H, m, CHN), 4.6 (1H, d, J  9.5 Hz, NH), 5.03 (2H, s, O C //2Ar), 6.89 
(2H, app. d, J  8.5 Hz, o-OArH), 7.10 (2H, app. d, J  8.5 Hz, m-OArH), 7.27-7.44 (5H, br. m, 
A r//); 13C NMR (CDC13, 75.5 MHz): 8 26.9 (CH3), 27.9 (CH3), 28.7 (CH3), 35.5 (CH2),
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60.9 (CH), 70.4 (CH2), 73.3 (C), 79.6 (C), 115.2 (CH), 127.8 (CH), 128.3 (CH), 128.9 
(CH), 130.5 (CH), 131.7 (C), 137.7 (C), 156.9 (C), 157.7 (C =0); IR (KBr) v max (c m 1): 
3493 (broad O-H), 3379 (broad N-H), 1669 (C =0); MS (CI+, NH3) mJz (%) 386 (88 ) 




A suspension of sodium hydride (0.788 g, 32.84 mmol) in THF (100 mL) was stirred at 
room temperature. A solution of alcohol 215 (4.220 g, 10.95 mmol) in THF (50 mL) was 
added dropwise and the reaction heated at 50 °C for 18 hrs. After this time, the reaction 
was allowed to cool, quenched with satd. NH4C1 solution and extracted into ethyl acetate 
(x3). The combined organic fractions were washed with IN  HC1, satd. N aH C 03 and brine, 
dried (M gS 04) and solvent removed in vacuo to yield crude product. Recrystallisation 
(petroleum ether 40-60°C, ethyl acetate) produced oxazolidin-2-one 216 (2.727 g, 8.76 
mmol, 80%) as pale yellow needles, m. p. 132-133°C; [a]D21 - 83° (c 1.00, CHC13) ; lU 
NMR (CDC13, 300 MHz): 5 1.31 (6H, s, CH 3), 2.53 (1H, dd, J  14.0, 9.5 Hz, C //AHBAr),
2.65 (1H, dd, J  14.0, 4.0 Hz, CHA/ / BAr), 3.55 (1H, dd, J  9.5, 4.0 CHN), 4.93 (2H, s, 
O C //2Ar), 5.41 (1H, s, NH), 6.83 (2H, app. d, J  8.5 Hz, o-OArH), 6.99 (2H, app. d, J  8.5 
Hz, m-OAxH), 7.18-7.34 (5H, br. m, A r//); 13C NMR (CDC13, 75.5 MHz): 5 22.3 (CH3),
28.0 (CH3), 36.6 (CH2), 63.6 (CH), 70.4 (CH2), 83.7 (C), 115.8 (CH), 127.9 (CH), 128.4 
(CH), 129.0 (CH), 129.6 (C), 130.3 (CH), 137.3 (C), 158.3 (C =0), 158.7 (C); IR (KBr) 
vmax (cm '1): 3417 (broad N-H), 1778 (C =0), 1715 (C =0); MS (CI+, NH3) m/z (%) 329 






According to General procedure 1 using SuperQuat oxazolidin-2-one 216 (2.600g, 8.350 
mmol), Pd/C (10%) (440 mg, 0.418 mmol) and methanol/ ethyl acetate (1:1, 60 mL), 217 
was prepared (1.755 g, 7.932 mmol, 94%) as cream coloured needles, m.p.139-140 °C; 
[ a ]D21 -65° (c 1.00, EtOH); !H NMR (d4-MeOD, 300 MHz): 6 1.24 (3H, s, CH3), 1.28 
(3H, s, CH3), 2.55 (1H, dd, J  14.0, 9.5 Hz, C //AHBAr), 2.67 (1H, dd, J  14.0, 4.0 Hz, 
CHA/ / BAr), 3.68 (1H, dd, J  9.5, 4.0 Hz, CHN), 6.66  (2H, app. d, J  8.5 Hz, o-O ArH ), 6.96 
(2H, app. d, J  8.5 Hz, m-OAr//); 13C NMR (d4-MeOD, 75.5 MHz): 5 22.5 (CH3), 28.3 
(CH3), 37.4 (CH2), 64.9 (CH), 85.6 (C), 117.0 (CH), 129.8 (C), 131.6 (CH), 157.7 (C =0),
161.4 (C); IR (KBr) v max (c m 1): 3430 (broad N-H), 1779 (C =0), 1718 (C =0); MS (CI+, 
NH3) m/z (%) 239 (100) [M+NH3]+, 222 (53) [M+H]+; HRMS (ES+) for C i2H i5N 0 3 
[M+NH4]+ Calc. 239.1390, Found 239.1390.
Immobilisation of phenolic SuperQuat-oxazolidin-2-one 217 onto 2-chlorotrityl- 
chloride resin to form 218
NH
According to general procedure 6 , 2-chlorotrityl-chloride resin (1.000 g, 1.20 m m olg'1, 1.20 
mmol) preswollen in DCM / THF (200 mL) was treated with A-H-SuperQuat-oxazolidin-2- 
one 217 (796.4 mg, 3.60 mmol) and diisopropylethylamine (2.090 mL, 12.0 mmol) to 
afford polymer-supported A-H-SuperQuat-oxazolidin-2-one 218.
According to General Procedure 8 , resin 218 (50 mg, 0.060 mmol) was treated with TFA 
cleavage solution (4 mL) to afford A-H-SuperQuat-oxazolidin-2-one 217 (11.7 mg, 0.053
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According to General Procedure 7, /VH-SuperQuat-functionalised resin (500 mg, 1.06 
mmol/g, 0.53 mmol) was treated with triethylamine (0.369 mL, 2.65 mmol) and propionic 
anhydride (0.340 mL, 2.65 mmol) to afford /V-propionyl-SuperQuat-functionalised resin. 
Resin then cleaved according to general procedure 8 (TFA cleavage) in which 
functionalised resin 218 (50 mg, 0.106 mmol) was treated with TFA cleavage solution (4 
mL) to afford (S)-4-(4-hydroxybenzyI)-5,5-dimethyI-3-propionyloxazolidin-2-one 219 
as a colourless oil (27 mg, 0.098 mmol, 92%). [a ]D21 -40 0 (c 1.0, CHC13); *H NMR 
(CDCI3, 300 MHz): 5 1.18 (3H, d, J  7.0 Hz, CH2C //3), 1.38 (3H, s, C //3), 1.39 (3H, s, 
C //3), 2.85 (1H, dd, J  14.0, 9.5 Hz, CHAHBAr), 2.91 (2H, q, J  7.0 Hz, CH2CH3), 3.04 (1H, 
dd, J  14.0 Hz, 4.0 Hz, CHA/ / BAr), 4.42 (1H, dd, J  9.5, 4.0 Hz, CHN), 6.77 (2H, app. d, J
8.5 Hz, o-OArH), 7.12 (2H, app. d, J  8.5 Hz, m-OAr//); 13C NMR (CDC13, 75.5 MHz): 6
8.9 (CH3), 22.8 (CH3), 29.2 (CH3), 29.8 (CH2), 35.6 (CH2), 63.9 (CH), 83.8 (C), 116.4 
(CH), 129.3 (C), 131.6 (CH), 153.2 (C =0), 161.7 (C), 173.8 (C =0); IR (thin film) v max 
(cm '1): 3310 (broad O-H), 1772 (C =0), 1709 (C =0); MS (CI+, NH3) mJz (%) 295 (100) 




According to General Procedure 7, AH-SuperQuat-functionalised resin 218 (500 mg, 1.06 
m m o lg 1, 0.53 mmol) was treated with triethylamine (0.370 mL, 2.65 mmol) and isovaleric 
anhydride (0.530 mL, 2.65 mmol) to afford AMsovaleryl-SuperQuat-functionalised resin. 
Resin then cleaved according to general procedure 8 (TFA cleavage) in which 
functionalised resin (50 mg, 0.106 mmol) was treated with TFA cleavage solution (4 mL) 
to afford (S)-3-(3-methylbutanoyl)-4-(4-hydroxybenzyl)-5,5-dimethyloxazolidin-2-one 
220 as a colourless oil (29.1 mg ,0.095 mmol, 90%). [ a ]D21 - 57 ° (c 1.2, CHC13); *H NMR 
(d4-MeOD, 300 MHz): 8 0.81 (6H, d, J  6.5 Hz, (C //3)2), 1.22 (3H, s, C //3), 1.28 (3H, s, 
C //3), 1.98 (1H, m, C //(C H 3)2), 2.61 (2H, m, COCH2), 2.81 (2H, m, C //AHBAr), 4.40 (1H, 
dd, J  9.5, 4.0 Hz, CHN), 6.61 (2H, app. d, J  8.5 Hz, o-OArH), 6.98 (2H, app. d, J  8.5 Hz, 
m -OAr//); 13C NMR (d4-MeOD, 75.5 MHz): 8 22.7 (CH3), 22.9 (CH3), 23.0 (CH3), 25.4 
(CH), 29.2 (CH3), 36.8 (CH2), 44.8 (CH2), 64.2 (CH), 84.2 (C), 115.8 (CH), 129.0 (C),
131.4 (CH), 153.9 (C =0), 156.3 (C), 175.0 (C =0); IR (thin film) v max (c m 1): 3389 (broad 




AH-SuperQuat-functionalised resin 218 (500 mg, 1.06 mmol/g, 0.53 mmol), sealed into 
IRORI mini-Kans ™  was preswollen in DCM at room temperature. DMAP (323.8 mg,
2.65 mmol) and hydrocinnamic acid (796.0 mg, 5.3 mmol) followed by DCC (1.094 g, 5.3 
mmol) and the reaction heated at reflux for 16 hours. After this time, the reaction was
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quenched by addition of saturated ammonium chloride solution and the resin removed via 
filtration. The resin was then washed thoroughly with DCM, DMF and DCM / MeOH, 
before being dried thoroughly in a vacuum oven at 40 °C.
The functionalised resin was then cleaved according to general procedure 8 (TFA cleavage) 
in which functionalised resin (50 mg, 0.106 mmol) was treated with TFA cleavage solution 
(4 mL) to afford (S)-3-(3-phenylpropanoyl)-4-(4-hydroxybenzyl)-5,5- 
dimethyloxazolidin-2-one 221 as a colourless oil (31.8 mg, 0.090 mmol, 85%). [a]o21 -36 
0 {c 1.1, CHC13); *H NMR (d4-MeOD, 300 MHz): 5 1.29 (3H, s, C tf3), 1.30 (3H, s, C tf3), 
2.58 (1H, dd, J  14.0, 9.5 Hz, C tfAHBAr), 2.65 -  2.98 (3H, br. m, CH2Ph, CHA/ / BAr), 3.06 
(2H, m, COCHaH b), 4.38 (1H, dd, J  9.5, 4.0 Hz, CHN), 6.61 (2H, app. d, J  8.5 Hz, 0 - 
OArH), 6.95 (2H, app. d, J  8.5 Hz, m-OArH), 7.02-7.20 (5H, br. m, Ar/T); 13C NM R (cL- 
MeOD, 75.5 MHz): 5 22.4 (CH3), 28.8 (CH3), 31.8 (CH2), 35.4 (CH2), 37.8 (CH2), 62.8 
(CH), 84.0 (C), 115.6 (CH), 127.6 (C), 127.7 (CH), 129.3 (C), 129.9 (CH), 130.0 (CH),
132.2 (CH), 154.2 (C =0), 158.3 (C), 173.8 (C =0); IR (thin film) v ma* (c m 1): 3398 (broad 
O-H), 1780 (C =0), 1692 (C =0); MS (CI+, NH3) m/z (%) 371 (100) [M+NH4+], 354 (50) 
[M+H+].
7.6 Compounds from Chapter 6
(R)-methyl 2-amino-3-phenylpropanoate hydrochloride, (/?)-251
o
Thionyl chloride (13.247 mL, 181.6 mmol) was added dropwise to a stirred suspension of 
D-phenylalanine (20.00g, 121 mmol) in methanol (240 mL) at 0 °C. The reaction was 
allowed to warm to room temperature and stirred for 24 hours, after which time the solvent 
was removed in vacuo to give (fl)-methyl 2-amino-3-phenylpropanoate hydrochloride 
(/?)-251 in quantitative yield. *H NMR (D20 ,  300 MHz): 5 3.17 (2H, m, CH2), 3.70 (3H, s, 
C //3), 4.33 (1H, app. t, J  4.3 Hz, C //N ), 7.12-7.33 (5H, m, Ar-//). Spectroscopic data
1 o z
identical to literature compound.
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(S)-methyl 2-amino-3-phenylpropanoate hydrochloride, (S)-251




Solid sodium hydrogen carbonate (30.494 g, 363 mmol) was added in one portion to a 
stirred solution of (i?)-251 (21.685 g, 121 mmol) in ethanol (300 mL) at 0 °C, immediately 
followed by addition of solid boc anhydride (27.740 g, 127.1 mmol) in one portion. The 
reaction was allowed to warm to room temperature and stirred for 48 hours, after which the 
reaction was filtered through celite, washed with diethyl ether and evaporated. The 
resulting residue was redissolved in diethyl ether, filtered through celite again, washed with 
ether and evaporated to afford tert- butyl (R)-l-(m ethoxycarbonyl)-2- 
phenylethylcarbamate (R)-252 (31.771 g, 113.7 mmol, 94%) as a colourless oil which 
solidified with time. m.p. 42-43 °C; [ a ]D21 -38 0 (c 1.4, CHC13); ‘H NMR (CDC13, 300 
MHz): 5 1.41 (9H, s, Boc-H), 3.08 (2H, m, CHAH B?h ), 3.72 (3H, s, O C //3), 4.59 (1H, m, 
C H N ), 4.98 (1H, d, J  6.0 Hz, NH), 7.11-7.32 (5H, br. m, A i-H ); 13C NMR (CDC13, 75.5 
MHz): 8 28.5 (CH3), 38.2 (CH2), 52.0 (CH3), 54.2 (CH), 80.3 (C), 127.4 (CH), 128.4 (CH),
129.3 (CH), 137.0 (C), 156.2 (C =0), 172.6 (C =0). Spectroscopic data identical to
1 7 7literature compound.
tert-butyl (S)-l-(methoxycarbonyl)-2-phenylethylcarbam ate, (S)-252
Identical method but employing (S)-251, 92% yield, [a ]D21 + 4 0  ° (c 1.0, CHC13).
tert-butyl (J?)-3-hydroxy-3-methyl-l-phenylbutan-2-ylcarbamate, (R)-253
According to literature method of Bull et al. a large 3-necked flask fitted with a reflux 
condenser and thermometer was charged with magnesium turnings (5.881 g, 242.0 mmol) 
and flushed with nitrogen. Diethyl ether (60 mL) was added via syringe. In order to
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initiate the reaction, approximately 2 mL o f iodomethane was added dropwise until the 
reaction was refluxing gently. The remainder o f the iodomethane (in total, 15.066 mL,
242.0 mmol) was diluted in diethyl ether (120 mL) and added dropwise over 1 hour so as to 
maintain a gentle reflux. The newly formed solution o f the Grignard reagent was then 
allowed to cool to room temperature before careful addition o f a solution o f ester (R)-252 
(16.899 g, 60.5 mmol) in THF (60 mL), again added dropwise so as to maintain a gentle 
reflux. After addition was complete, the reaction was allowed to stir at room temperature 
for a further 40 hrs. The reaction was quenched by careful addition o f a saturated solution 
o f potassium sodium tartrate, forming a pale grey, granular precipitate which was filtered 
through a pad o f celite. The precipitate was washed with diethyl ether, and the filtrate 
evaporated to yield (R )-253 as a white powder (14.188 g, 50.8 mmol, 84%). m. p. 101- 
103°C; [cxfo21 + 4 5 °  (c 1.00, CHC13); lU  NM R (CDC13, 300 MHz): 8 1.22 (9H, s, boc- 
C tf3), 1.23 (6H, s, C(OH)(CJf3)2), 2.53 (1H, dd, J  14.0, 9.5 Hz, C //AHBPh), 3.02 (1H, dd, J
14.0, 4.0 Hz, CHA/ / BPh), 3.62 (1H, m, CHN), 4.49 (1H, d, J  9.0, NH), 7.09-7.24 (5H, br. 
m, Artf); 13C NMR (CDC13, 75.5 MHz): 8 26.9 (CH3), 27.8 (CH3), 28.6 (CH3), 36.4 
(CH2), 60.8 (CH), 73.4 (C), 79.6 (C), 126.5 (CH), 128.6 (CH), 129.5 (CH), 139.4 (C),
156.8 (C =0); IR (KBr) v max (cm*1): 3475 (broad O-H), 3379 (broad N-H), 1662 (C =0); 
MS (CI+, NH3) m/z (%) 280  (100) [M+H]+, 224 (100); HRMS (ES+) for C i6H25N 0 3 
[M+H]+ Calc. 280.1907, Found 280.1911.
tert-butyl (S)-3-hydroxy-3-m ethyI-l-phenylbutan-2-ylcarbam ate, (S)-253
Identical method but employing (S)-253, 86% yield, [a]o21 - 45° (c 1.00, CHC13)
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(R)-4-benzyl-5,5-dimethyloxazolidin-2-one, (R)-211
According to the literature method of Bull et al., a solution of alcohol (/?)-253 (6.200 g, 
22.192 mmol) in THF (150 mL) was cooled to 0 °C. Potassium terr-butoxide (2.739 g,
mins until a yellow solution had been formed. The solvent was then removed in vacuo and 
the residue re-dissolved in ethyl acetate, washed with brine, dried (MgSCL) and evaporated 
to give crude oxazolidin-2-one as a pale yellow solid. Recrystallisation (petroleum ether 
40-60°C, ethyl acetate) yielded (/?)-211 as a white solid (4.100 g, 19.97 mmol, 90%). mp 
58-59 °C; [a]o21 105 0 (c 1.00, CHCI3) (Lit data for opposite enantiomer [a ]o21 -103.5° (c
J  9.5, 4.0 Hz, C H N ), 4.87 (1H, br. s, N//), 7.02-7.24 (5H, br. m, ArH)\ 13C NMR (CDC13,
75.5 MHz): 5 22.3 (CH3), 27.9 (CH3), 37.5 (CH2), 63.4 (CH), 83.5 (C), 127.6 (CH), 129.3 
(CH), 129.4 (CH), 137.3 (C), 158.3 (C =0). Spectroscopic data essentially identical to
9 0literature compound
(S)-4-benzyl-5,5-dimethyloxazolidin-2-one, (S)-211
Identical method but employing (S)-253. Yield 89%, [ a ]D21 -103° (c 1.00, CHC13) 
(R)-4-Benzyl-3-(2-chloroacetyl)-5,5-dimethyl-oxazoIidin-2-one, 246
N -H oxazolidin-2-one {R )-2 \\  (6.838 g, 30.91 mmol) was dissolved in dry THF and cooled 
to -78 °C. Ai-BuLi (12.980 mL, 2.5 M, 13.93 mmol) was then added dropwise over 15
24.411 mmol) was added as one portion and the resulting suspension stirred for a further 30
0.6, CHCI3)); *H NMR (CDCI3, 300 MHz): 5 1.32 (3H, s, CH 3), 1.34 (3H, s, C //3), 2.55 




minutes and the reaction stirred for a further 15 minutes before the slow addition of 
chloroacetyl chloride (3.687 mL, 46.56 mmol). The reaction was stirred at -78 °C for a 
further two hours before quenching with saturated ammonium chloride solution. The 
mixture was extracted into ether, and the combined organic extracts washed with sodium 
bicarbonate and brine, dried over M gS04, filtered and evaporated to dryness to afford the 
crude product. Recrytallisation (ether / hexane) afforded (/?)-4-BenzyI-3-(2-chloroacetyl)- 
5,5-dimethyl-oxazolidin-2-one 246 as a white crystalline solid (7.663 g, 27.20 mmol, 
88%). m.p. 69-70 °C; [a ]D21 + 3 7 °  (c 1.00, CHC13); NMR (CDC13, 300 MHz): 81.31 
(3H, s, CH3), 1.33 (3H, s, CH3), 2.83 (1H, dd, J  14.0, 9.5 Hz, CHAHBPh), 3.15 (1H, dd, J
14.0, 4.0 Hz, CHA/ / BPh), 4.44 (1H, dd, J  9.5, 4.0 Hz, C //N ), 4.58 (1H, d (as part o f AB 
quartet), J  15.8 Hz, C //AHBC1), 4.70 (1H, d (as part of AB quartet), J  15.8 Hz, CHA/ / BC1), 
7.13-7.28 (5H, br. m, ArH)\ 13C NMR (CDC13, 75.5 MHz): 8 22.8 (CH3), 29.1 (CH3), 35.4 
(CH2), 44.3 (CH2), 64.4 (CH), 84.0 (C), 127.4 (CH), 129.2 (CH), 129.4 (CH), 136.8 (C),
152.7 (C =0), 166.7 (C =0); IR (KBr disc) v max (c m 1): 1806 (C =0), 1715 (C =0), 791 (C- 
Cl); MS (CI+, NH3) m/z (%) 299.2 (100) [M+NH4]+, 265.2 (87), 223.2 (56); HRMS (ES+) 




According to General Procedure 5, /V-acyl-oxazolidin-2-one 246 (5.00 g, 17.747 mmol) in 
DCM at 0 °C was treated with 9-BBNOTf (19.521 mL, 19.521 m m o l), 'Pr2NEt (3.709 mL 
21.297 mmol) and (£)-dec-2-enal (3.910 mL, 21.297 mmol) to afford the crude product in 
92% de. Purification via column chromatography yielded (/?)-4-Benzyl-3-[(Z?)-(2/?,3S)-2- 
chloro-3-hydroxy-dodec-4-enoyl)-5,5-dimethyl-oxazolidin-2-one 250 as a colourless oil 
(5.725 g, 13.133 mmol, 74%) with >95% de. [cc]D21 + 11 0 (c 1.0, CHC13) ; !H NMR 
(CDC13, 300 MHz): 8 0.80 (3H, t, J  7.0 Hz, alkyl-CH3), 1.19 (10H, m, alkyl-CH2), 1.29 
(3H, s, C //3), 1.34 (3H, s, CH3), 1.98 (2H, m, C tf2CH=CH), 2.62 (1H, br. s, OH), 2.85 (1H,
243
dd, J  14.0, 9.5 Hz, CHAHBAr), 3.10 (1H, dd, J  14.0, 4.0 Hz, CHA/ / BAr), 4.43 (1H, dd, J  
9.5, 4.0 Hz, CHN), 4.49 (1H, app. t, J  5.5 Hz, C //O H ), 5.44 (1H, ddt, J  15.5, 6.5, 1.5 Hz, 
C(OH)C//=C), 5.64 (1H, d, J  5.0 Hz, CHC1), 5.74 (1H, dtd, J  15.5, 6.5, 1.0 Hz, 
=C //(C 7H 15)), 7.14-7.28 (5H, br. m, Ar); 13C NMR (CDC13, 75.5 MHz): 8 14.5 (CH3),
22.7 (CH3), 23.1 (CH2), 28.9 (CH3), 29.12 (CH2), 29.4 (CH2), 29.5 (CH2), 32.0 (CH2), 32.6 
(CH2), 35.3 (CH2), 59.6 (CH), 64.5 (CH), 73.2 (CH), 83.4 (C), 126.6 (CH), 127.4 (CH),
129.3 (CH), 129.4 (CH), 136.7 (C), 137.1 (CH), 152.3 (C =0), 168.4 (C =0); IR (thin film) 
v max (cm’1): 3353 (broad O-H), 1778 (C =0), 1708 (C =0); MS (CI+, NH3) m/z (%) 453 





a-chloro-p-hydroxy-250 (4.00g, 9.174 mmol) was dissolved in DCM (in a foil-wrapped 
flask to keep the contents dark) and cooled to -10 °C. Diethylzinc (45.874 mL, 1.0M in 
hexane, 45.874 mmol) and diiodomethane (3.700 mL, 45.874 mmol) were added slowly. 
The reaction was then stirred for a further two hours whilst allowing the reaction to warm 
slowly to 0 °C. The reaction was quenched by addition of sodium sulphite solution. The 
resulting white precipitate was redissolved by addition of 2 ml 1.0 N HC1 (aq) and the 
mixture was extracted into DCM. The combined organic extracts were washed with 
saturated sodium bicarbonate solution and brine, dried with M gS 04, filtered and evaporated 
to dryness (on a hot water-bath) to yield (/?)-4-Benzyl-3-[(2/f,3S')-2-chloro-3-((l/?,2/?)-2- 
heptylcyclopropyl)-3-hydroxy-propionyl]-5,5-dimethyl-oxazolidin-2-one 249 as a pale 
yellow oil (4.045 g, 8.990 mmol, 98%). [ a ]D25 + 11.0 (c 1.0, CHC13); !H-NMR (CDC13, 
300 MHz): 8 0 .40  (1H, m, cyc-CH2), 0.61 (1H, m, cyc-CH2), 0.79 ( 1H, m, cyc-CH), 0.85 
(3H, t, J  7.0 Hz, CH3), 0.90 (1H, m, cyc-CH ), 1.12-1.29 (12H, m, alkyl-CH2), 1.32 (3H, s, 
CH3), 1.36 (3H, s, CH 3), 2.61 (1H, br. s, OH), 2.87 (1H, dd, J  14.0, 9.5 Hz, C //AHBPh),
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3.20 (1H, dd, J  14.0, 4.0 Hz, CHA/ / BPh), 3.40 (1H, dd, J  8.0, 3.0 Hz, C //O H), 4.48 (1H, dd, 
J  9.5, 4.0 Hz, CH N ), 5.78 (1H, d, J  3.0 Hz, C//C1), 7.17-7.32 (5H, br. m, Ar-tf); 13C-NMR 
(CDC13, 75 MHz): 5 10.8 (CH2), 14.0 (CH3), 16.6 (CH), 21.7 (CH), 22.3 (CH3), 22.6 (CH2),
28.6 (CH3), 29.2 (CH2), 29.3 (CH2), 29.4 (CH2), 31.8 (CH2), 33.4 (CH2), 34.6 (CH2), 60.6 
(CH), 64.2 (CH), 75.1 (CH), 83.0 (C) 126.9 (CH) 128.7 (CH), 129.0 (CH), 136.4 (C), 151.8 
(C =0), 168.3 (C = 0); IR (thin film) v max (cm '1): 3500 (broad O-H), 1770 (C =0), 1716 
(C =0); MS (CI+, NH3) m/z (%) 467.3 (44) [M+NH4]+, 398 (100); HRMS (ES+) for 
C25H36C1N04  [M+NH4]+ Calc. 467.2671, Found 467.2668.
(/?)-4-benzyl-3-((£')-3-((l/?,2R)-2-heptylcyclopropyl)acryloyl)-5,5-dimethyloxazolidin- 
2-one, 248
Samarium diiodide (11.111 mL, 0.1M in THF, 1.111 mmol) was added dropwise to a 
solution of 249 (200 mg, 0.444 mmol) stirring in dry THF (5 mL) at room temperature and 
allowed to stir for a further 30 minutes. The reaction was then quenched with 4 mL IN 
HC1 (aq) and extracted into ether. The combined organic layers were washed three times 
with sodium thiosulphate, and then washed with brine, dried with M gS 04, filtered and 
solvent removed in vacuo. The resulting residue was purified via column chromatography 
and (/?)-4-benzyl-3-((E)-3-((l/?,2/?)-2-heptylcyclopropyl)acryloyl)-5,5-dimethyl-
oxazolidin-2-one 248 isolated as a pale yellow oil (69 mg, 0.173 mmol, 39%). [a ]o 25 - 11 
(c 1.0, CHC13); !H-NMR (CDC13, 300 MHz): 5 0.76-0.88 (5H, m, cyc-CH2, CHZ), 1.05 
( 1H, m, cyc-CH), 1.20-1.46 (19H, br. m, 2 x C //3, cyc-CH, 6 x alkyl-CH2), 2.85 ( 1H, dd, J
14.0, 4.0 Hz, a / AHBPh), 3.19 (1H, dd, J  14.0, 9.5 Hz, CHA/ / BPh), 4.52 (1H, dd, J  9.5, 4.0 
Hz, CHN), 6.63 (1H, dd, J  15.0, 10.5 Hz, HC=CH), 7.15-7.32 (6H, br. m, HC=CH, Ar-//); 
13C-NM R (CDC13, 75 MHz): 8 14.1 (CH3), 16.7 (CH2), 22.3 (CH), 22.6 (CH2), 23.1 (CH), 
24.1 (CH3), 28.5 (CH3), 29.1 (CH2), 29.2 (CH2), 29.3 (CH2), 31.8 (CH2), 33.5 (CH2), 35.2 
(CH2), 63.7 (CH), 81.9 (C), 116.6 (CH), 126.6 (CH), 128.5 (CH), 129.0 (CH), 137.2 (C),
152.6 (C =0), 156.6 (CH), 165.2 (C); IR (thin film) v max (cm '1): 1771 (C =0), 1699 (C =0);
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MS (CI+, NH3) m/z (%) 398 (100) [M+H]+, 265 (40); HRMS (ES+) for C25H35NO3 [M+H]+ 
Calc. 398.2690, Found 398.2690.
(l/?,2R)-2-heptylcyclopropanecarbaldehyde, 257
In the attempted synthesis of 248 from 249, (l/?,2/?)-2-heptylcyclopropanecarbaldehyde
257 was also formed and was recovered after column chromatography (13.5 mg, 0.080 
mmol, 18%) as a colourless oil. !H-NMR (CDC13, 300 MHz): 5 0.85 -  0.99 (4H, m, 
including 3H, t, J  7.2 Hz at 0.89, CH 3, cyc-CHAHBy, 1.25 -  1.55 (14H, m, 6 x alkyl-CH2, 
cyc-CHAHB and cyc-CH), 1.61 (1H, m, cyc-CH), 9.08 (1H, d, J  5.5 Hz, C //O ); 13C-NMR 
(CDCI3, 75 MHz): 6 15.0 (CH3), 16.3 (CH2), 23.8 (CH), 24.1 (CH), 30.6 (CH2), 30.7 (CH2),
31.6 (CH2), 32.4 (CH2), 33.5 (CH2), 34.1 (CH2), 202.8 (C =0). Spectroscopic data 
essentially identical to literature precedent. 97
2R,3S)-2-chloro-3-((l’/?,2’R)-2-heptyl-cyclopropyl)-3-hydroxy-iV-phenethyl- 
propionamide, 263
Oxazolidin-2-one 249 (l.OOg, 2.22 mmol) was dissolved in neat phenylethylamine (8 mL) 
and stirred for 16 hours at room temperature. After this time, the whole reaction mixture 
was applied to a large pad of silica to ensure retention of the excess amine. 2R,?>S)-2- 
ch loro-3-((l’R ,2’/?)-2-heptyl-cyclopropyl)-3-hydroxy-A-phenethyl-propionamide 263
was isolated as an off-white solid (724 mg, 1.98 mmol, 89%). m.p. 64-65 °C; [a]o25-  23 (c
1.0 ,CHC13); *H-NMR (CDC13, 300 MHz): 5 0.39 (1H, m, cyc-CHAHB), 0.59 (1H, m, cyc- 
CHAtfB), 0.70 (1H, m, cyc-CH), 0.87 (3H, t, J  7.0 Hz, CH2), 0.88 (1H, m, cyc-CH), 1.13- 
1.34 (12H, m, CH2), 2.83 (2H, t, J  7.0 Hz, C //2Ph), 3.49 (2H, m, NCH2), 3.55 (1H, m, 
C //O H), 4.43 (1H, d, J  3.0 Hz, CHC1), 6.77 (1H, br. s, NH), 7.18-7.34 (5H, br. m, A r-//); 
13C-NMR (CDCI3, 75 MHz): 5 11.3 (CH2), 14.6 (CH3), 17.2 (CH), 22.3 (CH), 23.0 (CH2),
29.7 (CH2), 29.8 (2 x CH2), 32.2 (CH2), 33.8 (CH2), 35.8 (CH2), 41.5 (CH2), 64.9 (CH),
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76.3 (CH), 127.0 (CH), 129.0 (CH), 129.2 (CH), 138.8 (C), 168.3 (C =0); IR (KBr) v max 
(cm '1): 3477 (broad O-H), 1647 (C =0); MS (CI+, NH3) m/z (%) 366 (45) [M+H]+, 314 
(100); HRMS (ES+) for C21H33CINO2 [M+H]+ Calc. 366.2194, Found 366.2198.
(£)-3-((l/?,2/?)-2-Heptyl-cyclopropyl)-A^-phenethyl-acrylamide, 264
Samarium diiodide (41.0 mL, 0.1 M in THF, 4.10 mmol) was added slowly to a solution of 
263 (600 mg, 1.64 mmol) stirring in dry THF (10 mL) at room temperature and allowed to 
stir for a further 30 minutes. The reaction was then quenched with 15 mL IN  HC1 (aq) and 
extracted into ether. The combined organic layers were washed three times with sodium 
thiosulphate, and then washed with brine, dried with MgSCL, filtered and solvent removed 
in vacuo. The resulting residue was purified via column chromatography affording (is)-3- 
((l/?,2/?)-2-HeptyI-cyclopropyl)-yV-phenethyl-acrylamide 264 as a white solid (437 mg,
1.39 mmol, 85%). m.p. 65-66 °C; [a ]D25 -37 (c 0.99, CHC13); ‘H-NMR (CDC13, 300 MHz): 
6 0.67 (1H, m, cyc-CHAHB), 0.75 (1H, m, cyc-CHA/ / B), 0.87 (3H, t, J  7.0 Hz, C //3), 0.94 
(1H, m, cyc-CH), 1.17-1.40 (13H, br. m, CH2 and cyc-CH ), 2.83 (2H, app. t, J  7.0 Hz, 
P hC i/2), 3.57 (2H, q, J  7.0 Hz, C i/2NH), 5.43 (1H, br. s, NH), 5.71 (1H, d, J  15.0 Hz, 
C=H), 6.35 (1H, dd, J  15.0, 10.2 Hz, C=H), 7.16-7.34 (5H, br. m, Ar-H)\ 13C-NMR 
(CDCI3, 75 MHz): 5 14.5 (CH3), 15.9 (CH2), 22.2 (CH), 23.0 (CH2), 23.2 (CH), 29.6 (CH2),
29.7 (CH2), 29.8 (CH2), 32.2 (CH2), 34.0 (CH2), 36.1 (CH2), 40.9 (CH2), 120.0 (CH), 126.8 
(CH), 129.0 (CH), 129.2 (CH), 139.4 (C), 149.9 (CH), 166.5 (C =0); IR (KBr) v max (cm '1): 
3398 (broad O-H), 1663 (C =0); MS (CI+, NH3) m/z (%) 314 (100) [M+H]+; HRMS (ES+) 
for C21H31NO [M+H]+ Calc. 314.2477, Found 314.2478.
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3-((17?,27?)-2’-heptyl-cyclopropan-l-yl)-A-phen-ethyl-propionam ide (Grenadamide) 
240
A solution of 264 (250 mg, 0.798 mmol) in MeOH / THF (2:1) (9 mL) was added to a flask 
charged with C0CI2.6H2O (37.9 mg, 0.160 mmol) and the mixture stirred for 30 minutes. 
A solution of NaBH4 (120 mg, 3.192 mmol) in DMF (3 mL) was then added and the 
reaction stirred for a further 3 hours. After this time, the reaction mixture was diluted with 
5 mL water and extracted into DCM. The combined organic fractions were washed three 
times with water, washed with brine, dried with M gS 04, filtered and solvent removed in 
vacuo to afford the crude product. Column chromatography afforded 3-((17?,27?)-2’- 
heptyl-cyclopropan-l-yl)-A-phenethyl-propionamide (Grenadamide) 240 as a white 
solid (221 mg, 0.702 mmol, 88%). m.p. 46-47 °C; [a ]D25- 11.0 (c 1.0, CHC13) (Lit. [a ]D25-
11.0, c 0.1, CHCI3); 96 ‘H-NMR (CDCI3, 300 MHz): 0.16 (2H, m, cyc-CH2), 0.38 (2H, m, 2 
x  cyc-CH), 0.87 (3H, t, J  7.0 Hz, C //3), 1.14 (2H, m, CH2), 1.24-1.33 (10H, m, CH2), 1.49 
(2H, m, CH2), 2.18 (2H, t, J  7.5 Hz, CH2CO), 2.81 (2H, t, J  7.0 Hz, PhCH2), 3.52 (2H, q, J
6.8 Hz, CH2NH), 5.51 (1H, br. s, NH), 7.17-7.34 (5H, br. m, ArH)\ 13C-NMR (CDC13, 75 
MHz): 12.2 (CH2), 14.5 (CH3), 18.6 (CH), 19.3 (CH), 23.1 (CH2), 29.8 (CH2), 29.9 (CH2),
30.0 (CH2), 30.7 (CH2), 32.3 (CH2), 34.5 (CH2), 36.1 (CH2), 37.3 (CH2), 40.9 (CH2), 126.9 
(CH), 129.0 (CH), 129.2 (CH), 139.3 (C), 173.5 (C =0); IR (KBr) v max (cm '1): 1638 (C =0); 
MS (CI+, NH3) m/z (%) 316 (100) [M+H]+; HRMS (ES+) for C21H34NO [M+H]+ Calc. 
316.2635, Found 316.2637.
(S)-4-benzyl-5,5-dimethyl-3-propionyIoxazolidin-2-one, 230
According to general procedure 2, (5)-4-benzyl-oxazolidin-2-one (S)-211 (3.675 g, 16.610 
mmol) treated with n-butyl lithium (6.976 mL, 2.5 M, 17.441 mmol) and propionyl
o
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chloride (2.175 mL, 24.915 mmol) to afford (S)-230 (3.602g, 13.786 mmol, 83%) as white 
needles, m. p. 61-62 °C; [a ]D21 -41° (c 1.00, CHC13); *H NM R (CDC13, 300 MHz): 
8 1.07 (3H, t, J  7.0 Hz, CH2Cff3), 1.29 (3H, s, CH3), 1.30 (3H, s, CH3), 2.81 (1H, dd, J
14.0, 9.5 Hz, C //AHBAr), 2.86 (2H, q, J  7.0 Hz, C tf2CH3), 3.08 (1H, dd, J  14.0, 4.0 Hz, 
CHa^bAt), 4.44 (1H, dd, J  9.5, 4.0 Hz, CHN), 7.12 (5H, br. m, Ar/f); 13C NMR (CDC13,
75.5 MHz): 8 8.7 (CH3), 22.7 (CH3), 28.9 (CH3), 29.7 (CH2), 35.7 (CH2), 63.9 (CH), 82.6 
(C), 127.2 (CH), 129.1 (CH), 129.4 (CH), 137.4 (C), 153.1 (C = 0), 174.7 (C =0); IR (KBr 
disc) v max (cm'1): 1771 (C =0), 1707 (C =0); MS (CI+, NH3) m/z (%) 262 (48) [M+H]+, 
279 (100) [M+NH3]+; HRMS (ES+) for C i5H i9N 0 3 [M+H]+ Calc. 262.1438, Found 
262.1442.
G eneral procedure 16: Solid phase syn-aldol reaction
Functionalised resin (1 equiv.) sealed into an IRORI minikan and placed into an oven-dried 
round bottomed flask. DCM (8 mL) was added to preswell the resin and the flask cooled to 
0 °C. 9-BBN-O Tf (0.5 M in DCM, 5.0 equiv.) was added slowly and the reaction stirred for 
one hour before removal o f the reaction solution via cannula. Fresh, pre-chilled DCM (10 
mL was then added to resuspend the resin and lPr2NEt (5.0 equiv.) added and the reaction 
stirred for a further hour. Finally the entire reaction was cooled to -78 °C before the 
addition o f aldehyde (7.0 equiv.), with the reaction then being allowed to warm slowly to 
room temperature whilst stirring for a further 12 hours. In order to quench the reaction, 
phosphate buffer pH 7 (0.1 M) was added and the resin immediately filtered and washed 
thoroughly (DCM, DCM/MeOH, THF) in alternate cycles. Side chain cleavage o f the 
resulting aldol-functionalised resin was achieved according to General procedure 9 





According to general procedure 5, employing A-propionyl-oxazolidin-2-one (S)-230 
(l.OOOg, 3.827 mmol) in DCM (40 mL), 9-BBN-OTf (8.419 mL, 0.5 M, 4.209 mmol), 
’Pr2NEt (0.800 mL, 4.592 mmol) and 2-ethylacrolein (0.440 mL, 4.592 mmol), the crude 
product was prepared as a pale yellow oil. Purification via column chromatography 
afforded (S)-4-benzyl-3-((25,3S)-3-hydroxy-2-methyl-4-methylene-hexanoyl)-5,5- 
dimethyl-oxazolidin-2-one 270 (1.070 g, 3.10 mmol, 81%) as a colourless oil. [ a ]D21 - 36 0 
(c 1.0, CHC13) ; !H NMR (CDC13, 300 MHz): 5 1. 07 (3H, t, J  7.0, CH2CH3), 1.11 (3H, d, 
J  7.0, CH3), 1.38 (3H, s, CH3), 1.40 (3H, s, C //3), 2.02 (2H, m, CH2CH3), 2.78 (1H, br. s, 
OH), 2.91 (1H, dd, J  14.0, 9.5 Hz, C //AHBAr), 3.08 (1H, dd, J  14.0, 4.0 Hz, CHA/ / BAr),
3.96 (1H, dq, J  3.5, 7.0 Hz, CHCH3), 4.40 (1H, d, J  3.5 Hz, C //O H ), 4.53 (1H, dd, J  9.5,
4.0 Hz, CHN), 4.98 (1H, app. t, J  1.0 Hz, C=C7/AH B), 5.16 (1H, app. t, J  1.0 Hz, 
C=CHa/ / b), 7.20-7.34 (5H, br. m, ArH ) ; 13C NMR (CDC13, 75.5 MHz): 5 11.0 (CH3),
12.5 (CH3), 22.6 (CH3), 25.7 (CH2), 28.8 (CH3), 35.8 (CH2), 41.0 (CH), 63.8 (CH), 74.0 
(CH), 82.7 (C), 109.9 (CH2), 127.3 (CH), 129.1 (CH), 129.5 (CH), 137.0 (C), 150.2 (C),
152.6 (C =0), 177.6 ( C = 0 ) ; IR (thin film) v max (c m 1): 3497 (broad O-H), 1773 (C =0), 
1700 (C =0); MS (CI+, NH3) m/z (%) 346 (38) [M+H]+, 279 (100), 262 (83), 223 (45 ); 
HRMS (ES+) for C2oH27N 0 4 [M+H]+ Calc. 346.2013, Found 346.2014.
General procedure 17: Solution phase epoxidation /  lactonisation
Solution of aldol substrate (1.0 equiv) in benzene added to VO(acac)2 (0.2 equiv) and 
stirred for 5 minutes. /-BuOOH (1.1 equiv.) added dropwise and reaction stirred at room 
temperature for a further 3 hours. After this time, reaction quenched by addition of 
saturated ammonium chloride solution and extracted into ether, with these organic fractions 
being retained in the case of non-water soluble lactones. The aqueous layer was then
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saturated with sodium chloride and back extracted into fresh EtOAc. The new organic 
fractions were combined, dried with M gS04, filtered and solvent removed in vacuo to 
yield the crude lactone product.
(35,4lS,5,S)-5-ethyl-dihydro-4-hydroxy-5-(hydroxymethyl)-3-methylfuran-2(3H)-one,
274
Solution phase method: According to General Procedure 16, employing aldol 270 (200.00 
mg, 0.579 mmol) in benzene (8.0 mL), VO(acac)2 (31.0 mg, 0.116 mmol) and r-BuOOH 
(0.12 mL, 5.5 M, 0.637 mmol) the crude lactone was prepared. Recrystallisation (ether) 
afforded (3S,4S,5S)-5-ethyl-dihydro-4-hydroxy-5-(hydroxymethyl)-3-methylfuran- 
2(3H)-one 274 (78 mg, 0.452 mmol, 78%) as a white solid, m.p. 76-77 °C; [a ]D21 - 19 0 (c 
0.16, CH2C12); *H NMR (D20 , 300 MHz): 8 0.72 (3H, t, J  7.5 Hz, CH3CH2), 1.03 (3H, d, 
J  7.0 Hz, C //3CH), 1.47 -  1.59 (2H, app. qd, J  7.5, 2.5 Hz, CH2CH3), 2.77 (1H, dq, J  9.5,
7.0 Hz, C //C H 3), 3.52 (1H, d, J  13.0 Hz, C //AHBOH), 3.71 (1H, d, J  13.0 Hz, C H a # b O H ) ,  
3.91 (1H, d, J  9.5 Hz, C//OH); 13C NMR (D20 ,  75.5 MHz): 8 6.9 (CH3), 12.8 (CH3), 27.4 
(CH2), 43.3 (CH), 62.5 (CH2), 77.9 (CH), 89.7 (C), 181.0 (C =0); IR (KBr disc) v max (cm' 
*): 3348 (broad OH), 1751 (C =0); HRMS (ES+) for C 8Hi40 4 [M+H]+ Calc 192.1230, 
Found 192.1233.
Solid phase method: Aldol-functionalised resin 295 (200mg, 0.90mmol/g, 0.18 mmol), 
preswollen in benzene (8 mL) was treated with VO(acac)2 (23.8 mg, 0.09 mmol) , and 
agitated for 30 minutes, followed by t-BuOOH (0.098 mL, 5.5 M, 0.54 mmol). The 
reaction was then agitated on an orbital shaker for 16 hours at room temperature. The resin 
was then filtered and washed thoroughly (DCM, DCM / MeOH) with all washings 
collected and evaporated to dryness. The resulting green residue was redissolved in DCM 
and passed through a plug to silica to afford (3S,4S,5S)-5-ethyl-dihydro-4-hydroxy-5- 
(hydroxymethyl)-3-methylfuran-2(3H)-one 274 (16.9 mg, 0.097 mmol, 58%) as a
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colourless oil, which later solidified. Spectroscopic data identical to that reported above. 




According to General Procedure 5 using A-acyl SuperQuat oxazolidinone (S)-230 (1.500 g, 
5.740 mmol), 9-BBN-OTf (12.63 mL, 0.5 M, 6.314 mmol), DIPEA (1.199 mL, 6.888 
mmol) and 3-methylcrotonaldehyde (0.605 mL, 6.314 mmol) with the reaction stirred at rt 
for 18 h, the crude product was prepared as a pale yellow oil . Column chromatography on 
silica using 4:1 petroleum ether (b.p.40-60 °C)/ethyl acetate as the eluent yielded 277 as a 
colourless oil (1.784 g, 5.166 mmol, 90%). [ a ]D21 - 27° (c 1.00, CHC13 ) ;  !H NMR 
(CDC13, 300 MHz): 8 1.11 (3H, d, J  7.0 Hz, C H C //3), 1.30 (3H, s, CH/),  1.32 (3H, s, 
C //3), 1.61 (3H, d, J  1.5 Hz, C =C (C //3)(CH3)), 1.65 (3H, d, J  1.0, C=C(CH3)(C //3)), 2.83 
(1H, dd, J  14.0, 9.5 Hz, C //AHBAr), 2.98 (1H, dd, J  14.0, 4.0 , CHA/ / BAr), 3.86 (1H, dq, J
5.0, 7.0 Hz, C //C H 3), 4.45 (1H, dd, J  9.5, 4.0 Hz, CHN), 4.53 (1H, dd, J  8.5, 5.0 Hz, 
C//O H ), 5.17 (1H, dm, J  8.5Hz, //C=C), 7.13-7.27 (5H, br. m, ArH)\ 13C NM R (CDC13,
75.5 MHz): 5 12.6 (CH3), 18.8 (CH3), 22.5 (CH3), 26.4 (CH3), 28.6 (CH3), 35.9 (CH2), 43.4 
(CH), 63.8 (CH), 69.9 (CH), 82.6 (C), 124.5 (CH), 127.3 (CH), 129.0 (CH), 129.5 (CH), 
137.1 (C), 137.2 (C), 153.0 (C =0), 176.7 (C =0); IR (thin film) v max (cm '1): 3479 (broad 
O-H), 1769 (C =0), 1681 (C =0); MS (CI+, NH3) m/z (%) 363 (19) [M+NH4] \  346 (20) 
[M+H]+, 328 (100) [M -H 20]+, 279 (75), 223 (42), 102 (97); HRMS (ES+) for C20H27NO4 




According to General Procedure 17, employing aldol 277 (200 mg, 0.579 mmol) in benzene 
(8.0 mL), VO(acac)2 (31.0 mg, 0.116 mmol) and f-BuOOH (0.12 mL, 5.5 M, 0.637 mmol), 
crude 284 was prepared. Purification via recrystallisation (Et2 0 , Hexane) gave 284 (153 
mg, 0.442 mmol, 73% yield, >95% de). mp decomposed >50 °C; [<x] d 25 -10 (c 0.48, 
CH2C12); *H NM R (Benzene-d6, 300 MHz): 5 0.85 (3H, s, epoxide-C //3), 0.86 (3H, s, 
epoxide-C //3), 1.03 (3H, s, CH3), 1.17 (3H, s, C //3), 1.25 (1H, d, J  7.0 Hz, CH3CH), 2.36 
(1H, obs. d, J  4.0 Hz, OH), 2.37 (1H, obs. dd, J  14.5, 9.5 Hz, CHA/ / BPh), 2.88 (1H, dd, J
14.5, 4.0 Hz, C7/AHBPh), 3.00 (1H, d, J  7.0 Hz, epoxide-C//), 3.80 (1H, m, CHCH3), 4.33 
(1H, dd, J  9.5, 4.0 Hz, CHN), 4.41 (1H, dd, J  7.0, 5.5 Hz, CHOU), 7.23-6.96 (5H, m, Ph); 
13C NMR (Benzene-d6, 75.5 MHz): 5 12.9 (CH3), 19.9 (CH3), 22.2 (CH3), 25.2 (CH3),
28.2 (CH3), 35.7 (CH2), 42.1 (CH), 59.6 (CH), 64.1 (CH), 65.5 (C), 71.4 (CH), 82.1 (C),
127.3 (CH), 129.2 (CH), 129.8 (CH), 137.9 (C), 152.9 (C =0), 175.3 (C =0): IR (K B r/c m ' 
*) 3466 (broad O-H), 1776 (C =0), 1693 (C =0); HRMS: no molecular ion found.
(35,45,5/?)-dihydro-4-hydroxy-5-(2-hydroxypropan-2-yl)-3-methylfuran-2(3H)-one,
278
According to General Procedure 17, employing aldol 277 (200 mg, 0.579 mmol) in benzene 
(8.0 mL), VO(acac)2 (31.0 mg, 0.116 mmol) and /-BuOOH (0.12 mL, 5.5 M, 0.637 mmol) 
but stirring for 12 hours, the crude lactone was prepared. Recrystallisation (ether) afforded 
(35,45,5/?)-dihydro-4-hydroxy-5-(2-hydroxypropan-2-yl)-3-methylfuran-2(3H)-one
278 (76 mg, 0.434 mmol, 75%) as a pale yellow solid, m.p. 71 -  72 °C; [cc]D21 16 0  (c
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0.19, CHC13 ); ]H NMR (CDC13, 300 MHz): 8 1.31 (3H, d, J  7.0 Hz, CH3), 1.33 (6H, s, 2 
x C //3), 2.68 (1H, m, C //C H 3), 3.96 (1H, d, J  7.0 Hz, C //C (C H 3)2OH), 4.18 (1H, app. t, J
7.0 Hz, C //O H ); 13C NMR (CDC13, 75.5 MHz): 8 11.4 (CH3), 24.7 (CH3), 25.0 (CH3), 42.8 
(CH), 69.6 (C), 73.4 (CH), 86.7 (CH), 175.16 (C =0); IR (KBr disc) v max (cm '1): 3356 
(broad OH), 1758 (C =0); MS (CI+, NH3) m/z (%) 192 (100) [M+NH4]+, 115 (27), 52 (56); 
HRMS (ES+) for C8H i40 4 [M+NH4]+ Calc. 192.1230, Found 192.1231.
(S)-4-Benzyl-3-((2S,3/?)-3-hydroxy-2-methyl-hex-4-enoyl)-5,5-dimethyl-oxazolidin-2- 
one, 279
According to General Procedure 5 using A-acyl SuperQuat oxazolidinone (S)-230 (1.00 g,
3.827 mmol), 9-BBN-OTf (8.419 mL, 0.5 M, 4.209 mmol), DIPEA (0.799 mL, 4.593 
mmol) and crotonaldehyde (0.349 mL, 4.209 mmol) with the reaction stirred at rt for 18 h, 
the crude product was prepared as a dark yellow oil. Column chromatography on silica 
using 4:1 petroleum ether (b.p.40-60 °C)/ethyl acetate as the eluent yielded 279 as a 
colourless oil ( 1.1726 g, 3.538 mmol, 93%). [ a ]D21 -22 0 (c 1.00, CHC13 ); *H NMR 
(CDCI3, 300 MHz): 8 1.06 (3H, d, J  7.0 Hz, C H C //3), 1.29 (3H, s, CH3), 1.30 (3H, s, 
CH3), 1.61 (3H, ddd, J  6.5, 1.5, 1.0 Hz, C=CUCH3), 2.49 (1H, br. s, OH), 2.82 (1H, dd, J
14.0, 9.5 Hz, C T / a H b A t ) ,  2.97 (1H, dd, J  14.0, 4.0 Hz, CHA/ / BAr), 3.82 (1H, dq, J  4.5, 7.0 
Hz, CHCH3), 4.26 (1H, m, C//OH), 4.44 (1H, dd, J  9.5, 4.0 Hz, CHN), 5.39 (1H, ddq, J
15.5, 6.5, 1.5 Hz, HC=CHCH3), 5.65 (1H, dqd, J  15.5, 6.5, 1.0 Hz, H C =C //C H 3), 7.11-7.25 
(5H, br. m, Ar//) ; 13C NMR (CDC13, 75.5 MHz): 8 12.2 (CH3), 18.2 (CH3), 22.5 (CH3),
28.7 (CH2), 35.9 (CH2), 43.2 (CH), 63.8 (CH), 73.6 (CH), 82.7 (C), 127.3 (CH), 128.9 
(CH), 128.1 (CH), 129.5 (CH), 130.6 (CH), 137.1 (C), 152.9 (C =0), 176.9 (C =0); IR (thin 
film) v max (cm '1): 3497 (broad O-H), 1777 (C =0), 1697 (C =0); MS (CI+, NH3) m/z (%) 




According to General Procedure 17, employing aldol 279 (200 mg, 0.61 mmol) in benzene 
(8 mL), VO(acac)2 (33.0 mg, 0.122 mmol) and r-BuOOH (0.12 mL, 5.5 M, 0.67 mmol), the 
crude lactone was prepared. Column chromatography afforded 280 (37.1 mg, 0.24 mmol, 
38% yield, >95% de) as a colourless oil. *H NMR (cU-MeOD, 300 MHz): 5 1 .1 5 (3 H ,d ,7
7.0 Hz, CH3), 1.53 (3H, d, J  7.0 Hz, C //3CHOH), 2.63 (1H, m, CHCH3), 3.92 (2H, m, 
C //O H , CHO ), 4.14 (1H, m, (CH3)C7/OH); 13C NM R (d4-MeOD, 75.5 MHz): 5 14.3 
(CH3), 22.4 (CH3), 44.7 (CH), 65.7 (CH), 82.7 (CH), 87.5 (CH), 180.0 (C =0); IR (thin 




According to General Procedure 5 using A-acyl SuperQuat oxazolidinone (S)-230 (1.000 g,
3.827 mmol), 9-BBN-OTf (8.419 mL, 0.5 M, 4.209 mmol), DIPEA (0.799 mL, 4.593 
mmol) and frans-cinnamaldehyde (0.531 mL, 4.209 mmol) with the reaction stirred at room 
temperature for 18 h, the crude product was prepared as a pale yellow solid . 
Recrystallisation (petroleum ether (b.p.40-60 °C)/ethyl acetate) yielded 281 as a colourless 
crystalline solid (1.325 g, 3.367 mmol, 88%). m.p. 148-149 °C ; [a ]D21 4 0 (c 1.1, 
CH2CI2) ; *H NM R (CDC13, 300 MHz): 8 1.13 (3H, d, J  7.0 Hz, C H C //3), 1.25 (3H, s, 
CH3), 1.33 (3H, s, CH3), 2.78 (1H, d, J  2.0 Hz, OH), 2.85 (1H, dd, J  14.0, 9.5 Hz, 
C //AHBAr), 3.00 (1H, dd, J  14.0, 4.0 Hz, CHA/ / BAr), 3.93 (1H, dq, J  4.0, 7.0 Hz, C //C H 3), 
4.48 (1H, dd, J  9.5, 4.0 Hz, CHN), 4.55 (1H, m, C //O H ), 6.12 (1H, dd, J  16.0, 6.0 Hz,
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HC=CHAr), 6.59 (1H, dd, J  16.0, 1.5 Hz, HC=C//Ar), 7.13-7.33 (10H, br. m, ArH ) ; 13C 
NMR (CDC13, 75.5 MHz): 6 12.1 (CH3), 22.6 (CH3), 28.7 (CH3), 35.9 (CH2), 43.3 (CH),
63.7 (CH), 73.3 (CH), 82.8 (C), 126.9 (CH), 127.3 (CH), 128.1 (CH), 128.9 (CH), 129.0 
(CH), 129.1 (CH), 129.5 (CH), 131.9 (CH), 135.2 (C), 136.9 (C), 152.8 (C =0), 177.0 
(C =0); IR (KBr) v max (cm '1): 3510 (broad O-H), 1771 (C =0), 1674 (C =0); MS (CI+, 
NH3) m/z (%) 393 (80), 395 (57), 411 (100) [M+NH4]+; HRMS (ES+) for C24H27NO4 




According to general procedure 5, employing A-propionyl-oxazolidin-2-one (S)-230 
(1.300g, 4.974 mmol) in DCM (60 mL), 9-BBN-OTf (10.94 mL, 0.5 M, 5.471 mmol), 
1Pr2NEt (1.040 mL, 5.969 mmol) and methacrolein (0.492 mL, 5.969 mmol), the crude 
product was prepared as a yellow oil. Purification via column chromatography afforded
(S)-4-benzyl-3-((21S,3‘5)-3-hydroxy-2,4-dimethyl-pent-4-enoyl)-5,5-dimethyl- 
oxazolidin-2-one 282 (1.467 g, 4.427 mmol, 89%) as a colourless oil. [a ]D21 - 33 0 (c
1.05, CHC13) ; ’H NMR (CDC13, 300 MHz): 8 1.04 (3H, d, J  7.2, C H C //3), 1.29 (3H, s, 
CH3), 1.31 (3H, s, CH3), 1.65 (3H, s, C(=C)CH 3), 2.83 (1H, dd, J  14.0, 9.5, C //AHBAr), 
2.99 (1H, dd, J  14.0, 4.0, CHA/ / BAr), 3.91 (1H, dq, J  4.0, 7.0, CHCH3), 4.28 (1H, d, J  4.0, 
C //O H ), 4.45 (1H, dd, J  9.5, 4.0, CHN), 4.86 (1H, br. s, C = C //AH B), 5.00 (1H, br. s, 
C=CHA/ / B), 7.11-7.25 (5H, br. m, A r//); ,3C NM R (CDC13, 75.5 MHz): 8 11.1 (CH3),
19.6 (CH3), 22.6 (CH3), 28.8 (CH3), 35.7 (CH2), 40.8 (CH), 63.8 (CH), 74.7 (CH), 82.8 (C),
112.3 (CH2), 127.3 (CH), 129.1 (CH), 129.6 (CH), 137.1 (C), 144.4 (C), 152.7 (C =0),
177.3 (C =0) ; IR (thin film ) v max (cm '1): 3516 (broad O -H ), 1777 (C =0), 1693 (C =0); 
MS (CI+, NH3) m/z (%) 332 (40) [M + H f, 279 (100), 262 (83), 223 (89); HRMS (ES+) for 
C19H25NO4 [M+H]+ Calc. 332.1856, Found 332.1856.
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(3S,4S,5S)-dihydro-4-hydroxy-5-(hydroxymethyl)-3,5-dimethylfuran-2(3H)-one, 283
According to General Procedure 17, employing aldol 282 (200.00 mg, 0.603 mmol) in 
benzene (8.0 mL), VO(acac)2 (32.0 mg, 0.121 mmol) and r-BuOOH (0.12 mL, 5.5 M, 0.663 
mmol) the crude lactone was prepared. Recrystallisation (ether) afforded (35,4S,55)- 
dihydro-4-hydroxy-5-(hydroxymethyl)-3,5-dimethylfuran-2(3H)-one 283 (67.6 mg, 
0.422 mmol, 70%) as a white crystalline solid (plates), m.p. 105-106 °C; [ cx] d 21 -27.2 0 (c 
0.85, CHC13); *H NMR (D20 ,  300 MHz): 1.29 (3H, d, J  7.3 Hz, CHCH3), 1.42 (3H, s, 
C C //3), 3.04 (1H, dq, J  9.5, 7.0 Hz, C //C H 3), 3.71 (1H, d, J  13.0 Hz, CHAHBOH), 3.94 
(1H, d, J  13.0 Hz, CHa/ / bOH), 4.11 (1H, d, J  9.5 Hz, C //O H ); 13C NMR (D20 ,  75.5 
MHz): 5 12.5 (CH3), 20.7 (CH3), 42.7 (CH), 63.5 (CH2), 80.0 (CH), 87.3 (C), 180.5 (C =0); 
IR (KBr disc) v max (cm '1): 3340 (broad OH), 2956, 1750 (C =0), 1440, 1320, 1170; MS 
(CI+, NH3) m/z (%) 178 (88 ) [M+NH4]+, 160 (19) [M+H]+, 130 (100); HRMS (ES+) for 
C7H 120 4 [M+NH4]+ Calc. 178.1074, Found 178.1074.
(2S,3S)-3-hydroxy-2-methyl-3-phenylpropanoic acid, 288
According to General Procedure 16 employing A-propionyl-oxazolidin-2-one resin 73a 
(200 mg, 0.95 mmol/g, 0.19 mmol), 9-BBNOTf (1.90 mL, 0.5 M, 0.95 mmol), ‘Pr2NEt 
(0.165 ml, 0.95 mmol) and benzaldehyde (0.135 mL, 1.33 mmol), aldol-functionalised 
resin 291 was prepared (not shown). LiOOH cleavage, according to General Procedure 9, 
employing the aldol-functionalised resin (0.19 mmol) preswollen in THF (4 mL), H20 2 
(0.18 mL, 1.90 mmol) and LiOH (39.9 mg, 0.95 mmol) dissolved in 0.5 mL H20 ,  afforded
(2S,3S)-3-hydroxy-2-methyl-3-phenylpropanoic acid 288 as a colourless oil (19.9 mg, 
0.11 mmol, 58%). [cc]D21 -29.0 0 (c 1.0, CHC13); lH NMR (CDC13, 300 MHz): 5 1.12 (3H,
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d, J  7.0 Hz, CH3), 2.81 (1H, dq, J  4.0, 7.0 Hz, C //C H 3), 5.16 (1H, d, J  4.0 Hz, C //O H ), 
7.24-7.36 (5H, br. m, Artf); 13C NMR (CDC13, 75.5 MHz): 5 10.2 (CH3), 46.2 (CH), 73.5 
(CH), 125.9 (CH), 127.8 (CH), 129.3 (CH), 140.9 (C), 180.6 (C =0). Spectroscopic data
c o
identical to literature compound.
(2,S,3/?)-3-hydroxy-2,4-dimethyIpentanoic acid, 289
Accordng to General Procedure 16, employing jV-propionyl-oxazolidin-2-one resin 73a 
(200 mg, 0.95 mmol/g, 0.19 mmol), 9-BBNOTf (1.90 mL, 0.5 M, 0.95 mmol), iPr2NEt 
(0.165 ml, 0.95 mmol) and isobutyraldehyde (0.121 mL, 1.33 mmol), aldol-functionalised 
resin was prepared (not shown). LiOOH cleavage, according to General Procedure 9, 
employing the aldol-functionalised resin preswollen in THF (4 mL), H2O2 (0.18 mL, 1.90 
mmol) and LiOH (39.9 mg, 0.95 mmol) dissolved in 0.5 mL H20 ,  afforded (2S,3J?)-3- 
hydroxy-2,4-dimethylpentanoic acid 289 as a colourless oil (17.5 mg, 0.120 mmol, 63%). 
[oc]D21 -9.5 0 (c 0.5, CHC13); *H NMR (CDC13, 300 MHz): 6 0.85 (3H, d, J  7.0 Hz, CH3), 
0.98 (3H, d, J  7.0 Hz, CH3), 1.17 (3H, d, J  7.0 Hz, CHCH3), 1.67 (1H, m, CH(CH 3)2), 2.65 
(1H, dq, J  3.5, 7.0 Hz, C O C //C H 3), 3.59 (1H, dd, J  7.5, 3.5 Hz, C //O H ), 4.65 (1H, br. s, 
OH)- 13C NM R (CDC13, 75.5 MHz): 5 14.3 (CH3), 17.1 (CH3), 19.6 (CH3), 30.9 (CH), 40.9 
(CH), 77.6 (CH), 180.4 (C =0). Spectroscopic data identical to literature com pound .58
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(2S,3R)-3-cyclohexyl-3-hydroxy-2-methylpropanoic acid, 290
According to General Procedure 16, employing A-propionyl-oxazolidin-2-one resin 73a 
(200 mg, 0.95 mmol/g, 0.19 mmol), 9-BBNOTf (1.90 mL, 0.5 M, 0.95 mmol), ‘P^N E t 
(0.165 ml, 0.95 mmol) and cyclohexanecarboxaldehyde (0.161 mL, 1.33 mmol), aldol- 
functionalised resin was prepared (not shown). LiOOH cleavage, according to General 
Procedure 9, employing the aldol-functionalised resin preswollen in THF (4 mL), H2O2 
(0.18 mL, 1.90 mmol) and LiOH (39.9 mg, 0.95 mmol) dissolved in 0.5 mL H2O, afforded 
(2S,3/?)-3-cyclohexyl-3-hydroxy-2-methylpropanoic acid 290 as a colourless oil (23.3 
mg, 0.126 mmol, 66%). [a ]D21-8 0 (c 1.1, CH2C12); *H NMR (CDC13, 300 MHz): 61.13 
(3H, d, J  7.0 Hz, C //3), 1.36-1.76 (10H, br. m, (CH2)s \  2.75 (1H, dq, J  7.0, 3.0 Hz, 
CHCH3), 3.67 (1H, dd, J  8.5, 3.0 Hz, C //O H ); 13C NMR (CDC13, 75.5 MHz): 5 9.9 (CH3),
26.2 (CH2), 26.4 (CH2), 26.6 (CH2), 29.3 (CH2), 29.7 (CH2), 40.4 (CH), 41.5 (CH), 76.1
1 OR(CH), 182.3 (C). Spectroscopic data identical to literature compound.
(2S,3/?)-3-hydroxy-2-methyldecanoic acid, 291
According to General Procedure 16, employing A-propionyl-oxazolidin-2-one resin 73a 
(200 mg, 0.95 mmol/g, 0.19 mmol), 9-BBNOTf (1.90 mL, 0.5 M, 0.95 mmol), iPr2NEt 
(0.165 ml, 0.95 mmol) and octylaldehyde (0.207 mL, 1.33 mmol), aldol-functionalised 
resin was prepared (not shown). LiOOH cleavage, according to General Procedure 9, 
employing the aldol-functionalised resin preswollen in THF (4 mL), H2O2 (0.18 mL, 1.90 
mmol) and LiOH (39.9 mg, 0.95 mmol) dissolved in 0.5 mL H2O, afforded (2S,3R)-3- 
hydroxy-2-methyldecanoic acid 291 as a colourless oil (19.2 mg, 0.095 mmol, 50%). 
[ a ]D21 + 15° (c 0.96, CHCI3) ; *H NMR (CDC13, 300 MHz): 6 0.86 (3H, t, J  7.0 Hz, 
CH2C //3), 1.15 (3H, d, J  7.0 Hz, C H C //3), 1.17-1.52 (12H, m, (C //2)6CH3), 2.51 ( 1H, dd, J
7.0, 3.0 Hz, CHCH3), 3.89 (1H, m, C //O H ); 13C NMR (CDC13, 75.5 MHz): 6 10.7 (CH3),
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14.5 (CH3), 23.0 (CH2), 26.4 (CH2), 29.5 (CH2), 29.6 (CH2), 32.2 (CH2), 34.0 (CH2), 44.4 
(CH), 72.1 (CH), 180.9 (C); IR (thin film) v max (cm '1): 3400 (broad O-H), 1709 (C =0); 




According to General Procedure 16, employing A-propionyl-oxazolidin-2-one resin 73a 
(500 mg, 0.90 mmol/g, 0.45 mmol), 9-BBNOTf (4.5 mL, 0.5 M, 2.25 mmol), ‘Pr2NEt 
(0.391 ml, 2.25 mmol) and fram'-cinnamaldehyde (0.397 mL, 3.15 mmol), aldol- 
functionalised resin 292 was prepared (not shown). NaBFU cleavage, according to General 
Procedure 11, employing functionalised resin 292 (200 mg, 0.90 mmol/g, 0.18 mmol) 
preswollen in 4ml THF and NaBH4 (34.0 mg, 0.90 mmol) dissolved in 0.5 mL water, 
afforded (£',2/?,3/?)-2-niethyl-5-phenylpent-4-ene-l,3-diol 293 (22.5 mg, 0.117 mmol, 
65%) as a colourless oil. [<x]D25 11 0 (c 0.18, CHC13); *H-NMR (CDC13, 300MHz): 5 0.96 
(3H, d, J  7.0 Hz, C //3), 2.06 (1H, m, C //C H 3), 2.15 (2H, s, 2 x OH), 3.74 (2H, m, C //2OH), 
4.50 (1H, m, CHOU), 6.30 (1H, dd, J  16.0, 6.2 Hz, HC=CH), 6.64 (1H, d, J  16.0 Hz, 
HC=CH), 7.23 -  7.43 (5H, br. m, ArH)\ 13C NMR (CDC13, 75.5 MHz): 5 11.8 (CH3), 40.6 
(CH), 66.8  (CH2), 78.8 (CH), 126.8 (CH), 128.0 (CH), 129.0 (CH), 130.0 (CH), 131.5 
(CH), 142.7 (C); HRMS (ES+) for C i2Hi60 2 [M+NH4]+ Calc. 210.1489, Found 210.1489. 
Spectroscopic data identical to literature com pound .129
(l/?,2/?)-2-m ethyl-l-((lS,2S)-2-phenylcyclopropyl)-propane-l,3-diol, 294
OH
Aldol functionalised resin 292 (200mg, 0.9mmol/g, 0.18 mmol) loose in a foil-wrapped 
flask, was preswollen in DCM (6 mL) and cooled to -10 °C. Diethyl zinc (0.90 ml, 1.0 M, 
0.90 mmol) was added, followed immediately by diiodomethane (0.725 mL, 0.90 mmol). 
The reaction was agitated on an orbital shaker for 2 hours, with the temperature allowed to
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warm slowly to 0 °C. After this time, the resin was washed thoroughly with DCM and 
DCM /  MeOH and then dried thoroughly in a vacuum oven at 40 °C. NaBH* cleavage, 
according to General Procedure 11, employing functionalised resin (200 mg, 0.90 mmol/g, 
0.18 mmol) preswollen in 4ml THF and NaBH 4  (34.0 mg, 0.90 mmol) dissolved in 0.5 mL 
water, afforded (IR ,2/?)-2-m ethyl-l-((lS ,25)-2-phenylcyclopropyl)propane-l,3-d iol 294  
(27.1 mg, 0.131 mmol, 73%) as a white solid, m.p. 91 -  92 °C; [ oi] d 25 48 ° (c 1.0, CHCI3 ); 
‘H-NMR (CDCI3 , 300MHz): 5 0.92 (3H, d, J  7.0 Hz, CH3), 0.95 (2H, m, cyc-CH2), 1.27 
(1H, m, cyc-CH ), 1.74 (1H, m, cyc-CH), 1.97 (1H, m, CHCH3), 2.65 (2H, s, 2 x OH), 3.26 
(1H, dd, /  8.0, 3.5 Hz, CtfOH), 3.60 (1H, dd, J  10.5, 4.5 Hz, CHAHBOH), 3.69 (1H, dd, J
10.5, 7.0 Hz, CHa//bOH), 6.96-7.21 (5H, br. m, Artf); 13C NM R (CDC13, 75.5 MHz): 8
11.9 (CH3), 13.9 (CH2), 21.4 (CH), 26.7 (CH), 40.3 (CH), 67.0 (CH2), 78.8 (CH), 126.1 
(CH), 126.2 (CH), 128.8 (CH), 142.6 (C); IR (KBr disc) v max (cm'1): 3330 (broad O-H); 
MS (CI+, NH 3) m /z (%) 206 (100) [M+H]+, 188 (36) [M-H2 0 ] +; HRMS (ES+) for C i3 H i8 0 2  
[M+NH4 ]+ Calc. 224.1645, Found 224.1647.
(2R ,3S)-2-m ethyl-4-m ethylenehexane-l,3-diol, 296
OH
According to General Procedure 16, employing A-propionyl-oxazolidin-2-one resin 73a  
(500 mg, 0.90 mmol/g, 0.45 mmol), 9-BBNOTf (4.5 mL, 0.5 M, 2.25 mmol), ‘Pr2NEt 
(0.391 ml, 2.25 mmol) and 2-ethylacrolein (0.308 mL, 3.15 mmol), aldol-functionalised 
resin 295 was prepared (not shown). NaBKU cleavage, according to General Procedure 11, 
employing functionalised resin 295 (200 mg, 0.90 mmol/g, 0.18 mmol) preswollen in 4ml 
THF and NaBH 4  (34.0 mg, 0.90 mmol) dissolved in 0.5 mL water, afforded (2R,3S)-2- 
m ethyl-4-m ethylenehexane-l,3-d iol 296 (16.1 mg, 0.112 mmol, 62%) as a colourless oil.
[a ] D 2 5  -26 0  (c 0.8, CHCI3 ); !H-NMR (CDC13, 300MHz): 5 0.84 (3H, d, J  7.0 Hz, C H C//3 ),
1.05 (3H, t, J  7.0 Hz, CH2CH3), 1.80-2.08 (3H, br. m, CHCH3, CH2CH3), 2.64 (2H, br. s, 2 
x OH), 3.68 (2H, m, CHAHBOH), 4.28 (1H, d, J  3.0 Hz, C//OH), 4.92 (1H, br. s, 
C=CHaHb), 5.05 ( 1 H, br. s, C=CHa#b); 13C NMR (CDC 13, 75.5 MHz): 8  9.9 (CH3), 12.6 
(CH3), 25.6 (CH2), 37.7 (CH), 67.0 (CH2), 76.4 (CH), 108.5 (CH2), 152.4 (C); IR (thin
261
film) v max (cm'1): 3380 (broad O-H); MS (CI+, NH3) m/z (%) 162 (100) [M+NH4]+, 144
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A ppen d ix
X-ray crystal structure of (S)-4-(4-Benzyloxy-benzyl)-oxazolidin-2-one 103
The structure and stereochemistry of 103 were proven via X-ray crystallography, see Fig.i 
The asymmetric unit o f crystal 103 contains two crystallographically independent 
molecules, which display similar geometry differing only at the benzyloxy moiety.
k01sdb1
Fig i: X-ray crystal structure o f  both conformers o f  4-(4-Benzyloxy-benzyl)-oxazolidin-2-one 103



















Packing Motif of 4-(4-Benzyloxy-benzyl)-oxazolidin-2-one, 103
Fig ii clearly shows the com plem entary hydrogen-bonding between the carbonyl oxygen 
and the carbamate hydrogen.
Fig ii: P a c k i n g  M o t i f  o f  4 - ( 4 - B e n z y l o x y - b e n z y l ) - o x a z o l i d i n - 2 - o n e  103






















Max. and min. transmission
Refinement method
Data / restraints / parameters
Goodness-of-fit on F2
Final R indices [I>2D(I)]
R indices (all data)
Absolute structure parameter 
Largest diff. peak and hole
kOlsdbl






a = 11.8790(2)A a  = 90o 
b = 8.3820(1)A p = 103.183(1)0 






0.15 x 0.15 x 0.08 mm
2.97 to 27.44o
-15<=h<= 15; -10<=k<=10; -19<=1<=19 
28819
6512 [R(int) = 0.0731]
5417
0.996
0.9933 and 0.9866 
Full-matrix least-squares on F2 
6 5 1 2 /3 /3 8 6  
1.066
R l=  0.0390 wR2 = 0.0932 
R1 =0.0560 wR2 = 0.1069 
1.1(7)
0.299 and -0.347 eA-3
Note: Chirality of compound cannot be assigned with confidence from the X-ray data.
Hydrogen bonds with H..A < r(A) + 2.000 Angstroms and <DHA >110 deg.
D-H d(D-H) d(H..A) <DHA d(D..A) A
N l-H l 0.979 1.994 154.35 2.907 01 [ -x, y+1/2,-z+1 ]
N101-H101 0.912 2.005 158.04 2.871 O101 [ -x+1, y+1/2,-z+1 ]
xn
Table ii. Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(A2 x 103) for 1.U(eq) is defined as one third of the trace of the orthogonalized Uij tensor.
Atom X y z U(eq)
0 (1) -428(1) 1036(1) 4886(1) 35(1)
0 (2) 1342(1) 103(1) 5525(1) 31(1)
0(3) 1186(1) 3954(2) 9768(1) 43(1)
0 (101) 4576(1) 861(2) 4992(1) 42(1)
0 (102) 6383(1) 16(1) 5588(1) 37(1)
0(103) 6626(1) 3625(2) 9833(1) 43(1)
N (l) 1109(1) 2721(2) 5461(1) 26(1)
N(101) 6116(1) 2598(2) 5368(1) 31(1)
C(l) 581(1) 1316(2) 5258(1) 26(1)
C(2) 2421(1) 777(2) 6048(1) 30(1)
C(3) 2368(1) 2527(2) 5755(1) 26(1)
C(4) 2960(1) 3706(2) 6502(1) 31(1)
C(5) 2507(1) 3732(2) 7381(1) 29(1)
C(6) 2966(1) 2760(2) 8130(1) 34(1)
C(7) 2550(1) 2774(2) 8941(1) 35(1)
C(8) 1661(1) 3805(2) 9003(1) 31(1)
C(9) 1187(2) 4786(2) 8260(1) 38(1)
C(10) 1602(2) 4749(2) 7457(1) 36(1)
C (ll) 1588(2) 2902(2) 10519(1) 36(1)
C(12) 965(1) 3241(2) 11281(1) 31(1)
C(13) 1406(2) 2607(2) 12151(1) 37(1)
C(14) 831(2) 2799(2) 12856(1) 40(1)
0(15) -178(2) 3639(2) 12708(1) 41(1)
C(16) -635(2) 4300(3) 11849(1) 48(1)
C(17) -62(2) 4093(2) 11127(1) 42(1)
C (102) 5601(1) 1183(2) 5288(1) 31(1)
C(103) 7492(1) 746(2) 5978(1) 33(1)
C(104) 7374(1) 2473(2) 5643(1) 29(1)
C(105) 7934(1) 3699(2) 6370(1) 33(1)
C(106) 7551(1) 3656(2) 7278(1) 31(1)
0(107) 8219(1) 2900(2) 8059(1) 38(1)
C(108) 7887(1) 2899(2) 8899(1) 39(1)
C(109) 6872(1) 3662(2) 8969(1) 34(1)
C(110) 6183(2) 4398(2) 8200(1) 35(1)
C ( l l l ) 6530(1) 4389(2) 7360(1) 34(1)
C(112) 5556(2) 4261(2) 9910(1) 38(1)
C(113) 5396(1) 4026(2) 10887(1) 34(1)
C(114) 6099(2) 3023(2) 11515(1) 40(1)
C(115) 5898(2) 2829(2) 12404(1) 46(1)
C(116) 5000(2) 3636(2) 12662(1) 43(1)
C(117) 4317(2) 4651(2) 12032(1) 44(1)
C(118) 4514(2) 4841(2) 11154(1) 41(1)
Table iii. Bond lengths [A] and angles [o] for 1.
0(1)-C(1) 1.2221(18)
0(2)-C(2) 1.4518(19)
0 (3 )-C (ll) 1.414(2)
0(102)-C(102) 1.353(2)
0(103)-C(109) 1.3752(19)



















C( 102)-O( 102)-C( 103) 108.64(12)
C(l)-N(l)-C(3) 111.29(12)
0(1)-C(1)-N(1) 129.20(15)













0(101 )-C( 102)-O( 102) 120.69(15)
0 (  102)-C( 103)-C( 104) 105.32(12)
N(101)-C(104)-C(103) 99.82(13)
C( 106)-C( 105)-C( 104) 116.00(13)
C( 111 )-C( 106)-C( 105) 120.85(15)


























C( 117)-C( 118) 1.380(3)
C (8)-0(3)-C(ll) 117.35(13)
C( 109)-O( 103)-C( 112) 117.01(13)
C(102)-N(101)-C(104) 112.50(13)














N( 101 )-C( 102)-O( 102) 110.38(14)
N(101)-C(l 04)-C( 105) 113.69(13)
C( 105)-C( 104)-C( 103) 114.64(13)
C( 111 )-C( 106)-C( 107) 118.09(15)
C( 107)-C( 106)-C( 105) 121.05(15)
C(107)-C(108)-C(109) 119.70(15)




C( 118)-C( 113)-C( 114) 119.30(16) C( 118)-C( 113)-C( 112) 118.53(15)
C(114)-C(113)-C(112) 122.16(15) C( 113)-C( 114)-C( 115) 119.72(16)
C(116)-C(115)-C(114) 120.56(17) C(117)-C(116)-C(115) 119.02(17)
C( 118)-C( 117)-C( 116) 120.43(18) C( 117)-C( 118)-C( 113) 120.96(18)
Table iv. Anisotropic displacement parameters (A2 x 103) for 1. The anisotropic displacement 
factor exponent takes the form: -2 g p i2 [h 2  a*2 U11 + ... + 2  h k a *  b* U
Atom U l l U22 U33 U23 U13 U12
0 ( 1) 30(1) 34(1) 42(1) -7(1) 10( 1) -7(1)
0 (2) 35(1) 23(1) 36(1) -2(1) 14(1) 0(1)
0(3) 56(1) 48(1) 29(1) 8(1) 16(1) 10(1)
0 (101) 34(1) 37(1) 58(1) -10(1) 15(1) -8(1)
0 (102) 41(1) 23(1) 53(1) -1(1) 21(1) KD
0(103) 37(1) 63(1) 31(1) -4(1) 10(1) 7(1)
N (l) 26(1) 23(1) 29(1) KD 6(1) 0(1)
N(101) 29(1) 24(1) 40(1) 2(1) 7(1) - 1(1)
C (l) 32(1) 24(1) 28(1) -2(1) 16(1) - 1(1)
C(2) 31(1) 29(1) 32(1) 2(1) 10(1) 2(1)
C(3) 25(1) 28(1) 27(1) 0(1) 9(1) 0(1)
C(4) 28(1) 35(1) 32(1) -2(1) 10(1) -7(1)
C(5) 26(1) 31(1) 28(1) -6(1) 6(1) -6(1)
C(6) 28(1) 42(1) 31(1) -3(1) 5(1) 5(1)
C(7) 36(1) 39(1) 27(1) 2(1) 2(1) 4(1)
C(8) 34(1) 35(1) 26(1) 0(1) 9(1) -1(1)
C(9) 43(1) 39(1) 37(1) 6(1) 15(1) 13(1)
C (10) 42(1) 35(1) 31(1) 6(1) 10(1) 3(1)
C (ll) 39(1) 38(1) 32(1) 2(1) 8(1) KD
C(12) 34(1) 28(1) 33(1) -4(1) 10(1) -6(1)
C(13) 39(1) 33(1) 38(1) 2(1) 6(1) 2(1)
C(14) 52(1) 37(1) 32(1) -1(1) 10(1) -6(1)
C(15) 53(1) 37(1) 39(1) -7(1) 21(1) -7(1)
0(16) 42(1) 48(1) 57(1) KD 19(1) 11(1)
0(17) 43(1) 44(1) 37(1) 6(1) 5(1) 4(1)
C(102) 36(1) 26(1) 36(1) -4(1) 18(1) -KD
0(103) 36(1) 29(1) 38(1) 3(1) 16(1) 3(1)
C(104) 29(1) 31(1) 31(1) 2(1) 13(1) 2(1)
C(105) 30(1) 33(1) 38(1) KD 13(1) -6(1)
C(106) 30(1) 32(1) 34(1) -5(1) 10(1) -7(1)
C(107) 29(1) 46(1) 38(1) -4(1) 8(1) 4(1)
C(108) 33(1) 51(1) 31(1) -2(1) 3(1) 4(1)
C(109) 33(1) 39(1) 30(1) -6(1) 8(1) -5(1)
0 (110) 31(1) 37(1) 38(1) -2(1) 11(1) 0 (1)
C ( l l l ) 34(1) 35(1) 34(1) 1( 1) 8(1) -1(1)
0 (112) 33(1) 44(1) 37(1) -5(1) 8(1) -3(1)
C( 113) 34(1) 34(1) 35(1) -9(1) 9(1) -8(1)
C(114) 40(1) 41(1) 39(1) -9(1) 10(1) 2(1)
C(115) 53(1) 43(1) 40(1) -1(1) 4(1) 2(1)
xv
C(116) 52(1) 45(1) 33(1) -9(1) 13(1) -9(1)
C(117) 41(1) 51(1) 44(1) -10(1) 17(1) 0 (1)
C(118) 39(1) 44(1) 40(1) -5(1) 11(1) 0 (1)
Table v. Hydrogen coordinates (x 104) and isotropic displacement parameters (A2 x 103) for 1.
Atom X y z U(eq)
H(2A) 3092 236 5890 36
H(2B) 2480 678 6724 36
H(3) 2711 2640 5200 32
H(4A) 3795 3452 6673 38
H(4B) 2880 4791 6231 38
H(6) 3582 2061 8092 41
H(7) 2874 2086 9443 42
H(9) 574 5490 8302 46
H(10) 1266 5424 6951 43
H(11A) 2431 3046 10758 43
H(11B) 1447 1785 10307 43
H(13) 2114 2033 12266 44
H(14) 1140 2343 13448 48
H(15) -567 3770 13197 49
H(16) -1334 4893 11747 57
H(17) -378 4536 10532 50
H(10A) 8116 197 5756 40
H(10B) 7669 699 6665 40
H(104) 7705 2583 5082 35
H(10C) 8782 3541 6507 40
H(10D) 7772 4776 6097 40
H(107) 8914 2378 8014 45
H(108) 8351 2378 9424 47
H(110) 5482 4904 8244 42
H ( l l l ) 6058 4895 6833 41
H(11C) 4922 3723 9462 45
H(11D) 5527 5413 9759 45
H(114) 6716 2468 11343 48
H(115) 6381 2140 12835 56
H(116) 4857 3491 13263 51
H(117) 3707 5222 12204 53
H(118) 4037 5543 10728 49
H (l) 670 3685 5235 44(5)
H(101) 5714(14) 3513(19) 5183(12) 44(6)
xvi
X-ray crystal structure for Lactone 274























Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [l>2a(l)]
R indices (all data)
Absolute structure parameter 
Largest diff. peak and hole
refinement for 274







a = 5.4370(2)A a  = 90° 
b = 14.1610(6)A p = 101.723(2)° 






0.18 x 0.18 x 0.03 mm 
5.46 to 27.47°
-6<=h<=7; -18<=k<=18; -7<=l<=7 
8674




Full-matrix least-squares on F2
20 25 /1  / 116
1.149
R1 = 0.0554 wR2 = 0.0926 
R1 = 0.0679 wR2 = 0.0959 
0.3(13)
0.191 and-0.154 eA'3
Notes: absolute configuration assigned on basis of known stereochemistry at one chiral 
centre. Lattice dominated by hydrogen bonded sheets in ac plane.
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8  Sr* o>
Table ix. Anisotropic displacement parameters (A2 x 1(f) for 1. The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a*2 U11 + ... + 2 h k a* b* U
Atom U11 U22 U33 U23 U13 U12
0(1) 28(1) 40(1) 28(1) 0(1) 12(1) -5(1)
0(2) 38(1) 44(1) 31(1) -7(1) 11(1) -3(1)
0(3) 34(1) 71(1) 19(1) -2(1) 9(1) -13(1)
0(4) 33(1) 65(1) 20(1) -2(1) 9(1) -9(1)
C(1) 31(1) 43(1) 24(1) 0(1) 12(1) -1(1)
0(2) 28(1) 41(2) 22(1) -4(1) 3(1) -8(1)
0(3) 33(1) 42(2) 22(1) -2(1) 5(1) -12(1)
0(4) 31(1) 44(1) 19(1) -2(1) 5(1) -7(1)
0(5) 59(2) 43(2) 31(1) 5(1) 5(1) -5(1)
0(6) 34(1) 47(2) 26(1) 5(1) 13(1) -3(1)
0(7) 38(1) 44(2) 42(1) -3(1) 14(1) -8(1)
0(8) 57(2) 49(2) 39(1) -6(1) 17(1) -6(1)
Table x. Hydrogen coordinates (x 1(f) and isotropic displacement parameters (A2 x  103) 
for 1.
Atom X y z U(eq)
H(3) 3822 8436 14286 60(8)
H(4A) 2238 8224 7801 41(7)
H(3A) 5445 7238 10591 39
H(4) 7423 8644 13891 38
H(5A) 9903 7157 14124 67
H(5B) 8828 6297 12464 67
H(5C) 7289 6676 14311 67
H(6A) 2658 9506 9449 41
H(6B) 4312 9856 7662 41
H(7A) 7681 10581 10186 48
H(7B) 9185 10075 12464 48
H(8A) 5700 10286 14248 71
H(8B) 4172 10782 11963 71
H(8C) 6606 11285 13450 71
xix
